e10vk
UNITED STATES SECURITIES AND
EXCHANGE COMMISSION
Washington, D.C.
20549
Form 10-K
|
|
|
(Mark One)
|
|
|
þ
|
|
ANNUAL REPORT PURSUANT TO SECTION 13(a) OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934.
|
|
|
For the fiscal year ended
December 31, 2007
|
OR
|
o
|
|
TRANSITION REPORT PURSUANT TO SECTION 13(a) OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934.
|
|
|
For the transition period
from to
|
Commission file number:
001-33757
THE ENSIGN GROUP,
INC.
(Exact Name of Registrant as
Specified in Its Charter)
|
|
|
Delaware
|
|
33-0861263
|
(State or Other Jurisdiction
of
Incorporation or Organization)
|
|
(I.R.S. Employer
Identification No.)
|
|
|
|
27101 Puerta Real, Suite 450,
Mission Viejo, CA
(Address of Principal
Executive Offices)
|
|
92691
(Zip Code)
|
Registrants Telephone Number, Including Area Code:
(949)
487-9500
Securities registered pursuant to Section 12(b) of the
Act:
|
|
|
Title of Each Class
|
|
Name of Each Exchange on Which Registered
|
|
Common Stock, par value $0.001 per share
|
|
NASDAQ Global Select Market
|
Securities registered pursuant to Section 12(g) of the
Act:
None
Indicate by check mark if the registrant is a well-known
seasoned issuer, as defined in Rule 405 of the Securities
Act. o Yes þ No
Indicate by check mark if the registrant is not required to file
reports pursuant to Section 13 or Section 15(d) of the
Act. o Yes þ No
Indicate by check mark whether the registrant (1) has filed
all reports required to be filed by Section 13 or 15(d) of
the Securities Exchange Act of 1934 during the
preceding 12 months (or for such shorter period that
the registrant was required to file such reports), and
(2) has been subject to such filing requirements for the
past
90 days. þ Yes o No
Indicate by check mark if disclosure of delinquent filers
pursuant to Item 405 of
Regulation S-K
is not contained herein, and will not be contained, to the best
of the registrants knowledge, in definitive proxy or
information statements incorporated by reference in
Part III of this
Form 10-K
or any amendment to this
Form 10-K. þ
Indicated by check mark whether the registrant is a large
accelerated filer, an accelerated filer, a non-accelerated
filer, or a smaller reporting company. See the definitions of
large accelerated filer, accelerated
filer and smaller reporting company in Rule
12b-2 of the
Exchange Act. (Check one):
Large accelerated
filer o Accelerated
filer o Non-accelerated
filer þ Smaller
reporting
company o
(Do not check if a smaller reporting company)
Indicate by check mark whether the registrant is a shell company
(as defined in
Rule 12b-2
of the
Act). o
Yes þ
No
Our common stock began trading on the Nasdaq Global Select
Market on November 8, 2007. The aggregate market value of
the common stock held by non-affiliates of the registrant on
November 8, 2007 was approximately $118,331,200 based on
the initial public offering price of the registrants
common stock on November 8, 2007, of $16.00 per share.
Shares of common stock held by executive officers, directors and
holders of more than 5% of the outstanding common stock have
been excluded from this calculation because such persons or
institutions may be deemed affiliates. This determination of
affiliate status is not a conclusive determination for other
purposes.
On February 29, 2008, The Ensign Group, Inc. had
20,519,680 shares of Common Stock outstanding.
DOCUMENTS
INCORPORATED BY REFERENCE:
Part III of this
Form 10-K
incorporates information by reference from the Registrants
definitive proxy statement for the Registrants 2008 Annual
Meeting of Stockholders to be filed within 120 days after
the close of the fiscal year covered by this annual report.
THE
ENSIGN GROUP, INC.
INDEX TO
ANNUAL REPORT ON
FORM 10-K
For the Fiscal Year Ended December 31, 2007
TABLE OF
CONTENTS
i
CAUTIONARY
NOTE REGARDING FORWARD-LOOKING STATEMENTS
This Annual Report on
Form 10-K
contains forward-looking statements. Forward-looking statements
relate to future events or our future financial performance. We
generally identify forward looking statements by terminology
such as may, will, should,
expects, plans, anticipates,
could, intends, target,
projects, contemplates,
believes, estimates,
predicts, potential or
continue or the negative of these terms or other
similar words. These statements are only predictions. We have
based these
forward-looking
statements largely on our current expectations and projections
about future events and financial trends that we believe may
affect our business, results of operations and financial
condition. The outcome of the events described in these
forward-looking statements is subject to risks, uncertainties
and other factors described in Risk Factors in
Part I, Item 1A of this Annual Report on
Form 10-K.
Accordingly, you should not rely upon forward-looking statements
as predictions of future events. We cannot assure you that the
events and circumstances reflected in the forward-looking
statements will be achieved or occur, and actual results could
differ materially from those projected in the forward-looking
statements. The forward-looking statements made in this Annual
Report on
Form 10-K
relate only to events as of the date on which the statements are
made. We undertake no obligation to update any forward-looking
statement to reflect events or circumstances after the date on
which the statement is made or to reflect the occurrence of
unanticipated events. Unless the context otherwise requires, we
use the terms Ensign, the Company,
we, us and our in this
Annual Report on
Form 10-K
to refer to The Ensign Group, Inc. and its subsidiaries.
The Ensign Group, Inc. is a holding company. All of our
facilities are operated by separate,
wholly-owned,
independent subsidiaries that have their own management,
employees and assets. The use of we, us
and our throughout this annual report is not meant
to imply that our facilities are operated by the same entity. In
addition, one of our wholly-owned subsidiaries, which we call
our Service Center, provides centralized accounting, payroll,
human resources, information technology, legal, risk management
and other centralized services to each operating subsidiary
through contractual relationships between the Service Center and
such subsidiaries. We were incorporated in 1999 in Delaware. Our
corporate address is 27101 Puerta Real, Suite 450, Mission
Viejo, CA 92691, and our telephone number is
(949) 487-9500.
Our corporate website is located at www.ensigngroup.net.
The information contained in, or that can be accessed
through, our website does not constitute a part of this annual
report.
Ensigntm
is our United States trademark. All other trademarks and trade
names appearing in this annual report are the property of their
respective owners.
PART I.
Overview
We are a provider of skilled nursing and rehabilitative care
services through the operation of facilities located in
California, Arizona, Texas, Washington, Utah and Idaho. As of
December 31, 2007, we owned or leased 61 facilities. All of
our facilities are skilled nursing facilities, other than three
stand-alone assisted living facilities in Arizona and Texas and
four campuses that offer both skilled nursing and assisted
living services in California, Arizona and Utah. Our facilities,
each of which strives to be the facility of choice in the
community it serves, provide a broad spectrum of skilled
nursing, physical, occupational and speech therapies, and other
rehabilitative and healthcare services and, in certain
facilities, assisted living services, for both
long-term
residents and short-stay rehabilitation patients. Our facilities
have a collective capacity of over 7,400 skilled nursing,
assisted living and independent living beds. As of
December 31, 2007 we owned 26 of our facilities and
operated an additional 35 facilities under long-term lease
arrangements, and had purchase agreements or options to purchase
10 of those 35 facilities. For the years ended December 31,
2007, 2006 and 2005 our skilled nursing services, including our
integrated rehabilitative therapy services, generated
approximately 97% of our revenue.
1
Our organizational structure is centered upon local leadership.
We believe our organizational structure, which empowers leaders
and staff at the facility level, is unique within the skilled
nursing industry. Each of our facilities is led by highly
dedicated individuals who are responsible for key operational
decisions at their facilities. Facility leaders and staff are
trained and incentivized to pursue superior clinical outcomes,
operating efficiencies and financial performance at their
facilities. In addition, our facility leaders are enabled and
incentivized to share real-time operating data and otherwise
benchmark clinical and operational performance against their
peers in other facilities in order to improve clinical care,
maximize patient satisfaction and augment operational
efficiencies, promoting the sharing of best practices.
We view skilled nursing primarily as a local business,
influenced by personal relationships and community reputation.
We believe our success is largely dependent upon our ability to
build strong relationships with key stakeholders from the local
healthcare community, based upon a solid foundation of reliably
superior care. Accordingly, our brand strategy is focused on
encouraging the leaders and staff of each facility to focus on
clinical excellence, and promote their facility independently
within their local community.
Much of our historical growth can be attributed to our expertise
in acquiring under-performing facilities and transforming them
into market leaders in clinical quality, staff competency,
employee loyalty and financial performance. We plan to continue
to grow our revenue and earnings by:
|
|
|
|
|
continuing to grow our talent base and develop future leaders;
|
|
|
|
increasing the overall percentage or mix of
higher-acuity residents;
|
|
|
|
focusing on organic growth and internal operating efficiencies;
|
|
|
|
continuing to acquire additional facilities in existing and new
markets; and
|
|
|
|
expanding and renovating our existing facilities, and
potentially constructing new facilities.
|
Company
History
Our company was formed in 1999 with the goal of establishing a
new level of quality care within the skilled nursing industry.
The name Ensign is synonymous with a
flag or a standard, and refers to our
goal of setting the standard by which all others are measured.
We believe that through our efforts and leadership, we can
foster a new level of patient care and professional competence
at our facilities, and set a new industry standard for quality
skilled nursing and rehabilitative care services.
We have an established track record of successful acquisitions.
Many of our earliest acquisitions were completed at a time when
the skilled nursing industry was undergoing a major
restructuring. From 2001 to 2003, we acquired a number of
underperforming facilities, as several long-term care providers
disposed of troubled facilities from their portfolios. We then
applied our core operating expertise to turn these facilities
around, both clinically and financially. In 2004 and 2005, we
focused on the integration and improvement of our existing
operations while limiting our acquisitions to strategically
situated properties, acquiring five facilities over that period.
We organized our facilities into five portfolio companies in
2006, which we believe has enabled us to attract additional
qualified leadership talent, and to identify, acquire, and
improve facilities at a generally faster rate. With the
introduction of the new portfolio companies and our New Market
CEO program, described below, in early 2006, our acquisition
activity accelerated, allowing us to add 15 facilities between
January 1, 2006 and July 31, 2007. We then effectively
suspended our acquisition program while we effected our initial
2
public offering, which was completed in November 2007. (See
Recent Developments). The following
table summarizes our growth from our formation in 1999 through
December 31, 2007:
Cumulative
Facility Growth
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As of December 31,
|
|
|
|
1999
|
|
|
2000
|
|
|
2001
|
|
|
2002
|
|
|
2003
|
|
|
2004
|
|
|
2005
|
|
|
2006
|
|
|
2007
|
|
|
Cumulative number of facilities
|
|
|
5
|
|
|
|
13
|
|
|
|
19
|
|
|
|
24
|
|
|
|
41
|
|
|
|
43
|
|
|
|
46
|
|
|
|
57
|
|
|
|
61
|
|
Cumulative number of skilled nursing, assisted living and
independent living beds(1)
|
|
|
710
|
|
|
|
1,645
|
|
|
|
2,244
|
|
|
|
2,919
|
|
|
|
5,147
|
|
|
|
5,401
|
|
|
|
5,780
|
|
|
|
6,940
|
|
|
|
7,448
|
|
|
|
|
(1) |
|
Includes 671 beds in our 460 assisted living units and 84
independent living units as of December 31, 2007. The
cumulative number of skilled nursing, assisted living and
independent living beds is calculated using the current number
of beds at each facility and may differ from the number of beds
at the time of acquisition. We may also temporarily or
permanently expand or reduce the number of beds in connection
with renovations or expansions of specific facilities. All bed
counts are licensed beds except independent living beds, and may
not reflect the number of beds actually available for patient
use. |
Recent
Developments
Reorganization of Operations under Portfolio
Companies. To preserve our entrepreneurial
culture and the scalability of our leadership-centered
management model, we have created several portfolio companies,
each with its own president and resources. We believe that this
structure is allowing us to better maintain organizational and
individual development across our large and rapidly-growing
organization, while continuing to maintain our
one-facility-at-a-time focus, and to implement the
key principles that have contributed to our success to date. To
facilitate this internal reorganization, we formed the following
five separate portfolio companies in 2006:
|
|
|
|
|
The Flagstone Group, Inc., with 15 facilities and 1,792 licensed
beds(1) in Southern California;
|
|
|
|
Touchstone Care, Inc., with ten facilities and 1,208 licensed
beds(1) in the Los Angeles area and in Southern
Californias Inland Empire and Palm Springs markets;
|
|
|
|
Northern Pioneers Healthcare, Inc., with nine facilities and 812
licensed beds(1) in Northern California and Washington;
|
|
|
|
Keystone Care, Inc., with 15 facilities and 1,684 licensed
beds(1) in Texas, Utah and Idaho; and
|
|
|
|
Bandera Healthcare, Inc., with 12 facilities and 1,952 licensed
beds(1) in Arizona.
|
|
|
|
(1) |
|
All bed counts are licensed beds except for independent living
beds, and may not reflect the number of beds actually available
for patient use. |
As noted above, each of our portfolio companies has its own
president. These presidents, who are experienced and proven
leaders taken from the ranks of our facility CEOs, serve as
leadership resources within their own portfolio companies, and
have the primary responsibility for recruiting qualified talent,
finding potential acquisition targets, and identifying other
internal and external growth opportunities. We believe this
reorganization has improved the quality of our recruiting and
will continue to facilitate successful acquisitions.
New Market CEO Program. In order to broaden
our reach to new markets, and in and effort to provide existing
leaders in our company with the entrepreneurial opportunity and
challenge of entering a new market and starting a new business,
we established our New Market CEO program in 2006. Supported by
our Service Center and other resources, a New Market CEO
evaluates a target market, develops a comprehensive business
plan, and relocates to the target market to find talent and
connect with other providers, regulators and the
3
healthcare community in that market, with the goal of ultimately
acquiring facilities and establishing an operating platform for
future growth.
We believe that this program will not only continue to drive
growth, but will also provide a valuable training ground for our
next generation of leaders, who will have experienced the
challenges of growing and operating a new business.
Recent Acquisition History and Growth. Since
January 1, 2007, we added an aggregate of four facilities
located in Texas and Utah that we had not operated previously,
three of which we purchased and one of which we acquired under a
long-term lease arrangement with a purchase option. Three of
these acquisitions are skilled nursing facilities, and one
offers both skilled nursing and assisted living services. These
facilities contributed 508 licensed beds to our operations,
increasing our total capacity by 7%. In Texas, we have increased
our capacity since January 1, 2007 by 282 beds, or
approximately 32%. In Utah, we have increased our capacity since
January 1, 2007 by 226 beds, or 105%.
The following table sets forth the location and number of
licensed and independent living beds located at our facilities
as of December 31, 2007:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
CA
|
|
|
AZ
|
|
|
TX
|
|
|
UT
|
|
|
WA
|
|
|
ID
|
|
|
Total
|
|
|
Number of facilities
|
|
|
31
|
|
|
|
12
|
|
|
|
10
|
|
|
|
4
|
|
|
|
3
|
|
|
|
1
|
|
|
|
61
|
|
Skilled nursing, assisted living and independent living beds(1)
|
|
|
3,529
|
|
|
|
1,952
|
|
|
|
1,154
|
|
|
|
442
|
|
|
|
283
|
|
|
|
88
|
|
|
|
7,448
|
|
|
|
|
(1) |
|
Includes 671 beds in our 460 assisted living units and 84
independent living units as of December 31, 2007. All bed
counts are licensed beds except for independent living beds, and
may not reflect the number of beds actually available for
patient use. |
Industry
Trends
The skilled nursing industry has evolved to meet the growing
demand for post-acute and custodial healthcare services
generated by an aging population, increasing life expectancies
and the trend toward shifting of patient care to lower cost
settings. The skilled nursing industry has evolved in recent
years, which we believe has led to a number of favorable
improvements in the industry, as described below:
|
|
|
|
|
Shift of Patient Care to Lower Cost
Alternatives. The growth of the senior population
in the United States continues to increase healthcare costs,
often faster than the available funding from
government-sponsored healthcare programs. In response, federal
and state governments have adopted cost-containment measures
that encourage the treatment of patients in more cost-effective
settings such as skilled nursing facilities, for which the
staffing requirements and associated costs are often
significantly lower than acute care hospitals, inpatient
rehabilitation facilities and other post-acute care settings. As
a result, skilled nursing facilities are serving a larger
population of higher-acuity patients than in the past.
|
|
|
|
Significant Acquisition and Consolidation
Opportunities. The skilled nursing industry is
large and highly fragmented, characterized predominantly by
numerous local and regional providers. We believe this
fragmentation provides significant acquisition and consolidation
opportunities for us.
|
|
|
|
Improving Supply and Demand Balance. The
number of skilled nursing facilities has declined modestly over
the past several years. We expect that the supply and demand
balance in the skilled nursing industry will continue to improve
due to the shift of patient care to lower cost settings, an
aging population and increasing life expectancies.
|
|
|
|
Increased Demand Driven by Aging Populations and Increased
Life Expectancy. As life expectancy continues to
increase in the United States and seniors account for a higher
percentage of the total U.S. population, we believe the
overall demand for skilled nursing services will increase. At
present, the primary market demographic for skilled nursing
services is individuals age 75 and older. According to
U.S. Census Bureau Interim Projections, there were
38 million people in the
|
4
|
|
|
|
|
United States in 2007 that were over 65 years old. The
U.S. Census Bureau estimates this group is one of the
fastest growing segments of the United States population and is
expected to more than double between 2000 and 2030.
|
We believe the skilled nursing industry has been and will
continue to be impacted by several other trends. The use of
long-term care insurance is increasing among seniors as a means
of planning for the costs of skilled nursing services. In
addition, as a result of increased mobility in society,
reduction of average family size, and the increased number of
two-wage earner couples, more seniors are looking for
alternatives outside the family for their care.
Effects of Changing Prices. Medicare
reimbursement rates and procedures are subject to change from
time to time, which could materially impact our revenue.
Medicare reimburses our skilled nursing facilities under a
prospective payment system (PPS) for certain inpatient covered
services. Under the PPS, facilities are paid a predetermined
amount per patient, per day, based on the anticipated costs of
treating patients. The amount to be paid is determined by
classifying each patient into a resource utilization group (RUG)
category that is based upon each patients acuity level. As
of January 1, 2006, the RUG categories were expanded from
44 to 53, with increased reimbursement rates for treating higher
acuity patients. Should future changes in skilled nursing
facility payments reduce rates or increase the standards for
reaching certain reimbursement levels, our Medicare revenues
could be reduced, with a corresponding adverse impact on our
financial condition or results of operation.
The Deficit Reduction Act of 2005 (DRA) was expected to
significantly reduce net Medicare and Medicaid spending.
Prior to the DRA, caps on annual reimbursements for
rehabilitation therapy became effective on January 1, 2006.
The DRA provides for exceptions to those caps for patients with
certain conditions or multiple complexities whose therapy is
reimbursed under Medicare Part B and provided in 2006. The
Tax Relief and Health Care Act of 2006 extended the exceptions
through the end of 2007. The Medicare, Medicaid and SCHIP
Extension Act of 2007 extended these exceptions until
June 30, 2008.
On February 4, 2008, the Bush Administration released its
fiscal year 2009 budget proposal, which, if enacted, would
significantly reduce Medicare spending totaling
$182 billion over five years. Approximately 62% of the
proposed five-year reduction total results from reductions in
provider update factors, including a three-year freeze for
skilled nursing facilities followed by annual updates of the
inflation adjustment (or market basket) minus
0.65 percentage points indefinitely thereafter. Additional
proposals would reduce provider payments by phasing out bad debt
payments to skilled nursing facilities and imposing payment
adjustments for five conditions commonly treated in skilled
nursing facilities. Further, the proposed budget reiterates a
proposal offered in past years by establishing an automatic
annual 0.4 percent payment reduction that would take effect
absent other Congressional action if general fund expenditures
for Medicare exceed 45 percent. The budget also includes a
series of proposals having an affect on Medicaid. For example,
the budget proposes $18.2 billion in five-year savings from
Medicaid, more than half of which, $10.1 billion, would
come from reducing matching rates for administrative costs, case
management, family planning services, and qualifying individuals.
Historically, adjustments to reimbursement under Medicare have
had a significant effect on our revenue. For a discussion of
historic adjustments and recent changes to the Medicare program
and related reimbursement rates see Risk Factors
Risks Related to Our Industry Our revenue
could be impacted by federal and state changes to reimbursement
and other aspects of Medicaid and Medicare, Our
future revenue, financial condition and results of operations
could be impacted by continued cost containment pressures on
Medicaid spending, and If Medicare reimbursement
rates decline, our revenue, financial condition and results of
operations could be adversely affected. The federal
government and state governments continue to focus on efforts to
curb spending on healthcare programs such as Medicare and
Medicaid. We are not able to predict the outcome of the
legislative process. We also cannot predict the extent to which
proposals will be adopted or, if adopted and implemented, what
effect, if any, such proposals and existing new legislation will
have on us. Efforts to impose reduced allowances, greater
discounts and more stringent cost controls by government and
other payors are expected to continue and could adversely affect
our business, financial condition and results of operations.
5
Competition
The skilled nursing industry is highly competitive, and we
expect that the industry will become increasingly competitive in
the future. The industry is highly fragmented and characterized
by numerous local and regional providers, in addition to large
national providers that have achieved geographic diversity and
economies of scale. We also compete with inpatient
rehabilitation facilities and long-term acute care hospitals.
Competitiveness may vary significantly from location to
location, depending upon factors such as the number of competing
facilities, availability of services, expertise of staff, and
the physical appearance and amenities of each location. We
believe that the primary competitive factors in the skilled
nursing industry are:
|
|
|
|
|
ability to attract and to retain qualified management and
caregivers;
|
|
|
|
reputation and commitment to quality;
|
|
|
|
attractiveness and location of facilities;
|
|
|
|
the expertise and commitment of the facility management team and
employees;
|
|
|
|
community value, including amenities and ancillary
services; and
|
|
|
|
for private pay and HMO patients, price of services.
|
We seek to compete effectively in each market by establishing a
reputation within the local community as the facility of
choice. This means that the facility leaders are generally
free to discern and address the unique needs and priorities of
healthcare professionals, customers and other stakeholders in
the local community or market, and then create a superior
service offering and reputation for that particular community or
market that is calculated to encourage prospective customers and
referral sources to choose or recommend the facility.
Increased competition could limit our ability to attract and
retain patients, maintain or increase rates or to expand our
business. Some of our competitors have greater financial and
other resources than we have, may have greater brand recognition
and may be more established in their respective communities than
we are. Competing companies may also offer newer facilities or
different programs or services than we offer, and may therefore
attract individuals who are currently residents of our
facilities, potential residents of our facilities, or who are
otherwise receiving our healthcare services. Other competitors
may have lower expenses or accept lower margins than us and,
therefore, provide services at lower prices than we offer.
Our
Competitive Strengths
We believe that we are well positioned to benefit from the
ongoing changes within our industry. We believe that our ability
to acquire, integrate and improve our facilities is a direct
result of the following key competitive strengths:
Experienced and Dedicated Employees. We
believe that our employees are among the best in the skilled
nursing industry. We believe each of our facilities is led by an
experienced and caring leadership team, including a dedicated
front-line care staff, who participates daily in the clinical
and operational improvement of their individual facilities. We
have been successful in attracting, training, incentivizing and
retaining a core group of outstanding business and clinical
leaders to lead our facilities. These leaders operate their
facilities as separate local businesses. With broad local
control, these talented leaders and their care staffs are able
to quickly meet the needs of their patients and residents,
employees and local communities, without waiting for permission
to act or being bound to a one-size-fits-all
corporate strategy.
Unique Incentive Programs. We believe that our
employee compensation programs are unique within the skilled
nursing industry. Employee stock options and performance
bonuses, based on achieving target clinical quality and
financial benchmarks, represent a significant component of total
compensation for our facility leaders. We believe that these
compensation programs assist us in encouraging our facility
leaders and key employees to act with a shared ownership
mentality. Furthermore, our facility leaders are incentivized to
help local facilities within a defined cluster,
which is a group of geographically-proximate facilities that
share clinical best practices, real-time financial data and
other resources and information.
6
Staff and Leadership Development. We have a
company-wide commitment to ongoing education, training and
professional development. Accordingly, our facility leaders
participate in regular training. Most participate in training
sessions at Ensign University, our in-house educational system,
generally four or five times each year. Other training
opportunities are generally offered on a monthly basis. Training
and educational topics include leadership development, our
values, updates on Medicaid and Medicare billing requirements,
updates on new regulations or legislation, emerging healthcare
service alternatives and other relevant clinical, business and
industry specific coursework. Additionally, we encourage and
provide ongoing education classes for our clinical staff to
maintain licensing and increase the breadth of their knowledge
and expertise. We believe that our commitment to, and
substantial investment in, ongoing education will further
strengthen the quality of our facility leaders and staff, and
the quality of the care they provide to our patients and
residents.
Innovative Service Center Approach. We do not
maintain a corporate headquarters; rather, we operate a Service
Center to support the efforts of each facility. Our Service
Center is a dedicated service organization that acts as a
resource and provides centralized information technology, human
resources, accounting, payroll, legal, risk management,
educational and other key services, so that local facility
leaders can focus on delivering top-quality care and efficient
business operations. Our Service Center approach allows
individual facilities to function with the strength, synergies
and economies of scale found in larger organizations, but
without what we believe are the disadvantages of a top-down
management structure or corporate hierarchy. We believe our
Service Center approach is unique within the industry, and
allows us to preserve the
one-facility-at-a-time
focus and culture that has contributed to our success.
Proven Track Record of Successful
Acquisitions. We have established a disciplined
acquisition strategy that is focused on selectively acquiring
facilities within our target markets. Our acquisition strategy
is highly operations driven. Prospective facility leaders are
included in the decision making process and compensated as these
acquired facilities reach pre-established clinical quality and
financial benchmarks, helping to ensure that we only undertake
acquisitions that key leaders believe can become clinically
sound and contribute to our financial performance.
Since April 1999, we have acquired 61 facilities with over 7,400
beds, including 671 beds in our 460 assisted living units and 84
independent living units, through both long-term leases and
purchases. We believe our experience in acquiring these
facilities and our demonstrated success in significantly
improving their operations enables us to consider a broad range
of acquisition targets. In addition, we believe we have
developed expertise in transitioning newly-acquired facilities
to our unique organizational culture and operating systems,
which enables us to acquire facilities with limited disruption
to patients, residents and facility operating staff, while
significantly improving quality of care. We also intend to
consider the construction of new facilities as we determine that
market conditions justify the cost of new construction in some
of our markets.
Reputation for Quality Care. We believe that
we have achieved a reputation for high-quality and
cost-effective care and services to our patients and residents
within the communities we serve. We believe that our reputation
for quality, coupled with the integrated skilled nursing and
rehabilitation services that we offer, allows us to attract
patients that require more intensive and medically complex care
and generally result in higher reimbursement rates than lower
acuity patients.
Community Focused Approach. We view skilled
nursing care primarily as a local, community-based business. Our
local leadership-centered management culture enables each
facilitys nursing and support staff and leaders to meet
the unique needs of their residents and local communities. We
believe that our commitment to this
one-facility-at-a-time philosophy helps to ensure
that each facility, its residents, their family members and the
community will receive the individualized attention they need.
By serving our residents, their families, the community and our
fellow healthcare professionals, we strive to make each
individual facility the facility of choice in its local
community.
We further believe that when choosing a healthcare provider,
consumers usually choose a person or people they know and trust,
rather than a corporation or business. Therefore, rather than
pursuing a traditional organization-wide branding strategy, we
actively seek to develop the facility brand at the local level,
serving
7
and marketing
one-on-one
to caregivers, our residents, their families, the community and
our fellow healthcare professionals in the local market.
Attractive Asset Base. We believe that our
facilities are among the best-operated in their respective
markets. As of December 31, 2007, we owned 26 of the 61
facilities that we operated, and had purchase agreements or
options to purchase ten of the 35 facilities that we operated
under long-term lease arrangements. We will consider exercising
some or all of these purchase options as they become
exercisable, and we expect that we will own a higher percentage
of our facilities in the future than we currently own. Assuming
that we consummate our pending purchase agreement, we eventually
exercise all purchase options we currently hold and we
dont dispose of any of our current facilities, we would
own approximately 59% of the facilities we currently operate. By
owning our facilities, we believe we will have better control
over our occupancy costs over time, as well as increased
financial and operational flexibility. We continually invest in
our facilities, both owned and leased, to keep them physically
attractive and clinically sound.
Investment in Information Technology. We have
acquired information technology that enables our facility
leaders to access, and to share with their peers, both clinical
and financial performance data in real time. Armed with relevant
and current information, our facility leaders and their
management teams are able to share best practices and latest
information, adjust to challenges and opportunities on a timely
basis, improve quality of care, mitigate risk and improve both
clinical outcomes and financial performance. We have also
invested in specialized healthcare technology systems to assist
our nursing and support staff. We have installed automated
software and touch-screen interface systems in each facility to
enable our clinical staff to more efficiently monitor and
deliver patient care and record patient information. We believe
these systems have improved the quality of our medical and
billing records, while improving the productivity of our staff.
Our
Growth Strategy
We believe that the following strategies are primarily
responsible for our growth to date, and will continue to drive
the growth of our business:
Grow Talent Base and Develop Future
Leaders. Our primary growth strategy is to expand
our talent base and develop future leaders. A key component of
our organizational culture is our belief that strong local
leadership is a primary key to the success of each facility.
While we believe that significant acquisition opportunities
exist, we have generally followed a disciplined approach to
growth that permits us to acquire a facility only when we
believe, among other things, that we will have qualified
leadership for that facility. To develop these leaders, we have
a rigorous
Administrator-in-Training
Program that attracts proven business leaders from various
industries and backgrounds, and provides them the knowledge and
hands-on training they need to successfully lead one of our
facilities. As of December 31, 2007, 12 prospective
administrators were progressing through the various stages of
this training program, which is generally much more rigorous,
hands-on and intensive than the minimum 1,000 hours of
training mandated by the licensing requirements of most states
where we do business. Once administrators are licensed and
assigned to a facility, they continue to learn and develop in
our facility Chief Executive Officer Program, which facilitates
the continued development of these talented business leaders
into outstanding facility CEOs, through regular peer review, our
Ensign University and on-the-job training.
In addition, our facility Chief Operating Officer Program
recruits and trains highly-qualified Directors of Nursing to
lead the clinical programs in our facilities. Working together
with their facility CEO
and/or
administrator, other key facility leaders and front-line staff,
these experienced nurses manage delivery of care and other
clinical personnel and programs to optimize both clinical
outcomes and employee and patient satisfaction.
Increase Mix of High Acuity Patients. Many
skilled nursing facilities are serving an increasingly larger
population of patients who require a high level of skilled
nursing and rehabilitative care, whom we refer to as high acuity
patients, as a result of government and other payors seeking
lower-cost alternatives to traditional acute-care hospitals. We
generally receive higher reimbursement rates for providing care
for these patients. In addition, many of these patients require
therapy and other rehabilitative services, which we are able to
provide as part of our integrated service offerings. Where
therapy services are prescribed by a patients physician or
8
other healthcare professional, we generally receive additional
revenue in connection with the provision of those services. By
making these integrated services available to such patients, and
maintaining established clinical standards in the delivery of
those services, we are able to increase our overall revenues. We
believe that we can continue to attract high acuity patients and
therapy patients to our facilities by maintaining and enhancing
our reputation for quality care, continuing our community
focused approach, and strengthening our referral networks.
Focus on Organic Growth and Internal Operating
Efficiencies. We are able to grow organically
through our ability to increase patient occupancy within our
existing facilities. Although some of the facilities we have
acquired were in good physical and operating condition, the
majority have been clinically and financially troubled, with
some facilities having had occupancy rates as low as 30% at the
time of acquisition. Additionally, we believe that incremental
operating margins on the last 20% of our beds are significantly
higher than on the first 80%, offering real opportunities to
improve financial performance within our existing facilities, as
we seek to improve overall occupancy beyond our average rates
for the years ended December 31, 2007, 2006 and 2005 of
77.8%, 81.1% and 82.0%, respectively.
We also believe we can generate organic growth by improving
operating efficiencies and the quality of care at the patient
level. By focusing on staff development, clinical systems and
the efficient delivery of quality patient care, we believe we
are able to deliver higher quality care at lower costs than many
of our competitors.
We also have achieved incremental occupancy and revenue growth
by creating or expanding outpatient therapy programs in existing
facilities. Physical, occupational and speech therapy services
account for a significant portion of revenue in most of our
skilled nursing facilities. By expanding therapy programs to
provide outpatient services in many markets, we are able to
increase revenue while spreading the fixed costs of maintaining
these programs over a larger patient base. Outpatient therapy
has also proven to be an effective marketing tool, raising the
visibility of our facilities in their local communities and
enhancing the reputation of our facilities with short-stay
rehabilitation patients.
Add New Facilities and Expand Existing
Facilities. A key element of our growth strategy
includes the acquisition of existing facilities from third
parties, the expansion of current facilities, and the potential
construction of new facilities. In the near term, we plan to
take advantage of the fragmented skilled nursing industry by
acquiring facilities within select geographic markets and may
consider the construction of new facilities. In addition,
historically we have targeted facilities that we believed were
underperforming, and where we believed we could improve service
delivery, occupancy rates and cash flow. With experienced
leaders in place at the community level, and demonstrated
success in significantly improving operating conditions at
acquired facilities, we believe that we are well positioned for
continued growth. While the integration of underperforming
facilities generally has a negative short-term effect on overall
operating margins, these facilities are typically accretive to
earnings within 12 to 18 months following acquisition. For
the 34 facilities that we acquired from 2001 through the first
quarter of 2006, the aggregate EBITDAR (defined below) as a
percentage of revenue improved from 11.4% during the first full
three months of operations to 14.2% during the thirteenth
through fifteenth months of operations.
Labor
The operation of our skilled nursing and assisted living
facilities requires a large number of highly skilled healthcare
professionals and support staff. At December 31, 2007, we
had approximately 5,603 full-time equivalent employees,
employed by our Service Center and our operating subsidiaries.
For the year ended December 31, 2007, approximately 67% of
our total expenses were payroll related. Periodically, market
forces, which vary by region, require that we increase wages in
excess of general inflation or in excess of increases in
reimbursement rates we receive. We believe that we staff
appropriately, focusing primarily on the acuity level and
day-to-day needs of our patients and residents. In most of the
states where we operate, our skilled nursing facilities are
subject to state mandated minimum staffing ratios, so our
ability to reduce costs by decreasing staff, notwithstanding
decreases in acuity or need, is limited. We seek to manage our
labor costs by improving
9
staff retention, improving operating efficiencies, maintaining
competitive wage rates and benefits and reducing reliance on
overtime compensation and temporary nursing agency services.
The healthcare industry as a whole has been experiencing
shortages of qualified professional clinical staff. We believe
that our ability to attract and retain qualified professional
clinical staff stems from our ability to offer attractive wage
and benefits packages, a high level of employee training, an
empowered culture that provides incentives for individual
efforts and a quality of work environment.
In 2002, a majority of certain categories of service and
maintenance employees at one of our facilities voted to accept
union representation. We are currently involved in collective
bargaining with this union, but have not yet consummated a
collective bargaining agreement. With the exception of this
facility, to our knowledge the staff at our facilities that have
been approached to unionize have rejected union organizing
efforts. We consider our relationship with our employees to be
good and have never experienced a work stoppage.
Government
Regulation
The regulatory environment within the skilled nursing industry
continues to intensify in the amount and type of laws and
regulations affecting it. In addition to this changing
regulatory environment, federal, state and local officials are
increasingly focusing their efforts on the enforcement of these
laws. In order to operate our facilities we must comply with
federal, state and local laws relating to licensure, delivery
and adequacy of medical care, distribution of pharmaceuticals,
equipment, personnel, operating policies, fire prevention,
rate-setting,
billing and reimbursement, building codes and environmental
protection. Additionally, we must also adhere to anti-kickback
laws, physician referral laws, and safety and health standards
set by the Occupational Safety and Health Administration (OSHA).
Changes in the law or new interpretations of existing laws may
have an adverse impact on our methods and costs of doing
business.
Skilled nursing facilities are also subject to various
regulations and licensing requirements promulgated by state and
local health and social service agencies and other regulatory
authorities. Requirements vary from state to state and these
requirements can affect, among other things, personnel education
and training, patient and personnel records, facility services,
staffing levels, monitoring of patient wellness, patient
furnishings, housekeeping services, dietary requirements,
emergency plans and procedures, certification and licensing of
staff prior to beginning employment, and patient rights. These
laws and regulations could limit our ability to expand into new
markets and to expand our services and facilities in existing
markets.
Regulations Regarding Our
Facilities. Governmental and other authorities
periodically inspect our facilities to assess our compliance
with various standards. The intensified regulatory and
enforcement environment continues to impact healthcare
providers, as these providers respond to periodic surveys and
other inspections by governmental authorities and act on any
noncompliance identified in the inspection process. Unannounced
surveys or inspections generally occur at least annually, and
also following a government agencys receipt of a complaint
about a facility. We must pass these inspections to maintain our
licensure under state law, to obtain or maintain certification
under the Medicare and Medicaid programs, to continue
participation in the Veterans Administration program at some
facilities, and to comply with our provider contracts with
managed care clients at many facilities. From time to time, we,
like others in the healthcare industry, may receive notices from
federal and state regulatory agencies alleging that we failed to
comply with applicable standards. These notices may require us
to take corrective action, may impose civil monetary penalties
for noncompliance, and may threaten or impose other operating
restrictions on facilities such as admission holds, provisional
skilled nursing license or increased staffing requirements. If
our facilities fail to comply with these directives or otherwise
fail to comply substantially with licensure and certification
laws, rules and regulations, we could lose our certification as
a Medicare or Medicaid provider, or lose our state licenses to
operate the facilities.
Regulations Protecting Against Fraud. Various
complex federal and state laws exist which govern a wide array
of referrals, relationships and arrangements, and prohibit fraud
by healthcare providers. Governmental agencies are devoting
increasing attention and resources to such anti-fraud efforts.
The Health Insurance Portability and Accountability Act of 1996
(HIPAA), and the Balanced Budget Act of 1997 (BBA)
10
expanded the penalties for healthcare fraud. Additionally, in
connection with our involvement with federal healthcare
reimbursement programs, the government or those acting on its
behalf may bring an action under the False Claims Act, alleging
that a healthcare provider has defrauded the government. These
claimants may seek treble damages for false claims and payment
of additional civil monetary penalties. The False Claims Act
allows a private individual with knowledge of fraud to bring a
claim on behalf of the federal government and earn a percentage
of the federal governments recovery. Due to these
whistleblower incentives, suits have become more
frequent.
Regulations Regarding Financial
Arrangements. We are also subject to federal and
state laws that regulate financial arrangement by healthcare
providers, such as the federal and state anti-kickback laws, the
Stark laws, and various state referral laws.
The federal anti-kickback laws and similar state laws make it
unlawful for any person to pay, receive, offer, or solicit any
benefit, directly or indirectly, for the referral or
commendation for products or services which are eligible for
payment under federal healthcare programs, including Medicare
and Medicaid. For the purposes of the anti-kickback law, a
federal healthcare program includes Medicare and
Medicaid programs and any other plan or program that provides
health benefits which are funded directly, in whole or in part,
by the United States Government.
The arrangements prohibited under these anti-kickback laws can
involve nursing homes, hospitals, physicians and other
healthcare providers, plans and suppliers. These laws have been
interpreted very broadly to include a number of practices and
relationships between healthcare providers and sources of
patient referral. The scope of prohibited payments is very
broad, including anything of value, whether offered directly or
indirectly, in cash or in kind. Federal safe harbor
regulations describe certain arrangements that will not be
deemed to constitute violations of the anti-kickback law.
Arrangements that do not comply with all of the strict
requirements of a safe harbor are not necessarily illegal, but,
due to the broad language of the statute, failure to comply with
a safe harbor may increase the potential that a government
agency or whistleblower will seek to investigate or challenge
the arrangement. The safe harbors are narrow and do not cover a
wide range of economic relationships.
Violations of the federal anti-kickback laws can result in
criminal penalties of up to $25,000 and five years imprisonment.
Violations of the anti-kickback laws can also result in civil
monetary penalties of up to $50,000 and an assessment of up to
three times the total amount of remuneration offered, paid,
solicited, or received. Violation of the anti-kickback laws may
also result in an individuals or organizations
exclusion from future participation in Medicare, Medicaid and
other state and federal healthcare programs. Exclusion of us or
any of our key employees from the Medicare or Medicaid program
could have a material adverse impact on our operations and
financial condition.
In addition to these regulations, we may face adverse
consequences if we violate the federal Stark laws related to
certain Medicare physician referrals. The Stark laws prohibit a
physician from referring Medicare patients for certain
designated health services where the physician has an ownership
interest in or compensation arrangement with the provider of the
services, with limited exceptions. Also, any services furnished
pursuant to a prohibited referral are not eligible for payment
by the Medicare programs, and the provider is prohibited from
billing any third party for such services. The Stark laws
provide for the imposition of a civil monetary penalty of
$15,000 per service and exclusion from Medicare for any person
who presents or causes to be presented a bill or claim the
person knows or should know is submitted in violation of the
Stark laws. Such designated health services include physical
therapy services; occupational therapy services; radiology
services, including CT, MRI and ultrasound; durable medical
equipment and services; radiation therapy services and supplies;
parenteral and enteral nutrients, equipment and supplies;
prosthetics, orthotics and prosthetic devices and supplies; home
health services; outpatient prescription drugs; inpatient and
outpatient hospital services; clinical laboratory services; and,
effective January 1, 2007, diagnostic and therapeutic
nuclear medical services.
Regulations Regarding Patient Record
Confidentiality. We are also subject to laws and
regulations enacted to protect the confidentiality of patient
health information. For example, the U.S. Department of
Health and Human Services has issued rules pursuant to HIPAA,
which relate to the privacy of certain patient
11
information. These rules govern our use and disclosure of
protected health information. We have established policies and
procedures to comply with HIPAA privacy requirements at these
facilities. We believe that we are in compliance with all
current HIPAA laws and regulations.
Antitrust Laws. We are also subject to federal
and state antitrust laws. Enforcement of the antitrust laws
against healthcare providers is common, and antitrust liability
may arise in a wide variety of circumstances, including third
party contracting, physician relations, joint venture, merger,
affiliation and acquisition activities. In some respects, the
application of federal and state antitrust laws to healthcare is
still evolving, and enforcement activity by federal and state
agencies appears to be increasing. At various times, healthcare
providers and insurance and managed care organizations may be
subject to an investigation by a governmental agency charged
with the enforcement of antitrust laws, or may be subject to
administrative or judicial action by a federal or state agency
or a private party. Violators of the antitrust laws could be
subject to criminal and civil enforcement by federal and state
agencies, as well as by private litigants.
Environmental
Matters
Our business is subject to a variety of federal, state and local
environmental laws and regulations. As a healthcare provider, we
face regulatory requirements in areas of air and water quality
control, medical and low-level radioactive waste management and
disposal, asbestos management, response to mold and lead-based
paint in our facilities and employee safety.
As an owner or operator of our facilities, we also may be
required to investigate and remediate hazardous substances that
are located on
and/or under
the property, including any such substances that may have
migrated off, or may have been discharged or transported from
the property. Part of our operations involves the handling, use,
storage, transportation, disposal and discharge of medical,
biological, infectious, toxic, flammable and other hazardous
materials, wastes, pollutants or contaminants. In addition, we
are sometimes unable to determine with certainty whether prior
uses of our facilities and properties or surrounding properties
may have produced continuing environmental contamination or
noncompliance, particularly where the timing or cost of making
such determinations is not deemed cost-effective. These
activities, as well as the possible presence of such materials
in, on and under our properties, may result in damage to
individuals, property or the environment; may interrupt
operations or increase costs; may result in legal liability,
damages, injunctions or fines; may result in investigations,
administrative proceedings, penalties or other governmental
agency actions; and may not be covered by insurance.
We believe that we are in material compliance with applicable
environmental and occupational health and safety requirements.
However, we cannot assure you that we will not encounter
environmental liabilities in the future, and such liabilities
may result in material adverse consequences to our operations or
financial condition.
Payor
Sources
Total Revenue by Payor Sources. We derive
revenue primarily from the Medicaid and Medicare programs,
private pay patients and managed care payors. Medicaid typically
covers patients that require standard room and board services,
and provides reimbursement rates that are generally lower than
rates earned from other sources. We monitor our quality mix,
which is the percentage of non-Medicaid revenue from each of our
facilities, to measure the level of more attractive
reimbursements that we received across each of our business
units. We intend to continue to focus on enhancing our care
offerings to accommodate more high acuity patients.
Medicaid. Medicaid is a state-administered
program financed by state funds and matching federal funds.
Medicaid programs are administered by the states and their
political subdivisions, and often go by state-specific names,
such as Medi-Cal in California and the Arizona Healthcare Cost
Containment System in Arizona. Medicaid programs generally
provide health benefits for qualifying individuals, and may
supplement Medicare benefits for financially needy persons aged
65 and older. Medicaid reimbursement formulas are established by
each state with the approval of the federal government in
accordance with federal guidelines.
12
Seniors who enter skilled nursing facilities as private pay
clients can become eligible for Medicaid once they have
substantially depleted their assets. Medicaid is the largest
source of funding for nursing home facilities.
Private and Other Payors. Private and other
payors consist primarily of individuals, family members or other
third parties who directly pay for the services we provide.
Medicare. Medicare is a federal program that
provides healthcare benefits to individuals who are
65 years of age or older or are disabled. To achieve and
maintain Medicare certification, a skilled nursing facility must
meet the CMS, Conditions of Participation on an
ongoing basis, as determined in periodic facility inspections or
surveys conducted primarily by the state licensing
agency in the state where the facility is located. Medicare pays
for inpatient skilled nursing facility services under the
prospective payment system. The prospective payment for each
beneficiary is based upon the medical condition of and care
needed by, the beneficiary. Medicare skilled nursing facility
coverage is limited to 100 days per episode of illness for
those beneficiaries who require daily care following discharge
from an acute care hospital.
Managed Care and Private Insurance. Managed
care patients consist of individuals who are insured by a
third-party entity, typically a senior HMO plan, or who are
Medicare beneficiaries who have assigned their Medicare benefits
to a senior HMO plan. Another type of insurance, long-term care
insurance, is also becoming more widely available to consumers,
but is not expected to contribute significantly to industry
revenues in the near term.
Billing and Reimbursement. Our revenue from
government payors, including Medicare and state Medicaid
agencies is subject to retroactive adjustments in the form of
claimed overpayments and underpayments based on rate
adjustments, asserted billing and reimbursement errors, and
claimed overpayments and underpayments. We believe billing and
reimbursement errors, disagreements, overpayments and
underpayments are common in our industry, and we are regularly
engaged with government payors and their fiscal intermediaries
in reviews, audits and appeals of our claims for reimbursement
due to the subjectivities inherent in the processes related to
patient diagnosis and care, recordkeeping, claims processing and
other aspects of the patient service and reimbursement
processes, and the errors and disagreements those subjectivities
can produce.
We take seriously our responsibility to act appropriately under
applicable laws and regulations, including Medicare and Medicaid
billing and reimbursement laws and regulations. Accordingly, we
employ accounting, reimbursement and compliance specialists who
train, mentor and assist our clerical, clinical and
rehabilitation staffs in the preparation of claims and
supporting documentation, regularly monitor billing and
reimbursement practices within our facilities, and assist with
the appeal of overpayment and recoupment claims generated by
governmental, fiscal intermediary and other auditors and
reviewers. In addition, due to the potentially serious
consequences that could arise from any impropriety in our
billing and reimbursement processes, we investigate all
allegations of impropriety or irregularity relative thereto, and
sometimes do so with the aid of outside auditors, other than our
independent registered public accounting firm, attorneys and
other professionals.
Whether information about our billing and reimbursement
processes is obtained from external sources or activities such
as Medicare and Medicaid audits or probe reviews, internal
investigations such as the one recently completed (discussed
below in Risk Factors), or our regular day-to-day monitoring and
training activities, we collect and utilize such information to
improve our billing and reimbursement functions and the various
processes related thereto. While, like other operators in our
industry, we experience billing and reimbursement errors,
disagreements and other effects of the inherent subjectivities
in reimbursement processes on a regular basis, we believe that
we are in substantial compliance with applicable Medicare and
Medicaid reimbursement requirements. We continually strive to
improve the efficiency and accuracy of all of our operational
and business functions, including our billing and reimbursement
processes.
13
The following table sets forth the payor sources of our total
revenue for the periods indicated:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31,
|
|
|
|
2007
|
|
|
2006
|
|
|
2005
|
|
|
|
(In thousands)
|
|
|
Payor Sources for All Facilities:
|
|
|
|
|
|
|
|
|
|
|
|
|
Medicare
|
|
$
|
123,170
|
|
|
$
|
117,511
|
|
|
$
|
96,208
|
|
Managed care
|
|
|
52,779
|
|
|
|
44,487
|
|
|
|
33,484
|
|
Private and other payors(1)
|
|
|
52,579
|
|
|
|
45,312
|
|
|
|
39,831
|
|
Medicaid
|
|
|
182,790
|
|
|
|
151,264
|
|
|
|
131,327
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total revenue
|
|
$
|
411,318
|
|
|
$
|
358,574
|
|
|
$
|
300,850
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
Includes revenue from our assisted living facilities. |
Payor Sources as a Percentage of Skilled Nursing
Services. We use both our skilled mix and quality
mix as measures of the quality of reimbursements we receive at
our skilled nursing facilities over various periods. The
following table sets forth our percentage of skilled nursing
patient days by payor source:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31,
|
|
Percentage of Skilled Nursing Days:
|
|
2007
|
|
|
2006
|
|
|
2005
|
|
|
Medicare
|
|
|
13.7
|
%
|
|
|
15.0
|
%
|
|
|
14.3
|
%
|
Managed care
|
|
|
9.0
|
|
|
|
9.3
|
|
|
|
8.1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Skilled mix
|
|
|
22.7
|
|
|
|
24.3
|
|
|
|
22.4
|
|
Private and other payors
|
|
|
13.0
|
|
|
|
13.1
|
|
|
|
13.6
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Quality mix
|
|
|
35.7
|
|
|
|
37.4
|
|
|
|
36.0
|
|
Medicaid
|
|
|
64.3
|
|
|
|
62.6
|
|
|
|
64.0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total skilled nursing
|
|
|
100.0
|
%
|
|
|
100.0
|
%
|
|
|
100.0
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Reimbursement
for Specific Services
Reimbursement for Skilled Nursing
Services. Skilled nursing facility revenue is
primarily derived from Medicaid, private pay, managed care and
Medicare payors. Our skilled nursing facilities provide
Medicaid-covered
services to eligible individuals consisting of nursing care,
room and board and social services. In addition, states may, at
their option, cover other services such as physical,
occupational and speech therapies.
Reimbursement for Rehabilitation Therapy
Services. Rehabilitation therapy revenue is
primarily received from private pay and Medicare for services
provided at skilled nursing facilities and assisted living
facilities. The payments are based on negotiated patient per
diem rates or a negotiated fee schedule based on the type of
service rendered.
Reimbursement for Assisted Living
Services. Assisted living facility revenue is
primarily derived from private pay residents at rates we
establish based upon the services we provide and market
conditions in the area of operation. In addition, Medicaid or
other state-specific programs in some states where we operate
supplement payments for board and care services provided in
assisted living facilities.
Available
Information
We are subject to the reporting requirements under the
Securities and Exchange Act of 1934. Consequently, we are
required to file reports and information with the Securities and
Exchange Commission (SEC), including reports on the following
forms: annual report on
Form 10-K,
quarterly reports on
Form 10-Q,
current reports on
Form 8-K,
and amendments to those reports filed or furnished pursuant to
Section 13(a) or
14
15(d) of the Securities Exchange Act of 1934. These reports and
other information concerning the company may be accessed through
the SECs website at
http://www.
sec.gov.
You may also find on our website at
http://www.
ensigngroup.net, electronic copies of our annual report on
Form 10-K,
quarterly reports on
Form 10-Q,
current reports on
Form 8-K
and amendments to those reports filed or furnished pursuant to
Section 13(a) or 15(d) of the Securities Exchange Act of
1934. Such filings are placed on our website as soon as
reasonably possible after they are filed with the SEC.
Information contained in our website is not deemed to be a part
of this Annual Report.
Set forth below are certain risk factors that could harm our
business, results of operations and financial condition. You
should carefully read the following risk factors, together with
the financial statements, related notes and other information
contained in this Annual Report on
Form 10-K.
This Annual Report on
Form 10-K
contains forward-looking statements that contain risks and
uncertainties. Please refer to the section entitled
Cautionary Note Regarding Forward-Looking Statements
on page 1 of this Annual Report on
Form 10-K
in connection with your consideration of the risk factors and
other important factors that may affect future results described
below.
Risks
Related to Our Business and Industry
Our
revenue could be impacted by federal and state changes to
reimbursement and other aspects of Medicaid and
Medicare.
We derived approximately 44% and 30% of our revenue from the
Medicaid and Medicare programs, respectively, for the year ended
December 31, 2007 and 42% and 33% for the year ended
December 31, 2006, respectively. If reimbursement rates
under these programs are reduced or fail to increase as quickly
as our costs, or if there are changes in the way these programs
pay for services, our business and results of operations could
be adversely affected. The services for which we are currently
reimbursed by Medicaid and Medicare may not continue to be
reimbursed at adequate levels or at all. Further limits on the
scope of services being reimbursed, delays or reductions in
reimbursement or changes in other aspects of reimbursement could
impact our revenue. For example, in the past, the enactment of
the Deficit Reduction Act of 2005 (DRA), the Medicaid Voluntary
Contribution and Provider-Specific Tax Amendments of 1991 and
the Balanced Budget Act of 1997 (BBA) caused changes in
government reimbursement systems, which, in some cases, made
obtaining reimbursements more difficult and costly and lowered
or restricted reimbursement rates for some of our residents.
The Medicaid and Medicare programs are subject to statutory and
regulatory changes affecting base rates or basis of payment,
retroactive rate adjustments, administrative or executive orders
and government funding restrictions, all of which may materially
adversely affect the rates and frequency at which these programs
reimburse us for our services. Implementation of these and other
measures to reduce or delay reimbursement could result in
substantial reductions in our revenue and profitability. Payors
may disallow our requests for reimbursement based on
determinations that certain costs are not reimbursable or
reasonable because either adequate or additional documentation
was not provided or because certain services were not covered or
considered reasonably necessary. Additionally, revenue from
these payors can be retroactively adjusted after a new
examination during the claims settlement process or as a result
of post-payment audits. New legislation and regulatory proposals
could impose further limitations on government payments to
healthcare providers. These and other changes to the
reimbursement and other aspects of Medicaid could adversely
affect our revenue.
Our
future revenue, financial condition and results of operations
could be impacted by continued cost containment pressures on
Medicaid spending.
Medicaid, which is largely administered by the states, is a
significant payor for our skilled nursing services. Rapidly
increasing Medicaid spending, combined with slow state revenue
growth, has led many states to institute measures aimed at
controlling spending growth. Because state legislatures control
the amount of
15
state funding for Medicaid programs, cuts or delays in approval
of such funding by legislatures could reduce the amount of, or
cause a delay in, payment from Medicaid to skilled nursing
facilities. We expect continuing cost containment pressures on
Medicaid outlays for skilled nursing facilities.
To generate funds to pay for the increasing costs of the
Medicaid program, many states utilize financial arrangements
such as provider taxes. Under provider tax arrangements, states
collect taxes or fees from healthcare providers and then return
the revenue to these providers as Medicaid expenditures.
Congress, however, has placed restrictions on states use
of provider tax and donation programs as a source of state
matching funds. Under the Medicaid Voluntary Contribution and
Provider-Specific Tax Amendments of 1991, the federal medical
assistance percentage available to a state was reduced by the
total amount of healthcare related taxes that the state imposed,
unless certain requirements are met. The federal medical
assistance percentage is not reduced if the state taxes are
broad-based and not applied specifically to Medicaid reimbursed
services. In addition, the healthcare providers receiving
Medicaid reimbursement must be at risk for the amount of tax
assessed and must not be guaranteed to receive reimbursement
through the applicable state Medicaid program for the tax
assessed. Lower Medicaid reimbursement rates would adversely
affect our revenue, financial condition and results of
operations.
If
Medicare reimbursement rates decline, our revenue, financial
condition and results of operations could be adversely
affected.
Over the past several years, the federal government has
periodically changed various aspects of Medicare reimbursements
for skilled nursing facilities. Medicare Part A covers
inpatient hospital services, skilled nursing care and some home
healthcare. Medicare Part B covers physician and other
health practitioner services, some supplies and a variety of
medical services not covered under Medicare Part A.
Medicare coverage of skilled nursing services is available only
if the patient is hospitalized for at least three consecutive
days, the need for such services is related to the reason for
the hospitalization, and the patient is admitted to the facility
within 30 days following discharge from a Medicare
participating hospital. Medicare coverage of skilled nursing
services is limited to 100 days per benefit period after
discharge from a Medicare participating hospital or critical
access hospital. The patient must pay coinsurance amounts for
the twenty-first day and each of the remaining days of covered
care per benefit period.
Medicare payments for skilled nursing services are paid on a
case-mix adjusted per diem prospective payment system (PPS) for
all routine, ancillary and capital-related costs. The
prospective payment for skilled nursing services is based solely
on the adjusted federal per diem rate. Although Medicare payment
rates under the skilled nursing facility PPS increased
temporarily for federal fiscal years 2003 and 2004, new payment
rates for federal fiscal year 2005 took effect for discharges
beginning October 1, 2004. A regulation by CMS sets forth a
schedule of prospective payment rates applicable to Medicare
Part A skilled nursing services that took effect on
October 1, 2007, and included a full market basket increase
of 3.3%. There can be no assurance that the skilled nursing
facility PPS rates will be sufficient to cover our actual costs
of providing skilled nursing facility services.
Skilled nursing facilities are also required to perform
consolidated billing for items and services furnished to
patients and residents during a Part A covered stay and
therapy services furnished during Part A and Part B
covered stays. The consolidated billing requirement essentially
confers on the skilled nursing facility itself the Medicare
billing responsibility for the entire package of care that its
residents receive in these situations. The BBA also affected
skilled nursing facility payments by requiring that
post-hospitalization skilled nursing services be
bundled into the hospitals Diagnostic Related
Group (DRG) payment in certain circumstances. Where this rule
applies, the hospital and the skilled nursing facility must, in
effect, divide the payment which otherwise would have been paid
to the hospital alone for the patients treatment, and no
additional funds are paid by Medicare for skilled nursing care
of the patient. At present, this provision applies to a limited
number of DRGs, but already is apparently having a negative
effect on skilled nursing facility utilization and payments,
either because hospitals are finding it difficult to place
patients in skilled nursing facilities which will not be paid as
before or because hospitals are reluctant to discharge the
patients to skilled nursing
16
facilities and lose part of their payment. This bundling
requirement could be extended to more DRGs in the future, which
would accentuate the negative impact on skilled nursing facility
utilization and payments.
Skilled nursing facility prospective payment rates, as they may
change from time to time, may be insufficient to cover our
actual costs of providing skilled nursing services to Medicare
patients. In addition, we may not be fully reimbursed for all
services for which each facility bills through consolidated
billing. If Medicare reimbursement rates decline, it could
adversely affect our revenue, financial condition and results of
operations.
We are
subject to various government reviews, audits and investigations
that could adversely affect our business, including an
obligation to refund amounts previously paid to us, potential
criminal charges, the imposition of fines, and/or the loss of
our right to participate in Medicare and Medicaid
programs.
As a result of our participation in the Medicaid and Medicare
programs, we are subject to various governmental reviews, audits
and investigations to verify our compliance with these programs
and applicable laws and regulations. Private pay sources also
reserve the right to conduct audits. An adverse review, audit or
investigation could result in:
|
|
|
|
|
an obligation to refund amounts previously paid to us pursuant
to the Medicare or Medicaid programs or from private payors, in
amounts that could be material to our business;
|
|
|
|
state or federal agencies imposing fines, penalties and other
sanctions on us;
|
|
|
|
loss of our right to participate in the Medicare or Medicaid
programs or one or more private payor networks;
|
|
|
|
an increase in private litigation against us; and
|
|
|
|
damage to our reputation in various markets.
|
We believe that billing and reimbursement errors and
disagreements are common in our industry. We are regularly
engaged in reviews, audits and appeals of our claims for
reimbursement due to the subjectivities inherent in the
processes related to patient diagnosis and care, record keeping,
claims processing and other aspects of the patient service and
reimbursement processes, and the errors and disagreements those
subjectivities can produce.
In 2004, our Medicare fiscal intermediary began to conduct
selected reviews of claims previously submitted by and paid to
some of our facilities. While we have always been subject to
post-payment audits and reviews, more intensive probe
reviews are relatively new and appear to be a permanent
procedure with our fiscal intermediary.
In some cases, probe reviews can also result in a facility being
temporarily placed on prepayment review of reimbursement claims,
requiring additional documentation and adding steps and time to
the reimbursement process for the affected facility. Payment
delays resulting from the prepayment review process could have
an adverse effect on our cash flow, and such adverse effect
could be material if multiple facilities were placed on
prepayment review simultaneously.
Failure to meet claim filing and documentation requirements
during the prepayment review could subject a facility to an even
more intensive targeted review, where a corrective
action plan addressing perceived deficiencies must be prepared
by the facility and approved by the fiscal intermediary. During
a targeted review, additional claims are reviewed post-payment
to ensure that the prescribed corrective actions are being
followed. Failure to make corrections or to otherwise meet the
claim documentation and submission requirements could eventually
result in Medicare decertification.
Separately, the federal government has also introduced a program
that utilizes independent contractors (other than the fiscal
intermediaries) to identify and recoup Medicare overpayments.
These contractors are paid a contingent fee based on
recoupments. In 2007 this program was extended and expanded, and
it could be extended or expanded further in the future based on
the recommendation of CMS and the decision of Congress. Should
this occur, we anticipate that the number of overpayment reviews
could increase in the
17
future, and that the reviewers could be more aggressive in
making claims for recoupment. If future Medicare reviews result
in significant refund payments to the federal government, it
would have an adverse effect on our financial results.
The
reduction in overall Medicaid and Medicare spending pursuant to
the Deficit Reduction Act of 2005 and the increased costs to
comply with the Deficit Reduction Act of 2005 could adversely
affect our revenue, financial condition or results of
operations.
The DRA provides for a reduction in overall Medicaid and
Medicare spending by approximately $11.0 billion over five
years. Under the DRA, individuals who transferred assets for
less than fair market value during a five year look-back period
will be ineligible for Medicaid for so long as they would have
been able to fund their cost of care absent the transfer or
until the transfer would no longer have been made during the
look-back period. This period is referred to as the penalty
period. The DRA also changes the calculation for determining
when the penalty period begins, and prohibits states from
ignoring small asset transfers and other asset transfer
mechanisms. In addition, the legislation reduces Medicare
skilled nursing facility bad debt payments by 30% for those
individuals who are not dually eligible for Medicaid and
Medicare. If any of our existing Medicaid patients become
ineligible under the DRA during their stay, it would be
difficult for us to collect from them or transfer them, and our
revenue could decrease without a corresponding decrease in
expenses related to the care of those patients. The loss of
revenue associated with potential reductions in skilled nursing
facility payments could adversely affect our revenue, financial
condition or results of operations. The DRA also requires
entities which receive at least $5.0 million in annual
Medicaid dollars each year to provide education to their
employees concerning false claims laws and protections for
whistleblowers. The DRA also requires those entities to provide
contractors and vendors with similar information. As a result,
we have and will continue to expend resources to meet these
requirements. Further, the requirement that we provide education
to employees and contractors regarding false claims laws and
other fraud and abuse laws may result in increased
investigations into these matters.
Each year the federal government releases a budget proposal,
which, if enacted, may have a material affect on our business.
On February 4, 2008, the Bush Administration released its
fiscal year 2009 budget proposal, which, if enacted, would
significantly reduce Medicare spending totaling
$182 billion over five years. Approximately 62% of the
proposed five-year reduction total results from reductions in
provider update factors, including a three-year freeze for
skilled nursing facilities followed by annual updates of the
inflation adjustment (or market basket) minus
0.65 percentage points indefinitely thereafter. Additional
proposals would reduce provider payments by phasing out bad debt
payments to skilled nursing facilities and imposing payment
adjustments for five conditions commonly treated in skilled
nursing facilities. Further, the proposed budget reiterates a
proposal offered in past years by establishing an automatic
annual 0.4 percent payment reduction that would take effect
absent other Congressional action if general fund expenditures
for Medicare exceed 45 percent. The budget also includes a
series of proposals having an affect on Medicaid. For example,
the budget proposes $18.2 billion in five-year savings from
Medicaid, more than half of which, $10.1 billion, would
come from reducing matching rates for administrative costs, case
management, family planning services, and qualifying individuals.
Annual
caps that limit the amounts that can be paid for outpatient
therapy services rendered to any Medicare beneficiary may reduce
our future revenue and profitability or cause us to incur
losses.
Some of our rehabilitation therapy revenue is paid by the
Medicare Part B program under a fee schedule. Congress has
established annual caps that limit the amounts that can be paid
(including deductible and coinsurance amounts) for
rehabilitation therapy services rendered to any Medicare
beneficiary under Medicare Part B. The BBA requires a
combined cap for physical therapy and
speech-language
pathology and a separate cap for occupational therapy. Due to a
series of moratoria enacted subsequent to the BBA, the caps were
only in effect in 1999 and for a few months in 2003. With the
expiration of the most recent moratorium, the caps were
reinstated on January 1, 2006 at $1,740 for physical
therapy and speech therapy, and $1,740 for occupational therapy.
Each of these caps increased to $1,780 on January 1, 2007
and $1,810 on January 1, 2008.
18
The DRA directs CMS to create a process to allow exceptions to
therapy caps for certain medically necessary services provided
on or after January 1, 2006 for patients with certain
conditions or multiple complexities whose therapy services are
reimbursed under Medicare Part B. A significant portion of
the residents in our skilled nursing facilities and patients
served by our rehabilitation therapy programs whose therapy is
reimbursed under Medicare Part B have qualified for the
exceptions to these reimbursement caps. The Tax Relief and
Health Care Act of 2006 extended the exceptions through the end
of 2007. The Medicare, Medicaid and SCHIP Extension Act of 2007
extended these exceptions until June 30, 2008.
The application of annual caps, or the discontinuation of
exceptions to the annual caps, could have an adverse effect on
our rehabilitation therapy revenue. Additionally, the exceptions
to these caps may not be extended beyond June 30, 2008,
which would have an even greater adverse effect on our revenue.
We are
subject to extensive and complex federal and state government
laws and regulations which could change at any time and increase
our cost of doing business and subject us to enforcement
actions.
We, along with other companies in the healthcare industry, are
required to comply with extensive and complex laws and
regulations at the federal, state and local government levels
relating to, among other things:
|
|
|
|
|
facility and professional licensure, certificates of need,
permits and other government approvals;
|
|
|
|
adequacy and quality of healthcare services;
|
|
|
|
qualifications of healthcare and support personnel;
|
|
|
|
quality of medical equipment;
|
|
|
|
confidentiality, maintenance and security issues associated with
medical records and claims processing;
|
|
|
|
relationships with physicians and other referral sources and
recipients;
|
|
|
|
constraints on protective contractual provisions with patients
and third-party payors;
|
|
|
|
operating policies and procedures;
|
|
|
|
certification of additional facilities by the Medicare
program; and
|
|
|
|
payment for services.
|
The laws and regulations governing our operations, along with
the terms of participation in various government programs,
regulate how we do business, the services we offer, and our
interactions with patients and other healthcare providers. These
laws and regulations are subject to frequent change. For
example, legislation was recently introduced in the
U.S. Senate that would require increased public disclosure
about our facilities and significantly increase the size of
penalties the government can impose for certain deficiencies. We
believe that such regulations may increase in the future and we
cannot predict the ultimate content, timing or impact on us of
any healthcare reform legislation. Changes in existing laws or
regulations, or the enactment of new laws or regulations, could
negatively impact our business. If we fail to comply with these
applicable laws and regulations, we could suffer civil or
criminal penalties and other detrimental consequences, including
denial of reimbursement, imposition of fines, temporary
suspension of admission of new patients, suspension or
decertification from the Medicaid and Medicare programs,
restrictions on our ability to acquire new facilities or expand
or operate existing facilities, the loss of our licenses to
operate and the loss of our ability to participate in federal
and state reimbursement programs.
We are subject to federal and state laws, such as the Federal
False Claims Act, state false claims acts, the illegal
remuneration provisions of the Social Security Act, the federal
anti-kickback laws, state anti-kickback laws, and the federal
Stark laws, that govern financial and other
arrangements among healthcare providers, their owners, vendors
and referral sources, and that are intended to prevent
healthcare fraud and abuse. Among other things, these laws
prohibit kickbacks, bribes and rebates, as well as other direct
and indirect payments or fee-splitting arrangements that are
designed to induce the referral of patients to a particular
provider for medical products or services payable by any federal
healthcare program, and prohibit presenting a false or
misleading claim for payment under a federal or state program.
They also prohibit some physician self-
19
referrals. Possible sanctions for violation of any of these
restrictions or prohibitions include loss of eligibility to
participate in federal and state reimbursement programs and
civil and criminal penalties. Changes in these laws could
increase our cost of doing business. If we fail to comply, even
inadvertently, with any of these requirements, we could be
required to alter our operations, refund payments to the
government, enter into corporate integrity, deferred prosecution
or similar agreements with state or federal government agencies,
and become subject to significant civil and criminal penalties.
We are also required to comply with state and federal laws
governing the transmission, privacy and security of health
information. The Health Insurance Portability and Accountability
Act of 1996 (HIPAA) requires us to comply with certain standards
for the use of individually identifiable health information
within our company, and the disclosure and electronic
transmission of such information to third parties, such as
payors, business associates and patients. These include
standards for common electronic healthcare transactions and
information, such as claim submission, plan eligibility
determination, payment information submission and the use of
electronic signatures; unique identifiers for providers,
employers and health plans; and the security and privacy of
individually identifiable health information. In addition, some
states have enacted comparable or, in some cases, more stringent
privacy and security laws. If we fail to comply with these state
and federal laws, we could be subject to criminal penalties and
civil sanctions and be forced to modify our policies and
procedures.
We are unable to predict the future course of federal, state and
local regulation or legislation, including Medicaid and Medicare
statutes and regulations. Changes in the regulatory framework,
our failure to obtain or renew required regulatory approvals or
licenses or to comply with applicable regulatory requirements,
the suspension or revocation of our licenses or our
disqualification from participation in federal and state
reimbursement programs, or the imposition of other harsh
enforcement sanctions could increase our cost of doing business
and expose us to potential sanctions. Furthermore, if we were to
lose licenses or certifications for any of our facilities as a
result of regulatory action or otherwise, we could be deemed to
be in default under some of our agreements, including agreements
governing outstanding indebtedness and lease obligations.
Any
changes in the interpretation and enforcement of the laws or
regulations governing our business could cause us to modify our
operations, increase our cost of doing business and subject us
to potential regulatory action.
The interpretation and enforcement of federal and state laws and
regulations governing our operations, including, but not limited
to, laws and regulations relating to Medicaid and Medicare, the
Federal False Claims Act, state false claims acts, the illegal
remuneration provisions of the Social Security Act, the federal
anti-kickback laws, state anti-kickback laws, the federal Stark
laws, and HIPAA, are subject to frequent change. Governmental
authorities may interpret these laws in a manner inconsistent
with our interpretation and application. If we fail to comply,
even inadvertently, with any of these requirements, we could be
required to alter our operations and reduce, forego or refund
reimbursements to the government, or incur other significant
penalties. We could also be compelled to divert personnel and
other resources to responding to an investigation or other
enforcement action under these laws or regulations, or to
ongoing compliance with a corporate integrity agreement,
deferred prosecution agreement, court order or similar
agreement. The diversion of these resources, including our
management team, clinical and compliance staff, and others,
would take away from the time and energy these individuals
devote to routine operations. Furthermore, federal, state and
local officials are increasingly focusing their efforts on
enforcement of these laws, particularly with respect to
providers who share common ownership or control with other
providers. The increased enforcement of these requirements could
affect our ability to expand into new markets, to expand our
services and facilities in existing markets and, if any of our
presently licensed facilities were to operate outside of its
licensing authority, may subject us to penalties, including
closure of the facility. Changes in the interpretation and
enforcement of existing laws or regulations could increase our
cost of doing business.
We are unable to predict the intensity of federal and state
enforcement actions or the areas in which regulators may choose
to focus their investigations at any given time. Changes in
government agency interpretation of applicable regulatory
requirements, or changes in enforcement methodologies, including
20
increases in the scope and severity of deficiencies determined
by survey or inspection officials, could increase our cost of
doing business. Furthermore, should we lose licenses or
certifications for any of our facilities as a result of changing
regulatory interpretations, enforcement actions or otherwise, we
could be deemed to be in default under some of our agreements,
including agreements governing outstanding indebtedness and
lease obligations.
Increased
civil and criminal enforcement efforts of government agencies
against skilled nursing facilities could harm our business, and
could preclude us from participating in federal healthcare
programs.
Both federal and state government agencies have heightened and
coordinated civil and criminal enforcement efforts as part of
numerous ongoing investigations of healthcare companies and, in
particular, skilled nursing facilities. The focus of these
investigations includes, among other things:
|
|
|
|
|
cost reporting and billing practices;
|
|
|
|
quality of care;
|
|
|
|
financial relationships with referral sources; and
|
|
|
|
medical necessity of services provided.
|
If any of our facilities is decertified or loses its licenses,
our revenue, financial condition or results of operations would
be adversely affected. In addition, the report of such issues at
any of our facilities could harm our reputation for quality care
and lead to a reduction in our patient referrals and ultimately
a reduction in occupancy at these facilities. Also, responding
to enforcement efforts would divert material time, resources and
attention from our management team and our staff, and could have
a materially detrimental impact on our results of operations
during and after any such investigation or proceedings,
regardless of whether we prevail on the underlying claim.
Federal law provides that practitioners, providers and related
persons may not participate in most federal healthcare programs,
including the Medicaid and Medicare programs, if the individual
or entity has been convicted of a criminal offense related to
the delivery of a product or service under these programs or if
the individual or entity has been convicted under state or
federal law of a criminal offense relating to neglect or abuse
of patients in connection with the delivery of a healthcare
product or service. Other individuals or entities may be, but
are not required to be, excluded from such programs under
certain circumstances, including, but not limited to, the
following:
|
|
|
|
|
conviction related to fraud;
|
|
|
|
conviction relating to obstruction of an investigation;
|
|
|
|
conviction relating to a controlled substance;
|
|
|
|
licensure revocation or suspension;
|
|
|
|
exclusion or suspension from state or other federal healthcare
programs;
|
|
|
|
filing claims for excessive charges or unnecessary services or
failure to furnish medically necessary services;
|
|
|
|
ownership or control of an entity by an individual who has been
excluded from the Medicaid or Medicare programs, against whom a
civil monetary penalty related to the Medicaid or Medicare
programs has been assessed or who has been convicted of a
criminal offense under federal healthcare programs; and
|
|
|
|
the transfer of ownership or control interest in an entity to an
immediate family or household member in anticipation of, or
following, a conviction, assessment or exclusion from the
Medicare or Medicaid programs.
|
The Office of Inspector General (OIG), among other priorities,
is responsible for identifying and eliminating fraud, abuse and
waste in certain federal healthcare programs. The OIG has
implemented a
21
nationwide program of audits, inspections and investigations and
from time to time issues fraud alerts to segments of
the healthcare industry on particular practices that are
vulnerable to abuse. The fraud alerts inform healthcare
providers of potentially abusive practices or transactions that
are subject to criminal activity and reportable to the OIG. An
increasing level of resources has been devoted to the
investigation of allegations of fraud and abuse in the Medicaid
and Medicare programs, and federal and state regulatory
authorities are taking an increasingly strict view of the
requirements imposed on healthcare providers by the Social
Security Act and Medicaid and Medicare programs. Although we
have created a corporate compliance program that we believe is
consistent with the OIG guidelines, the OIG may modify its
guidelines or interpret its guidelines in a manner inconsistent
with our interpretation or the OIG may ultimately determine that
our corporate compliance program is insufficient.
In some circumstances, if one facility is convicted of abusive
or fraudulent behavior, then other facilities under common
control or ownership may be decertified from participating in
Medicaid or Medicare programs. Federal regulations prohibit any
corporation or facility from participating in federal contracts
if it or its principals have been barred, suspended or declared
ineligible from participating in federal contracts. In addition,
some state regulations provide that all facilities under common
control or ownership licensed within a state may be de-licensed
if one or more of the facilities are de-licensed. If any of our
facilities were decertified or excluded from participating in
Medicaid or Medicare programs, our revenue would be adversely
affected.
Public
and governmental calls for increased survey and enforcement
efforts against long-term care facilities could result in
increased scrutiny by state and federal survey
agencies.
CMS has undertaken several initiatives to increase or intensify
Medicaid and Medicare survey and enforcement activities,
including federal oversight of state actions. CMS is taking
steps to focus more survey and enforcement efforts on facilities
with findings of substandard care or repeat violations of
Medicaid and Medicare standards, and to identify multi-facility
providers with patterns of noncompliance. In addition, the
Department of Health and Human Services has adopted a rule that
requires CMS to charge user fees to healthcare facilities cited
during regular certification, recertification or substantiated
complaint surveys for deficiencies, which require a revisit to
assure that corrections have been made. CMS is also increasing
its oversight of state survey agencies and requiring state
agencies to use enforcement sanctions and remedies more promptly
when substandard care or repeat violations are identified, to
investigate complaints more promptly, and to survey facilities
more consistently.
In addition, CMS has adopted, and is considering additional
regulations expanding, federal and state authority to impose
civil monetary penalties in instances of noncompliance. When a
facility is found to be deficient under state licensing and
Medicaid and Medicare standards, sanctions may be threatened or
imposed such as denial of payment for new Medicaid and Medicare
admissions, civil monetary penalties, focused state and federal
oversight and even loss of eligibility for Medicaid and Medicare
participation or state licensure. Sanctions such as denial of
payment for new admissions often are scheduled to go into effect
before surveyors return to verify compliance. Generally, if the
surveyors confirm that the facility is in compliance upon their
return, the sanctions never take effect. However, if they
determine that the facility is not in compliance, the denial of
payment goes into effect retroactive to the date given in the
original notice. This possibility sometimes leaves affected
operators, including us, with the difficult task of deciding
whether to continue accepting patients after the potential
denial of payment date, thus risking the retroactive denial of
revenue associated with those patients care if the
operators are later found to be out of compliance, or simply
refusing admissions from the potential denial of payment date
until the facility is actually found to be in compliance.
Facilities with otherwise acceptable regulatory histories
generally are given an opportunity to correct deficiencies and
continue their participation in the Medicare and Medicaid
programs by a certain date, usually within six months, although
where denial of payment remedies are asserted, such interim
remedies go into effect much sooner. Facilities with
deficiencies that immediately jeopardize patient health and
safety and those that are classified as poor performing
facilities, however, are not generally given an opportunity to
correct their deficiencies prior to the imposition of remedies
and other enforcement actions. Moreover, facilities with poor
regulatory histories continue to be classified by CMS as poor
performing facilities notwithstanding any
22
intervening change in ownership, unless the new owner obtains a
new Medicare provider agreement instead of assuming the
facilitys existing agreement. However, new owners
(including us, historically) nearly always assume the existing
Medicare provider agreement due to the difficulty and time
delays generally associated with obtaining new Medicare
certifications, especially in previously-certified locations
with sub-par operating histories. Accordingly, facilities that
have poor regulatory histories before we acquire them and that
develop new deficiencies after we acquire them are more likely
to have sanctions imposed upon them by CMS or state regulators.
In addition, CMS has increased its focus on facilities with a
history of serious quality of care problems through the special
focus facility initiative. A facilitys administrators and
owners are notified when it is identified as a special focus
facility. This information is also provided to the general
public. The special focus facility designation is based in part
on the facilitys compliance history typically dating
before our acquisition of the facility. Local state survey
agencies recommend to CMS that facilities be placed on special
focus status. A special focus facility receives heightened
scrutiny and more frequent regulatory surveys. Failure to
improve the quality of care can result in fines and termination
from participation in Medicare and Medicaid. A facility
graduates from the program once it demonstrates
significant improvements in quality of care that are continued
over time. We currently have two facilities operating under
special focus status, and the state survey agency has indicated
that a portion of the historical non-compliance considered in
placing one of the facilities on special focus status predated
our October 2006 acquisition of the facility.
State
efforts to regulate or deregulate the healthcare services or
construction or expansion of healthcare facilities could impair
our ability to expand our operations, or could result in
increased competition.
Some states require healthcare providers, including skilled
nursing facilities, to obtain prior approval, known as a
certificate of need, for:
|
|
|
|
|
the purchase, construction or expansion of healthcare facilities;
|
|
|
|
capital expenditures exceeding a prescribed amount; or
|
|
|
|
changes in services or bed capacity.
|
In addition, other states that do not require certificates of
need have effectively barred the expansion of existing
facilities and the development of new ones by placing partial or
complete moratoria on the number of new Medicaid beds they will
certify in certain areas or in the entire state. Other states
have established such stringent development standards and
approval procedures for constructing new healthcare facilities
that the construction of new facilities, or the expansion or
renovation of existing facilities, may become cost-prohibitive
or extremely time-consuming. Our ability to acquire or construct
new facilities or expand or provide new services at existing
facilities would be adversely affected if we are unable to
obtain the necessary approvals, if there are changes in the
standards applicable to those approvals, or if we experience
delays and increased expenses associated with obtaining those
approvals. We may not be able to obtain licensure, certificate
of need approval, Medicaid certification, or other necessary
approvals for future expansion projects. Conversely, the
elimination or reduction of state regulations that limit the
construction, expansion or renovation of new or existing
facilities could result in increased competition to us or result
in overbuilding of facilities in some of our markets.
Overbuilding
in certain markets, increased competition and increased
operating costs may adversely affect our ability to generate and
increase our revenue and profits and to pursue our growth
strategy.
The skilled nursing and long-term care industries are highly
competitive and may become more competitive in the future. We
compete with numerous other companies that provide long-term and
rehabilitative care alternatives such as home healthcare
agencies, life care at home, facility-based service programs,
retirement communities, convalescent centers and other
independent living, assisted living and skilled nursing
providers, including not-for-profit entities. We have
experienced and expect to continue to experience increased
competition in our efforts to acquire and operate skilled
nursing facilities. Consequently, we may encounter increased
competition that could limit our ability to attract new
patients, raise patient fees or expand our business.
23
In addition, if overbuilding in the skilled nursing industry in
the markets in which we operate were to occur, it could reduce
the occupancy rates of existing facilities and, in some cases,
might reduce the private rates that we charge for our services.
Changes
in federal and state employment-related laws and regulations
could increase our cost of doing business.
Our operations are subject to a variety of federal and state
employment-related laws and regulations, including, but not
limited to, the U.S. Fair Labor Standards Act which governs
such matters as minimum wages, overtime and other working
conditions, the Americans with Disabilities Act (ADA) and
similar state laws that provide civil rights protections to
individuals with disabilities in the context of employment,
public accommodations and other areas, the National Labor
Relations Act, regulations of the Equal Employment Opportunity
Commission, regulations of the Office of Civil Rights,
regulations of state Attorneys General, family leave mandates
and a variety of similar laws enacted by the federal and state
governments that govern these and other employment law matters.
Because labor represents such a large portion of our operating
costs, changes in federal and state employment-related laws and
regulations could increase our cost of doing business.
The compliance costs associated with these laws and evolving
regulations could be substantial. For example, all of our
facilities are required to comply with the ADA. The ADA has
separate compliance requirements for public
accommodations and commercial properties, but
generally requires that buildings be made accessible to people
with disabilities. Compliance with ADA requirements could
require removal of access barriers and non-compliance could
result in imposition of government fines or an award of damages
to private litigants. Further legislation may impose additional
burdens or restrictions with respect to access by disabled
persons. In addition, federal proposals to introduce a system of
mandated health insurance and flexible work time and other
similar initiatives could, if implemented, adversely affect our
operations. We also may be subject to employee-related claims
such as wrongful discharge, discrimination or violation of equal
employment law. While we are insured for these types of claims,
we could experience damages that are not covered by our
insurance policies or that exceed our insurance limits, and we
may be required to pay such damages directly, which would
negatively impact our cash flow from operations.
Compliance
with federal and state fair housing, fire, safety and other
regulations may require us to make unanticipated expenditures,
which could be costly to us.
We must comply with the federal Fair Housing Act and similar
state laws, which prohibit us from discriminating against
individuals on certain bases in any of our practices if it would
cause such individuals to face barriers in gaining residency in
any of our facilities. Additionally, the Fair Housing Act and
other similar state laws require that we advertise our services
in such a way that we promote diversity and not limit it. We may
be required, among other things, to change our marketing
techniques to comply with these requirements.
In addition, we are required to operate our facilities in
compliance with applicable fire and safety regulations, building
codes and other land use regulations and food licensing or
certification requirements as they may be adopted by
governmental agencies and bodies from time to time. Like other
healthcare facilities, our skilled nursing facilities are
subject to periodic surveys or inspections by governmental
authorities to assess and assure compliance with regulatory
requirements. Surveys occur on a regular (often annual or
biannual) schedule, and special surveys may result from a
specific complaint filed by a patient, a family member or one of
our competitors. We may be required to make substantial capital
expenditures to comply with these requirements.
24
We are
subject to environmental and occupational health and safety
regulations, which may subject us to sanctions, penalties and
increased costs.
We are subject to a wide variety of federal, state and local
environmental and occupational health and safety laws and
regulations. The types of regulatory requirements to which we
are subject include, but are not limited to:
|
|
|
|
|
air and water quality control requirements;
|
|
|
|
occupational health and safety requirements (such as standards
regarding blood-borne pathogens and ergonomics) and waste
management requirements;
|
|
|
|
specific regulatory requirements applicable to asbestos, mold,
lead-based paint and underground storage tanks; and
|
|
|
|
requirements for providing notice to employees and members of
the public about hazardous materials and wastes.
|
If we fail to comply with these and other standards, we may be
subject to sanctions and penalties. In addition, complying with
these and other standards may increase our cost of doing
business.
We
depend largely upon reimbursement from third-party payors, and
our revenue, financial condition and results of operations could
be negatively impacted by any changes in the acuity mix of
patients in our facilities as well as payor mix and payment
methodologies.
Our revenue is affected by the percentage of our patients who
require a high level of skilled nursing and rehabilitative care,
whom we refer to as high acuity patients, and by our mix of
payment sources. Changes in the acuity level of patients we
attract, as well as our payor mix among Medicaid, Medicare,
private payors and managed care companies, significantly affect
our profitability because we generally receive higher
reimbursement rates for high acuity patients and because the
payors reimburse us at different rates. Governmental payment
programs are subject to statutory and regulatory changes,
retroactive rate adjustments, administrative or executive orders
and government funding restrictions, all of which may materially
increase or decrease the rate of program payments to us for our
services. For the years ended December 31, 2007 and 2006,
74% and 75% of our revenue, respectively, was provided by
government payors that reimburse us at predetermined rates. If
our labor or other operating costs increase, we will be unable
to recover such increased costs from government payors.
Accordingly, if we fail to maintain our proportion of high
acuity patients or if there is any significant increase in the
percentage of our patients for whom we receive Medicaid
reimbursement, our results of operations may be adversely
affected.
Initiatives undertaken by major insurers and managed care
companies to contain healthcare costs may adversely affect our
business. These payors attempt to control healthcare costs by
contracting with healthcare providers to obtain services on a
discounted basis. We believe that this trend will continue and
may limit reimbursements for healthcare services. If insurers or
managed care companies from whom we receive substantial payments
were to reduce the amounts they pay for services, we may lose
patients if we choose not to renew our contracts with these
insurers at lower rates.
Increased
competition for, or a shortage of, nurses and other skilled
personnel could increase our staffing and labor costs and
subject us to monetary fines.
Our success depends upon our ability to retain and attract
nurses, Certified Nurse Assistants (CNAs) and therapists. Our
success also depends upon our ability to retain and attract
skilled management personnel who are responsible for the
day-to-day operations of each of our facilities. Each facility
has a facility leader responsible for the overall day-to-day
operations of the facility, including quality of care, social
services and financial performance. Depending upon the size of
the facility, each facility leader is supported by facility
staff who are directly responsible for day-to-day care of the
patients and either facility staff or regional support to
oversee the facilitys marketing and community outreach
programs. Other key positions supporting each facility may
include individuals responsible for physical, occupational and
speech therapy, food service and
25
maintenance. We compete with various healthcare service
providers, including other skilled nursing providers, in
retaining and attracting qualified and skilled personnel.
We operate one or more skilled nursing facilities in the states
of California, Arizona, Texas, Washington, Utah and Idaho. With
the exception of Utah, which follows federal regulations, each
of these states has established minimum staffing requirements
for facilities operating in that state. In California, the
California Department of Health Services (DHS) enforces
legislation that requires each skilled nursing facility to
provide a minimum of 3.2 nursing hours per patient day. DHS
enforces this requirement primarily through
on-site
reviews conducted during periodic licensing and certification
surveys and in response to complaints. If a facility is
determined to be out of compliance with this minimum staffing
requirement, DHS may issue a notice of deficiency, or a
citation, depending on the impact on patient care. A citation
carries with it the imposition of monetary fines that can range
from $100 to $100,000 per citation. The issuance of either a
notice of deficiency or a citation requires the facility to
prepare and implement an acceptable plan of correction. If we
are unable to satisfy the minimum staffing requirements required
by DHS, we could be subject to significant monetary fines. In
addition, if DHS were to issue regulations which materially
change the way compliance with the minimum staffing standard is
calculated or enforced, our labor costs could increase and the
current shortage of healthcare workers could impact us more
significantly.
Washington requires that at least one registered nurse directly
supervise resident care for a minimum of 16 hours per day,
seven days per week, and that one registered nurse or licensed
practical nurse directly supervise resident care during the
remaining eight hours per day, seven days per week. State
regulators may inspect skilled nursing facilities at any time to
verify compliance with these requirements. If deficiencies are
found, regulators may issue a citation and require the facility
to prepare and execute a plan of correction. Failure to
satisfactorily complete a plan of correction can result in civil
fines of between $50 and $3,000 per day or between $1,000 and
$3,000 per instance. Failure to correct deficiencies can also
result in the suspension, revocation or nonrenewal of the
skilled nursing facilitys license. In addition,
deficiencies can result in the suspension of resident admissions
and/or the
termination of Medicaid participation. If we are unable to
satisfy the minimum staffing requirements in Washington, we
could be subject to monetary fines and potential loss of license.
In Idaho, skilled nursing facilities with 59 or fewer residents
must provide an average of 2.4 nursing hours per resident per
day, including the supervising nurses hours. Skilled
nursing facilities with 60 or more residents must provide an
average of 2.4 nursing hours per resident per day, excluding the
supervising nurses hours. A facility complies with these
requirements if the total nursing hours for the previous seven
days equal or exceed the minimum staffing ratio for the period,
averaged on a daily basis, if the facility has received prior
approval to calculate nursing hours in this manner. State
regulators may inspect at any time to verify compliance with
these requirements. If any deficiencies are found and not timely
or adequately corrected, regulators can revoke the
facilitys skilled nursing facility license. If we are
unable to satisfy the minimum staffing requirements in Idaho, we
could be subject to potential loss of our license.
Texas requires that a facility maintain a ratio of one licensed
nursing staff person for each 20 residents for every
24 hour period, or a minimum of 0.4 licensed-care hours per
resident day. State regulators may inspect a facility at any
time to verify compliance with these requirements. Uncorrected
deficiencies can result in the civil fines of between $100 and
$10,000 per day per deficiency. Failure to correct deficiencies
can further result in the revocation of the facilitys
skilled nursing facility license. In addition, deficiencies can
result in the suspension of patient admissions
and/or the
termination of Medicaid participation. If we are unable to
satisfy the minimum staffing requirements in Texas, we could be
subject to monetary fines and potential loss of our license.
Arizona requires that at least one nurse must be present and
responsible for providing direct care to not more than 64
residents. State regulators may impose civil fines for a
facilitys failure to comply with the laws and regulations
governing skilled nursing facilities. Violations can result in
civil fines in an amount not to exceed $500 per violation. Each
day that a violation occurs constitutes a separate violation. In
addition, such noncompliance can result in the suspension or
revocation of the facilitys license. If we are unable to
satisfy the minimum staffing requirements in Arizona, we could
be subject to fines
and/or
revocation of license.
26
Utah has no state-specific minimum staffing requirement beyond
those required by federal regulations. Federal law requires that
a facility have sufficient nursing staff to provide nursing and
related services. Sufficient staff means, unless waived under
certain circumstances, a licensed nurse to function as the
charge nurse, and the services of a registered nurse for at
least eight consecutive hours per day, seven days per week.
Failure to comply with these requirements can, among other
things, jeopardize a facilitys compliance with the
conditions of participation under relevant state and federal
healthcare programs.
We have hired personnel, including skilled nurses and
therapists, from outside the United States. If immigration laws
are changed, or if new and more restrictive government
regulations proposed by the Department of Homeland Security are
enacted, our access to qualified and skilled personnel may be
limited. Increased competition for or a shortage of nurses or
other trained personnel, or general inflationary pressures may
require that we enhance our pay and benefits packages to compete
effectively for such personnel. We may not be able to offset
such added costs by increasing the rates we charge to our
patients. Turnover rates and the magnitude of the shortage of
nurses or other trained personnel vary substantially from
facility to facility. An increase in costs associated with, or a
shortage of, skilled nurses, could negatively impact our
business. In addition, if we fail to attract and retain
qualified and skilled personnel, our ability to conduct our
business operations effectively would be harmed.
We are
subject to litigation that could result in significant legal
costs and large settlement amounts or damage
awards.
The skilled nursing business involves a significant risk of
liability given the age and health of our patients and residents
and the services we provide. We and others in our industry are
subject to a large and increasing number of claims and lawsuits,
including professional liability claims, alleging that our
services have resulted in personal injury, elder abuse, wrongful
death or other related claims. The defense of these lawsuits may
result in significant legal costs, regardless of the outcome,
and can result in large settlement amounts or damage awards.
Plaintiffs tend to sue every healthcare provider who may have
been involved in the patients care and, accordingly, we
respond to multiple lawsuits and claims every year.
In addition, plaintiffs attorneys have become increasingly
more aggressive in their pursuit of claims against healthcare
providers, including skilled nursing providers and other
long-term care companies, and have employed a wide variety of
advertising and publicity strategies. Among other things, these
strategies include establishing their own Internet websites,
paying for premium advertising space on other websites, paying
Internet search engines to optimize their plaintiff solicitation
advertising so that it appears in advantageous positions on
Internet search results, including results from searches for our
company and facilities, using newspaper, magazine and television
ads targeted at customers of the healthcare industry generally,
as well as at customers of specific providers, including us.
From time to time, law firms claiming to specialize in long-term
care litigation have named us, our facilities and other specific
healthcare providers and facilities in their advertising and
solicitation materials. These advertising and solicitation
activities could result in more claims and litigation, which
could increase our liability exposure and legal expenses, divert
the time and attention of our personnel from day-to-day business
operations, and materially and adversely affect our financial
condition and results of operations.
Certain lawsuits filed on behalf of patients of long-term care
facilities for alleged negligence
and/or
alleged abuses have resulted in large damage awards against
other companies, both in and related to our industry. In
addition, there has been an increase in the number of class
action suits filed against long-term and rehabilitative care
companies. A class action suit was previously filed against us
alleging, among other things, violations of certain California
Health and Safety Code provisions and a violation of the
California Consumer Legal Remedies Act at certain of our
facilities. We settled this class action suit and this
settlement was approved by the affected class and the Court in
April 2007. However, we could be subject to similar actions in
the future.
In addition to the class action, professional liability and
other types of lawsuits and claims described above, we are also
subject to potential lawsuits under the Federal False Claims Act
and comparable state laws governing submission of fraudulent
claims for services to any healthcare program (such as Medicare)
or payor.
27
These lawsuits, which may be initiated by the government or by a
private party asserting direct knowledge of the claimed fraud or
misconduct, can result in the imposition on a company of
significant monetary damages, fines and attorney fees (a portion
of which may be awarded to the private parties who successfully
identify the subject practices), as well as significant legal
expenses and other costs to the company in connection with
defending against such claims. Insurance is not available to
cover such losses. Penalties for Federal False Claims Act
violations include fines ranging from $5,500 to $11,000 for each
false claim, plus up to three times the amount of damages
sustained by the federal government. A violation may also
provide the basis for exclusion from federally-funded healthcare
programs. If one of our facilities or key employees were
excluded from such participation, such exclusion could have a
correlative negative impact on our financial performance. In
addition, some states, including California, Arizona and Texas,
have enacted similar whistleblower and false claims laws and
regulations.
In addition, the DRA created incentives for states to enact
anti-fraud legislation modeled on the Federal False Claims Act.
The DRA sets forth standards for state false claims acts to
meet, including: (a) liability to the state for false or
fraudulent claims with respect to any expenditure described in
the Medicaid program; (b) provisions at least as effective
as federal provisions in rewarding and facilitating
whistleblower actions; (c) requirements for filing actions
under seal for sixty days with review by the states
attorney general; and (d) civil penalties no less than
authorized under the federal statutes. As such, we could face
increased scrutiny, potential liability and legal expenses and
costs based on claims under state false claims acts in existing
and future markets in which we do business. Any of this
potential litigation could result in significant legal costs and
large settlement amounts or damage awards.
In addition, we contract with a variety of landlords, lenders,
vendors, suppliers, consultants and other individuals and
businesses. These contracts typically contain covenants and
default provisions. If the other party to one or more of our
contracts were to allege that we have violated the contract
terms, we could be subject to civil liabilities. In one case,
one of our landlords has filed suit alleging we are in default
under one of our facility leases and is claiming damages arising
from the alleged default. If we are unsuccessful in defending
the litigation, we could be required to pay significant damages,
which we believe have been adequately reserved for,
and/or
submit to other remedies available to the landlord under the
lease agreement or applicable laws, which could have a material
adverse effect on our financial condition and results of
operations.
Were litigation to be instituted against one or more of our
subsidiaries, a successful plaintiff might attempt to hold us or
another subsidiary liable for the alleged wrongdoing of the
subsidiary principally targeted by the litigation. If a court in
such litigation decided to disregard the corporate form, the
resulting judgment could increase our liability and adversely
affect our financial condition and results of operations.
As
Medicare and Medicaid certified providers, our operating
subsidiaries undergo periodic audits and probe
reviews by government agents, which can result in
recoupments of prior revenue of the government, cause further
reimbursements to be delayed or held and could result in civil
or criminal sanctions.
Our facilities undergo regular claims submission audits by
government reimbursement programs in the normal course of their
business, and such audits can result in adjustments to their
past billings and reimbursements from such programs. In addition
to such audits, several of our facilities have recently
participated in more intensive probe reviews as
described above, conducted by our Medicare fiscal intermediary.
Some of these probe reviews identified patient miscoding,
documentation deficiencies and other errors in recordkeeping and
Medicare billing. If the government or court were to conclude
that such errors and deficiencies constituted criminal
violations, or were to conclude that such errors and
deficiencies resulted in the submission of false claims to
federal healthcare programs, or if it were to discover other
problems in addition to the ones identified by the probe reviews
that rose to actionable levels, we and certain of our officers
might face potential criminal charges
and/or civil
claims, administrative sanctions and penalties for amounts that
could be material to our business, results of operations and
financial condition. Such amounts could include claims for
treble damages and penalties of up to $11,000 per false claim
submitted to a federal healthcare program.
28
In addition, we
and/or some
of our key personnel could be temporarily or permanently
excluded from future participation in state and federal
healthcare reimbursement programs such as Medicaid and Medicare.
In any event, it is likely that a governmental investigation
alone, regardless of its outcome, would divert material time,
resources and attention from our management team and our staff,
and could have a materially detrimental impact on our results of
operations during and after any such investigation or
proceedings.
The
U.S. Department of Justice is conducting an investigation into
the billing and reimbursement processes of some of our operating
subsidiaries, which could adversely affect our operations and
financial condition.
In March 2007, we and certain of our officers received a series
of notices from our bank indicating that the United States
Attorney for the Central District of California had issued an
authorized investigative demand, a request for records similar
to a subpoena, to our bank requesting documents related to
financial transactions involving us, ten of our operating
subsidiaries, an outside investor group, and certain of our
current and former officers. The U.S. Attorney voluntarily
rescinded the demand before the bank delivered any documents.
Subsequently, in June 2007, the U.S. Attorney sent a letter
to one of our current employees requesting a meeting. The letter
indicated that the U.S. Attorney and the
U.S. Department of Health and Human Services Office of
Inspector General were conducting an investigation of claims
submitted to the Medicare program for rehabilitation services
provided at our skilled nursing facilities. Although both we and
the employee offered to cooperate, the U.S. Attorney later
withdrew its meeting request. From these contacts, we believed
that an investigation was underway, but to date we have been
unable to determine the exact cause or nature of the
U.S. Attorneys interest in us or our subsidiaries,
and until recently we have been unable to even verify whether
the investigation was continuing.
On December 17, 2007, we were informed by
Deloitte & Touche LLP, our independent registered
public accounting firm that the U.S. Attorney served a
grand jury subpoena on Deloitte & Touche LLP, relating
to The Ensign Group, Inc., and several of our operating
subsidiaries. The subpoena confirmed our previously reported
belief that the U.S. Attorney is conducting an
investigation involving certain of our operating subsidiaries.
Based on these most recent events, we believe that the United
States Government may be conducting parallel criminal, civil and
administrative investigations involving The Ensign Group and one
or more of our skilled nursing facilities. To our knowledge,
however, neither The Ensign Group, Inc. nor any of its operating
subsidiaries or employees has been formally charged with any
wrongdoing, served with any related subpoenas or requests, or
directly notified of any concerns or investigations by the
U.S. Attorney or any government agency. Subsequently, in
February 2008, the U.S. Attorney contacted two additional
current employees. Both we and all three of the employees
contacted have offered to cooperate and meet with the
U.S. Attorney. To date, the U.S. Attorneys
office has declined to provide us with any specific information
with respect to this matter, other than to confirm that an
investigation is ongoing. We have continued to request a meeting
with the U.S. Attorney to discuss the grand jury subpoena,
our internal investigation described below, and any specific
allegations or concerns they may have. We cannot predict or
provide any assurance as to the possible outcome of the
investigation or any possible related proceedings, or as to the
possible outcome of any qui tam litigation that may
follow, nor can we estimate the possible loss or range of loss
that may result from any such proceedings and, therefore, we
have not recorded any related accruals. To the extent the
U.S. Attorneys office elects to pursue this matter,
or if the investigation has been instigated by a qui tam
relator who elects to pursue the matter, our business,
financial condition and results of operations could be
materially and adversely affected and our stock price could
decline.
We
conducted an internal investigation into the billing and
reimbursement processes of some of our operating
subsidiaries.
We initiated an internal investigation in November 2006 when we
became aware of an allegation of possible reimbursement
irregularities at one or more of our facilities. We retained
outside counsel to assist us in looking into these matters. We
and our outside counsel have concluded this investigation
without identifying any systemic or patterns and practices of
fraudulent or intentional misconduct. We made observations at
certain facilities regarding areas of potential improvement in
some of our recordkeeping and billing practices,
29
and have implemented measures, some of which were already
underway before the investigation began, that we believe will
strengthen our recordkeeping and billing processes. None of
these additional findings or observations appears to be rooted
in fraudulent or intentional misconduct. We continue to evaluate
the measures we have implemented for effectiveness, and we are
continuing to seek ways to improve these processes.
As a byproduct of our investigation we identified a limited
number of selected Medicare claims for which adequate backup
documentation could not be located or for which other billing
deficiencies exist. We, with the assistance of independent
consultants experienced in Medicare billing, completed a billing
review on these claims. To the extent missing documentation was
not located, we treated the claims as overpayments. Consistent
with healthcare industry accounting practices, we record any
charge for refunded payments against revenue in the period in
which the claim adjustment becomes known. During the year ended
December 31, 2007, we accrued a liability of approximately
$224,000, plus interest, for selected Medicare claims for which
documentation has not been located or for other billing
deficiencies identified to date. The remittance of these claims
started with the filing of our Quarterly Credit Balance Reports
which were submitted to our Medicare Fiscal Intermediary on or
before January 31, 2008, and will be completed with the
next Quarterly Credit Balance Reports which will be submitted on
or before April 30, 2008. If additional reviews result in
identification and quantification of additional amounts to be
refunded, we would accrue additional liabilities for claim costs
and interest, and repay any amounts due in normal course. If
future investigations ultimately result in findings of
significant billing and reimbursement noncompliance which could
require us to record significant additional provisions or remit
payments, our business, financial condition and results of
operations could be materially and adversely affected and our
stock price could decline.
We may
be unable to complete future facility acquisitions at attractive
prices or at all, which may adversely affect our revenue; we may
also elect to dispose of underperforming or non-strategic
operations, which would also decrease our revenue.
To date, our revenue growth has been significantly driven by our
acquisition of new facilities. Subject to general market
conditions and the availability of essential resources and
leadership within our company, we continue to seek both single-
and multi-facility acquisition opportunities that are consistent
with our geographic, financial and operating objectives.
We face competition for the acquisition of facilities and expect
this competition to increase. Based upon factors such as our
ability to identify suitable acquisition candidates, the
purchase price of the facilities, prevailing market conditions,
the availability of leadership to manage new facilities and our
own willingness to take on new operations, the rate at which we
have historically acquired facilities has fluctuated
significantly. In the future, we anticipate the rate at which we
may acquire facilities will continue to fluctuate, which may
affect our revenue.
We have also historically acquired a few facilities, either
because they were included in larger, indivisible groups of
facilities or under other circumstances, which were or have
proven to be non-strategic or less desirable, and we may
consider disposing of such facilities or exchanging them for
facilities which are more desirable. To the extent we dispose of
such a facility without simultaneously acquiring a facility in
exchange, our revenues might decrease.
We may
not be able to successfully integrate acquired facilities into
our operations, and we may not achieve the benefits we expect
from any of our facility acquisitions.
We may not be able to successfully or efficiently integrate new
acquisitions with our existing operations, culture and systems.
The process of integrating acquired facilities into our existing
operations may result in unforeseen operating difficulties,
divert managements attention from existing operations, or
require an unexpected commitment of staff and financial
resources, and may ultimately be unsuccessful. Existing
facilities available for acquisition frequently serve or target
different markets than those that we currently serve. We also
may determine that renovations of acquired facilities and
changes in staff and operating management personnel are
necessary to successfully integrate those facilities into our
existing operations. We
30
may not be able to recover the costs incurred to reposition or
renovate newly acquired facilities. The financial benefits we
expect to realize from many of our acquisitions are largely
dependent upon our ability to improve clinical performance,
overcome regulatory deficiencies, rehabilitate or improve the
reputation of the facilities in the community, increase and
maintain occupancy, control costs, and in some cases change the
patient acuity mix. If we are unable to accomplish any of these
objectives at facilities we acquire, we will not realize the
anticipated benefits and we may experience lower-than
anticipated profits, or even losses.
In 2006, we acquired ten skilled nursing facilities and one
assisted living facility with a total of 1,160 beds. In 2007, we
acquired three skilled nursing facilities and one campus that
offers both skilled nursing and assisted living services, with a
total of 508 beds. This growth has placed and will continue to
place significant demands on our current management resources.
Our ability to manage our growth effectively and to successfully
integrate new acquisitions into our existing business will
require us to continue to expand our operational, financial and
management information systems and to continue to retain,
attract, train, motivate and manage key employees, including
facility-level leaders and our local directors of nursing. We
may not be successful in attracting qualified individuals
necessary for any future acquisitions to be successful, and our
management team may expend significant time and energy working
to attract qualified personnel to manage facilities we may
acquire in the future. Also, the newly acquired facilities may
require us to spend significant time improving services that
have historically been substandard, and if we are unable to
improve such facilities quickly enough, we may be subject to
litigation
and/or loss
of licensure or certification. If we are not able to
successfully overcome these and other integration challenges, we
may not achieve the benefits we expect from any of our facility
acquisitions, and our business may suffer.
In
undertaking acquisitions, we may be adversely impacted by costs,
liabilities and regulatory issues that may adversely affect our
operations.
In undertaking acquisitions, we also may be adversely impacted
by unforeseen liabilities attributable to the prior providers
who operated those facilities, against whom we may have little
or no recourse. Many facilities we have historically acquired
were underperforming financially and had clinical and regulatory
issues. Even though we believe we have improved operations and
patient care at facilities that we have acquired, we still may
face post-acquisition regulatory issues, including, without
limitation, payment recoupment related to our predecessors
prior noncompliance
and/or our
own inability to quickly bring non-compliant facilities into
full compliance. Diligence materials pertaining to acquisition
targets, especially the underperforming facilities that often
represent the greatest opportunity for return, are often
inadequate, inaccurate or impossible to obtain, sometimes
requiring us to make acquisition decisions with incomplete
information. Despite our due diligence procedures, facilities
that we may acquire in the future may generate unexpectedly low
returns, may cause us to incur substantial losses, or may not
meet a risk profile that our investors find acceptable. For
example, in October 2006 we acquired a facility that had a
history of intermittent noncompliance. Based, in part, on the
facilitys compliance history dating before our acquisition
of the facility, local state survey agencies recommended to CMS
that the facility be placed on special focus facility status.
The facility will remain on special focus until it is able to
successfully meet a number of heightened regulatory
requirements. In addition, in July of 2006, we acquired a
facility which had a history of non-compliance. Although the
facility has since been surveyed by the local state survey
agency and the survey met the heightened requirements to
graduate from the special focus facility program, the state
officials nevertheless recommend that the facility remain on the
special focus facility status based on a serious incidence of
non-compliance which occurred prior to our acquisition of the
facility. This facility will remain in special focus until it is
able to successfully meet the heightened regulatory requirements
which will include passing two surveys under the heightened
requirements.
In addition, we might encounter unanticipated difficulties and
expenditures relating to any of the acquired facilities,
including contingent liabilities. For example, when we acquire a
facility, we generally assume the facilitys existing
Medicare provider number for purposes of billing Medicare for
services. If CMS later determined that the prior owner of the
facility had received overpayments from Medicare for the period
of time during which it operated the facility, or had incurred
fees in connection with the operation of the facility, CMS could
hold us liable for repayment of the overpayments or fines. If
the prior operator is defunct or
31
otherwise unable to reimburse us, we may be unable to recover
these funds. We may be unable to improve every facility that we
acquire. In addition, operation of these facilities may divert
management time and attention from other operations and
priorities, negatively impact cash flows, result in adverse or
unanticipated accounting charges, or otherwise damage other
areas of our company if they are not timely and adequately
improved.
We are
subject to reviews relating to Medicare overpayments, which
could result in recoupment to the federal government of Medicare
revenue.
We are subject to reviews relating to Medicare services,
billings and potential overpayments. Recent probe reviews, as
described above, resulted in Medicare revenue recoupment, net of
appeal recoveries, to the federal government and related
resident copayments of approximately $35,000 during the year
ended December 31, 2007, $253,000 in fiscal year 2006 and
$215,000 in fiscal year 2005. We anticipate that these probe
reviews will increase in frequency in the future. In addition,
two of our facilities are currently on prepayment review, and
others may be placed on prepayment review in the future. If a
facility fails prepayment review, the facility could then be
subject to undergo targeted review, which is a review that
targets perceived claims deficiencies. We have no facilities
that are currently undergoing targeted review.
Separately, the federal government has also introduced a program
that utilizes independent contractors (other than the fiscal
intermediaries) to identify and recoup Medicare overpayments.
These recovery audit contractors are paid a contingent fee on
recoupments. This pilot program is now being expanded by CMS and
we anticipate that the number of overpayment reviews will
increase in the future, and that the reviewers could be more
aggressive in making claims for recoupment. One of our
facilities has been subjected to review under this program,
resulting in a recoupment to the federal government of
approximately $12,000. If future Medicare reviews result in
revenue recoupment to the federal government, it would have an
adverse effect on our financial results.
Potential
sanctions and remedies based upon alleged regulatory
deficiencies could negatively affect our financial condition and
results of operations.
We have received notices of potential sanctions and remedies
based upon alleged regulatory deficiencies from time to time,
and such sanctions have been imposed on some of our facilities.
CMS has included two of our facilities on its recently released
list of special focus facilities, which are described above and
other facilities may be identified for such status in the
future. From time to time, we have opted to voluntarily stop
accepting new patients pending completion of a new state survey,
in order to avoid possible denial of payment for new admissions
during the deficiency cure period, or simply to avoid straining
staff and other resources while retraining staff, upgrading
operating systems or making other operational improvements. In
the past, some of our facilities have been in denial of payment
status due to findings of continued regulatory deficiencies,
resulting in an actual loss of the revenue associated with the
Medicare and Medicaid patients admitted after the denial of
payment date. Additional sanctions could ensue and, if imposed,
these sanctions, entailing various remedies up to and including
decertification, would further negatively affect our financial
condition and results of operations.
The intensified and evolving enforcement environment impacts
providers like us because of the increase in the scope or number
of inspections or surveys by governmental authorities and the
severity of consequent citations for alleged failure to comply
with regulatory requirements. We also divert personnel resources
to respond to federal and state investigations and other
enforcement actions. The diversion of these resources, including
our management team, clinical and compliance staff, and others
take away from the time and energy that these individuals could
otherwise spend on routine operations. As noted, from time to
time in the ordinary course of business, we receive deficiency
reports from state and federal regulatory bodies resulting from
such inspections or surveys. The focus of these deficiency
reports tends to vary from year to year. Although most
inspection deficiencies are resolved through an
agreed-upon
plan of corrective action, the reviewing agency typically has
the authority to take further action against a licensed or
certified facility, which could result in the imposition of
fines, imposition of a provisional or conditional license,
suspension or revocation of a
32
license, suspension or denial of payment for new admissions,
loss of certification as a provider under state or federal
healthcare programs, or imposition of other sanctions, including
criminal penalties. In the past, we have experienced inspection
deficiencies that have resulted in the imposition of a
provisional license and could experience these results in the
future. We currently have one facility whereby the provisional
license status is the result of inspection deficiencies.
Furthermore, in some states citations in one facility impact
other facilities in the state. Revocation of a license at a
given facility could therefore impair our ability to obtain new
licenses or to renew existing licenses at other facilities,
which may also trigger defaults or cross-defaults under our
leases and our credit arrangements, or adversely affect our
ability to operate or obtain financing in the future. If state
or federal regulators were to determine, formally or otherwise,
that one facilitys regulatory history ought to impact
another of our existing or prospective facilities, this could
also increase costs, result in increased scrutiny by state and
federal survey agencies, and even impact our expansion plans.
Therefore, our failure to comply with applicable legal and
regulatory requirements in any single facility could negatively
impact our financial condition and results of operations as a
whole.
We may
not be successful in generating internal growth at our
facilities by expanding occupancy at these facilities. We also
may be unable to improve patient mix at our
facilities.
Overall occupancy across all of our facilities was approximately
78% and 81% at December 31, 2007 and December 31,
2006, respectively, leaving opportunities for internal growth
without the acquisition or construction of new facilities.
Because a large portion of our costs are fixed, a decline in our
occupancy could adversely impact our financial performance. In
addition, our profitability is impacted heavily by our patient
mix. We generally generate greater profitability from
non-Medicaid patients. If we are unable to maintain or increase
the proportion of non-Medicaid patients in our facilities, our
financial performance could be adversely affected.
Termination
of our patient admission agreements and the resulting vacancies
in our facilities could cause revenue at our facilities to
decline.
Most state regulations governing skilled nursing and assisted
living facilities require written patient admission agreements
with each patient. Several of these regulations also require
that each patient have the right to terminate the patient
agreement for any reason and without advance notice. Consistent
with these regulations, all of our skilled nursing patient
agreements allow patients to terminate their agreements without
notice, and all of our assisted living resident agreements allow
residents to terminate their agreements upon thirty days
notice. Patients and residents terminate their agreements from
time to time for a variety of reasons, causing some fluctuations
in our overall occupancy as patients and residents are admitted
and discharged in normal course. If an unusual number of
patients or residents elected to terminate their agreements
within a short time, occupancy levels at our facilities could
decline. As a result, beds may be unoccupied for a period of
time, which would have a negative impact on our revenue,
financial condition and results of operations.
We
face significant competition from other healthcare providers and
may not be successful in attracting patients and residents to
our facilities.
The skilled nursing and assisted living industries are highly
competitive, and we expect that these industries may become
increasingly competitive in the future. Our skilled nursing
facilities compete primarily on a local and regional basis with
many long-term care providers, from national and regional
multi-facility providers that have substantially greater
financial resources to small providers who operate a single
nursing facility. We also compete with other skilled nursing and
assisted living facilities, and with inpatient rehabilitation
facilities, long-term acute care hospitals, home healthcare and
other similar services and care alternatives. Increased
competition could limit our ability to attract and retain
patients, attract and retain skilled personnel, maintain or
increase private pay and managed care rates or expand our
business. Our ability to compete successfully varies from
location to location depending upon a number of factors,
including:
|
|
|
|
|
our ability to attract and retain qualified facility leaders,
nursing staff and other employees;
|
|
|
|
the number of competitors in the local market;
|
|
|
|
the types of services available;
|
33
|
|
|
|
|
our local reputation for quality care of patients;
|
|
|
|
the commitment and expertise of our staff;
|
|
|
|
our local service offerings; and
|
|
|
|
the cost of care in each locality and the physical appearance,
location, age and condition of our facilities.
|
We may not be successful in attracting patients to our
facilities, particularly Medicare, managed care, and private pay
patients who generally come to us at higher reimbursement rates.
Some of our competitors have greater financial and other
resources than us, may have greater brand recognition and may be
more established in their respective communities than we are.
Competing skilled nursing companies may also offer newer
facilities or different programs or services than we do and may
thereby attract current or potential patients. Other competitors
may accept a lower margin, and, therefore, present significant
price competition for managed care and private pay patients. In
addition, some of our competitors operate on a not-for-profit
basis or as charitable organizations and have the ability to
finance capital expenditures on a tax-exempt basis or through
the receipt of charitable contributions, neither of which are
available to us.
Competition
for the acquisition of strategic assets from buyers with lower
costs of capital than us or that have lower return expectations
than we do could limit our ability to compete for strategic
acquisitions and therefore to grow our business
effectively.
Several real estate investment trusts (REITs), other real estate
investment companies, institutional lenders who have not
traditionally taken ownership interests in operating businesses
or real estate, as well as several skilled nursing and assisted
living facility providers, have similar asset acquisition
objectives as we do, along with greater financial resources and
lower costs of capital than we are able to obtain. This may
increase competition for acquisitions that would be suitable to
us, making it more difficult for us to compete and successfully
implement our growth strategy. Significant competition exists
among potential acquirers in the skilled nursing and assisted
living industries, including with REITs, and we may not be able
to successfully implement our growth strategy or complete
acquisitions, which could limit our ability to grow our business
effectively.
If we
do not achieve and maintain competitive quality of care ratings
from CMS and private organizations engaged in similar monitoring
activities, or if the frequency of CMS surveys and enforcement
sanctions increases, our business may be negatively
affected.
CMS, as well as certain private organizations engaged in similar
monitoring activities, provides comparative data available to
the public on its web site, rating every skilled nursing
facility operating in each state based upon quality-of-care
indicators. These quality-of-care indicators include such
measures as percentages of patients with infections, bedsores
and unplanned weight loss. In addition, CMS has undertaken an
initiative to increase Medicaid and Medicare survey and
enforcement activities, to focus more survey and enforcement
efforts on facilities with findings of substandard care or
repeat violations of Medicaid and Medicare standards, and to
require state agencies to use enforcement sanctions and remedies
more promptly when substandard care or repeat violations are
identified. For example, one of our facilities is now surveyed
every six months instead of every 12 to 15 months as a
result of historical survey results that may date back to prior
operators. We have found a correlation between negative Medicaid
and Medicare surveys and the incidence of professional liability
litigation. In 2006, we experienced a higher than normal number
of negative survey findings in some of our facilities. If we are
unable to achieve quality-of-care ratings that are comparable or
superior to those of our competitors, our ability to attract and
retain patients could be adversely affected.
Significant
legal actions and liability claims against us in excess of
insurance limits or outside of our insurance coverage could
subject us to increased insurance costs, litigation reserves,
operating costs and substantial uninsured
liabilities.
We maintain liability insurance policies in amounts and with
coverage limits and deductibles we believe are appropriate based
on the nature and risks of our business, historical experience,
industry standards and the
34
price and availability of coverage in the insurance market. At
any given time, we may have multiple current professional
liability cases
and/or other
types of claims pending, which is common in our industry. In the
past year, we have not paid or settled any claims in excess of
the policy limits of our insurance coverages. We may face claims
which exceed our insurance limits or are not covered by our
policies.
We also face potential exposure to other types of liability
claims, including, without limitation, directors and
officers liability, employment practices
and/or
employment benefits liability, premises liability, and vehicle
or other accident claims. Given the litigious environment in
which all businesses operate, it is impossible to fully
catalogue all of the potential types of liability claims that
might be asserted against us. As a result of the litigation and
potential litigation described above, as well as factors
completely external to our company and endemic to the skilled
nursing industry, during the past several years the overall cost
of both general and professional liability insurance to the
industry has dramatically increased, while the availability of
affordable and favorable insurance coverage has dramatically
decreased. If federal and state medical liability insurance
reforms to limit future liability awards are not adopted and
enforced, we expect that our insurance and liability costs may
continue to increase.
In some states, the law prohibits or limits insurance coverage
for the risk of punitive damages arising from professional
liability and general liability claims or litigation. Coverage
for punitive damages is also excluded under some insurance
policies. As a result, we may be liable for punitive damage
awards in these states that either are not covered or are in
excess of our insurance policy limits. Claims against us,
regardless of their merit or eventual outcome, also could
inhibit our ability to attract patients or expand our business,
and could require our management to devote time to matters
unrelated to the day-to-day operation of our business.
If we
are unable to obtain insurance, or if insurance becomes more
costly for us to obtain, our business may be adversely
affected.
It may become more difficult and costly for us to obtain
coverage for resident care liabilities and other risks,
including property and casualty insurance. For example, the
following circumstances may adversely affect our ability to
obtain insurance at favorable rates:
|
|
|
|
|
we experience higher-than-expected professional liability,
property and casualty, or other types of claims or losses;
|
|
|
|
we receive survey deficiencies or citations of
higher-than-normal scope or severity;
|
|
|
|
we acquire especially troubled operations or facilities that
present unattractive risks to current or prospective insurers;
|
|
|
|
insurers tighten underwriting standards applicable to us or our
industry; or
|
|
|
|
insurers or reinsurers are unable or unwilling to insure us or
the industry at historical premiums and coverage levels.
|
If any of these potential circumstances were to occur, our
insurance carriers may require us to significantly increase our
self-insured retention levels or pay substantially higher
premiums for the same or reduced coverage for insurance,
including workers compensation, property and casualty,
automobile, employment practices liability, directors and
officers liability, employee healthcare and general and
professional liability coverages.
With few exceptions, workers compensation and employee
health insurance costs have also increased markedly in recent
years. To partially offset these increases, we have increased
the amounts of our self-insured retention (SIR) and deductibles
in connection with general and professional liability claims. We
also have implemented a self-insurance program for workers
compensation in California, and elected non-subscriber status
for workers compensation in Texas. If we are unable to obtain
insurance, or if insurance becomes more costly for us to obtain,
our business may be adversely affected.
35
Our
self-insurance programs may expose us to significant and
unexpected costs and losses.
Since 2001, we have maintained workers compensation and
general and professional liability insurance through a
wholly-owned subsidiary insurance company, Standardbearer
Insurance Company, Ltd. (Standardbearer), to insure our SIR and
deductibles as part of a continually evolving overall risk
management strategy. In addition, from 2001 to 2002, we used
Standardbearer to reinsure a fronted professional
liability policy, and we may elect to do so again in the future.
We establish the premiums to be paid to Standardbearer, and the
loss reserves set by that subsidiary, based on an estimation
process that uses information obtained from both
company-specific and industry data. The estimation process
requires us to continuously monitor and evaluate the life cycle
of the claims. Using data obtained from this monitoring and our
assumptions about emerging trends, we, along with an independent
actuary, develop information about the size of ultimate claims
based on our historical experience and other available industry
information. The most significant assumptions used in the
estimation process include determining the trend in costs, the
expected cost of claims incurred but not reported and the
expected costs to settle or pay damages with respect to unpaid
claims. It is possible, however, that the actual liabilities may
exceed our estimates of loss. We may also experience an
unexpectedly large number of successful claims or claims that
result in costs or liability significantly in excess of our
projections. For these and other reasons, our self-insurance
reserves could prove to be inadequate, resulting in liabilities
in excess of our available insurance and self-insurance. If a
successful claim is made against us and it is not covered by our
insurance or exceeds the insurance policy limits, our business
may be negatively and materially impacted. Further, because our
SIR under our general and professional liability and workers
compensation programs applies on a per claim basis, there is no
limit to the maximum number of claims or the total amount for
which we could incur liability in any policy period.
Our self-insured liabilities are based upon estimates, and while
our management believes that the estimates of loss are
appropriate, the ultimate liability may be in excess of, or less
than, recorded amounts. Due to the inherent volatility of
actuarially determined loss estimates, it is reasonably possible
that we could experience changes in estimated losses which could
be material to net income. We believe that we have recorded
reserves for general liability, professional liability,
workers compensation and healthcare benefits, at a level
which has substantially mitigated the potential negative impact
of adverse developments
and/or
volatility. In addition, if coverage becomes too difficult or
costly to obtain from insurance carriers, we would have to
self-insure a greater portion of our risks.
In May 2006, we began self-insuring our employee health
benefits. With respect to our health benefits self-insurance, we
do not yet have a meaningful loss history by which to set
reserves or premiums, and have consequently employed general
industry data that is not specific to our own company to set
reserves and premiums. Therefore, our reserves may prove to be
insufficient and we may be exposed to significant and unexpected
losses.
The
geographic concentration of our facilities could leave us
vulnerable to an economic downturn, regulatory changes or acts
of nature in those areas.
Our facilities located in California and Arizona account for the
majority of our total revenue. As a result of this
concentration, the conditions of local economies, changes in
governmental rules, regulations and reimbursement rates or
criteria, changes in demographics, acts of nature and other
factors that may result in a decrease in demand
and/or
reimbursement for skilled nursing services in these states could
have a disproportionately adverse effect on our revenue, costs
and results of operations. Moreover, since approximately half of
our facilities are located in California, we are particularly
susceptible to revenue loss, cost increase or damage caused by
natural disasters such as fires, earthquakes or mudslides. In
addition, to the extent we acquire additional facilities in
Texas, we become more susceptible to revenue loss, cost increase
or damage caused by hurricanes or flooding. Any significant loss
due to a natural disaster may not be covered by insurance or may
exceed our insurance limits and may also lead to an increase in
the cost of insurance.
36
The
actions of a national labor union that has been pursuing a
negative publicity campaign criticizing our business may
adversely affect our revenue and our
profitability.
Unlike many other companies in our industry, we continue to
assert our right to inform our employees about our views of the
potential impact of unionization upon the workplace generally
and upon individual employees. With one exception, to our
knowledge the staffs at our facilities that have been approached
to unionize have uniformly rejected union organizing efforts.
Because a majority of certain categories of service and
maintenance employees at one of our facilities voted to accept
union representation, we have recognized the union and been
engaged in collective bargaining with that union since 2005. If
employees of other facilities decide to unionize, our cost of
doing business could increase, and we could experience contract
delays, difficulty in adapting to a changing regulatory and
economic environment, cultural conflicts between unionized and
non-unionized employees, and strikes and work stoppages, and we
may conclude that affected facilities or operations would be
uneconomical to continue operating.
The unwillingness on the part of both our management and staff
to accede to union demands for neutrality and other
concessions has resulted in a negative labor campaign by at
least one labor union, the Service Employees International Union
and its local chapter based in Oakland, California. Since 2002,
this union has prosecuted a negative retaliatory publicity
action, also known as a corporate campaign, against
us and has filed, promoted or participated in multiple legal
actions against us. The unions campaign asserts, among
other allegations, poor treatment of patients, inferior medical
services provided by our employees, poor treatment of our
employees, and health code violations by us. In addition, the
union has publicly mischaracterized actions taken by the DHS
against us and our facilities. In numerous cases, the
unions allegations have created the false impression that
violations and other events that occurred at facilities prior to
our acquisition of those facilities were caused by us. Since a
large component of our business involves acquiring
underperforming and distressed facilities, and improving the
quality of operations at these facilities, we may therefore be
associated with the past poor performance of these facilities.
This union, along with other similar agencies and organizations,
has demanded focused regulatory oversight and public boycotts of
some of our facilities. It has also attempted to pressure
hospitals, doctors, insurers and other healthcare providers and
professionals to cease doing business with or referring patients
to us. If this union or another union is successful in
convincing our patients, their families or our referral sources
to reduce or cease doing business with us, our revenue may be
reduced and our profitability could be adversely affected.
Additionally, if we are unable to attract and retain qualified
staff due to negative public relations efforts by this or other
union organizations, our quality of service and our revenue and
profits could decline. Our strategy for responding to union
allegations involves clear public disclosure of the unions
identity, activities and agenda, and rebuttals to its negative
campaign. Our ability to respond to unions, however, may be
limited by some state laws, which purport to make it illegal for
any recipient of state funds to promote or deter union
organizing. For example, such a state law passed by the
California Legislature was successfully challenged on the
grounds that it was preempted by the National Labor Relations
Act, only to have the challenge overturned by the Ninth Circuit
in 2006. The case is now before the United States Supreme Court.
If the Supreme Court upholds the Ninth Circuits ruling,
our ability to oppose unionization efforts could be hindered,
and our business could be negatively affected.
A
number of our facilities are operated under master lease
arrangements or leases that contain
cross-default
provisions, and in some cases the breach of a single facility
lease could subject multiple facilities to the same
risk.
We currently occupy approximately 10% of our facilities under
agreements that are structured as master leases. Under a master
lease, we may lease a large number of geographically dispersed
properties through an indivisible lease. With an indivisible
lease, it is difficult to restructure the composition of the
portfolio or economic terms of the lease without the consent of
the landlord. Failure to comply with Medicare or Medicaid
provider requirements is a default under several of our master
lease and debt financing instruments. In addition, other
potential defaults related to an individual facility may cause a
default of an entire master lease portfolio and could trigger
cross-default provisions in our outstanding debt arrangements
and other leases, which would have a negative impact on our
capital structure and our ability to generate future revenue,
and
37
could interfere with our ability to pursue our growth strategy.
In addition, we occupy approximately 25% of our facilities under
individual facility leases that are held by the same or related
landlords, the largest of which covers nine of our facilities
and represented 13.4% and 2.6% of our net income for the years
ended December 31, 2007 and 2006, respectively. These
leases typically contain cross-default provisions that could
cause a default at one facility to trigger a technical default
with respect to one or more other locations, potentially
subjecting us to the various remedies available to the landlords
under each of the related leases.
Failure
to generate sufficient cash flow to cover required payments or
meet operating covenants under our long-term debt, mortgages and
long-term operating leases could result in defaults under such
agreements and cross-defaults under other debt, mortgage or
operating lease arrangements, which could harm our operations
and cause us to lose facilities or experience
foreclosures.
At December 31, 2007, we had $60.6 million of
outstanding indebtedness under our Third Amended and Restated
Loan Agreement (the Term Loan), our Amended and Restated Loan
and Security Agreement, as amended (the Revolver) and mortgage
notes, plus $152.0 million of operating lease obligations.
We intend to continue financing our facilities through mortgage
financing, long-term operating leases and other types of
financing, including borrowings under our lines of credit and
future credit facilities we may obtain. The Revolver was set to
mature in March 2007, but was extended until February 22,
2008.
On February 21, 2008, we amended our Revolver by extending
the term to 2012, increasing the available credit thereunder up
to the lesser of $50.0 million or 85% of the eligible
accounts receivable, and changing the interest rate for all or
any portion of the outstanding indebtedness thereunder to any of
three options, as we may elect from time to time, (i) the
1, 2, 3 or 6 month LIBOR (at our option) plus 2.5%, or
(ii) the greater of (a) prime plus 1.0% or
(b) the federal funds rate plus 1.5% or (iii) a
floating LIBOR rate. The signed agreement is contingent on final
execution and delivery of appropriate amendatory documentation.
The Revolver contains typical representations and financial and
non-financial covenants for a loan of this type, a violation of
which could result in a default under the Revolver and could
possibly cause all amounts owed by us, including amounts due
under the Term Loan, to be declared immediately due and payable.
We may not generate sufficient cash flow from operations to
cover required interest, principal and lease payments. In
addition, from time to time the financial performance of one or
more of our mortgaged facilities may not comply with the
required operating covenants under the terms of the mortgage.
Any non-payment, noncompliance or other default under our
financing arrangements could, subject to cure provisions, cause
the lender to foreclose upon the facility or facilities securing
such indebtedness or, in the case of a lease, cause the lessor
to terminate the lease, each with a consequent loss of revenue
and asset value to us or a loss of property. Furthermore, in
many cases, indebtedness is secured by both a mortgage on one or
more facilities, and a guaranty by us. In the event of a default
under one of these scenarios, the lender could avoid judicial
procedures required to foreclose on real property by declaring
all amounts outstanding under the guaranty immediately due and
payable, and requiring us to fulfill our obligations to make
such payments. If any of these scenarios were to occur, our
financial condition would be adversely affected. For tax
purposes, a foreclosure on any of our properties would be
treated as a sale of the property for a price equal to the
outstanding balance of the debt secured by the mortgage. If the
outstanding balance of the debt secured by the mortgage exceeds
our tax basis in the property, we would recognize taxable income
on foreclosure, but would not receive any cash proceeds, which
would negatively impact our earnings and cash position. Further,
because our mortgages and operating leases generally contain
cross-default and cross-collateralization provisions, a default
by us related to one facility could affect a significant number
of other facilities and their corresponding financing
arrangements and operating leases.
Because our Term Loan, mortgage and lease obligations are fixed
expenses and secured by specific assets, and because our
revolving loan obligations are secured by virtually all of our
assets, if reimbursement rates, patient acuity mix or occupancy
levels decline, or if for any reason we are unable to meet our
loan or lease obligations, we may not be able to cover our costs
and some or all of our assets may become at risk. Our ability to
make payments of principal and interest on our indebtedness and
to make lease payments on our operating leases depends upon our
future performance, which will be subject to general economic
conditions, industry cycles and financial, business and other
factors affecting our operations, many of which
38
are beyond our control. If we are unable to generate sufficient
cash flow from operations in the future to service our debt or
to make lease payments on our operating leases, we may be
required, among other things, to seek additional financing in
the debt or equity markets, refinance or restructure all or a
portion of our indebtedness, sell selected assets, reduce or
delay planned capital expenditures or delay or abandon desirable
acquisitions. Such measures might not be sufficient to enable us
to service our debt or to make lease payments on our operating
leases. The failure to make required payments on our debt or
operating leases or the delay or abandonment of our planned
growth strategy could result in an adverse effect on our future
ability to generate revenue and sustain profitability. In
addition, any such financing, refinancing or sale of assets
might not be available on terms that are economically favorable
to us, or at all.
Our
existing credit facilities and mortgage loans contain
restrictive covenants and any default under such facilities or
loans could result in a freeze on additional advances, the
acceleration of indebtedness, the termination of leases, or
cross-defaults, any of which would negatively impact our
liquidity and inhibit our ability to grow our business and
increase revenue.
Our outstanding credit facilities and mortgage loans contain
restrictive covenants and require us to maintain or satisfy
specified coverage tests on a consolidated basis and on a
facility or facilities basis. These financial restrictions and
operating covenants include, among other things, requirements
with respect to occupancy, capital expenditures, fixed charge
coverage and net worth. The fixed charge coverage ratios are
generally calculated as EBITDA for such period, less an
aggregate of the higher of (i) unfinanced cash capital
expenditures and (ii) a capital replacement reserve equal
to $300.00 per licensed bed for such period divided by
fixed charges for such period, such as interest expenses,
payments on indebtedness, cash taxes, distributions and
dividends, and expenditures in connection with capital leases.
These restrictions may interfere with our ability to obtain
additional advances under existing credit facilities or to
obtain new financing or to engage in other business activities,
which may inhibit our ability to grow our business and increase
revenue. At times in the past we have failed to timely deliver
audited financial statements to our lender as required under our
loan covenants. In each such case, we obtained waivers from our
lender. In addition, in December 2000, we were unable to make
balloon payments due under two mortgages on one of our
facilities, but we were able to negotiate extensions with both
lenders, and paid off both loans in January 2001 as required by
the terms of the extensions. If we fail to comply with any of
our loan requirements, or if we experience any defaults, then
the related indebtedness could become immediately due and
payable prior to its stated maturity date. We may not be able to
pay this debt if it becomes immediately due and payable.
If we
decide to expand our presence in the assisted living industry,
we would become subject to risks in a market in which we have
limited experience.
The majority of our facilities have historically been skilled
nursing facilities. If we decide to expand our presence in the
assisted living industry, our existing overall business model
would change and we would become subject to risks in a market in
which we have limited experience. Although assisted living
operations generally have lower costs and higher margins than
skilled nursing, they typically generate lower overall revenue
than skilled nursing operations. In addition, assisted living
revenue is derived primarily from private payors as opposed to
government reimbursement. In most states, skilled nursing and
assisted living are regulated by different agencies, and we have
less experience with the agencies that regulate assisted living.
In general, we believe that assisted living is a more
competitive industry than skilled nursing. If we decided to
expand our presence in the assisted living industry, we would
have to change our existing business model, which could have an
adverse affect on our business.
If our
referral sources fail to view us as an attractive skilled
nursing provider, or if our referral sources otherwise refer
fewer patients, our patient base may decrease.
We rely significantly on appropriate referrals from physicians,
hospitals and other healthcare providers in the communities in
which we deliver our services to attract appropriate residents
and patients to our facilities. Our referral sources are not
obligated to refer business to us and may refer business to
other healthcare providers. We believe many of our referral
sources refer business to us as a result of the quality of our
patient
39
care and our efforts to establish and build a relationship with
our referral sources. If we lose, or fail to maintain, existing
relationships with our referral resources, fail to develop new
relationships, or if we are perceived by our referral sources as
not providing high quality patient care, our occupancy rate and
the quality of our patient mix could suffer. In addition, if any
of our referral sources have a reduction in patients whom they
can refer due to a decrease in their business, our occupancy
rate and the quality of our patient mix could suffer.
We may
need additional capital to fund our operations and finance our
growth, and we may not be able to obtain it on terms acceptable
to us, or at all, which may limit our ability to
grow.
Continued expansion of our business through the acquisition of
existing facilities, expansion of our existing facilities and
construction of new facilities may require additional capital,
particularly if we were to accelerate our acquisition and
expansion plans. Financing may not be available to us or may be
available to us only on terms that are not favorable. In
addition, some of our outstanding indebtedness and long-term
leases restrict, among other things, our ability to incur
additional debt. If we are unable to raise additional funds or
obtain additional funds on terms acceptable to us, we may have
to delay or abandon some or all of our growth strategies.
Further, if additional funds are raised through the issuance of
additional equity securities, the percentage ownership of our
stockholders would be diluted. Any newly issued equity
securities may have rights, preferences or privileges senior to
those of our common stock.
Delays
in reimbursement may cause liquidity problems.
If we experience problems with our information systems or if
issues arise with Medicare, Medicaid or other payors, we may
encounter delays in our payment cycle. From time to time, we
have experienced such delays as a result of government payors
instituting planned reimbursement delays for budget balancing
purposes or as a result of prepayment reviews. For example, in
August 2007, we experienced a four week reimbursement delay in
California due to a budget impasse in the California legislature
that was resolved in September 2007. Any future timing delay may
cause working capital shortages. As a result, working capital
management, including prompt and diligent billing and
collection, is an important factor in our results of operations
and liquidity. Our working capital management procedures may not
successfully ameliorate the effects of any delays in our receipt
of payments or reimbursements. Accordingly, such delays could
have an adverse effect on our liquidity and financial condition.
Compliance
with the regulations of the Department of Housing and Urban
Development may require us to make unanticipated expenditures
which could increase our costs.
Four of our facilities are currently subject to regulatory
agreements with the Department of Housing and Urban Development
(HUD) that give the Commissioner of HUD broad authority to
require us to be replaced as the operator of those facilities in
the event that the Commissioner determines there are operational
deficiencies at such facilities under HUD regulations. In 2006,
one of our HUD-insured mortgaged facilities did not pass its HUD
inspection. Following an unsuccessful appeal of the decision, we
requested a re-inspection, which we are currently awaiting. If
our facility fails the re-inspection, the HUD Commissioner could
exercise its authority to replace us as the facility operator.
In such event, we could be forced to repay the HUD mortgage on
this facility to avoid being replaced as the facility operator,
which would negatively impact our cash and financial condition.
The balance on this mortgage as of December 31, 2007 was
approximately $6.6 million. In addition, we would be
required to pay a prepayment penalty of approximately
$0.3 million if this mortgage was repaid on
December 31, 2007. This alternative is not available to us
if any of our other three HUD-insured facilities were determined
by HUD to be operationally deficient because they are leased
facilities. Compliance with HUDs requirements can often be
difficult because these requirements are not always consistent
with the requirements of other federal and state agencies.
Appealing a failed inspection can be costly and time-consuming
and, if we do not successfully remediate the failed inspection,
we could be precluded from obtaining HUD financing in the future
or we may encounter limitations or prohibitions on our operation
of HUD-insured facilities.
40
Upkeep
of healthcare properties is capital intensive, requiring us to
continually direct financial resources to the maintenance and
enhancement of our facilities and equipment.
Our ability to maintain and enhance our facilities and equipment
in a suitable condition to meet regulatory standards, operate
efficiently and remain competitive in our markets requires us to
commit substantial resources to continued investment in our
facilities and equipment. Some of our competitors may operate
facilities that are not as old as ours, or may appear more
modernized than our facilities, and therefore may be more
attractive to prospective patients. We are sometimes more
aggressive than our competitors in capital spending to address
issues that arise in connection with aging facilities. If we are
unable to direct the necessary financial and human resources to
the maintenance of, upgrades to and modernization of our
facilities and equipment, our business may suffer.
Failure
to comply with existing environmental laws could result in
increased expenditures, litigation and potential loss to our
business and in our asset value.
Our operations are subject to regulations under various federal,
state and local environmental laws, primarily those relating to
the handling, storage, transportation, treatment and disposal of
medical waste; the identification and warning of the presence of
asbestos-containing materials in buildings, as well as the
encapsulation or removal of such materials; and the presence of
other substances in the indoor environment.
Our facilities generate infectious or other hazardous medical
waste due to the illness or physical condition of the patients.
Each of our facilities has an agreement with a waste management
company for the proper disposal of all infectious medical waste,
but the use of a waste management company does not immunize us
from alleged violations of such laws for operations for which we
are responsible even if carried out by a third party, nor does
it immunize us from third-party claims for the cost to cleanup
disposal sites at which such wastes have been disposed.
Some of the facilities we lease, own or may acquire may have
asbestos-containing materials. Federal regulations require
building owners and those exercising control over a
buildings management to identify and warn their employees
and other employers operating in the building of potential
hazards posed by workplace exposure to installed
asbestos-containing materials and potential asbestos-containing
materials in their buildings. Significant fines can be assessed
for violation of these regulations. Building owners and those
exercising control over a buildings management may be
subject to an increased risk of personal injury lawsuits.
Federal, state and local laws and regulations also govern the
removal, encapsulation, disturbance, handling and disposal of
asbestos-containing materials and potential asbestos-containing
materials when such materials are in poor condition or in the
event of construction, remodeling, renovation or demolition of a
building. Such laws may impose liability for improper handling
or a release into the environment of asbestos-containing
materials and potential asbestos-containing materials and may
provide for fines to, and for third parties to seek recovery
from, owners or operators of real properties for personal injury
or improper work exposure associated with asbestos-containing
materials and potential asbestos-containing materials. The
presence of asbestos-containing materials, or the failure to
properly dispose of or remediate such materials, also may
adversely affect our ability to attract and retain patients and
staff, to borrow when using such property as collateral or to
make improvements to such property.
The presence of mold, lead-based paint, underground storage
tanks, contaminants in drinking water, radon
and/or other
substances at any of the facilities we lease, own or may acquire
may lead to the incurrence of costs for remediation, mitigation
or the implementation of an operations and maintenance plan and
may result in third party litigation for personal injury or
property damage. Furthermore, in some circumstances, areas
affected by mold may be unusable for periods of time for
repairs, and even after successful remediation, the known prior
presence of extensive mold could adversely affect the ability of
a facility to retain or attract patients and staff and could
adversely affect a facilitys market value and ultimately
could lead to the temporary or permanent closure of the facility.
If we fail to comply with applicable environmental laws, we
would face increased expenditures in terms of fines and
remediation of the underlying problems, potential litigation
relating to exposure to such materials, and a potential decrease
in value to our business and in the value of our underlying
assets.
41
We are unable to predict the future course of federal, state and
local environmental regulation and legislation. Changes in the
environmental regulatory framework could result in increased
costs. In addition, because environmental laws vary from state
to state, expansion of our operations to states where we do not
currently operate may subject us to additional restrictions in
the manner in which we operate our facilities.
If we
fail to safeguard the monies held in our patient trust funds, we
will be required to reimburse such monies, and we may be subject
to citations, fines and penalties.
Each of our facilities is required by federal law to maintain a
patient trust fund to safeguard certain assets of their
residents and patients. If any money held in a patient trust
fund is misappropriated, we are required to reimburse the
patient trust fund for the amount of money that was
misappropriated. In 2005 we became aware of two separate and
unrelated instances of employees misappropriating an aggregate
of approximately $380,000 in patient trust funds, some of which
was recovered from the employees and some of which we were
required to reimburse from our funds. If any monies held in our
patient trust funds are misappropriated in the future and are
unrecoverable, we will be required to reimburse such monies, and
we may be subject to citations, fines and penalties pursuant to
federal and state laws.
We are
a holding company with no operations and rely upon our multiple
independent operating subsidiaries to provide us with the funds
necessary to meet our financial obligations. Liabilities of any
one or more of our subsidiaries could be imposed upon us or our
other subsidiaries.
We are a holding company with no direct operating assets,
employees or revenues. Each of our facilities is operated
through a separate, wholly-owned, independent subsidiary, which
has its own management, employees and assets. Our principal
assets are the equity interests we directly or indirectly hold
in our multiple operating and real estate holding subsidiaries.
As a result, we are dependent upon distributions from our
subsidiaries to generate the funds necessary to meet our
financial obligations and pay dividends. Our subsidiaries are
legally distinct from us and have no obligation to make funds
available to us. The ability of our subsidiaries to make
distributions to us will depend substantially on their
respective operating results and will be subject to restrictions
under, among other things, the laws of their jurisdiction of
organization, which may limit the amount of funds available for
distribution to investors or shareholders, agreements of those
subsidiaries, the terms of our financing arrangements and the
terms of any future financing arrangements of our subsidiaries.
Risks
Related to Ownership of our Common Stock
We may
not be able to pay or maintain dividends and the failure to do
so would adversely affect our stock price.
Our ability to pay and maintain cash dividends is based on many
factors, including our ability to make and finance acquisitions,
our ability to negotiate favorable lease and other contractual
terms, anticipated operating cost levels, the level of demand
for our beds, the rates we charge and actual results that may
vary substantially from estimates. Some of the factors are
beyond our control and a change in any such factor could affect
our ability to pay or maintain dividends. In addition, the
Revolver with General Electric Capital Corporation (the Lender)
restricts our ability to pay dividends to stockholders if we
receive notice that we are in default under this agreement.
While we do not have a formal dividend policy, we currently
intend to continue to pay regular quarterly dividends to the
holders of our common stock, but future dividends will continue
to be at the discretion of our board of directors and will
depend on many factors, including our results of operations,
financial condition and capital requirements, earnings, general
business conditions, restrictions imposed by financing
arrangements including pursuant to the loan and security
agreement governing our revolving line of credit, legal
restrictions on the payment of dividends and other factors the
board of directors deems relevant. From 2002 through 2007, we
paid aggregate annual dividends equal to approximately 5% to 15%
of our net income. We may not be able to pay or maintain
dividends, and we may at any time elect not to pay dividends but
to retain cash for other purposes. We also cannot assure you
that the level of dividends will be maintained or increase over
time
42
or that increases in demand for our beds and monthly patient
fees will increase our actual cash available for dividends to
stockholders. It is possible that we may pay dividends in a
future period that may exceed our net income for such period.
The failure to pay or maintain dividends could adversely affect
our stock price.
If the
ownership of our common stock continues to be highly
concentrated, it may prevent you and other stockholders from
influencing significant corporate decisions and may result in
conflicts of interest that could cause our stock price to
decline.
As of December 31, 2007, our executive officers, directors
and their affiliates beneficially own or control approximately
60.3% of the outstanding shares of our common stock, of which
Roy Christensen, our Chairman of the board of directors,
Christopher Christensen, our President and Chief Executive
Officer, and Gregory Stapley, our Vice President and General
Counsel, beneficially own approximately 17.0%, 18.1% and 5.4%,
respectively, of the outstanding shares. Accordingly, our
current executive officers, directors and their affiliates, if
they act together, will have substantial control over the
outcome of corporate actions requiring stockholder approval,
including the election of directors, any merger, consolidation
or sale of all or substantially all of our assets or any other
significant corporate transactions. These stockholders may also
delay or prevent a change of control of us, even if such a
change of control would benefit our other stockholders. The
significant concentration of stock ownership may adversely
affect the trading price of our common stock due to
investors perception that conflicts of interest may exist
or arise.
If
securities or industry analysts do not publish research or
reports about our business, if they change their recommendations
regarding our stock adversely or if our operating results do not
meet their expectations, our stock price and trading volume
could decline.
The trading market for our common stock is influenced by the
research and reports that industry or securities analysts
publish about us or our business. If one or more of these
analysts cease coverage of our company or fail to publish
reports on us regularly, we could lose visibility in the
financial markets, which in turn could cause our stock price or
trading volume to decline. Moreover, if one or more of the
analysts who cover us downgrade our stock or if our operating
results do not meet their expectations, our stock price could
decline.
The
market price and trading volume of our common stock may be
volatile, which could result in rapid and substantial losses for
our stockholders.
The market price of our common stock may be highly volatile and
could be subject to wide fluctuations. In addition, the trading
volume in our common stock may fluctuate and cause significant
price variations to occur. We cannot assure you that the market
price of our common stock will not fluctuate or decline
significantly in the future. In the past, when the market price
of a stock has been volatile, holders of that stock have
instituted securities class action litigation against the
company that issued the stock. If any of our stockholders
brought a lawsuit against us, we could incur substantial costs
defending or settling the lawsuit. Such a lawsuit could also
divert the time and attention of our management from our
business.
Future
offerings of debt or equity securities by us may adversely
affect the market price of our common stock.
In the future, we may attempt to increase our capital resources
by offering debt or additional equity securities, including
commercial paper, medium-term notes, senior or subordinated
notes, series of preferred shares or shares of our common stock.
Upon liquidation, holders of our debt securities and preferred
shares, and lenders with respect to other borrowings, would
receive a distribution of our available assets prior to any
distribution to the holders of our common stock. Additional
equity offerings may dilute the economic and voting rights of
our existing stockholders or reduce the market price of our
common stock, or both. Because our decision to issue securities
in any future offering will depend on market conditions and
other factors beyond our control, we cannot predict or estimate
the amount, timing or nature of our future offerings. Thus,
holders of our common stock bear the risk of our future
offerings reducing the market price of our common
43
stock and diluting their share holdings in us. We also intend to
continue to actively pursue acquisitions of facilities and may
issue shares of stock in connection with these acquisitions.
Any shares issued in connection with our acquisitions, the
exercise of outstanding stock options or otherwise would dilute
the holdings of the investors who purchase our shares.
Failure
to achieve and maintain effective internal controls in
accordance with Section 404 of the
Sarbanes-Oxley
Act could result in a restatement of our financial statements,
cause investors to lose confidence in our financial statements
and our company and have a material adverse effect on our
business and stock price.
We produce our consolidated financial statements in accordance
with the requirements of GAAP. Effective internal controls are
necessary for us to provide reliable financial reports to help
mitigate the risk of fraud and to operate successfully as a
publicly traded company. As a public company, we will be
required to document and test our internal control procedures in
order to satisfy the requirements of Section 404 of the
Sarbanes-Oxley Act of 2002, or Section 404, which will
require annual management assessments of the effectiveness of
our internal controls over financial reporting. This requirement
will apply to us starting with our annual report for the year
ended December 31, 2008.
During 2006, we identified certain accounting errors in our
financial statements for the three years ended December 31,
2005. These errors primarily related to the appropriate
classification of self-insurance liabilities between short-term
and long-term. As a result of discovering these errors, we
undertook a further review of our historical financial
statements and identified similar reclassifications to deferred
taxes and captive insurance subsidiary cash and cash
equivalents. Following this review, our board of directors and
independent registered public accounting firm concluded that an
amendment of our consolidated financial statements, which
included the restatement of our financial statements for the
three years ended December 31, 2005, was necessary. It was
not deemed that these errors were caused by a significant
deficiency or material weakness in internal controls over
financial reporting.
As we prepare to comply with Section 404, we may identify
significant deficiencies or errors that we may not be able to
remediate in time to meet our deadline for compliance with
Section 404. Testing and maintaining internal controls can
divert our managements attention from other matters that
are important to our business. We may not be able to conclude on
an ongoing basis that we have effective internal controls over
financial reporting in accordance with Section 404 or our
independent registered public accounting firm may issue an
adverse opinion if we conclude that our internal controls over
financial reporting are not effective. If either we are unable
to conclude that we have effective internal controls over
financial reporting or our independent registered public
accounting firm issues an adverse opinion on the effectiveness
of our internal controls over financial reporting under
Section 404, investors could lose confidence in our
reported financial information and our company, which could
result in a decline in the market price of our common stock, and
cause us to fail to meet our reporting obligations in the
future, which in turn could impact our ability to raise
additional financing if needed in the future.
If we fail to implement the requirements of Section 404 in
a timely manner, we may also be subject to sanctions or
investigation by regulatory authorities such as the Securities
and Exchange Commission or NASDAQ.
The
requirements of being a public company, including compliance
with the reporting requirements of the Securities Exchange Act
of 1934, as amended, and the requirements of the Sarbanes-Oxley
Act, may strain our resources, increase our costs and distract
management, and we may be unable to comply with these
requirements in a timely or cost-effective manner.
As a public company, we need to comply with laws, regulations
and requirements, certain corporate governance provisions of the
Sarbanes-Oxley Act of 2002, related regulations of the
Securities and Exchange Commission, and requirements of NASDAQ.
As a result, we will incur significant legal, accounting and
other expenses. Complying with these statutes, regulations and
requirements occupies a significant amount of the time of our
board of directors and management, requires us to have
additional finance and accounting staff, makes it difficult to
attract and retain qualified officers and members of our board
of directors, particularly to
44
serve on our audit committee, and make some activities
difficult, time consuming and costly. Among other things, we are
required to:
|
|
|
|
|
maintain a comprehensive compliance function;
|
|
|
|
maintain internal policies, such as those relating to disclosure
controls and procedures and insider trading;
|
|
|
|
design, establish, evaluate and maintain a system of internal
control over financial reporting in compliance with the
requirements of Section 404 and the related rules and
regulations of the Securities and Exchange Commission and the
Public Company Accounting Oversight Board;
|
|
|
|
prepare and distribute periodic reports in compliance with our
obligations under the federal securities laws;
|
|
|
|
involve and retain outside counsel and accountants in the above
activities; and
|
|
|
|
maintain an investor relations function.
|
If we are unable to accomplish these objectives in a timely and
effective fashion, our ability to comply with our financial
reporting requirements and other rules that apply to reporting
companies could be impaired. If our finance and accounting
personnel insufficiently support us in fulfilling these
public-company compliance obligations, or if we are unable to
hire adequate finance and accounting personnel, we could face
significant legal liability, which could have a material adverse
effect on our financial condition and results of operations.
Furthermore, if we identify any issues in complying with those
requirements (for example, if we or our independent registered
public accountants identified a material weakness or significant
deficiency in our internal control over financial reporting), we
could incur additional costs rectifying those issues, and the
existence of those issues could adversely affect us, our
reputation or investor perceptions of us.
Our
amended and restated certificate of incorporation, amended and
restated bylaws and Delaware law contain provisions that could
discourage transactions resulting in a change in control, which
may negatively affect the market price of our common
stock.
In addition to the effect that the concentration of ownership by
our significant stockholders may have, our amended and restated
certificate of incorporation and our amended and restated bylaws
contain provisions that may enable our management to resist a
change in control. These provisions may discourage, delay or
prevent a change in the ownership of our company or a change in
our management, even if doing so might be beneficial to our
stockholders. In addition, these provisions could limit the
price that investors would be willing to pay in the future for
shares of our common stock. Such provisions set forth in our
amended and restated certificate of incorporation or amended and
restated bylaws include:
|
|
|
|
|
our board of directors are authorized, without prior stockholder
approval, to create and issue preferred stock, commonly referred
to as blank check preferred stock, with rights
senior to those of common stock;
|
|
|
|
advance notice requirements for stockholders to nominate
individuals to serve on our board of directors or to submit
proposals that can be acted upon at stockholder meetings;
|
|
|
|
our board of directors are classified so not all members of our
board are elected at one time, which may make it more difficult
for a person who acquires control of a majority of our
outstanding voting stock to replace our directors;
|
|
|
|
stockholder action by written consent is limited;
|
|
|
|
special meetings of the stockholders are permitted to be called
only by the chairman of our board of directors, our chief
executive officer or by a majority of our board of directors;
|
|
|
|
stockholders are not permitted to cumulate their votes for the
election of directors;
|
|
|
|
newly created directorships resulting from an increase in the
authorized number of directors or vacancies on our board of
directors are filled only by majority vote of the remaining
directors;
|
45
|
|
|
|
|
our board of directors is expressly authorized to make, alter or
repeal our bylaws; and
|
|
|
|
stockholders are permitted to amend our bylaws only upon
receiving the affirmative vote of at least a majority of our
outstanding common stock.
|
These and other provisions in our amended and restated
certificate of incorporation, amended and restated bylaws and
Delaware law could discourage acquisition proposals and make it
more difficult or expensive for stockholders or potential
acquirers to obtain control of our board of directors or
initiate actions that are opposed by our then-current board of
directors, including delaying or impeding a merger, tender offer
or proxy contest involving us. Any delay or prevention of a
change of control transaction or changes in our board of
directors could cause the market price of our common stock to
decline.
|
|
Item 1B.
|
Unresolved
Staff Comments
|
None.
Service Center. We currently lease
15,920 square feet of office space in Mission Viejo,
California for our Service Center pursuant to a lease that
expires in 2009. We have two options to extend our lease term at
this location for an additional three-year term for each option.
In addition, we have entered into an amendment to our existing
lease with our landlord to expand our office space by an
additional 4,277 square feet. This amendment will expire
conterminously with our existing lease.
Facilities. We currently operate 61 facilities
in California, Arizona, Texas, Washington, Utah and Idaho, with
the capacity to serve over 7,400 patients and residents. Of
the facilities that we operate as of December 31, 2007, we
own 26 facilities and lease 35 facilities pursuant to operating
leases, 10 of which contain purchase options that provide us
with the right to purchase or agreements to purchase the
facility in the future, which we believe will enable us to
better control our occupancy costs over time. We currently do
not manage any facilities for third parties and do not actively
seek to manage facilities for others, except on a short-term
basis pending receipt of new operating licenses by our operating
subsidiaries.
The following table provides summary information regarding the
number of licensed and independent living beds at our facilities
at December 31, 2007:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Purchase
|
|
|
|
|
|
|
|
|
|
|
|
|
Agreement or
|
|
|
|
|
|
Total Licensed and
|
|
|
|
Leased without a
|
|
|
Leased with a
|
|
|
|
|
|
Independent Living
|
|
State
|
|
Purchase Option
|
|
|
Purchase Option
|
|
|
Owned
|
|
|
Beds(4)
|
|
|
California
|
|
|
1,654
|
|
|
|
903
|
|
|
|
972
|
|
|
|
3,529
|
|
Arizona
|
|
|
738
|
|
|
|
130
|
|
|
|
1,084
|
|
|
|
1,952
|
|
Texas
|
|
|
470
|
|
|
|
|
|
|
|
684
|
|
|
|
1,154
|
|
Utah
|
|
|
108
|
|
|
|
106
|
|
|
|
228
|
|
|
|
442
|
|
Washington(1)
|
|
|
|
|
|
|
|
|
|
|
283
|
|
|
|
283
|
|
Idaho
|
|
|
|
|
|
|
88
|
|
|
|
|
|
|
|
88
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
2,970
|
|
|
|
1,227
|
|
|
|
3,251
|
|
|
|
7,448
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Skilled nursing
|
|
|
2,829
|
|
|
|
1,130
|
|
|
|
2,818
|
|
|
|
6,777
|
|
Assisted living(2)
|
|
|
141
|
|
|
|
97
|
|
|
|
349
|
|
|
|
587
|
|
Independent living(3)
|
|
|
|
|
|
|
|
|
|
|
84
|
|
|
|
84
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
2,970
|
|
|
|
1,227
|
|
|
|
3,251
|
|
|
|
7,448
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
Our facility in Walla Walla recently obtained a Certificate of
Need to add 30 more beds and construction activities are
currently underway. |
|
(2) |
|
Represents 460 assisted living units. |
46
|
|
|
(3) |
|
Represents 84 independent living units located within one of our
assisted living facilities. |
|
(4) |
|
All bed counts are licensed beds except independent living beds,
and may not reflect the number of beds actually available for
patient use. |
|
|
Item 3.
|
Legal
Proceedings
|
In March 2007, we and certain of our officers received a series
of notices from our bank indicating that the United States
Attorney for the Central District of California had issued an
authorized investigative demand, a request for records similar
to a subpoena, to our bank and then rescinded that demand. This
rescinded demand originally requested documents from our bank
related to financial transactions involving the Company, ten of
our operating subsidiaries, an outside investor group, and
certain of our current and former officers. Subsequently, in
June 2007, the U.S. Attorney sent a letter to one of our
current employees requesting a meeting. The letter indicated
that the U.S. Attorney and the U.S. Department of
Health and Human Services Office of Inspector General were
conducting an investigation of claims submitted to the Medicare
program for rehabilitation services provided at our facilities.
Although both we and the employee offered to cooperate, the
U.S. Attorney later withdrew its meeting request. From
these contacts, we believed that an investigation was underway,
but to date we have been unable to determine the exact cause or
nature of the U.S. Attorneys interest in us or our
subsidiaries, and until recently we have been unable to even
verify whether the investigation was continuing.
On December 17, 2007, we were informed by
Deloitte & Touche LLP, our independent registered
public accounting firm that the U.S. Attorney served a
grand jury subpoena on Deloitte & Touche LLP, relating
to us and several of our operating subsidiaries. The subpoena
confirmed our previously reported belief that the
U.S. Attorney is conducting an investigation involving
certain of our operating subsidiaries. Based on these most
recent events, we believe that the United States Government may
be conducting parallel criminal, civil and administrative
investigations involving The Ensign Group and one or more of our
skilled nursing facilities. To our knowledge, however, neither
us nor any of our operating subsidiaries or employees have been
formally charged with any wrongdoing, served with any related
subpoenas or requests, or been directly notified of any concerns
or related investigations by the U.S. Attorney or any
government agency. Subsequently, in February 2008, the
U.S. Attorney contacted two additional current employees.
Both the Company and all three of the employees contacted have
offered to cooperate and meet with the U.S. Attorney. While
we have no reason to believe that the assertion of criminal
charges, civil claims, administrative sanctions or whistleblower
actions would be warranted, to date the
U.S. Attorneys office has declined to provide us with
any specific information with respect to this matter, other than
to confirm that an investigation is ongoing. See further
discussion regarding this matter at Note 16 in our
Consolidated Financial Statements.
We are party to various legal actions and administrative
proceedings and are subject to various claims arising in the
ordinary course of business, including claims that our services
have resulted in injury or death to the residents of our
facilities and claims related to employment and commercial
matters. Although we intend to vigorously defend ourselves in
these matters, there can be no assurance that the outcomes of
these matters will not have a material adverse effect on our
results or operations and financial condition. In certain states
in which we have or have had operations, insurance coverage for
the risk of punitive damages arising from general and
professional liability litigation may not be available due to
state law public policy prohibitions. There can be no assurance
that we will not be liable for punitive damages awarded in
litigation arising in states for which punitive damage insurance
coverage is not available.
We operate in an industry that is extremely regulated. As such,
in the ordinary course of business, we are continuously subject
to state and federal regulatory scrutiny, supervision and
control. Such regulatory scrutiny often includes inquiries,
investigations, examinations, audits, site visits and surveys,
some of which are non-routine. In addition to being subject to
direct regulatory oversight of state and federal regulatory
agencies, our industry is frequently subject to the regulatory
practices, which could subject us to civil, administrative or
criminal fines, penalties or restitutionary relief, and
reimbursement authorities could also seek the suspension or
exclusion of the provider or individual from participation in
their program. We believe that there has been, and will continue
to be, an increase in governmental investigations of long-term
care providers, particularly in the area of Medicare/Medicaid
false claims, as well as an increase in enforcement actions
resulting from these
47
investigations. Adverse discriminations in legal proceedings or
governmental investigations, whether currently asserted or
arising in the future, could have a material adverse effect on
our financial position, results of operations and cash flows.
|
|
Item 4.
|
Submission
of Matters to a Vote of Security Holders
|
On September 6, 2007 and October 10, 2007, we
submitted to a vote of our security holders the following
matters: (i) an amendment to our then effective certificate
of incorporation to increase the number of authorized shares of
common stock to 75 million, (ii) approval of an
amended and restated certificate of incorporation, which became
effective upon the completion of our initial public offering in
November 2007, (iii) approval of amended and restated
bylaws, which became effective upon the completion of our
initial public offering in November 2007 (iv) approval of
our 2007 Omnibus Incentive Plan, which became effective upon the
effectiveness of the Registration Statement, and
(v) approval of the indemnification agreement to be entered
into by us and each of our directors and executive officers.
Each of the foregoing matters was approved, by written consent,
by stockholders holding approximately
9.0 million shares of our common stock and all of our
outstanding preferred stock.
PART II.
|
|
Item 5.
|
Market
for Registrants Common Equity, Related Stockholder Matters
and Issuer Purchases of Equity Securities
|
Market
Information
Our common stock has been traded under the symbol
ENSG on the NASDAQ Global Select Market since our
initial public offering on November 8, 2007. Prior to that
time, there was no public market for our common stock. The
following table shows the high and low sale prices for the
common stock as reporting by the NASDAQ Global Select Market for
the periods indicated:
|
|
|
|
|
|
|
|
|
|
|
High
|
|
|
Low
|
|
|
Fiscal year 2007
|
|
|
|
|
|
|
|
|
Fourth Quarter (commencing November 8, 2007)*
|
|
$
|
16.65
|
|
|
$
|
12.10
|
|
|
|
|
* |
|
Initial public offering price on November 8, 2007 was $16.00 |
As of February 29, 2008 there were approximately
180 holders of record of our common stock.
48
The graph below shows the cumulative total stockholder return of
an investment of $100 (and the reinvestment of any dividends
thereafter) on November 9, 2007 in (i) our common
stock, (ii) the Skilled Nursing Facilities Peer Group(1)
and (iii) the NASDAQ Market Index. Our stock price
performance shown in the graph below is not indicative of future
stock price performance.
COMPARISON
OF CUMULATIVE TOTAL RETURN
AMONG THE ENSIGN GROUP, INC.,
NASDAQ MARKET INDEX AND SIC CODE INDEX
ASSUMES $100
INVESTED ON NOV. 9, 2007
ASSUMES DIVIDEND REINVESTED
FISCAL YEAR ENDING DEC. 31, 2007
|
|
|
(1) |
|
The Skilled Nursing Facilities Peer Group is comprised of the
following companies: Adcare Health Systems, Advocat Inc.,
Assisted Living Concepts, Cabeltel International, Five Star
Quality Care Inc., Kindred Healthcare Inc., National Healthcare
Corp., Skilled Healthcare Group, Sun Healthcare Group and
Sunrise Senior Living. |
Dividend
Policy
The following table summarizes common stock dividends declared
to shareholders during the two most recent fiscal years:
|
|
|
|
|
|
|
|
|
|
|
Dividend
|
|
|
Aggregate
|
|
|
|
per Share
|
|
|
Dividend Declared
|
|
|
2006
|
|
|
|
|
|
|
|
|
First Quarter
|
|
$
|
0.03
|
|
|
$
|
490
|
|
Second Quarter
|
|
$
|
0.03
|
|
|
$
|
492
|
|
Third Quarter
|
|
$
|
0.03
|
|
|
$
|
493
|
|
Fourth Quarter
|
|
$
|
0.04
|
|
|
$
|
657
|
|
2007
|
|
|
|
|
|
|
|
|
First Quarter
|
|
$
|
0.04
|
|
|
$
|
658
|
|
Second Quarter
|
|
$
|
0.04
|
|
|
$
|
658
|
|
Third Quarter
|
|
$
|
0.04
|
|
|
$
|
658
|
|
Fourth Quarter
|
|
$
|
0.04
|
|
|
$
|
819
|
|
49
We do not have a formal dividend policy but we currently intend
to continue to pay regular quarterly dividends to the holders of
our common stock. From 2002 to 2007, we paid aggregate annual
dividends equal to approximately 5% to 15% of our net income.
However, future dividends will continue to be at the discretion
of our board of directors, and we may or may not continue to pay
dividends at such rate. We expect that the payment of dividends
will depend on many factors, including our results of
operations, financial condition and capital requirements,
earnings, general business conditions, legal restrictions on the
payment of dividends and other factors the board of directors
deems relevant. The loan and security agreement governing our
revolving line of credit with General Electric Capital
Corporation restricts our ability to pay dividends to
stockholders if we receive notice that we are in default under
this agreement. In addition, we are a holding company with no
direct operating assets, employees or revenues. As a result, we
are dependent upon distributions from our independent operating
subsidiaries to generate the funds necessary to meet our
financial obligations and pay dividends. It is possible that in
certain quarters, we may pay dividends that exceed our net
income for such period as calculated in accordance with
U.S. generally accepted accounting principles (GAAP).
Issuer
Repurchases of Equity Securities
We did not repurchase any of our equity securities during the
quarter ended December 31, 2007, nor issue any securities
that were not registered under the Securities Exchange Act of
1933.
Use of
Proceeds
On November 8, 2007, the SEC declared effective our
Registration Statement on
Form S-1
(File
No. 333-142897)
relating to our initial public offering. The registration
statement related to 4.6 million shares of our common
stock, par value $0.001 per share, including 0.6 million
shares of common stock subject to an over-allotment option that
certain selling stockholders granted to the underwriters. On
November 8, 2007, we sold 4.0 million shares of our
common stock at the IPO price of $16.00 per share, for an
aggregate sale price of $64.0 million, settling those sales
on November 15, 2007. On November 16, 2007, the
underwriters exercised their over-allotment option and the
selling stockholders sold 0.6 million shares of their
common stock at an offering price of $16.00 per share, for an
aggregate sale price of $9.6 million. The sale of the
over-allotment was settled on November 20, 2007. No
proceeds from the over-allotment were distributed to us. The
managing underwriters for our IPO were D.A. Davidson &
Co. and Stifel, Nicolaus & Company, Incorporated.
Following the sale of the 4.6 million shares of our common
stock, the offering terminated.
We paid approximately $4.5 million in underwriting
discounts and commissions in connection with the offering of the
shares sold on our behalf and the selling stockholders paid
underwriting discounts and commissions of approximately
$0.7 million in connection with the shares sold on their
behalf. We also incurred approximately $2.9 million of
other offering expenses, which when added to the IPO commissions
paid by us, amounted to total estimated expenses of
approximately $7.4 million. The net offering proceeds to
us, after deducting underwriting discounts and commissions and
estimated offering expenses paid by us, were approximately
$56.6 million. We did not receive any of the proceeds from
the offering that were paid to the selling stockholders.
None of the underwriting discounts and commissions or offering
expenses were paid, directly or indirectly, to any of our
directors or officers or their associates or to persons owning
10% or more of our common stock or to any affiliates of ours.
We used approximately $12.1 million of IPO proceeds to
purchase the underlying assets at three facilities which we
previously operated under a long-term leasing arrangement,
$2.8 million to fund capital refurbishments at 11 of our
facilities, $1.2 million to fund remaining IPO related
costs and $9.7 million for working capital and other
general corporate purposes. During the first seven months of the
year ended December 31, 2007, we used approximately
$9.5 million in working capital to fund the purchase of
four facilities and as such, were required to use IPO funds for
working capital purposes later in the year.
50
We currently have approximately $10.7 million budgeted for
significant capital refurbishments at existing facilities in
2008. We currently plan to use approximately $3.0 million
of the net proceeds from this offering to purchase one facility,
which we currently operate under an operating lease agreement,
from Lone Peak Properties, LLC, in which the purchase is pending
the property owners resolution of certain boundary line
issues with neighboring property owners. As of December 31,
2007, we held purchase agreements or options to purchase 10 of
our leased facilities. We will consider exercising some or all
of such options as they become exercisable and may use a portion
of the net proceeds to pay the purchase price for these
facilities. We anticipate paying off our $2.0 million
mortgage note in 2008, which has a fixed interest rate of 7.49%
and is due on September 1, 2008, and we will also consider
paying off all or a portion of our short-term debt, if any, that
is incurred in connection with facility acquisitions. We expect
to use the remainder of the net proceeds from this offering for
working capital and for general corporate purposes. Until the
above noted uses of IPO proceeds are initiated, these funds will
remain invested in a money market account with our bank. We will
continue to look for additional low risk investment
opportunities for these funds.
51
|
|
Item 6.
|
Selected
Financial Data
|
The following selected consolidated financial data for the
periods indicated have been derived from our consolidated
financial statements. The financial data set forth below should
be read in connection with Item 7
Managements Discussion and Analysis of Financial
Condition and Results of Operations and with our
consolidated financial statements and related notes thereto (in
thousands, except per share data):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2007
|
|
|
2006
|
|
|
2005
|
|
|
2004
|
|
|
2003
|
|
|
Revenue
|
|
$
|
411,318
|
|
|
$
|
358,574
|
|
|
$
|
300,850
|
|
|
$
|
244,536
|
|
|
$
|
158,007
|
|
Expense:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cost of services (exclusive of facility rent and depreciation
and amortization shown separately below)
|
|
|
335,014
|
|
|
|
284,847
|
|
|
|
239,379
|
|
|
|
199,986
|
|
|
|
128,522
|
|
Facility rent cost of services
|
|
|
16,675
|
|
|
|
16,404
|
|
|
|
16,118
|
|
|
|
14,773
|
|
|
|
9,964
|
|
General and administrative expense
|
|
|
15,945
|
|
|
|
14,210
|
|
|
|
10,909
|
|
|
|
8,537
|
|
|
|
6,246
|
|
Depreciation and amortization
|
|
|
6,966
|
|
|
|
4,221
|
|
|
|
2,458
|
|
|
|
1,934
|
|
|
|
1,229
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total expenses
|
|
|
374,600
|
|
|
|
319,682
|
|
|
|
268,864
|
|
|
|
225,230
|
|
|
|
145,961
|
|
Income from operations
|
|
|
36,718
|
|
|
|
38,892
|
|
|
|
31,986
|
|
|
|
19,306
|
|
|
|
12,046
|
|
Other income (expense):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest expense
|
|
|
(4,844
|
)
|
|
|
(2,990
|
)
|
|
|
(2,035
|
)
|
|
|
(1,565
|
)
|
|
|
(1,268
|
)
|
Interest income
|
|
|
1,558
|
|
|
|
772
|
|
|
|
491
|
|
|
|
85
|
|
|
|
4
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other expense, net
|
|
|
(3,286
|
)
|
|
|
(2,218
|
)
|
|
|
(1,544
|
)
|
|
|
(1,480
|
)
|
|
|
(1,264
|
)
|
Income before provision for income taxes
|
|
|
33,432
|
|
|
|
36,674
|
|
|
|
30,442
|
|
|
|
17,826
|
|
|
|
10,782
|
|
Provision for income taxes
|
|
|
12,905
|
|
|
|
14,125
|
|
|
|
12,054
|
|
|
|
6,723
|
|
|
|
4,284
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
$
|
20,527
|
|
|
$
|
22,549
|
|
|
$
|
18,388
|
|
|
$
|
11,103
|
|
|
$
|
6,498
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income per share(1):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
$
|
1.39
|
|
|
$
|
1.66
|
|
|
$
|
1.35
|
|
|
$
|
0.83
|
|
|
$
|
0.49
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted
|
|
$
|
1.17
|
|
|
$
|
1.34
|
|
|
$
|
1.05
|
|
|
$
|
0.63
|
|
|
$
|
0.38
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average common shares outstanding:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
|
14,497
|
|
|
|
13,366
|
|
|
|
13,468
|
|
|
|
13,285
|
|
|
|
12,905
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted
|
|
|
17,470
|
|
|
|
16,823
|
|
|
|
17,505
|
|
|
|
17,519
|
|
|
|
16,985
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
See Note 2 of the Notes to the Consolidated Financial
Statements. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As of December 31,
|
|
|
|
2007
|
|
|
2006
|
|
|
2005
|
|
|
2004
|
|
|
2003
|
|
|
Consolidated Balance Sheet Data:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents
|
|
$
|
51,732
|
|
|
$
|
25,491
|
|
|
$
|
11,635
|
|
|
$
|
14,755
|
|
|
$
|
745
|
|
Working capital
|
|
|
62,969
|
|
|
|
28,281
|
|
|
|
19,087
|
|
|
|
21,526
|
|
|
|
10,191
|
|
Total assets
|
|
|
267,389
|
|
|
|
190,531
|
|
|
|
119,390
|
|
|
|
80,255
|
|
|
|
62,538
|
|
Long-term debt, less current maturities
|
|
|
60,577
|
|
|
|
63,587
|
|
|
|
25,520
|
|
|
|
24,820
|
|
|
|
16,239
|
|
Redeemable, convertible preferred stock
|
|
|
|
|
|
|
2,725
|
|
|
|
2,725
|
|
|
|
2,725
|
|
|
|
2,722
|
|
Stockholders equity
|
|
|
129,677
|
|
|
|
51,147
|
|
|
|
32,634
|
|
|
|
17,828
|
|
|
|
7,343
|
|
Cash dividends declared per common share
|
|
$
|
0.16
|
|
|
$
|
0.13
|
|
|
$
|
0.09
|
|
|
$
|
0.05
|
|
|
$
|
0.03
|
|
52
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31,
|
|
|
|
2007
|
|
|
2006
|
|
|
2005
|
|
|
2004
|
|
|
2003
|
|
|
Other Non-GAAP Financial Data:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
EBITDA(1)
|
|
$
|
43,684
|
|
|
$
|
43,113
|
|
|
$
|
34,444
|
|
|
$
|
21,240
|
|
|
$
|
13,275
|
|
EBITDAR(1)
|
|
|
60,359
|
|
|
|
59,517
|
|
|
|
50,562
|
|
|
|
36,013
|
|
|
|
23,239
|
|
|
|
|
(1) |
|
EBITDA and EBITDAR are supplemental non-GAAP financial measures.
Regulation G, Conditions for Use of
Non-GAAP Financial Measures, and other provisions of
the Securities Exchange Act of 1934, as amended, define and
prescribe the conditions for use of certain non-GAAP financial
information. We calculate EBITDA as net income before
(a) interest expense, net, (b) provision for income
taxes, and (c) depreciation and amortization. We calculate
EBITDAR by adjusting EBITDA to exclude facility rent
cost of services. These non-GAAP financial measures are used in
addition to and in conjunction with results presented in
accordance with GAAP. These non-GAAP financial measures should
not be relied upon to the exclusion of GAAP financial measures.
These non-GAAP financial measures reflect an additional way of
viewing aspects of our operations that, when viewed with our
GAAP results and the accompanying reconciliations to
corresponding GAAP financial measures, provide a more complete
understanding of factors and trends affecting our business. |
We believe EBITDA and EBITDAR are useful to investors and other
external users of our financial statements in evaluating our
operating performance because:
|
|
|
|
|
they are widely used by investors and analysts in our industry
as a supplemental measure to evaluate the overall operating
performance of companies in our industry without regard to items
such as interest expense, net and depreciation and amortization,
which can vary substantially from company to company depending
on the book value of assets, capital structure and the method by
which assets were acquired; and
|
|
|
|
they help investors evaluate and compare the results of our
operations from period to period by removing the impact of our
capital structure and asset base from our operating results.
|
We use EBITDA and EBITDAR:
|
|
|
|
|
as measurements of our operating performance to assist us in
comparing our operating performance on a consistent basis;
|
|
|
|
to design incentive compensation and goal setting;
|
|
|
|
to allocate resources to enhance the financial performance of
our business;
|
|
|
|
to evaluate the effectiveness of our operational
strategies; and
|
|
|
|
to compare our operating performance to that of our competitors.
|
We typically use EBITDA and EBITDAR to compare the operating
performance of each skilled nursing and assisted living
facility. EBITDA and EBITDAR are useful in this regard because
they do not include such costs as net interest expense, income
taxes, depreciation and amortization expense, and, with respect
to EBITDAR, facility rent cost of services, which
may vary from
period-to-period
depending upon various factors, including the method used to
finance facilities, the amount of debt that we have incurred,
whether a facility is owned or leased, the date of acquisition
of a facility or business, or the tax law of the state in which
a business unit operates. As a result, we believe that the use
of EBITDA and EBITDAR provide a meaningful and consistent
comparison of our business between periods by eliminating
certain items required by GAAP.
We also establish compensation programs and bonuses for our
facility level employees that are partially based upon the
achievement of EBITDAR targets.
Despite the importance of these measures in analyzing our
underlying business, designing incentive compensation and for
our goal setting, EBITDA and EBITDAR are non-GAAP financial
measures that have no standardized meaning defined by GAAP.
Therefore, our EBITDA and EBITDAR measures have limitations
53
as analytical tools, and they should not be considered in
isolation, or as a substitute for analysis of our results as
reported under GAAP. Some of these limitations are:
|
|
|
|
|
they do not reflect our current or future cash requirements for
capital expenditures or contractual commitments;
|
|
|
|
they do not reflect changes in, or cash requirements for, our
working capital needs;
|
|
|
|
they do not reflect the net interest expense, or the cash
requirements necessary to service interest or principal
payments, on our debt;
|
|
|
|
they do not reflect any income tax payments we may be required
to make;
|
|
|
|
although depreciation and amortization are non-cash charges, the
assets being depreciated and amortized will often have to be
replaced in the future, and EBITDA and EBITDAR do not reflect
any cash requirements for such replacements; and
|
|
|
|
other companies in our industry may calculate these measures
differently than we do, which may limit their usefulness as
comparative measures.
|
We compensate for these limitations by using them only to
supplement net income on a basis prepared in accordance with
GAAP in order to provide a more complete understanding of the
factors and trends affecting our business.
Management strongly encourages investors to review our
consolidated financial statements in their entirety and to not
rely on any single financial measure. Because these non-GAAP
financial measures are not standardized, it may not be possible
to compare these financial measures with other companies
non-GAAP financial measures having the same or similar names.
For information about our financial results as reported in
accordance with GAAP, see our consolidated financial statements
and related notes included elsewhere in this Form
10-K.
The table below reconciles net income to EBITDA and EBITDAR for
the periods presented:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31,
|
|
|
|
2007
|
|
|
2006
|
|
|
2005
|
|
|
2004
|
|
|
2003
|
|
|
Consolidated Statement of Income Data:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
$
|
20,527
|
|
|
$
|
22,549
|
|
|
$
|
18,388
|
|
|
$
|
11,103
|
|
|
$
|
6,498
|
|
Interest expense, net
|
|
|
3,286
|
|
|
|
2,218
|
|
|
|
1,544
|
|
|
|
1,480
|
|
|
|
1,264
|
|
Provision for income taxes
|
|
|
12,905
|
|
|
|
14,125
|
|
|
|
12,054
|
|
|
|
6,723
|
|
|
|
4,284
|
|
Depreciation and amortization
|
|
|
6,966
|
|
|
|
4,221
|
|
|
|
2,458
|
|
|
|
1,934
|
|
|
|
1,229
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
EBITDA
|
|
$
|
43,684
|
|
|
$
|
43,113
|
|
|
$
|
34,444
|
|
|
$
|
21,240
|
|
|
$
|
13,275
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Facility rent cost of services
|
|
|
16,675
|
|
|
|
16,404
|
|
|
|
16,118
|
|
|
|
14,773
|
|
|
|
9,964
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
EBITDAR
|
|
$
|
60,359
|
|
|
$
|
59,517
|
|
|
$
|
50,562
|
|
|
$
|
36,013
|
|
|
$
|
23,239
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
54
|
|
Item 7.
|
Managements
Discussion and Analysis of Financial Condition and Results of
Operations
|
The following discussion should be read in conjunction with
the consolidated financial statements and accompanying notes,
which appear elsewhere in this Annual Report. This discussion
contains forward-looking statements that involve risks and
uncertainties. Our actual results could differ materially from
those anticipated in these forward-looking statements as a
result of various factors, including those discussed below and
elsewhere in this Annual Report. See Item 1A.
Risk Factors.
Overview
We are a provider of skilled nursing and rehabilitative care
services through the operation of 61 facilities located in
California, Arizona, Texas, Washington, Utah and Idaho. All of
these facilities are skilled nursing facilities, other than
three stand-alone assisted living facilities in Arizona and
Texas and four campuses that offer both skilled nursing and
assisted living services in California, Arizona and Utah. Our
facilities provide a broad spectrum of skilled nursing and
assisted living services, physical, occupational and speech
therapies, and other rehabilitative and healthcare services, for
both long-term residents and short-stay rehabilitation patients.
We encourage and empower our facility leaders and staff to make
their facility the facility of choice in the
community it serves. This means that our facility leaders and
staff are generally free to discern and address the unique needs
and priorities of healthcare professionals, customers and other
stakeholders in the local community or market, and then work to
create a superior service offering and reputation for that
particular community or market to encourage prospective
customers and referral sources to choose or recommend the
facility. As of December 31, 2007, we owned 26 of our
facilities and operated an additional 35 facilities under
long-term lease arrangements, and had options to purchase, or
purchase agreements in place, for 10 of those 35 facilities. The
following table summarizes our facilities and licensed and
independent living beds by ownership status as of
December 31, 2007:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Leased (with a
|
|
|
Leased (without a
|
|
|
|
|
|
|
Owned
|
|
|
Purchase Option)
|
|
|
Purchase Option)
|
|
|
Total
|
|
|
Number of facilities
|
|
|
26
|
|
|
|
10
|
|
|
|
25
|
|
|
|
61
|
|
Percent of total
|
|
|
42.6
|
%
|
|
|
16.4
|
%
|
|
|
41.0
|
%
|
|
|
100
|
%
|
Skilled nursing, assisted living and independent living beds(1)
|
|
|
3,251
|
|
|
|
1,227
|
|
|
|
2,970
|
|
|
|
7,448
|
|
Percent of total
|
|
|
43.6
|
%
|
|
|
16.5
|
%
|
|
|
39.9
|
%
|
|
|
100
|
%
|
|
|
|
(1) |
|
Includes 671 beds in our 460 assisted living units and 84
independent living units as of December 31, 2007. All of
the independent living units are located at one of our assisted
living facilities. All bed counts are licensed beds except for
independent living beds, and may not reflect the number of beds
actually available for patient use. |
The Ensign Group, Inc. is a holding company with no direct
operating assets, employees or revenues. All of our facilities
are operated by separate, wholly-owned, independent
subsidiaries, which have their own management, employees and
assets. In addition, one of our wholly-owned independent
subsidiaries, which we call our Service Center, provides
centralized accounting, payroll, human resources, information
technology, legal, risk management and other services to each
operating subsidiary through contractual relationships between
such subsidiaries. In addition, we have a wholly-owned captive
insurance subsidiary that provides some claims-made coverage to
our operating subsidiaries for general and professional
liability, as well as for certain workers compensation
insurance liabilities.
Recent
Developments
On November 15, 2007, in connection with our IPO, we sold
4.0 million shares of common stock, and on
November 20, 2007, certain selling stockholders sold
0.6 million shares of common stock upon exercise in full of
the over-allotment option, each at the IPO price of $16.00 per
share. The proceeds to us from the IPO, net of underlying
discounts and commissions and estimated offering expenses
payable by us (Net Proceeds), were
55
approximately $56.5 million. Concurrently with the closing
of our IPO, all previously outstanding shares of preferred stock
converted into approximately 2.7 million shares of our
common stock.
Key
Performance Indicators
We manage our skilled nursing business by monitoring key
performance indicators that affect our financial performance.
These indicators and their definitions include the following:
|
|
|
|
|
Routine revenue: Routine revenue is generated
by the contracted daily rate charged for all contractually
inclusive services. The inclusion of therapy and other ancillary
treatments varies by payor source and by contract. Services
provided outside of the routine contractual agreement are
recorded separately as ancillary revenue, including Medicare
Part B therapy services, and are not included in the
routine revenue definition.
|
|
|
|
Skilled revenue: The amount of routine revenue
generated from patients in our skilled nursing facilities who
are receiving care under Medicare or managed care reimbursement,
referred to as Medicare and managed care patients.
Skilled revenue excludes any revenue generated from our assisted
living services.
|
|
|
|
Skilled mix: The amount of our skilled revenue
as a percentage of our total routine revenue. Skilled mix (in
days) represents the number of days our Medicare and managed
care patients are receiving services at our skilled nursing
facilities divided by the total number of days patients from all
payor sources are receiving services at our skilled nursing
facilities for any given period.
|
|
|
|
Quality mix: The amount of routine
non-Medicaid revenue as a percentage of our total routine
revenue. Quality mix (in days) represents the number of days our
non-Medicaid patients are receiving services at our skilled
nursing facilities divided by the total number of days patients
from all payor sources are receiving services at our skilled
nursing facilities for any given period.
|
|
|
|
Average daily rates: The routine revenue by
payor source for a period at our skilled nursing facilities
divided by actual patient days for that revenue source for that
given period.
|
|
|
|
Occupancy percentage: The total number of
residents occupying a bed in a skilled nursing, assisted living
or independent living facility as a percentage of the number of
licensed and independent living beds in the facility.
|
|
|
|
Number of facilities and licensed beds: The
total number of skilled nursing, assisted living and independent
living facilities that we own or operate and the total number of
licensed and independent living beds associated with these
facilities. Independent living beds do not have a licensing
requirement.
|
Skilled and Quality Mix. Like most skilled
nursing providers, we measure both patient days and revenue by
payor. Medicare and managed care patients, whom we refer to as
high acuity patients, typically require a higher level of
skilled nursing and rehabilitative care. Accordingly, Medicare
and managed care reimbursement rates are typically higher than
from other payors. In most states, Medicaid reimbursement rates
are generally the lowest of all payor types. Changes in the
payor mix can significantly affect our revenue and profitability.
56
The following table summarizes our skilled mix and quality mix
for the periods indicated as a percentage of our total routine
revenue (less revenue from assisted living services) and as a
percentage of total patient days:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31,
|
|
|
|
2007
|
|
|
2006
|
|
|
2005
|
|
|
Skilled Mix:
|
|
|
|
|
|
|
|
|
|
|
|
|
Days
|
|
|
22.7
|
%
|
|
|
24.3
|
%
|
|
|
22.4
|
%
|
Revenue
|
|
|
43.1
|
%
|
|
|
45.6
|
%
|
|
|
42.9
|
%
|
Quality Mix:
|
|
|
|
|
|
|
|
|
|
|
|
|
Days
|
|
|
35.7
|
%
|
|
|
37.4
|
%
|
|
|
36.0
|
%
|
Revenue
|
|
|
53.4
|
%
|
|
|
55.5
|
%
|
|
|
53.5
|
%
|
Occupancy. We define occupancy as the actual
patient days (one patient day equals one patient or resident
occupying one bed for one day) during any measurement period as
a percentage of the number of available patient days for that
period. Available patient days are determined by multiplying the
number of licensed and independent living beds in service during
the measurement period by the number of calendar days in the
measurement period. During any measurement period, the number of
licensed and independent living beds in a skilled nursing,
assisted living or independent living facility that are actually
available to us may be less than the actual licensed and
independent living bed capacity due to, among other things,
temporary bed suspensions as a result of low occupancy levels,
the voluntary or other imposition of quarantines or bed holds,
or the dedication of bed space to other uses.
The following table summarizes our occupancy statistics for the
periods indicated:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31,
|
|
|
|
2007
|
|
|
2006
|
|
|
2005
|
|
|
Occupancy:
|
|
|
|
|
|
|
|
|
|
|
|
|
Licensed and independent living beds at end of period(1)
|
|
|
7,448
|
|
|
|
6,940
|
|
|
|
5,796
|
|
Available patient days
|
|
|
2,673,006
|
|
|
|
2,281,735
|
|
|
|
2,034,270
|
|
Actual patient days
|
|
|
2,078,893
|
|
|
|
1,849,932
|
|
|
|
1,668,566
|
|
Occupancy percentage based on licensed beds
|
|
|
77.8
|
%
|
|
|
81.1
|
%
|
|
|
82.0
|
%
|
|
|
|
(1) |
|
The number of licensed beds is calculated using the historical
number of beds licensed at each facility. All bed counts are
licensed beds except for independent living beds, and may not
reflect the number of beds actually available for patient use. |
Revenue
Sources
Our total revenue represents revenue derived primarily from
providing services to patients and residents of skilled nursing
facilities, and to a lesser extent from assisted living
facilities and ancillary services. We receive service revenue
from Medicaid, Medicare, private payors and other third-party
payors, and managed care sources. The sources and amounts of our
revenue are determined by a number of factors, including
licensed bed capacity and occupancy rates of our healthcare
facilities, the mix of patients at our facilities and the rates
of reimbursement among payors. Payment for ancillary services
varies based upon the service
57
provided and the type of payor. The following table sets forth
our total revenue by payor source and as a percentage of total
revenue for the periods indicated:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31,
|
|
|
|
2007
|
|
|
2006
|
|
|
2005
|
|
|
|
$
|
|
|
%
|
|
|
$
|
|
|
%
|
|
|
$
|
|
|
%
|
|
|
|
(In thousands)
|
|
|
Revenue:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Medicare
|
|
$
|
123,170
|
|
|
|
30.0
|
%
|
|
$
|
117,511
|
|
|
|
32.8
|
%
|
|
$
|
96,208
|
|
|
|
32.0
|
%
|
Managed care
|
|
|
52,779
|
|
|
|
12.8
|
|
|
|
44,487
|
|
|
|
12.4
|
|
|
|
33,484
|
|
|
|
11.1
|
|
Private and other(1)
|
|
|
52,579
|
|
|
|
12.8
|
|
|
|
45,312
|
|
|
|
12.6
|
|
|
|
39,831
|
|
|
|
13.2
|
|
Medicaid
|
|
|
182,790
|
|
|
|
44.4
|
|
|
|
151,264
|
|
|
|
42.2
|
|
|
|
131,327
|
|
|
|
43.7
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total revenue
|
|
$
|
411,318
|
|
|
|
100.0
|
%
|
|
$
|
358,574
|
|
|
|
100.0
|
%
|
|
$
|
300,850
|
|
|
|
100.0
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
Includes revenue from assisted living facilities. |
Primary
Components of Expense
Cost of Services (exclusive of facility rent and depreciation
and amortization shown separately below). Our
cost of services represents the costs of operating our
facilities and primarily consists of payroll and related
benefits, supplies, purchased services, and ancillary expenses
such as the cost of pharmacy and therapy services provided to
residents. Cost of services also includes the cost of general
and professional liability insurance and other general cost of
services with respect to our facilities.
Facility Rent Cost of
Services. Facility rent cost of
services consists solely of base minimum rent amounts payable
under lease agreements to third-party owners of the facilities
that we operate but do not own and does not include taxes,
insurance, impounds, capital reserves or other charges payable
under the applicable lease agreements.
General and Administrative Expense. General
and administrative expense consists primarily of payroll and
related benefits and travel expenses for our administrative
Service Center personnel, including training and other
operational support. General and administrative expense also
includes professional fees (including accounting and legal
fees), costs relating to our information systems, stock-based
compensation and rent for our Service Center office.
We expect our general and administrative expense to remain
approximately the same as 2007 in the future as a result of
becoming a public company. Our anticipated additional expenses
include:
|
|
|
|
|
increased salaries, bonuses and benefits necessary to attract
and retain qualified accounting professionals as we seek to
expand the size and enhance the skills of our accounting and
finance staff;
|
|
|
|
increased professional fees as we complete the process of
complying with Section 404 of the Sarbanes-Oxley Act,
including incurring additional audit fees in connection with our
independent registered public accounting firms audit of
the effectiveness of our internal controls over financial
reporting;
|
|
|
|
increased costs associated with creating and developing an
internal audit function, which we have not had historically;
|
|
|
|
increased legal costs associated with complying with reporting
requirements under the federal securities laws; and
|
|
|
|
the incurrence of miscellaneous costs, such as stock exchange
fees, investor relations fees, filing expenses, training
expenses and increased directors and officers
liability insurance.
|
58
Depreciation and Amortization. Property and
equipment are recorded at their original historical cost.
Depreciation is computed using the straight-line method over the
estimated useful lives of the depreciable assets. The following
is a summary of the depreciable lives of our depreciable assets:
|
|
|
Buildings and improvements
|
|
15 to 30 years
|
Leasehold improvements
|
|
Shorter of the lease term or estimated useful life, generally 5
to 15 years
|
Furniture and equipment
|
|
3 to 10 years
|
Critical
Accounting Policies
Our discussion and analysis of our financial condition and
results of operations are based on our consolidated financial
statements, which have been prepared in accordance with
accounting principles generally accepted in the United States.
The preparation of these financial statements and related
disclosures requires us to make judgments, estimates and
assumptions that affect the reported amounts of assets and
liabilities and disclosure of contingent asset and liabilities
at the date of the financial statements and the reported amounts
of revenue and expenses during the reporting period. On an
ongoing basis we review our judgments and estimates, including
those related to doubtful accounts, income taxes and loss
contingencies. We base our estimates and judgments upon our
historical experience, knowledge of current conditions and our
belief of what could occur in the future considering available
information, including assumptions that we believe to be
reasonable under the circumstances. By their nature, these
estimates and judgments are subject to an inherent degree of
uncertainty and actual results could differ materially from the
amounts reported. The following summarizes our critical
accounting policies, defined as those policies that we believe:
(a) are the most important to the portrayal of our
financial condition and results of operations; and
(b) require managements most subjective or complex
judgments, often as a result of the need to make estimates about
the effects of matters that are inherently uncertain.
Revenue
Recognition
We follow the provisions of Staff Accounting Bulletin (SAB)
No. 104, Revenue Recognition in Financial Statements
(SAB 104), for revenue recognition. Under SAB 104,
four conditions must be met before revenue can be recognized:
(i) there is persuasive evidence that an arrangement
exists; (ii) delivery has occurred or service has been
rendered; (iii) the price is fixed or determinable; and
(iv) collection is reasonably assured.
Our revenue is derived primarily from providing long-term
healthcare services to residents and is recognized on the date
services are provided at amounts billable to individual
residents. For residents under reimbursement arrangements with
third-party payors, including Medicaid, Medicare and private
insurers, revenue is recorded based on contractually
agreed-upon
amounts on a per patient, daily basis.
Revenue from the Medicare and Medicaid programs accounted for
approximately 74%, 75% and 76% of our revenue in the years ended
December 31, 2007, 2006 and 2005, respectively. We record
our revenue from these governmental and managed care programs as
services are performed at their expected net realizable amounts
under these programs. Our revenue from governmental and managed
care programs is subject to audit and retroactive adjustment by
governmental and third-party agencies. Consistent with
healthcare industry accounting practices, any changes to these
revenue estimates are recorded in the period the change or
adjustment becomes known based on final settlements. We recorded
retroactive adjustments that increased revenue by
$0.7 million, $0.2 million and $0.2 million for
the years ended December 31, 2007, 2006 and 2005,
respectively. The adjustment for 2005 does not include the 2004
retroactive adjustment to record a California state Medicaid
rate increase. Because of the complexity of the laws and
regulations governing Medicare and Medicaid assistance programs,
our estimates may potentially change by a material amount. We
record our revenue from private pay patients as services are
performed. Also, see Note 17 for further discussion.
59
Accounts
Receivable
Accounts receivable are comprised of amounts due from patients
and residents, Medicare and Medicaid payor programs, third party
insurance payors and other nursing facilities and customers. We
value our receivables based on the net amount we expect to
receive from these payors. In evaluating the collectibility of
our accounts receivable, management considers a number of
factors including changes in collection patterns, accounts
receivable aging trends by payor category and the status of
ongoing disputes with third party payors. The percentages
applied to our aged receivable balances for purposes of
establishing allowances for doubtful accounts are based on our
historical experience and time limits, if any, for managed care,
Medicare and Medicaid. We periodically refine our procedures for
estimating the allowance for doubtful accounts based on
experience with the estimation process and changes in
circumstances. Our receivables from Medicare and Medicaid payor
programs accounted for approximately 61% and 65% of our total
accounts receivable as of December 31, 2007 and 2006,
respectively, and represents our only significant concentration
of credit risk.
Self-Insurance
We are partially self-insured for general and professional
liability up to a base amount per claim (the self-insured
retention) with an aggregate, one time deductible above this
limit. Losses beyond these amounts are insured through
third-party policies with coverage limits per occurrence, per
location and on an aggregate basis for our company. For claims
made in 2007, the self-insured retention was $0.4 million
per claim with a $0.9 million deductible. The third-party
coverage above these limits is $1.0 million per occurrence,
$3.0 million per facility with a $6.0 million company
aggregate. The insurers maximum aggregate loss limits are
generally above our actuarially determined probable losses;
therefore, we believe the likelihood of losses exceeding the
insurers maximum aggregate loss is remote.
The self-insured retention and deductible limits for general and
professional liability and workers compensation are
self-insured through a wholly-owned insurance captive (the
Captive), the related assets and liabilities of which are
included in the consolidated financial statements. The Captive
is subject to certain statutory requirements as an insurance
provider. These requirements include, but are not limited to,
maintaining statutory capital. Our policy is to accrue amounts
equal to the estimated costs to settle open claims of insureds,
as well as an estimate of the cost of insured claims that have
been incurred but not reported. We develop information about the
size of the ultimate claims based on historical experience,
current industry information and actuarial analysis, and have
evaluated the estimates for claim loss exposure on an annual
basis through 2006, and on a quarterly basis beginning with the
first quarter of 2007. Accrued general liability and
professional malpractice liabilities recorded on an undiscounted
basis in the consolidated balance sheets were $18.6 million
and $16.0 million as of December 31, 2007 and 2006,
respectively.
Our operating subsidiaries are self-insured for workers
compensation liability in California. In Texas, the operating
subsidiaries have elected non-subscriber status for
workers compensation claims. Our operating subsidiaries in
other states have third party guaranteed cost coverage. In
California and Texas, we accrue amounts equal to the estimated
costs to settle open claims, as well as an estimate of the cost
of claims that have been incurred but not reported. We use
actuarial valuations to estimate the liability based on
historical experience and industry information. Accrued
workers compensation liabilities are recorded on an
undiscounted basis in the consolidated balance sheets and were
$4.1 million and $4.4 million as of December 31,
2007 and 2006, respectively.
During 2003 and 2004, our California and Arizona operating
subsidiaries were insured for workers compensation
liability by a third-party carrier under a policy where the
retrospective premium was adjusted annually based on incurred
developed losses and allocated expenses. Based on a comparison
of the computed retrospective premium to the actual payments
funded, amounts will be due to the insurer or insured. The
funded accrual in excess of the estimated liabilities is
included in prepaid expenses and other current assets in the
consolidated balance sheets and was $0.4 million and
$0.9 million as of December 31, 2007 and 2006,
respectively.
Effective May 1, 2006, we began to provide self-insured
medical (including prescription drugs) and dental healthcare
benefits to the majority of our employees. Prior to this, we had
multiple third-party HMO and PPO
60
plans, of which certain HMO plans are still active. We are not
aware of any run-off claim liabilities from the prior plans. We
are fully liable for all financial and legal aspects of these
benefit plans. To protect ourselves against loss exposure with
this policy, we have purchased individual stop-loss insurance
coverage that insures individual claims that exceed
$0.1 million for each covered person which resets every
plan year or a maximum of $6.0 million per each covered
persons lifetime on the PPO plan and unlimited on the HMO
plan. We have also purchased aggregate stop-loss coverage that
reimburses the plan up to $5.0 million to the extent that
paid claims exceed $7.2 million. The aforementioned
coverage only applies to claims paid during the plan year. Our
accrued liability under these plans recorded on an undiscounted
basis in the consolidated balance sheets was $1.9 million
and $1.0 million at December 31, 2007 and 2006,
respectively.
We believe that adequate provision has been made in the
consolidated financial statements for liabilities that may arise
out of patient care, workers compensation, healthcare
benefits and related services provided to date. The amount of
our reserves was determined based on an estimation process that
uses information obtained from both company-specific and
industry data. This estimation process requires us to
continuously monitor and evaluate the life cycle of the claims.
Using data obtained from this monitoring and our assumptions
about emerging trends, we, with the assistance of an independent
actuary, develop information about the size of ultimate claims
based on our historical experience and other available industry
information. The most significant assumptions used in the
estimation process include determining the trend in costs, the
expected cost of claims incurred but not reported and the
expected costs to settle or pay damage awards with respect to
unpaid claims. It is possible, however, that the actual
liabilities may exceed our estimate of loss.
The self-insured liabilities are based upon estimates, and while
management believes that the estimates of loss are reasonable,
the ultimate liability may be in excess of or less than the
recorded amounts. Due to the inherent volatility of actuarially
determined loss estimates, it is reasonably possible that we
could experience changes in estimated losses that could be
material to net income. If our actual liability exceeds its
estimate of loss, our future earnings and financial condition
would be adversely affected.
Impairment
of Long-Lived Assets
Management reviews the carrying value of long-lived assets that
are held and used in our operations for impairment whenever
events or changes in circumstances indicate that the carrying
amount of an asset may not be recoverable. Recoverability of
these assets is determined based upon expected undiscounted
future net cash flows from the operations to which the assets
relate, utilizing managements best estimate, appropriate
assumptions, and projections at the time. If the carrying value
is determined to be unrecoverable from future operating cash
flows, the asset is deemed impaired and an impairment loss would
be recognized to the extent the carrying value exceeded the
estimated fair value of the asset. We estimate the fair value of
assets based on the estimated future discounted cash flows of
the asset. Management has evaluated its long-lived assets and
has not identified any impairment as of December 31, 2007
and 2006.
Intangible
Assets and Goodwill
Intangible assets consist primarily of deferred financing costs,
lease acquisition costs and trade names. Deferred financing
costs are amortized over the term of the related debt, ranging
from seven to 26 years. Lease acquisition costs are
amortized over the life of the lease of the facility acquired,
ranging from ten to 20 years. Trade names are amortized
over 30 years.
Goodwill is accounted for under Statement of Financial
Accounting Standards (SFAS) No. 141, Business
Combinations (SFAS 141) and represents the excess
of the purchase price over the fair value of identifiable net
assets acquired in business combinations. In accordance with
SFAS No. 142, Goodwill and Other Intangible Assets
(SFAS 142), goodwill is subject to annual testing for
impairment. In addition, goodwill is tested for impairment if
events occur or circumstances change that would reduce the fair
value of a reporting unit below its carrying amount. We perform
our annual test for impairment during the fourth quarter of each
year. We did not record any impairment charges during the years
ended December 31, 2007 and 2006.
61
Stock-Based
Compensation
As of January 1, 2006, we adopted
SFAS No. 123(R), Share-Based Payment
(SFAS 123(R)), which requires the measurement and
recognition of compensation expense for all share-based payment
awards made to employees and directors including employee stock
options based on estimated fair values, ratably over the
requisite service period of the award. Net income is reduced by
the recognition of the fair value of all stock options issued on
and subsequent to January 1, 2006, the amount of which is
contingent upon the number of future options granted and other
variables. Prior to the adoption of SFAS 123(R), we
accounted for stock-based awards to employees and directors
using the intrinsic value method in accordance with Accounting
Principles Board (APB) Opinion No. 25, Accounting for
Stock Issued to Employees (APB 25) as allowed under
SFAS No. 123, Accounting for Stock-Based
Compensation (SFAS 123).
We adopted SFAS 123(R) using the prospective transition
method. Our consolidated financial statements as of and for the
periods ended December 31, 2007 and 2006 reflect the impact
of SFAS 123(R). In accordance with the prospective
transition method, our consolidated financial statements for
periods prior to January 1, 2006 have not been restated to
reflect, and do not include, the impact of SFAS 123(R).
Historically, no compensation expense was recognized by us in
our financial statements in connection with the awarding of
stock option grants to employees provided that, as of the grant
date, all terms associated with the award were fixed and the
fair value of our stock, as of the grant date, was equal to or
less than the amount an employee must pay to acquire the stock.
We would have recognized compensation expense in situations
where the fair value of our common stock on the grant date was
greater than the amount an employee must pay to acquire the
stock. Stock-based compensation expense recognized in our
consolidated statement of income for the year ended
December 31, 2007 does not include compensation expense for
share-based payment awards granted prior to, but not yet vested
as of January 1, 2006, in accordance with the pro forma
provisions of SFAS 123, but does include compensation
expense for the share-based payment awards granted subsequent to
January 1, 2006 based on the fair value on the grant date
estimated in accordance with the provisions of SFAS 123(R).
Existing options at January 1, 2006 will continue to be
accounted for in accordance with APB 25 unless such options are
modified, repurchased or canceled after the effective date.
Income
Taxes
Income taxes are accounted for in accordance with
SFAS No. 109, Accounting for Income Taxes
(SFAS 109). Under this method, deferred tax assets and
liabilities are established for temporary differences between
the financial reporting basis and the tax basis of our assets
and liabilities at tax rates expected to be in effect when such
temporary differences are expected to reverse. The temporary
differences are primarily attributable to compensation accruals,
straight line rent adjustments and reserves for doubtful
accounts and insurance liabilities. When necessary, we record a
valuation allowance to reduce our net deferred tax assets to the
amount that is more likely than not to be realized. In
considering the need for a valuation allowance against some
portion or all of our deferred tax assets, we must make certain
estimates and assumptions regarding future taxable income, the
feasibility of tax planning strategies and other factors.
Estimates and judgments regarding deferred tax assets and the
associated valuation allowance, if any, are based on, among
other things, knowledge of operations, markets, historical
trends and likely future changes and, when appropriate, the
opinions of advisors with knowledge and expertise in certain
fields. However, due to the nature of certain assets and
liabilities, there are risks and uncertainties associated with
some of our estimates and judgments. Actual results could differ
from these estimates under different assumptions or conditions.
The net deferred tax assets as of December 31, 2007 and
2006 were $11.7 and $12.6 million, respectively. We expect
to fully utilize these deferred tax assets; however, their
ultimate realization is dependent upon the amount of future
taxable income during the periods in which the temporary
differences become deductible.
As of January 1, 2007, we adopted Financial Accounting
Standards Board (FASB) Interpretation No. 48, Accounting
for Uncertainty in Income Taxes an interpretation of
FASB Statement No. 109 (FIN 48). FIN 48
requires us to maintain a liability for underpayment of income
taxes and related interest and penalties, if any, for uncertain
income tax positions. In considering the need for and magnitude
of a liability for uncertain
62
income tax positions, we must make certain estimates and
assumptions regarding the amount of income tax benefit that will
ultimately be realized. The ultimate resolution of an uncertain
tax position may not be known for a number of years, during
which time we may be required to adjust these reserves, in light
of changing facts and circumstances.
We used an estimate of our annual income tax rate to recognize a
provision for income taxes in financial statements for interim
periods. However, changes in facts and circumstances could
result in adjustments to our effective tax rate in future
quarterly or annual periods.
Acquisition
Policy
We periodically enter into agreements to acquire assets
and/or
businesses. The considerations involved in each of these
agreements may include cash, financing,
and/or
long-term lease arrangements for real properties. We evaluate
each transaction to determine whether the acquired interests are
assets or businesses using the framework provided by Emerging
Issue Task Force (EITF) Issue
No. 98-3,
Determining Whether a Nonmonetary Transaction Involves
Receipt of Productive Assets or of a Business
(EITF 98-3).
EITF 98-3
defines a business as a self sustaining integrated set of
activities and assets conducted and managed for the purpose of
providing a return to investors. A business consists of
(a) input; (b) processes applied to those inputs; and
(c) resulting outputs that are used to generate revenues.
In order for an acquired set of activities and assets to be a
business, it must contain all of the inputs and processes
necessary for it to continue to conduct normal operations after
the acquired entity is separated from the seller, including the
ability to sustain a revenue stream by providing its outputs to
customers. An acquired set of activities and assets fail the
definition of a business if it excludes one or more of the above
items such that it is not possible to continue normal operations
and sustain a revenue stream by providing its products
and/or
services to customers.
Operating
Leases
We account for operating leases in accordance with
SFAS No. 13, Accounting for Leases, and FASB
Technical
Bulletin 85-3,
Accounting for Operating Leases with Scheduled Rent
Increases. Accordingly, we recognize rent expense under the
operating leases for our facilities and administrative offices
on a straight-line basis over the original term of such leases,
inclusive of predetermined rent escalations or modifications.
Recently
Issued Accounting Pronouncements
In December 2007, the FASB issued SFAS No. 141(R),
Business Combinations (SFAS 141(R)), which replaces
SFAS 141. The provisions of SFAS 141(R) are similar to
those of SFAS 141; however, SFAS 141(R) requires
companies to record most identifiable assets, liabilities,
noncontrolling interests, and goodwill acquired in a business
combination at full fair value. SFAS 141(R)
also requires companies to record fair value estimates of
contingent consideration and certain other potential liabilities
during the original purchase price allocation and to expense
acquisition costs as incurred. This statement applies to all
business combinations, including combinations by contract alone.
Further, under SFAS 141(R), all business combinations will
be accounted for by applying the acquisition method.
SFAS 141(R) is effective for fiscal years beginning on or
after December 15, 2008. We are currently evaluating the
impact that SFAS 141(R) will have on our consolidated
financial statements.
In December 2007, the FASB issued SFAS No. 160,
Noncontrolling Interests in Consolidated Financial Statements
(SFAS 160), which will require noncontrolling interests
(previously referred to as minority interests) to be treated as
a separate component of equity, not as a liability or other item
outside of permanent equity. This Statement applies to the
accounting for noncontrolling interests and transactions with
noncontrolling interest holders in consolidated financial
statements. SFAS 160 will be applied prospectively to all
noncontrolling interests, including any that arose before the
effective date except that comparative period information must
be recast to classify noncontrolling interests in equity,
attribute net income and other comprehensive income to
noncontrolling interests, and provide other disclosures required
by Statement 160. SFAS 160 is effective for periods
beginning on or after December 15, 2008. We are currently
evaluating the impact that SFAS 160 will have on our
consolidated financial statements.
63
In September 2006, the FASB issued SFAS No. 157,
Fair Value Measurements (SFAS 157), which defines
fair value, establishes a framework for measuring fair value
under GAAP, and expands disclosures about fair value
measurements. SFAS 157 applies to other accounting
pronouncements that require or permit fair value measurements.
SFAS 157 is effective for fiscal years beginning after
November 15, 2007, and for interim periods within those
fiscal years. Subsequently, in February 2008, the FASB issued
two staff positions on SFAS 157 (FSP
FAS 157-1
and 157-2)
which scope out the lease classification measurements under FASB
Statement No. 13 from SFAS 157 and delays the
effective date on SFAS 157 for all nonrecurring fair value
measurements of nonfinancial assets and nonfinancial liabilities
until fiscal years beginning after November 15, 2008. We
are currently evaluating the impact, if any, that SFAS 157
will have on our consolidated financial statements.
In February 2007, the FASB issued SFAS No. 159, The
Fair Value Option For Financial Assets and Financial
Liabilities including an amendment of FASB Statement
No. 115 (SFAS 159). SFAS 159 permits entities
to choose to measure many financial instruments and certain
other items at fair value. SFAS 159 is effective for fiscal
years beginning after November 15, 2007. We are currently
evaluating the impact, if any, that SFAS 159 will have on
our consolidated financial statements.
In June 2007, the FASB ratified EITF consensus
06-11,
Accounting for Income Tax Benefits of Dividends on
Share-Based Payment Awards. This EITF prescribes that the
tax benefit received on dividends associated with share-based
awards that are charged to retained earnings should be recorded
in additional paid-in capital and included in the pool of excess
tax benefits available to absorb potential future tax
deficiencies of share-based payment awards. The consensus is
effective for the tax benefits of dividends declared in fiscal
years beginning after December 15, 2007. We are currently
evaluating the impact that
EITF 06-11
will have on our consolidated financial statements.
Adoption
of New Accounting Pronouncements
In June 2006, the FASB issued FIN 48, which is effective
for fiscal years beginning after December 15, 2006.
FIN 48 clarifies the accounting for uncertainty in income
taxes recognized in financial statements in accordance with
SFAS No. 109, Accounting for Income Taxes, by
prescribing a recognition threshold and measurement attribute
for the financial statement recognition and measurement of a tax
position taken or expected to be taken in a tax return.
FIN 48 also provides guidance on de-recognition,
classification, interest and penalties, accounting in interim
periods, disclosure and transition. We adopted FIN 48 at
the beginning of fiscal year 2007. See Note 10 in Notes to
the Consolidated Financial Statements for a description of the
impact of this adoption on our consolidated financial position
and results of operations.
64
Results
of Operations
The following table sets forth details of our revenue, expenses
and earnings as a percentage of total revenue for the periods
indicated:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31,
|
|
|
|
2007
|
|
|
2006
|
|
|
2005
|
|
|
Revenue
|
|
|
100.0
|
%
|
|
|
100.0
|
%
|
|
|
100.0
|
%
|
Expenses:
|
|
|
|
|
|
|
|
|
|
|
|
|
Cost of services (exclusive of facility rent and depreciation
and amortization shown separately below)
|
|
|
81.4
|
|
|
|
79.4
|
|
|
|
79.6
|
|
Facility rent cost of services
|
|
|
4.1
|
|
|
|
4.6
|
|
|
|
5.4
|
|
General and administrative expense
|
|
|
3.9
|
|
|
|
4.0
|
|
|
|
3.6
|
|
Depreciation and amortization
|
|
|
1.7
|
|
|
|
1.2
|
|
|
|
0.8
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total expenses
|
|
|
91.1
|
|
|
|
89.2
|
|
|
|
89.4
|
|
Income from operations
|
|
|
8.9
|
|
|
|
10.8
|
|
|
|
10.6
|
|
Other income (expense):
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest expense
|
|
|
(1.2
|
)
|
|
|
(0.8
|
)
|
|
|
(0.7
|
)
|
Interest income
|
|
|
0.4
|
|
|
|
0.2
|
|
|
|
0.2
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other expense, net
|
|
|
(0.8
|
)
|
|
|
(0.6
|
)
|
|
|
(0.5
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income before provision for income taxes
|
|
|
8.1
|
|
|
|
10.2
|
|
|
|
10.1
|
|
Provision for income taxes
|
|
|
3.1
|
|
|
|
3.9
|
|
|
|
4.0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
|
5.0
|
%
|
|
|
6.3
|
%
|
|
|
6.1
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year
Ended December 31, 2007 Compared to Year Ended
December 31, 2006
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31,
|
|
|
|
|
|
|
2007
|
|
|
2006
|
|
|
Change
|
|
|
|
(Dollars in thousands)
|
|
|
|
|
|
Same Facility Results(1):
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenue
|
|
$
|
344,712
|
|
|
$
|
337,004
|
|
|
|
2.3
|
%
|
Number of facilities at period end
|
|
|
46
|
|
|
|
46
|
|
|
|
0
|
%
|
Actual patient days
|
|
|
1,713,103
|
|
|
|
1,730,689
|
|
|
|
(1.0
|
)%
|
Occupancy percentage
|
|
|
81.4
|
%
|
|
|
82.0
|
%
|
|
|
(0.6
|
)%
|
Skilled mix by nursing days
|
|
|
23.7
|
%
|
|
|
24.8
|
%
|
|
|
(1.1
|
)%
|
Recently Acquired Facility Results(2):
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenue
|
|
$
|
66,606
|
|
|
$
|
21,571
|
|
|
|
208.8
|
%
|
Number of facilities at period end
|
|
|
15
|
|
|
|
11
|
|
|
|
36.4
|
%
|
Actual patient days
|
|
|
365,790
|
|
|
|
119,243
|
|
|
|
206.8
|
%
|
Occupancy percentage
|
|
|
64.4
|
%
|
|
|
67.9
|
%
|
|
|
(3.5
|
)%
|
Skilled mix by nursing days
|
|
|
18.3
|
%
|
|
|
17.7
|
%
|
|
|
0.6
|
%
|
Total Facility Results:
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenue
|
|
$
|
411,318
|
|
|
$
|
358,575
|
|
|
|
14.7
|
%
|
Number of facilities at period end
|
|
|
61
|
|
|
|
57
|
|
|
|
7.0
|
%
|
Actual patient days
|
|
|
2,078,893
|
|
|
|
1,849,932
|
|
|
|
12.4
|
%
|
Occupancy percentage
|
|
|
77.8
|
%
|
|
|
81.1
|
%
|
|
|
(3.3
|
)%
|
Skilled mix by nursing days
|
|
|
22.7
|
%
|
|
|
24.3
|
%
|
|
|
(1.6
|
)%
|
|
|
|
(1) |
|
Same Facility represents all facilities acquired prior to
January 1, 2006. |
|
(2) |
|
Recently Acquired Facility represents all facilities acquired
subsequent to January 1, 2006. |
65
Revenue. Revenue increased $52.7 million,
or 14.7%, to $411.3 million for the year ended
December 31, 2007 compared to $358.6 million for the
year ended December 31, 2006. Of the $52.7 million
increase, skilled revenue (Medicare and managed care) increased
$13.9 million, or 9.0%, Medicaid revenue increased
$31.5 million, or 20.9%, and private and other revenue
increased $7.3 million, or 16.0%.
Revenue generated by facilities acquired prior to
January 1, 2006 (Same Facilities) increased
$7.7 million, or 2.3%, for the year ended December 31,
2007 as compared to the year ended December 31, 2006. This
increase was primarily due to higher reimbursement rates
relative to the year ended December 31, 2006, as described
below, partially offset by declines in skilled mix by nursing
days and occupancy rate. Same Facility skilled mix and occupancy
rate declines of 1.1% and 0.6%, respectively, were primarily
attributable to three facilities, where revenues decreased by an
aggregate of approximately $4.7 million. These three
facilities experienced occupancy rate declines of 1.3%, 9.8% and
12.0% as compared to the year ended December 31, 2006.
These declines were primarily attributable to Medicare day
declines. The occupancy declines at two of these facilities were
primarily the result of admission holds during the first quarter
of 2007, followed by a slower than anticipated climb to more
normalized occupancy levels. The decline at the remaining
facility is attributable to a change in local market factors.
These revenue declines were more than offset by the increase in
same facility revenues primarily attributable to increases in
reimbursement rates; see further discussion below. For
additional discussion on admission holds see our Risk
Factors Risks Related to Our Industry Public
and governmental calls for increased survey and enforcement
efforts against long-term care facilities could result in
increased scrutiny by state and federal survey agencies.
Approximately $45.0 million of the total revenue increase
was due to revenue generated by facilities acquired during 2006
and 2007 (Recently Acquired Facilities) which was primarily
attributable to the increase in actual patient days,
complemented by an increase in skilled mix and quality mix by
nursing day at such facilities. This growth was hindered in part
by generally lower occupancy rates. The occupancy rate, skilled
mix and quality mix at Recently Acquired Facilities were 64.4%,
18.3% and 34.1%, respectively, as compared to corresponding
rates at Same Facilities of 81.4%, 23.7% and 36.1%,
respectively. Historically, we have generally experienced lower
occupancy rates, lower skilled mix and quality mix in Recently
Acquired Facilities, and we expect this trend to continue.
The following table reflects the change in the skilled nursing
average daily revenue rates by payor source, excluding therapy
and other ancillary services that are not covered by the daily
rate:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31,
|
|
|
|
Total
|
|
|
Acquisitions
|
|
|
Same Facility
|
|
|
|
2007
|
|
|
2006
|
|
|
2007
|
|
|
2006
|
|
|
2007
|
|
|
2006
|
|
|
Skilled Nursing Average Daily Revenue Rates:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Medicare
|
|
$
|
451.33
|
|
|
$
|
441.78
|
|
|
$
|
391.13
|
|
|
$
|
385.10
|
|
|
$
|
467.64
|
|
|
$
|
446.31
|
|
Managed care
|
|
|
297.42
|
|
|
|
274.39
|
|
|
|
352.50
|
|
|
|
301.81
|
|
|
|
294.25
|
|
|
|
274.07
|
|
Total skilled revenue
|
|
|
389.96
|
|
|
|
377.54
|
|
|
|
385.53
|
|
|
|
377.77
|
|
|
|
390.74
|
|
|
|
377.53
|
|
Medicaid
|
|
|
149.53
|
|
|
|
143.17
|
|
|
|
133.22
|
|
|
|
135.72
|
|
|
|
153.42
|
|
|
|
144.54
|
|
Private and other payors
|
|
|
161.64
|
|
|
|
152.74
|
|
|
|
142.38
|
|
|
|
137.81
|
|
|
|
167.01
|
|
|
|
154.04
|
|
Total skilled nursing revenue
|
|
$
|
206.07
|
|
|
$
|
201.45
|
|
|
$
|
180.92
|
|
|
$
|
178.89
|
|
|
$
|
211.86
|
|
|
$
|
204.13
|
|
The average Medicare daily rate increased by approximately 2.2%
in the year ended December 31, 2007 as compared to the year
ended December 31, 2006, primarily as a result of statutory
inflationary increases. The average Medicaid rate increase of
3.9% in the year ended December 31, 2007 relative to the
same period in the prior year primarily resulted from increases
in reimbursement rates. The change in the daily rate in the
private and other payors category was primarily due to net rate
changes based on local market dynamics.
66
Payor Sources as a Percentage of Skilled Nursing
Services. We use both our skilled mix and quality
mix as measures of the quality of reimbursements we receive at
our skilled nursing facilities over various periods. The
following table sets forth our percentage of skilled nursing
patient revenue and days by payor source:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31,
|
|
|
|
Total
|
|
|
Acquisitions
|
|
|
Same Facility
|
|
|
|
2007
|
|
|
2006
|
|
|
2007
|
|
|
2006
|
|
|
2007
|
|
|
2006
|
|
|
Percentage of Skilled Nursing Revenue:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Medicare
|
|
|
30.0
|
%
|
|
|
32.9
|
%
|
|
|
33.9
|
%
|
|
|
34.8
|
%
|
|
|
29.3
|
%
|
|
|
32.8
|
%
|
Managed care
|
|
|
13.1
|
|
|
|
12.7
|
|
|
|
5.2
|
|
|
|
2.6
|
|
|
|
14.7
|
|
|
|
13.4
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Skilled mix
|
|
|
43.1
|
|
|
|
45.6
|
|
|
|
39.1
|
|
|
|
37.4
|
|
|
|
44.0
|
|
|
|
46.2
|
|
Private and other payors
|
|
|
10.3
|
|
|
|
9.9
|
|
|
|
12.4
|
|
|
|
11.8
|
|
|
|
9.8
|
|
|
|
9.8
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Quality mix
|
|
|
53.4
|
|
|
|
55.5
|
|
|
|
51.5
|
|
|
|
49.2
|
|
|
|
53.8
|
|
|
|
56.0
|
|
Medicaid
|
|
|
46.6
|
|
|
|
44.5
|
|
|
|
48.5
|
|
|
|
50.8
|
|
|
|
46.2
|
|
|
|
44.0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total skilled nursing
|
|
|
100.0
|
%
|
|
|
100.0
|
%
|
|
|
100.0
|
%
|
|
|
100.0
|
%
|
|
|
100.0
|
%
|
|
|
100.0
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31,
|
|
|
|
Total
|
|
|
Acquisitions
|
|
|
Same Facility
|
|
|
|
2007
|
|
|
2006
|
|
|
2007
|
|
|
2006
|
|
|
2007
|
|
|
2006
|
|
|
Percentage of Skilled Nursing Days:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Medicare
|
|
|
13.6
|
%
|
|
|
15.0
|
%
|
|
|
15.7
|
%
|
|
|
16.1
|
%
|
|
|
13.2
|
%
|
|
|
14.9
|
%
|
Managed care
|
|
|
9.1
|
|
|
|
9.3
|
|
|
|
2.6
|
|
|
|
1.6
|
|
|
|
10.5
|
|
|
|
9.9
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Skilled mix
|
|
|
22.7
|
|
|
|
24.3
|
|
|
|
18.3
|
|
|
|
17.7
|
|
|
|
23.7
|
|
|
|
24.8
|
|
Private and other payors
|
|
|
13.0
|
|
|
|
13.1
|
|
|
|
15.8
|
|
|
|
15.3
|
|
|
|
12.4
|
|
|
|
13.0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Quality mix
|
|
|
35.7
|
|
|
|
37.4
|
|
|
|
34.1
|
|
|
|
33.0
|
|
|
|
36.1
|
|
|
|
37.8
|
|
Medicaid
|
|
|
64.3
|
|
|
|
62.6
|
|
|
|
65.9
|
|
|
|
67.0
|
|
|
|
63.9
|
|
|
|
62.2
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total skilled nursing
|
|
|
100.0
|
%
|
|
|
100.0
|
%
|
|
|
100.0
|
%
|
|
|
100.0
|
%
|
|
|
100.0
|
%
|
|
|
100.0
|
%
|
The period to period decline in the quality mix is primarily
attributable to the decline in Medicare occupancy rates, which
is described above.
Cost of Services (exclusive of facility rent and depreciation
and amortization shown separately below). Cost of
services increased $50.2 million, or 17.6%, to
$335.0 million for the year ended December 31, 2007
compared to $284.8 million for the year ended
December 31, 2006. Of the $50.2 million increase,
$12.4 million was attributable to Same Facility increases
and the remaining $37.8 million was attributable to
Recently Acquired Facilities. The $50.2 million increase
was primarily due to a $27.9 million increase in salaries
and benefits, a $4.1 million increase in insurance costs
and a $7.3 million increase in ancillary expenses. Of the
$27.9 million increase in salaries and benefits,
$6.4 million was attributable to Same Facility increases
and the remaining $21.5 million was attributable to
Recently Acquired Facilities. The increase in salaries and
benefits was primarily due to increases in nursing wages and
benefits. The increase in insurance costs was primarily a result
of increased self-insured medical and dental healthcare benefits
due to an increase in current and projected claims.
Additionally, as a result of the adoption of SFAS 123(R),
we have, and will continue to experience higher stock-based
compensation expense. We granted approximately 0.4 million
stock options to employees and non employee directors in January
2008. The quantity of grants was somewhat elevated over our
normal option grant patterns because we did not make grants
during 2007 while in the process of becoming a public company.
We expect that the flow of option grants will generally occur at
reduced levels in subsequent periods.
Facility Rent Cost of
Services. Facility rent cost of
services increased $0.3 million, or 1.7%, to
$16.7 million for the year ended December 31, 2007
compared to $16.4 million for the year ended
December 31, 2006. This expense includes an increase of
$0.9 million due to the acquisition of facilities under
67
operating lease agreements that we began operating during 2006
and 2007 and annual increases in rent tied to the change in the
Consumer Price Index (CPI) at Same Facilities. This increase was
directly offset by a decrease in rent expense of
$0.6 million as a result of our purchases of previously
leased properties during 2006 and 2007.
General and Administrative Expense. General
and administrative expense increased $1.7 million, or
12.2%, to $15.9 million for the year ended
December 31, 2007 compared to $14.2 million for the
year ended December 31, 2006. The $1.7 million
increase was primarily due to increases in professional fees of
$1.8 million and wage and benefits of $2.4 million.
The increase in professional fees was primarily due to increases
in accounting and tax services and professional staffing fees,
all of which were increased in scope as compared to
December 31, 2006 as we were transitioning to a public
company. The increase in wages and benefits was primarily due to
additional staffing in our accounting and legal departments.
These increases were offset in part by reductions in incentive
compensation of $1.8 million due to reduced profitability
as well as reduced litigation costs due to the settlement of a
class action lawsuit during 2006 which did not recur in 2007.
Additionally, as a result of the adoption of SFAS 123(R),
we have, and will continue to experience higher stock-based
compensation expense. We granted approximately 0.4 million
stock options to employees and non employee directors in January
2008. The quantity of grants was somewhat elevated over our
normal option grant patterns because we did not make grants
during 2007 while in the process of becoming a public company.
We expect that the flow of option grants will generally occur at
reduced levels in subsequent periods.
Depreciation and Amortization. Depreciation
and amortization expense increased $2.8 million, or 65.0%,
to $7.0 million for the year ended December 31, 2007
compared to $4.2 million for the year ended
December 31, 2006. This increase was related to the
additional depreciation and amortization of Recently Acquired
Facilities, as well as an increase in Same Facility depreciation
expense due to increased capital improvements.
Other Income (Expense). Other income (expense)
increased $1.1 million, or 48.1%, to $3.3 million for
the year ended December 31, 2007 compared to
$2.2 million for the year ended December 31, 2006.
This increase was primarily due to an increase in interest
expense primarily related to an increase in overall borrowings
that occurred throughout 2006 and thereby resulted in a larger
balance outstanding under the Term Loan during the year ended
December 31, 2007. The increase in interest expense was
partially offset by an increase in interest income of
$0.8 million to $1.6 million for the year ended
December 31, 2007 compared to $0.8 million for the
year ended December 31, 2006. This increase primarily
resulted from interest earned on our higher average cash
balances within our insurance subsidiarys investment
balances and IPO funds.
Provision for Income Taxes. Provision for
income taxes decreased $1.2 million, or 8.6%, to
$12.9 million for the year ended December 31, 2007
compared to $14.1 million for the year ended
December 31, 2006. This decrease resulted from lower income
before income taxes, which was offset in part by an increase in
the 2007 effective tax rate of 0.1% due to the adoption of
FIN 48 and its impact on our permanent non-deductible items
and accruals for tax related interest.
68
Year
Ended December 31, 2006 Compared to Year Ended
December 31, 2005
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31,
|
|
|
|
|
|
|
2006
|
|
|
2005
|
|
|
Change
|
|
|
|
(Dollars in thousands)
|
|
|
|
|
|
Same Facility Results(1):
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenue
|
|
$
|
310,963
|
|
|
$
|
290,685
|
|
|
|
7.0
|
%
|
Number of facilities at period end
|
|
|
43
|
|
|
|
43
|
|
|
|
0
|
%
|
Actual patient days
|
|
|
1,615,757
|
|
|
|
1,619,637
|
|
|
|
(0.2
|
)%
|
Occupancy percentage
|
|
|
81.9
|
%
|
|
|
82.1
|
%
|
|
|
(0.2
|
)%
|
Skilled mix by nursing days
|
|
|
24.7
|
%
|
|
|
22.3
|
%
|
|
|
2.4
|
%
|
Recently Acquired Facility Results(2):
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenue
|
|
$
|
47,612
|
|
|
$
|
10,165
|
|
|
|
368.4
|
%
|
Number of facilities at period end
|
|
|
14
|
|
|
|
3
|
|
|
|
366.7
|
%
|
Actual patient days
|
|
|
234,175
|
|
|
|
48,929
|
|
|
|
378.6
|
%
|
Occupancy percentage
|
|
|
74.6
|
%
|
|
|
81.6
|
%
|
|
|
(7.0
|
)%
|
Skilled mix by nursing days
|
|
|
21.9
|
%
|
|
|
22.4
|
%
|
|
|
(0.5
|
)%
|
Total Facility Results:
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenue
|
|
$
|
358,575
|
|
|
$
|
300,850
|
|
|
|
19.2
|
%
|
Number of facilities at period end
|
|
|
57
|
|
|
|
46
|
|
|
|
23.9
|
%
|
Actual patient days
|
|
|
1,849,932
|
|
|
|
1,668,566
|
|
|
|
10.9
|
%
|
Occupancy percentage
|
|
|
81.1
|
%
|
|
|
82.1
|
%
|
|
|
(1.0
|
)%
|
Skilled mix by nursing days
|
|
|
24.3
|
%
|
|
|
22.4
|
%
|
|
|
1.9
|
%
|
|
|
|
(1) |
|
Same Facility represents all facilities acquired prior to
January 1, 2005. |
|
(2) |
|
Recently Acquired Facility represent all facilities acquired
subsequent to January 1, 2005. |
Revenue. Revenue increased $57.7 million,
or 19.2%, to $358.6 million for the year ended
December 31, 2006 compared to $300.9 million for the
year ended December 31, 2005. Of the $57.7 million
increase in 2006, skilled revenue (Medicare and managed care)
increased $32.3 million, or 24.9%, Medicaid revenue
increased $19.9 million, or 15.2%, and private and other
revenue increased $5.5 million, or 13.8%. Approximately
$37.5 million of the increase in 2006 was due to revenue
generated by acquired facilities. We acquired 11 facilities in
2006, which contributed approximately $21.6 million of the
2006 increase in revenue. In addition, approximately
$15.9 million of the increase in the revenue in 2006 was
due to the effect of having the full 12 months of
operations in 2006 of three facilities that we acquired during
2005.
The remaining $20.2 million increase in revenue in 2006 was
primarily due to additional revenues of approximately
$4.1 million related to a net occupancy increase in the
overall skilled nursing population and $18.2 million from
the continuing shift to higher acuity/higher rate category
residents combined with higher reimbursement rates relative to
2005, as described below. This increase in skilled revenues was
partially offset by lower ancillary revenues of approximately
$2.1 million for the year ended December 31, 2006,
which was primarily due to the application of annual maximum
limits per resident for Medicare therapy reimbursement.
69
The following table reflects the change in the skilled nursing
average daily revenue rates by payor source, excluding therapy
and other ancillary services that are not covered by the daily
rate:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31,
|
|
|
|
Total
|
|
|
Acquisitions
|
|
|
Same Facility
|
|
|
|
2006
|
|
|
2005
|
|
|
2006
|
|
|
2005
|
|
|
2006
|
|
|
2005
|
|
|
Skilled Nursing Average Daily Revenue Rates:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Medicare
|
|
$
|
441.78
|
|
|
$
|
411.51
|
|
|
$
|
420.68
|
|
|
$
|
425.76
|
|
|
$
|
445.62
|
|
|
$
|
411.08
|
|
Managed care
|
|
|
274.39
|
|
|
|
263.80
|
|
|
|
293.91
|
|
|
|
286.19
|
|
|
|
272.82
|
|
|
|
262.91
|
|
Total skilled revenue
|
|
|
377.54
|
|
|
|
357.84
|
|
|
|
391.40
|
|
|
|
366.32
|
|
|
|
375.59
|
|
|
|
357.56
|
|
Medicaid
|
|
|
143.17
|
|
|
|
135.22
|
|
|
|
143.60
|
|
|
|
147.56
|
|
|
|
143.93
|
|
|
|
135.68
|
|
Private and other payors
|
|
|
152.74
|
|
|
|
144.21
|
|
|
|
153.16
|
|
|
|
151.90
|
|
|
|
152.65
|
|
|
|
143.73
|
|
Total skilled nursing revenue
|
|
$
|
201.45
|
|
|
$
|
186.20
|
|
|
$
|
199.52
|
|
|
$
|
197.71
|
|
|
$
|
202.84
|
|
|
$
|
186.89
|
|
The average Medicare daily rate increased by approximately 7.4%
in 2006 as compared to 2005, primarily as a result of statutory
inflationary increases, as well as a higher patient acuity mix.
The average Medicaid rate increase of 5.9% in 2006 primarily
resulted from increases in reimbursement rates in Texas and
California. The increase in the California rate was partially
offset by a daily enhancement fee charged for each occupied day
recorded and discussed in cost of services below. The change in
the daily rate in the private and other category was primarily
due to rate increases based on market dynamics.
Payor Sources as a Percentage of Skilled Nursing
Services. We use both our skilled mix and quality
mix as measures of the quality of reimbursements we receive at
our skilled nursing facilities over various periods. The
following table sets forth our percentage of skilled nursing
patient days and revenue by payor source:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31,
|
|
|
|
Total
|
|
|
Acquisitions
|
|
|
Same Facility
|
|
|
|
2006
|
|
|
2005
|
|
|
2006
|
|
|
2005
|
|
|
2006
|
|
|
2005
|
|
|
Percentage of Skilled Nursing Revenue:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Medicare
|
|
|
32.9
|
%
|
|
|
31.4
|
%
|
|
|
35.5
|
%
|
|
|
27.8
|
%
|
|
|
32.5
|
%
|
|
|
31.6
|
%
|
Managed care
|
|
|
12.7
|
|
|
|
11.5
|
|
|
|
7.4
|
|
|
|
13.8
|
|
|
|
13.5
|
|
|
|
11.4
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Skilled mix
|
|
|
45.6
|
|
|
|
42.9
|
|
|
|
42.9
|
|
|
|
41.6
|
|
|
|
46.0
|
|
|
|
43.0
|
|
Private and other payors
|
|
|
9.9
|
|
|
|
10.5
|
|
|
|
13.4
|
|
|
|
18.9
|
|
|
|
9.4
|
|
|
|
10.3
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Quality mix
|
|
|
55.5
|
|
|
|
53.4
|
|
|
|
56.3
|
|
|
|
60.5
|
|
|
|
55.4
|
|
|
|
53.3
|
|
Medicaid
|
|
|
44.5
|
|
|
|
46.6
|
|
|
|
43.7
|
|
|
|
39.5
|
|
|
|
44.6
|
|
|
|
46.7
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total skilled nursing
|
|
|
100.0
|
%
|
|
|
100.0
|
%
|
|
|
100.0
|
%
|
|
|
100.0
|
%
|
|
|
100.0
|
%
|
|
|
100.0
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31,
|
|
|
|
Total
|
|
|
Acquisitions
|
|
|
Same Facility
|
|
|
|
2006
|
|
|
2005
|
|
|
2006
|
|
|
2005
|
|
|
2006
|
|
|
2005
|
|
|
Percentage of Skilled Nursing Days:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Medicare
|
|
|
15.0
|
%
|
|
|
14.3
|
%
|
|
|
16.8
|
%
|
|
|
12.9
|
%
|
|
|
14.7
|
%
|
|
|
14.3
|
%
|
Managed care
|
|
|
9.3
|
|
|
|
8.1
|
|
|
|
5.1
|
|
|
|
9.5
|
|
|
|
10.0
|
|
|
|
8.1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Skilled mix
|
|
|
24.3
|
|
|
|
22.4
|
|
|
|
21.9
|
|
|
|
22.4
|
|
|
|
24.7
|
|
|
|
22.4
|
|
Private and other payors
|
|
|
13.1
|
|
|
|
13.6
|
|
|
|
17.4
|
|
|
|
24.6
|
|
|
|
12.4
|
|
|
|
13.2
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Quality mix
|
|
|
37.4
|
|
|
|
36.0
|
|
|
|
39.3
|
|
|
|
47.0
|
|
|
|
37.1
|
|
|
|
35.6
|
|
Medicaid
|
|
|
62.6
|
|
|
|
64.0
|
|
|
|
60.7
|
|
|
|
53.0
|
|
|
|
62.9
|
|
|
|
64.4
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total skilled nursing
|
|
|
100.0
|
%
|
|
|
100.0
|
%
|
|
|
100.0
|
%
|
|
|
100.0
|
%
|
|
|
100.0
|
%
|
|
|
100.0
|
%
|
70
With our marketing focus on the skilled segment of the business,
we experienced growth in the skilled categories and a
corresponding decline in the revenue and occupancy percentage in
the Medicaid, and private and other payors categories.
Cost of Services (exclusive of facility rent and depreciation
and amortization shown separately below). Cost of
services increased $45.4 million, or 19.0%, to
$284.8 million for the year ended December 31, 2006
compared to $239.4 million for the year ended
December 31, 2005. Of the $45.4 million increase,
$17.8 million was due to cost of services of facilities
acquired in 2006 and $12.7 million reflected the impact in
2006 relating to facilities acquired in 2005. The remaining
$14.9 million increase was primarily due to a
$7.3 million increase in wages and benefits (mainly nursing
labor), which was partially offset by a reduction of
$0.9 million in California workers compensation cost,
$1.7 million resulted from the increased use of contract
nursing personnel (mainly in Arizona due to a state-wide acute
nursing shortage), $4.7 million was due to higher ancillary
costs related to increased therapy and other treatment needs
associated with the higher skilled occupancy percentage, and
$1.3 million was due to an increase in the California
Enhancement Fee. The California Enhancement Fee is a per
occupied daily charge imposed by the state that increased by
$2.33 per resident occupied day from a weighted average rate of
$5.18 in 2005 to $7.51 in 2006. This enhancement fee is directly
related to, and partially offset, the reimbursement rate
increase discussed above. The increase in our cost of services
in 2006 was offset in part by a reduction of $0.5 million
in professional liability insurance costs in 2006.
Facility Rent Cost of
Services. Facility rent cost of
services increased $0.3 million, or 1.8%, to
$16.4 million for the year ended December 31, 2006
compared to $16.1 million for the year ended
December 31, 2005. Of this increase, $0.2 million
resulted from acquired leased facilities in 2006.
General and Administrative Expense. General
and administrative expense increased $3.3 million, or
30.3%, to $14.2 million for the year ended
December 31, 2006 compared to $10.9 million for the
year ended December 31, 2005. Of the $3.3 million
increase, $1.9 million was due to increased wages and
benefits primarily due to a $1.1 million increase in
incentive compensation, $0.5 million resulted from
increased audit and professional fees primarily due to the
increased scope of financial and tax audits in preparation for
our initial public offering, and $1.0 million related to
the settlement of a class action lawsuit. The remaining net
change included $0.4 million in SFAS 123(R) stock
compensation expense.
Depreciation and Amortization. Depreciation
and amortization expense increased $1.8 million, or 71.7%,
to $4.2 million for the year ended December 31, 2006
compared to $2.4 million for the year ended
December 31, 2005. Of this increase, $1.4 million is
related to the additional depreciation and amortization of
facilities acquired in 2006.
Other Income (Expense). Interest expense
increased $1.0 million, or 50.0% to $3.0 million for
the year ended December 31, 2006 compared to
$2.0 million for the year ended December 31, 2005.
This increase in interest expense primarily related to increased
borrowings in 2006 under our long-term loan to provide the
capital to purchase a portion of the facilities acquired in
2006. The increase in interest expense was partially offset by
an increase in interest income of $0.3 million to
$0.8 million for the year ended December 31, 2006
compared to $0.5 million for the year ended
December 31, 2005. This increase primarily resulted from
interest earned on our insurance subsidiarys investment
balances.
Provision for Income Taxes. Provision for
income taxes increased $2.0 million, or 17.2%, to
$14.1 million for the year ended December 31, 2006
compared to $12.1 million for the year ended
December 31, 2005. This increase primarily resulted from
higher income before income taxes, which was offset in part by a
decrease in the 2006 effective tax rate of 1.1% due to an
increased benefit in the application of employment tax credits
in 2006.
71
Quarterly
Financial Data (Unaudited)
The following table presents our unaudited quarterly
consolidated results of operations for each of the eight
quarters in the two year period ended December 31, 2007.
The unaudited quarterly consolidated information has been
prepared on the same basis as our audited consolidated financial
statements. You should read the following table presenting our
quarterly consolidated results of operations in conjunction with
our audited consolidated financial statements and the related
notes included elsewhere in this Annual Report on
Form 10-K.
The operating results for any quarter are not necessarily
indicative of the operating results for any future period.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Dec. 31,
|
|
|
Sept. 30,
|
|
|
June 30,
|
|
|
Mar. 31,
|
|
|
Dec. 31,
|
|
|
Sept. 30,
|
|
|
June 30,
|
|
|
March 31,
|
|
|
|
2007
|
|
|
2007
|
|
|
2007
|
|
|
2007
|
|
|
2006
|
|
|
2006
|
|
|
2006
|
|
|
2006
|
|
|
|
(In thousands)
|
|
|
Revenue
|
|
$
|
108,979
|
|
|
$
|
104,092
|
|
|
$
|
100,269
|
|
|
$
|
97,978
|
|
|
$
|
97,509
|
|
|
$
|
92,338
|
|
|
$
|
85,375
|
|
|
$
|
83,352
|
|
Cost of services (exclusive of facility rent and depreciation
and amortization)
|
|
|
87,837
|
|
|
|
86,176
|
|
|
|
80,154
|
|
|
|
80,847
|
|
|
|
78,705
|
|
|
|
72,792
|
|
|
|
67,749
|
|
|
|
65,601
|
|
Total expenses
|
|
|
98,270
|
|
|
|
96,166
|
|
|
|
89,884
|
|
|
|
90,280
|
|
|
|
87,948
|
|
|
|
81,946
|
|
|
|
76,120
|
|
|
|
73,668
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from operations
|
|
|
10,709
|
|
|
|
7,926
|
|
|
|
10,385
|
|
|
|
7,698
|
|
|
|
9,561
|
|
|
|
10,392
|
|
|
|
9,255
|
|
|
|
9,684
|
|
Net income
|
|
$
|
6,229
|
|
|
$
|
4,466
|
|
|
$
|
5,695
|
|
|
$
|
4,137
|
|
|
$
|
5,350
|
|
|
$
|
6,381
|
|
|
$
|
5,211
|
|
|
$
|
5,607
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income per share:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
$
|
0.35
|
|
|
$
|
0.32
|
|
|
$
|
0.41
|
|
|
$
|
0.30
|
|
|
$
|
0.39
|
|
|
$
|
0.47
|
|
|
$
|
0.39
|
|
|
$
|
0.41
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted
|
|
$
|
0.32
|
|
|
$
|
0.26
|
|
|
$
|
0.34
|
|
|
$
|
0.24
|
|
|
$
|
0.31
|
|
|
$
|
0.38
|
|
|
$
|
0.32
|
|
|
$
|
0.33
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average common shares outstanding:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic(1)
|
|
|
17,566
|
|
|
|
13,506
|
|
|
|
13,463
|
|
|
|
13,420
|
|
|
|
13,393
|
|
|
|
13,312
|
|
|
|
13,230
|
|
|
|
13,530
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted
|
|
|
19,204
|
|
|
|
16,878
|
|
|
|
16,878
|
|
|
|
16,904
|
|
|
|
16,984
|
|
|
|
16,865
|
|
|
|
16,514
|
|
|
|
16,929
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
The number of shares included in the weighted average common
shares outstanding basic calculation for the quarter ended
December 31, 2007 incorporate shares issued in connection
with our IPO and the conversion of our Series A preferred
stock. |
Liquidity
and Capital Resources
Our primary sources of liquidity have historically been derived
from our cash flow from operations, long-term debt secured by
our real property and our Amended and Restated Loan and Security
Agreement, as amended (the Revolver). As of December 31,
2007 and 2006, the maximum available for borrowing under the
Revolver was approximately $20.0 million, respectively.
Approximately $8.4 million of borrowing capacity was
pledged to secure outstanding letters of credit.
Since 2004, we have financed the majority of our facility
acquisitions primarily with cash. Cash paid for acquisitions was
$9.5 million, $29.0 million and $14.9 million for
the years ended December 31, 2007, 2006 and 2005. Where we
enter into a facility operating lease agreement, we typically do
not pay any material amount to the prior facility operator, nor
do we acquire any assets or assume any liabilities, other than
our rights and obligations under the new operating lease and
operations transfer agreement, as part of the transaction.
Operating leases are included in the contractual obligations
section below.
Additionally in 2007, we purchased the underlying assets of four
facilities that we were previously operating under long-term
lease arrangements. These facilities were purchased for an
aggregate of $16.1 million, of which $4.0 million was
paid in cash and $12.1 million ultimately was paid using
proceeds from our IPO and is presented in the purchase of
capital expenditures for the year ended 2007. Total capital
expenditures for property and equipment were $35.7 million,
$14.1 million and $5.7 million for the years ended
December 31, 2007, 2006 and 2005, respectively. We
currently have $15.2 million budgeted for capital
expenditures projects in 2008.
72
We believe that the proceeds from our initial public offering,
together with our cash flow from operations and our Revolver,
will be sufficient to cover our operating needs for at least the
next 12 months. We may in the future seek to raise
additional capital to fund acquisitions and capital renovations,
but such additional capital may not be available on acceptable
terms, on a timely basis, or at all.
The following table presents selected data from our consolidated
statement of cash flows for the periods presented:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31,
|
|
|
|
2007
|
|
|
2006
|
|
|
2005
|
|
|
|
(In thousands)
|
|
|
Net cash provided by operating activities
|
|
$
|
18,649
|
|
|
$
|
30,945
|
|
|
$
|
20,446
|
|
Net cash used in investing activities
|
|
|
(45,764
|
)
|
|
|
(43,709
|
)
|
|
|
(20,872
|
)
|
Net cash provided by (used in) financing activities
|
|
|
53,356
|
|
|
|
26,620
|
|
|
|
(2,694
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net increase (decrease) in cash and cash equivalents
|
|
|
26,241
|
|
|
|
13,856
|
|
|
|
(3,120
|
)
|
Cash and cash equivalents at beginning of period
|
|
|
25,491
|
|
|
|
11,635
|
|
|
|
14,755
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents at end of period
|
|
$
|
51,732
|
|
|
$
|
25,491
|
|
|
$
|
11,635
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year
Ended December 31, 2007 Compared to Year Ended
December 31, 2006
Net cash provided by operations for the year ended
December 31, 2007 was $18.6 million compared to
$30.9 million for the year ended December 31, 2006, a
decrease of $12.3 million. This decrease was due in part to
a decline of $9.4 million which included increased accounts
receivable balances due to acquisitions and increased cash
disbursements related to prepaid expenses. The increase in
accounts receivable was primarily attributable to our increased
revenues in 2007, combined with a reduction in accounts
receivable collection which was primarily attributable to our
collection of approximately $4.7 million in retroactive
California rate increases related to prior years, during 2006,
which did not reoccur in 2007. The increase in prepaid expenses
during 2007 was primarily driven by higher prepaid income taxes
as compared to 2006. Other contributors to the remaining decline
of $2.9 million included cash disbursements related to
accrued wages and other liabilities.
Net cash used in investing activities for the year ended
December 31, 2007 was $45.8 million compared to
$43.7 million for the year ended December 31, 2006, an
increase of $2.1 million. The increase was primarily the
result of cash we paid for property and equipment during the
year ended December 31, 2007 compared to the year ended
December 31, 2006, partially offset by the decrease in cash
paid for facility acquisitions during the year ended
December 31, 2007 compared to the year ended
December 31, 2006.
Net cash provided by financing activities for the year ended
December 31, 2007 totaled $53.4 million compared to
$26.6 million for the year ended December 31, 2006, an
increase of $26.8 million. The increase was primarily due
to the receipt of proceeds from our IPO, net of underlying
discounts and commissions and estimated offering expenses
payable by us (Net Proceeds), of approximately
$56.6 million during the year ended December 31, 2007.
This increase was partially offset by the receipt of proceeds
from the issuance of debt during the year ended
December 31, 2006, which did not recur during the year
ended December 31, 2007.
Year
Ended December 31, 2006 Compared to Year Ended
December 31, 2005
Net cash provided by operations for the year ended
December 31, 2006 was $30.9 million compared to
$20.4 million for the year ended December 31, 2005, an
increase of $10.5 million. The primary reason for the
increase in cash flow in 2006 was our improved operating
results, which contributed $22.5 million to cash flow or
$31.4 million after adding back non-cash charges for
depreciation, amortization, allowance for doubtful accounts and
stock compensation expense. Other contributors to the increase
in working capital included the continued
build-up of
general, professional and workers compensation insurance
accruals in excess of paid claims due to incurred but not yet
reported claims and the increase in facilities. Accrued wages
and related liabilities were a continued source of working
capital due to our 2006 acquisitions, increased
73
accruals for incentive pay due to improved operating results and
general wage and salary increases. Deferred taxes represented a
use of working capital primarily as a result of the increase in
our self-insured liability. Other working capital fluctuations
for 2006 primarily resulted from the increase in our facility
acquisitions.
Net cash used in investing activities for the year ended
December 31, 2006 was $43.7 million compared to
$20.9 million for the year ended December 31, 2005, an
increase of $22.8 million. The increase was primarily the
result of cash we paid for our 11 facility acquisitions in 2006
compared to three facilities acquired in 2005 and the increase
in purchased property and equipment in 2006 and 2005.
Net cash provided by financing activities for the year ended
December 31, 2006 was $26.6 million compared to cash
used for the year ended December 31, 2005 of
$2.7 million, an increase of $29.3 million. The
increase in cash provided by financing activities in 2006
compared to 2005 primarily consisted of the proceeds of
$34.8 million in long-term notes, net, after refinancing
$16.8 million in outstanding real estate loans and
financing a $4.3 million facility acquisition. In addition,
we repurchased $2.8 million in treasury stock in 2006, an
increase of $0.5 million compared to the prior year period,
and our dividend payments were $2.0 million in 2006, an
increase of $0.7 million compared to 2005.
Principal
Debt Obligations and Capital Expenditures
Revolving
Credit Facility with General Electric Capital
Corporation
On March 25, 2004, we entered into the Revolver, as amended
on December 3, 2004, with General Electric Capital
Corporation (the Lender), which consisted of a
$20.0 million revolving credit facility. The Revolver bears
interest at the prime rate of interest as designated by
Citibank, N.A., or any successor thereto, as the same may
fluctuate from time to time, plus a margin of 1.0%. In
connection with the Revolver, we paid a commitment fee of
$0.2 million, and, so long as the loan is available to us,
we will pay a loan management fee to this lender equal to 0.08%
of the average amount of the outstanding principal balance of
the Revolver during the preceding month. The proceeds of the
loans under the Revolver have been and continue to be used for
working capital and other expenses arising in our ordinary
course of business. As of December 31, 2007 and
December 31, 2006, the maximum available for borrowing
under the Revolver was approximately $20.0 million,
respectively, but approximately $8.4 million of borrowing
capacity was pledged to secure outstanding letters of credit.
The Revolver was set to mature in March 2007 but was extended
until February 22, 2008.
On February 21, 2008, we amended our Revolver by extending
the term to 2012, increasing the available credit thereunder up
to the lesser of $50.0 million or 85% of the eligible
accounts receivable, and changing the interest rate for all or
any portion of the outstanding indebtedness thereunder to any of
three options, as we may elect from time to time, (i) the
1, 2, 3 or 6 month LIBOR (at our option) plus 2.5%, or
(ii) the greater of (a) prime plus 1.0% or
(b) the federal funds rate plus 1.5% or (iii) a
floating LIBOR rate. The signed agreement is contingent on final
execution and delivery of appropriate amendatory documentation.
The Revolver contains typical representations and financial and
non-financial covenants for a loan of this type, a violation of
which could result in a default under the Revolver and could
possibly cause all amounts owed by us, including amounts due
under the Term Loan, to be declared immediately due and payable.
The proceeds of the loans under the Revolver have been and
continue to be used for working capital and other expenses
arising in our ordinary course of business.
The Revolver contains affirmative and negative covenants,
including limitations on:
|
|
|
|
|
certain indebtedness;
|
|
|
|
certain investments, loans, advances and acquisitions;
|
|
|
|
certain sales or other dispositions of our assets;
|
|
|
|
certain liens and negative pledges;
|
|
|
|
financial covenants;
|
74
|
|
|
|
|
changes of control (as defined in the loan agreement);
|
|
|
|
certain mergers, consolidations, liquidations and dissolutions;
|
|
|
|
certain sale and leaseback transactions without the
Lenders consent;
|
|
|
|
dividends and distributions during the existence of an event of
default;
|
|
|
|
guarantees and other contingent liabilities;
|
|
|
|
affiliate transactions that are not in the ordinary course of
business; and
|
|
|
|
certain changes in capital structure.
|
A violation of these or other representations or covenants of
ours could result in a default under the Revolver and could
possibly cause the entire amount outstanding under the Revolver
and a cross-default of all amounts owed by the Company,
including amounts due under the Third Amended and Restated Loan
Agreement (Term Loan), to be declared immediately due and
payable.
In connection with the Revolver, the majority of our
subsidiaries granted a first priority security interest to the
Lender in, among other things: (1) all accounts, accounts
receivable and rights to payment of every kind, contract rights,
chattel paper, documents and instruments with respect thereto,
and all of our rights, remedies, securities and liens in, to,
and in respect of our accounts, (2) all moneys, securities,
and other property and the proceeds thereof under the control of
the Lender and its affiliates, (3) all right, title and
interest in, to and in respect of all goods relating to or
resulting in accounts, (4) all deposit accounts into which
our accounts are deposited, (5) general intangibles and
other property of every kind relating to our accounts,
(6) all other general intangibles, including, without
limitation, proceeds from insurance policies, intellectual
property rights, and goodwill, (7) inventory, machinery,
equipment, tools, fixtures, goods, supplies, and all related
attachments, accessions and replacements, and (8) proceeds,
including insurance proceeds, of all of the foregoing. In the
event of our default, the Lender has the right to take
possession of the foregoing with or without judicial process.
Term Loan
with General Electric Capital Corporation
On December 29, 2006, a number of our independent real
estate holding subsidiaries jointly entered into a Third Amended
and Restated Loan Agreement (the Term Loan) with the Lender,
which consists of an approximately $64.7 million
multiple-advance term loan, approximately $55.7 million of
which had been drawn down at that time. The Term Loan matures on
June 29, 2016, and is currently secured by the real and
personal property comprising the ten facilities owned by these
subsidiaries.
The Term Loan has been funded in advances, with each advance
bearing interest at a separate rate. The interest rates range
from 6.95% to 7.50% per annum. Subject to certain conditions, we
may also receive additional advances that would bear interest at
the rate of 2.25% plus the applicable U.S. Treasury rate at
the time of advance. The proceeds of the advances made under the
Term Loan have been used to refinance an existing loan from the
Lender secured by certain of the properties, and to purchase
other additional properties that we were previously leasing.
In connection with the Term Loan, we have guaranteed the payment
and performance of all the obligations of our real estate
holding subsidiaries under the loan documents for the Term Loan.
In the event of our default under the Term Loan, all amounts
owed by our subsidiaries, and guaranteed by us, under this loan
agreement and any other loan with the Lender, including the
Revolver discussed above, would become immediately due and
payable. In addition, in the event of our default under the Term
Loan, the Lender has the right to take control of our facilities
encumbered by the loan to the extent necessary to make such
payments and perform such acts required under the loan.
Under the Term Loan, we are subject to standard reporting
requirements and other typical covenants for a loan of this
type. Effective October 1, 2006 and continuing each
calendar quarter thereafter, we are subject to restrictive
financial covenants, including average occupancy, Debt Service
(as defined in the agreement) and Project Yield (as defined in
the agreement). As of December 31, 2007, we were in
compliance with all loan
75
covenants. As of December 31, 2007, our borrowing
subsidiaries had $54.9 million outstanding on the Term
Loan, with the right to draw an additional $9.0 million
upon meeting certain covenants under the loan documents.
Mortgage
Loan with Wells Fargo Bank, N.A.
Cherry Health Holdings, Inc., one of our real estate holding
subsidiaries, is the borrower under a mortgage loan that it
assumed in October 2006. The Loan Assumption Agreement was
entered into with Wells Fargo Bank, N.A. as Trustee for GMAC
Commercial Mortgage Securities, Inc., the original lender. At
the time of the Loan Assumption Agreement, the principal balance
outstanding under the corresponding promissory note was
approximately $2.1 million. The unpaid balance of principal
and accrued interest from the mortgage loan is due on
September 1, 2008, and is not prepayable until March 2008.
The mortgage loan bears interest at the rate of 7.49% per annum.
The mortgage loan is secured by Cherry Health Holdings
Inc.s interest in the Pacific Care Center facility and the
rents, issues and profits thereof, as well as all personal
property used in the operation of the facility. In connection
with the mortgage loan, we have guaranteed the full and prompt
payment and performance of all the obligations of Cherry Health
Holdings, Inc. under the loan and assumption documents. As of
December 31, 2007, the balance outstanding on this mortgage
loan was approximately $2.0 million.
Mortgage
Loan with Continental Wingate Associates, Inc.
Ensign Southland LLC, a subsidiary of The Ensign Group, Inc.,
entered into a mortgage loan on January 30, 2001 with
Continental Wingate Associates, Inc. The mortgage loan is
insured with the U.S. Department of Housing and
Development, or HUD, which subjects our Southland facility to
HUD oversight and periodic inspections. As of December 31,
2007, the balance outstanding on this mortgage loan was
approximately $6.6 million. The unpaid balance of principal
and accrued interest from this mortgage loan is due on
February 1, 2027. The mortgage loan bears interest at the
rate of 7.5% per annum.
This mortgage loan is secured by the real property comprising
the Southland Care Center facility and the rents, issues and
profits thereof, as well as all personal property used in the
operation of the facility.
Contractual
Obligations, Commitments and Contingencies
Our principal contractual obligations and commitments as of
December 31, 2007 were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2008
|
|
|
2009
|
|
|
2010
|
|
|
2011
|
|
|
2012
|
|
|
Thereafter
|
|
|
Other(1)
|
|
|
Total
|
|
|
|
(In thousands)
|
|
|
Operating lease obligations
|
|
$
|
16,810
|
|
|
$
|
16,508
|
|
|
$
|
15,019
|
|
|
$
|
14,793
|
|
|
$
|
14,585
|
|
|
$
|
74,294
|
|
|
|
|
|
|
$
|
152.009
|
|
Long-term debt obligations
|
|
|
2,993
|
|
|
|
1,075
|
|
|
|
1,158
|
|
|
|
1,246
|
|
|
|
1,330
|
|
|
|
55,768
|
|
|
|
|
|
|
|
63,570
|
|
Interest payments on long-term debt
|
|
|
4,628
|
|
|
|
4,426
|
|
|
|
4,344
|
|
|
|
4,256
|
|
|
|
4,172
|
|
|
|
16,149
|
|
|
|
|
|
|
|
37,975
|
|
FIN 48 obligations, including interest and penalties
|
|
|
63
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
368
|
|
|
|
431
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
24,494
|
|
|
$
|
22,009
|
|
|
$
|
20,521
|
|
|
$
|
20,295
|
|
|
$
|
20,087
|
|
|
$
|
146,211
|
|
|
$
|
368
|
|
|
$
|
253,985
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
In addition to the FIN 48 obligations in the 2008 column above,
approximately $0.4 million of unrecognized tax benefits and
potential interest have been recorded as liabilities in
accordance with FIN 48. None of the Companys liabilities
for uncertain tax positions are currently subject to
examination. As a result, the Company cannot reasonably
determine the expected timing for the cash resolution of the
majority of these liabilities and has excluded them from any of
the time certain categories in this table of contractual
obligations. |
Not included in the table above are our actuarially determined
self-insured general and professional malpractice liability,
workers compensation and medical (including prescription
drugs) and dental healthcare obligations which are broken out
between current and long-term liabilities in our financial
statements included in this annual report.
76
We lease certain facilities and our Service Center offices under
operating leases, most of which have initial lease terms ranging
from five to 20 years and all of which include options to
extend the lease term. Most of these leases contain renewal
options, some of which involve rent increases. We also lease a
majority of our equipment under operating leases with initial
terms ranging from three to five years. Total rent expense,
inclusive of straight-line rent adjustments, was
$17.0 million, $16.7 million and $16.4 million
for the years ended December 31, 2007, 2006 and 2005,
respectively.
On December 11, 2007, we completed an asset purchase
agreement to purchase two skilled nursing facilities in
California and one assisted living facility in Arizona, which
also provides independent living services, for an aggregate
purchase price of approximately $12.8 million. Prior to the
purchase, we operated these three facilities under a single
master lease agreement. The master lease agreement included
purchase options for the two skilled nursing facilities that
were not exercisable at the time of purchase. Purchasing these
leased facilities resulted in no net change in our total number
of beds. Taking into consideration the above facility purchase,
we own 26 of our facilities and operate 35 of our facilities
under long-term lease arrangements, with options to purchase or
purchase agreements for ten of those 35 facilities.
In March 2007, we and certain of our officers received a series
of notices from our bank indicating that the United States
Attorney for the Central District of California had issued an
authorized investigative demand, a request for records similar
to a subpoena, to our bank and then rescinded that demand. This
rescinded demand originally requested documents from our bank
related to financial transactions involving us, ten of our
operating subsidiaries, an outside investor group, and certain
of our current and former officers. Subsequently, in June 2007,
the U.S. Attorney sent a letter to one of our current
employees requesting a meeting. The letter indicated that the
U.S. Attorney and the U.S. Department of Health and
Human Services Office of Inspector General were conducting an
investigation of claims submitted to the Medicare program for
rehabilitation services provided at our facilities. Although
both we and the employee offered to cooperate, the
U.S. Attorney later withdrew its meeting request. From
these contacts, we believed that an investigation was underway,
but to date we have been unable to determine the exact cause or
nature of the U.S. Attorneys interest in us or our
subsidiaries, and until recently we have been unable to even
verify whether the investigation was continuing.
On December 17, 2007, we were informed by
Deloitte & Touche LLP, our independent registered
public accounting firm that the U.S. Attorney served a
grand jury subpoena on Deloitte & Touche LLP, relating
to us and several of our operating subsidiaries. The subpoena
confirmed our previously reported belief that the
U.S. Attorney is conducting an investigation involving
certain of our operating subsidiaries. Based on these most
recent events, we believe that the United States Government may
be conducting parallel criminal, civil and administrative
investigations involving The Ensign Group and one or more of our
skilled nursing facilities. To our knowledge, however, neither
The Ensign Group, Inc. nor any of our operating subsidiaries or
employees has been formally charged with any wrongdoing, served
with any related subpoenas or requests, or been directly
notified of any concerns or related investigations by the
U.S. Attorney or any government agency. Subsequently, in
February 2008, the U.S. Attorney contacted two additional
current employees. Both we and the all three of the employees
contacted have offered to cooperate and meet with the
U.S. Attorney. While we have no reason to believe that the
assertion of criminal charges, civil claims, administrative
sanctions or whistleblower actions would be warranted, to date
the U.S. Attorneys office has declined to provide us
with any specific information with respect to this matter, other
than to confirm that an investigation is ongoing. We continued
to request a meeting with the U.S. Attorney to discuss the
grand jury subpoena, our internal investigation described below,
and any specific allegations or concerns they may have. We
cannot predict or provide any assurance as to the possible
outcome of the investigation or any possible related
proceedings, or as to the possible outcome of any qui tam
litigation that may follow, nor can we estimate the possible
loss or range of loss that may result from any such proceedings
and, therefore, we have not recorded any related accruals. To
the extent the U.S. Attorneys office elects to pursue
this matter, or if the investigation has been instigated by a
qui tam relator who elects to pursue the matter, our
business, financial condition and results of operations could be
materially and adversely affected.
In November 2006, we became aware of an allegation of possible
reimbursement irregularities at one or more of our facilities.
That same month, we retained outside counsel and initiated an
internal investigation into these matters. We and our outside
counsel concluded this investigation without identifying any
systemic
77
or patterns and practices of fraudulent or intentional
misconduct. We made observations at certain facilities regarding
areas of potential improvement in some of our recordkeeping and
billing practices and have implemented measures, some of which
were already underway before the investigation began, that we
believe will strengthen recordkeeping and billing processes.
None of these additional findings or observations appears to be
rooted in fraudulent or intentional misconduct. We continue to
evaluate the measures implemented for effectiveness, and are
continuing to seek ways to improve these processes.
As a byproduct of our investigation, we identified a limited
number of selected Medicare claims for which adequate backup
documentation could not be located or for which other billing
deficiencies exist. We, with the assistance of independent
consultants experienced in Medicare billing, completed a billing
review on these claims. To the extent missing documentation was
not located, we treated the claims as overpayments. Consistent
with healthcare industry accounting practices, we record any
charge for refunded payments against revenue in the period in
which the claim adjustment becomes known. During the year ended
December 31, 2007, we accrued a liability of approximately
$0.2 million, plus interest, for selected Medicare claims
for which documentation had not been located or for other
billing deficiencies identified to date. The remittance of these
claims started with the filing of our Quarterly Credit Balance
Reports, which were submitted to our Medicare Fiscal
Intermediary on or before January 31, 2008 and will be
completed with the next Quarterly Credit Balance Reports which
will be submitted on or before April 30, 2008. If
additional reviews result in identification and quantification
of additional amounts to be refunded, we would accrue additional
liabilities for claim costs and interest and repay any amounts
due in normal course. If future investigations ultimately result
in findings of significant billing and reimbursement
noncompliance which could require us to record significant
additional provisions or remit payments, our business, financial
condition and results of operations could be materially and
adversely affected.
See additional description of our contingencies in Notes 11
and 16 in Notes to Consolidated Financial Statements.
Inflation
We have historically derived a substantial portion of our
revenue from the Medicare program. We also derive revenue from
state Medicaid and similar reimbursement programs. Payments
under these programs generally provide for reimbursement levels
that are adjusted for inflation annually based upon the
states fiscal year for the Medicaid programs and in each
October for the Medicare program. These adjustments may not
continue in the future, and even if received, such adjustments
may not reflect the actual increase in our costs for providing
healthcare services.
Labor and supply expenses make up a substantial portion of our
cost of services. Those expenses can be subject to increase in
periods of rising inflation and when labor shortages occur in
the marketplace. To date, we have generally been able to
implement cost control measures or obtain increases in
reimbursement sufficient to offset increases in these expenses.
We may not be successful in offsetting future cost increases.
Off-Balance
Sheet and Other Arrangements
We have no off-balance sheet arrangements.
|
|
Item 7A.
|
Quantitative
and Qualitative Disclosures About Market Risk
|
Interest Rate Risk. We are exposed to interest
rate changes as a result of the Revolver, which is used to
maintain liquidity and fund capital expenditures and operations.
Our interest rate risk management objective is to limit the
impact of interest rate changes on earnings and cash flows and
to provide more predictability to our overall borrowing costs.
To achieve this objective, we borrow primarily at fixed rates,
although we use the Revolver for short-term borrowing purposes.
At December 31, 2007, we had no outstanding floating rate
debt. In addition, we are entitled, upon meeting certain
covenants under the Term Loan, to take up to approximately
$9.0 million in future advances under our Term Loan and
each advance will bear interest based upon market rates in
effect at the time of the advance.
78
Our cash and cash equivalents and short-term investments as of
December 31, 2007 consisted primarily of cash balances and
money market funds. Our market risk exposure is interest income
sensitivity, which is affected by changes in the general level
of U.S. interest rates, particularly because our
investments are in short-term marketable securities. The primary
objective of our investment activities is to preserve principal
while at the same time maximizing the income we receive from our
investments without significantly increasing risk. Due to the
short-term duration of our investment portfolio and the low risk
profile of our investments, an immediate 10% change in interest
rates would not have a material effect on the fair market value
of our portfolio. Accordingly, we would not expect our operating
results or cash flows to be affected to any significant degree
by the effect of a sudden change in market interest rates on our
securities portfolio. In general, money market funds are not
subject to market risk because the interest paid on such funds
fluctuates with the prevailing interest rate.
The above only incorporates those exposures that exist as of
December 31, 2007, and does not consider those exposures or
positions which could arise after that date. As we anticipate
diversifying our investment portfolio into securities and other
investment alternatives, we may face increased risk and
exposures as a result of interest risk and the securities
markets in general.
|
|
Item 8.
|
Financial
Statements and Supplementary Data
|
The information require by this Item 8 is included in
appendix pages 82 through 114 of this Annual Report on
Form 10-K.
|
|
Item 9.
|
Changes
in and Disagreements with Accountants and Financial
Disclosures
|
Not applicable
|
|
Item 9A.
|
Controls
and Procedures
|
Disclosure
Controls and Procedures
Under the supervision and with the participation of our
management, including our Chief Executive Officer and Chief
Financial Officer, we evaluated the effectiveness of the design
and operation of our disclosure controls and procedures (as
defined in
Rule 13a-15(e)
under the Securities Exchange Act of 1934 (the Exchange
Act). Based upon that evaluation, the Chief Executive
Officer and Chief Financial Officer concluded that, as of the
end of the period covered by this report, our disclosure
controls and procedures were effective.
Internal
Control Over Financial Information
This annual report on
Form 10-K
does not include a report of managements assessment
regarding internal control over financial reporting or an
attestation report of the Companys registered public
accounting firm due to a transition period established by rules
of the SEC for newly public companies.
Changes
in Internal Control Over Financial Reporting
No change in our internal control over financial reporting (as
defined in
Rules 13a-15(f)
and
15d-15(f)
under the Exchange Act) occurred during the fourth quarter of
2007 that has materially affected, or is reasonably likely to
materially affect, our internal control over financial reporting.
|
|
Item 9B.
|
Other
Information
|
Not applicable
79
PART III.
|
|
Item 10.
|
Directors,
Executive Officers and Corporate Governance
|
The information required under Item 10 is incorporated
herein by reference to our definitive proxy statement for our
2008 Annual Meeting of Stockholders to be filed with the
Securities and Exchange Commission pursuant to Exchange Act
Regulation 14A within 120 days after the end of our
2007 fiscal year (the 2008 Proxy Statement).
|
|
Item 11.
|
Executive
Compensation
|
The information required under Item 11 is incorporated
herein by reference to the 2008 Proxy Statement.
|
|
Item 12.
|
Security
Ownership of Certain Beneficial Owners and Management and
Related Stockholder Matters
|
The information required under Item 12 is incorporated
herein by reference to the 2008 Proxy Statement.
|
|
Item 13.
|
Certain
Relationships and Related Transactions and Director
Independence
|
The information required under Item 13 is incorporated
herein by reference to the 2008 Proxy Statement.
|
|
Item 14.
|
Principal
Accounting Fees and Services
|
The information required under Item 14 is incorporated
herein by reference to the 2008 Proxy Statement.
PART IV.
|
|
Item 15.
|
Exhibits,
Financial Statements and Schedules
|
The following documents are filed as a part of this report:
(a) (1) Financial Statements:
The Financial Statements are included in Item 8 and are
filed as part of this report.
(2) Financial Statement
Schedule:
(a) (3) Exhibits: An Exhibit Index
has been filed as a part of this Annual Report on
Form 10-K
beginning on page 115 hereof and is incorporated herein by
reference
80
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the
Securities Act of 1934, the Registrant has duly caused this
Report to be signed on its behalf by the undersigned, thereunto
duly authorized.
The Ensign Group, Inc.
|
|
|
|
By:
|
/s/ Christopher
R. Christensen
|
Christopher R. Christensen
Chief Executive Officer and President
Pursuant to the requirements of the Securities Exchange Act of
1934, this Report has been signed below by the following persons
on behalf of the Registrant in the capacities and on the dates
indicated.
|
|
|
|
|
|
|
Signature
|
|
Title
|
|
Date
|
|
|
|
|
|
|
/s/ Christopher
R. Christensen
Christopher
R. Christensen
|
|
Chief Executive Officer, President and Director (principal
executive officer)
|
|
March 6, 2008
|
|
|
|
|
|
/s/ Alan
J. Norman
Alan
J. Norman
|
|
Chief Financial Officer (principal financial and accounting
officer)
|
|
March 6, 2008
|
|
|
|
|
|
/s/ Roy
E. Christensen
Roy
E. Christensen
|
|
Chairman of the Board
|
|
March 6, 2008
|
|
|
|
|
|
/s/ Antoinette
T. Hubenette
Antoinette
T. Hubenette
|
|
Director
|
|
March 6, 2008
|
|
|
|
|
|
/s/ Thomas
A. Maloof
Thomas
A. Maloof
|
|
Director
|
|
March 6, 2008
|
|
|
|
|
|
/s/ Charles
M. Blalack
Charles
M. Blalack
|
|
Director
|
|
March 6, 2008
|
81
THE
ENSIGN GROUP, INC.
INDEX TO
CONSOLIDATED FINANCIAL STATEMENTS
AND
FINANCIAL STATEMENT SCHEDULES
|
|
|
|
|
|
|
|
83
|
|
Consolidated Financial Statements:
|
|
|
|
|
|
|
|
84
|
|
|
|
|
85
|
|
|
|
|
86
|
|
|
|
|
87
|
|
|
|
|
88
|
|
82
REPORT OF
INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To the Board of Directors and Stockholders of
The Ensign Group, Inc.
Mission Viejo, California
We have audited the accompanying consolidated balance sheets of
The Ensign Group, Inc. and subsidiaries (the
Company) as of December 31, 2007 and 2006, and
the related consolidated statements of income,
stockholders equity and cash flows for each of the three
years in the period ended December 31, 2007. Our audits
also included the financial statement schedule listed in the
Index at Item 15. These consolidated financial statements
and the financial statement schedule are the responsibility of
the Companys management. Our responsibility is to express
an opinion on these consolidated financial statements and the
financial statement schedule based on our audits.
We conducted our audits in accordance with the standards of the
Public Company Accounting Oversight Board (United States). Those
standards require that we plan and perform the audit to obtain
reasonable assurance about whether the financial statements are
free of material misstatement. The Company is not required to
have, nor were we engaged to perform, an audit of its internal
control over financial reporting. Our audit included
consideration of internal control over financial reporting as a
basis for designing audit procedures that are appropriate in the
circumstances but not for the purpose of expressing an opinion
on the effectiveness of the Companys internal control over
financial reporting. Accordingly, we express no such opinion. An
audit also includes examining, on a test basis, evidence
supporting the amounts and disclosures in the financial
statements, assessing the accounting principles used and
significant estimates made by management, as well as evaluating
the overall financial statement presentation. We believe that
our audits provide a reasonable basis for our opinion.
In our opinion, such consolidated financial statements present
fairly, in all material respects, the financial position of The
Ensign Group, Inc. and subsidiaries as of December 31, 2007
and 2006, and the results of their operations and their cash
flows for each of the three years in the period ended
December 31, 2007, in conformity with accounting principles
generally accepted in the United States of America. Also, in our
opinion, such financial statement schedule, when considered in
relation to the basic consolidated financial statements taken as
a whole, presents fairly in all material respects the
information set forth therein.
As discussed in Note 2 to the consolidated financial
statements, the Company adopted the provisions of Statement of
Financial Accounting Standards No. 123 (revised 2004),
Share-Based Payment, in 2006.
/s/ DELOITTE &
TOUCHE LLP
Costa Mesa, California
March 3, 2008
83
THE
ENSIGN GROUP, INC.
(In
thousands, except per share data)
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2007
|
|
|
2006
|
|
|
ASSETS
|
Current assets:
|
|
|
|
|
|
|
|
|
Cash and cash equivalents
|
|
$
|
51,732
|
|
|
$
|
25,491
|
|
Accounts receivable less allowance for doubtful
accounts of $7,454 and $7,543 at December 31, 2007 and
2006, respectively
|
|
|
50,615
|
|
|
|
45,285
|
|
Prepaid income taxes
|
|
|
5,835
|
|
|
|
|
|
Prepaid expenses and other current assets
|
|
|
5,319
|
|
|
|
4,185
|
|
Deferred tax asset current
|
|
|
6,862
|
|
|
|
8,844
|
|
|
|
|
|
|
|
|
|
|
Total current assets
|
|
|
120,363
|
|
|
|
83,805
|
|
Property and equipment, net
|
|
|
124,861
|
|
|
|
87,133
|
|
Insurance subsidiary deposits
|
|
|
8,810
|
|
|
|
8,530
|
|
Deferred tax asset
|
|
|
4,865
|
|
|
|
3,714
|
|
Restricted and other assets
|
|
|
3,273
|
|
|
|
2,618
|
|
Intangible assets, net
|
|
|
2,335
|
|
|
|
2,659
|
|
Goodwill
|
|
|
2,882
|
|
|
|
2,072
|
|
|
|
|
|
|
|
|
|
|
Total assets
|
|
$
|
267,389
|
|
|
$
|
190,531
|
|
|
|
|
|
|
|
|
|
|
|
LIABILITIES AND STOCKHOLDERS EQUITY
|
Current liabilities:
|
|
|
|
|
|
|
|
|
Accounts payable
|
|
$
|
14,699
|
|
|
$
|
12,329
|
|
Accrued wages and related liabilities
|
|
|
21,141
|
|
|
|
24,026
|
|
Accrued self-insurance liabilities current
|
|
|
7,424
|
|
|
|
6,122
|
|
Other accrued liabilities
|
|
|
11,137
|
|
|
|
12,106
|
|
Current maturities of long-term debt
|
|
|
2,993
|
|
|
|
941
|
|
|
|
|
|
|
|
|
|
|
Total current liabilities
|
|
|
57,394
|
|
|
|
55,524
|
|
Long-term debt less current maturities
|
|
|
60,577
|
|
|
|
63,587
|
|
Accrued self-insurance liability
|
|
|
17,236
|
|
|
|
15,384
|
|
Deferred rent and other long-term liabilities
|
|
|
2,505
|
|
|
|
2,164
|
|
Commitments and contingencies (Notes 11 and 16)
|
|
|
|
|
|
|
|
|
Series A redeemable convertible preferred stock;
$0.001 par value; 1,000 shares authorized; 0 and
685 shares issued and outstanding at December 31, 2007
and 2006, respectively; liquidation preference of $2,401 at
December 31, 2006
|
|
|
|
|
|
|
2,725
|
|
Stockholders equity:
|
|
|
|
|
|
|
|
|
Common stock; $0.001 par value; 75,000 shares
authorized; 20,480 and 13,694 shares issued and outstanding
at December 31, 2007 and 2006, respectively
|
|
|
21
|
|
|
|
14
|
|
Additional paid-in capital
|
|
|
62,142
|
|
|
|
1,250
|
|
Retained earnings
|
|
|
72,119
|
|
|
|
54,724
|
|
Common stock in treasury, at cost, 716 and 755 shares at
December 31, 2007 and 2006, respectively
|
|
|
(4,605
|
)
|
|
|
(4,841
|
)
|
|
|
|
|
|
|
|
|
|
Total stockholders equity
|
|
|
129,677
|
|
|
|
51,147
|
|
|
|
|
|
|
|
|
|
|
Total liabilities and stockholders equity
|
|
$
|
267,389
|
|
|
$
|
190,531
|
|
|
|
|
|
|
|
|
|
|
See accompanying notes to consolidated financial statements.
84
THE
ENSIGN GROUP, INC.
(In
thousands, except per share data)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31,
|
|
|
|
2007
|
|
|
2006
|
|
|
2005
|
|
|
Revenue
|
|
$
|
411,318
|
|
|
$
|
358,574
|
|
|
$
|
300,850
|
|
Expense:
|
|
|
|
|
|
|
|
|
|
|
|
|
Cost of services (exclusive of facility rent and depreciation
and amortization shown separately below)
|
|
|
335,014
|
|
|
|
284,847
|
|
|
|
239,379
|
|
Facility rent cost of services
|
|
|
16,675
|
|
|
|
16,404
|
|
|
|
16,118
|
|
General and administrative expense
|
|
|
15,945
|
|
|
|
14,210
|
|
|
|
10,909
|
|
Depreciation and amortization
|
|
|
6,966
|
|
|
|
4,221
|
|
|
|
2,458
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total expenses
|
|
|
374,600
|
|
|
|
319,682
|
|
|
|
268,864
|
|
Income from operations
|
|
|
36,718
|
|
|
|
38,892
|
|
|
|
31,986
|
|
Other income (expense):
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest expense
|
|
|
(4,844
|
)
|
|
|
(2,990
|
)
|
|
|
(2,035
|
)
|
Interest income
|
|
|
1,558
|
|
|
|
772
|
|
|
|
491
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other expense, net
|
|
|
(3,286
|
)
|
|
|
(2,218
|
)
|
|
|
(1,544
|
)
|
Income before provision for income taxes
|
|
|
33,432
|
|
|
|
36,674
|
|
|
|
30,442
|
|
Provision for income taxes
|
|
|
12,905
|
|
|
|
14,125
|
|
|
|
12,054
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
$
|
20,527
|
|
|
$
|
22,549
|
|
|
$
|
18,388
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income per share:
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
$
|
1.39
|
|
|
$
|
1.66
|
|
|
$
|
1.35
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted
|
|
$
|
1.17
|
|
|
$
|
1.34
|
|
|
$
|
1.05
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average common shares outstanding:
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
|
14,497
|
|
|
|
13,366
|
|
|
|
13,468
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted
|
|
|
17,470
|
|
|
|
16,823
|
|
|
|
17,505
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
See accompanying notes to consolidated financial statements.
85
THE
ENSIGN GROUP, INC.
(In
thousands)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Additional
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common Stock
|
|
|
Paid-In
|
|
|
Retained
|
|
|
Treasury Stock
|
|
|
|
|
|
|
Shares
|
|
|
Amount
|
|
|
Capital
|
|
|
Earnings
|
|
|
Shares
|
|
|
Amount
|
|
|
Total
|
|
|
Balance December 31, 2004
|
|
|
14,064
|
|
|
$
|
14
|
|
|
$
|
393
|
|
|
$
|
17,421
|
|
|
|
|
|
|
$
|
|
|
|
$
|
17,828
|
|
Issuance of common stock to employees and directors resulting
from the exercise of stock options
|
|
|
253
|
|
|
|
|
|
|
|
221
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
221
|
|
Repurchase of common stock
|
|
|
(3
|
)
|
|
|
|
|
|
|
(1
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1
|
)
|
Dividends declared
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1,502
|
)
|
|
|
|
|
|
|
|
|
|
|
(1,502
|
)
|
Purchase of treasury stock
|
|
|
(400
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
400
|
|
|
|
(2,300
|
)
|
|
|
(2,300
|
)
|
Net income
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
18,388
|
|
|
|
|
|
|
|
|
|
|
|
18,388
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance December 31, 2005
|
|
|
13,914
|
|
|
|
14
|
|
|
|
613
|
|
|
|
34,307
|
|
|
|
400
|
|
|
|
(2,300
|
)
|
|
|
32,634
|
|
Issuance of common stock to employees and directors resulting
from the exercise of stock options
|
|
|
184
|
|
|
|
|
|
|
|
195
|
|
|
|
|
|
|
|
(45
|
)
|
|
|
259
|
|
|
|
454
|
|
Repurchase of common stock
|
|
|
(4
|
)
|
|
|
|
|
|
|
(1
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1
|
)
|
Dividends declared
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(2,132
|
)
|
|
|
|
|
|
|
|
|
|
|
(2,132
|
)
|
Employee stock award compensation
|
|
|
|
|
|
|
|
|
|
|
443
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
443
|
|
Purchase of treasury stock
|
|
|
(400
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
400
|
|
|
|
(2,800
|
)
|
|
|
(2,800
|
)
|
Net income
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
22,549
|
|
|
|
|
|
|
|
|
|
|
|
22,549
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance December 31, 2006
|
|
|
13,694
|
|
|
|
14
|
|
|
|
1,250
|
|
|
|
54,724
|
|
|
|
755
|
|
|
|
(4,841
|
)
|
|
|
51,147
|
|
Issuance of common stock to employees and directors resulting
from the exercise of stock options
|
|
|
48
|
|
|
|
|
|
|
|
117
|
|
|
|
|
|
|
|
(39
|
)
|
|
|
236
|
|
|
|
353
|
|
Conversion of preferred shares
|
|
|
2,741
|
|
|
|
3
|
|
|
|
2,722
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2,725
|
|
Issuance of common stock in connection with initial public
offering
|
|
|
4,000
|
|
|
|
4
|
|
|
|
56,586
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
56,590
|
|
Repurchase of common stock
|
|
|
(3
|
)
|
|
|
|
|
|
|
(1
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1
|
)
|
Dividends declared
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(2,792
|
)
|
|
|
|
|
|
|
|
|
|
|
(2,792
|
)
|
Employee stock award compensation
|
|
|
|
|
|
|
|
|
|
|
1,468
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,468
|
|
Net income
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
20,527
|
|
|
|
|
|
|
|
|
|
|
|
20,527
|
|
Cumulative effect to prior year accumulated deficit related to
the adoption of FIN 48
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(340
|
)
|
|
|
|
|
|
|
|
|
|
|
(340
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance December 31, 2007
|
|
|
20,480
|
|
|
$
|
21
|
|
|
$
|
62,142
|
|
|
$
|
72,119
|
|
|
|
716
|
|
|
$
|
(4,605
|
)
|
|
$
|
129,677
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
See accompanying notes to consolidated financial statements.
86
THE
ENSIGN GROUP, INC.
(In
thousands)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31,
|
|
|
|
2007
|
|
|
2006
|
|
|
2005
|
|
|
Cash flows from operating activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
$
|
20,527
|
|
|
$
|
22,549
|
|
|
$
|
18,388
|
|
Adjustments to reconcile net income to net cash provided by
operating activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
Depreciation and amortization
|
|
|
6,978
|
|
|
|
4,221
|
|
|
|
2,458
|
|
Deferred income taxes
|
|
|
831
|
|
|
|
(4,426
|
)
|
|
|
(3,913
|
)
|
Provision for doubtful accounts
|
|
|
3,135
|
|
|
|
4,191
|
|
|
|
3,092
|
|
Stock-based compensation
|
|
|
1,468
|
|
|
|
443
|
|
|
|
|
|
Excess tax benefit from share based compensation
|
|
|
(87
|
)
|
|
|
|
|
|
|
|
|
Loss on disposition of property and equipment
|
|
|
117
|
|
|
|
30
|
|
|
|
6
|
|
Change in operating assets and liabilities
|
|
|
|
|
|
|
|
|
|
|
|
|
Accounts receivable
|
|
|
(8,465
|
)
|
|
|
(6,113
|
)
|
|
|
(19,189
|
)
|
Prepaid expenses and other current assets
|
|
|
(6,969
|
)
|
|
|
89
|
|
|
|
(970
|
)
|
Insurance subsidiary deposits
|
|
|
(280
|
)
|
|
|
(3,983
|
)
|
|
|
(2,865
|
)
|
Accounts payable
|
|
|
2,370
|
|
|
|
1,300
|
|
|
|
5,718
|
|
Accrued wages and related liabilities
|
|
|
(2,885
|
)
|
|
|
5,788
|
|
|
|
4,402
|
|
Other accrued liabilities
|
|
|
(1,108
|
)
|
|
|
782
|
|
|
|
6,314
|
|
Accrued self-insurance liabilities
|
|
|
3,154
|
|
|
|
6,235
|
|
|
|
6,820
|
|
Deferred rent liability
|
|
|
(137
|
)
|
|
|
(161
|
)
|
|
|
185
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash provided by operating activities
|
|
|
18,649
|
|
|
|
30,945
|
|
|
|
20,446
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash flows from investing activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
Purchase of property and equipment
|
|
|
(35,657
|
)
|
|
|
(14,086
|
)
|
|
|
(5,685
|
)
|
Restricted and other assets
|
|
|
(655
|
)
|
|
|
(656
|
)
|
|
|
(303
|
)
|
Cash payment for acquisitions
|
|
|
(9,452
|
)
|
|
|
(28,967
|
)
|
|
|
(14,884
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash used in investing activities
|
|
|
(45,764
|
)
|
|
|
(43,709
|
)
|
|
|
(20,872
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash flows from financing activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
Proceeds from issuance of debt
|
|
|
|
|
|
|
34,782
|
|
|
|
1,500
|
|
Payments on long term debt
|
|
|
(958
|
)
|
|
|
(2,689
|
)
|
|
|
(859
|
)
|
Issuance of treasury stock upon exercise of options
|
|
|
236
|
|
|
|
259
|
|
|
|
|
|
Issuance of common stock upon exercise of options
|
|
|
117
|
|
|
|
195
|
|
|
|
221
|
|
Repurchase of common stock
|
|
|
(1
|
)
|
|
|
(1
|
)
|
|
|
(1
|
)
|
Dividends paid
|
|
|
(2,631
|
)
|
|
|
(1,975
|
)
|
|
|
(1,254
|
)
|
Proceeds from sale of common stock in connection with initial
public offering (IPO), net of issuance costs
|
|
|
56,590
|
|
|
|
|
|
|
|
|
|
Excess tax benefit from share based compensation
|
|
|
87
|
|
|
|
|
|
|
|
|
|
Payments of deferred financing costs
|
|
|
(84
|
)
|
|
|
(1,151
|
)
|
|
|
(1
|
)
|
Purchase of treasury stock
|
|
|
|
|
|
|
(2,800
|
)
|
|
|
(2,300
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash provided by (used in) financing activities
|
|
|
53,356
|
|
|
|
26,620
|
|
|
|
(2,694
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net increase (decrease) in cash and cash equivalents
|
|
|
26,241
|
|
|
|
13,856
|
|
|
|
(3,120
|
)
|
Cash and cash equivalents beginning of year
|
|
|
25,491
|
|
|
|
11,635
|
|
|
|
14,755
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents end of year
|
|
$
|
51,732
|
|
|
$
|
25,491
|
|
|
$
|
11,635
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Supplemental disclosures of cash flow information
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash paid during the period for:
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest
|
|
$
|
4,456
|
|
|
$
|
2,978
|
|
|
$
|
2,037
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income taxes
|
|
$
|
19,642
|
|
|
$
|
18,105
|
|
|
$
|
14,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-cash investing and financing activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
Transfer of capital reserves from other assets to property and
equipment
|
|
$
|
|
|
|
$
|
43
|
|
|
$
|
35
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Conditional asset retirement obligations under FIN 47
|
|
$
|
104
|
|
|
$
|
50
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt assumed in connection with acquisitions
|
|
$
|
|
|
|
$
|
2,104
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
See accompanying notes to consolidated financial statements.
87
THE
ENSIGN GROUP, INC.
(Dollars
and shares in thousands, except per share data)
|
|
1.
|
Description
of Business
|
The Company The Ensign Group, Inc., through
its subsidiaries (collectively, Ensign or the Company), provides
skilled nursing and rehabilitative care services through the
operation of 61 facilities as of December 31, 2007, located
in California, Arizona, Texas, Washington, Utah and Idaho. All
of these facilities are skilled nursing facilities, other than
three stand-alone assisted living facilities in Arizona and
Texas and four campuses that offer both skilled nursing and
assisted living services located in California, Arizona and
Utah. The Companys facilities, each of which strives to be
the facility of choice in the community it serves, provide a
broad spectrum of skilled nursing and assisted living services,
physical, occupational and speech therapies, and other
rehabilitative and healthcare services, for both long-term
residents and short-stay rehabilitation patients. The
Companys facilities have a collective capacity of over
7,400 skilled nursing, assisted living and independent living
beds. As of December 31, 2007, the Company owned 26 of its
61 facilities and operated an additional 35 facilities through
long-term lease arrangements, and had options to purchase or
purchase agreements for 10 of those 35 facilities.
The Ensign Group, Inc. is a holding company with no direct
operating assets, employees or revenue. All of the
Companys facilities are operated by separate,
wholly-owned, independent subsidiaries, each of which has its
own management, employees and assets. One of the Companys
wholly-owned subsidiaries provides centralized accounting,
payroll, human resources, information technology, legal, risk
management and other centralized services to the other operating
subsidiaries through contractual relationships between such
subsidiaries.
The Company also has a wholly-owned captive insurance subsidiary
that provides some claims-made coverage to the Companys
operating subsidiaries for general and professional liability,
as well as for certain workers compensation insurance
liabilities.
Initial Public Offering In October 2007, the
Companys board of directors approved the Companys
amended and restated certificate of incorporation that became
effective immediately following the completion of the
Companys initial public offering (the IPO). The amended
and restated certificate of incorporation:
|
|
|
|
|
authorizes 1,000 shares of preferred stock, $0.001 par
value; and
|
|
|
|
authorizes 75,000 shares of common stock, $0.001 par
value
|
In November 2007, in connection with the Companys IPO, the
Company sold 4,000 shares of common stock and certain
selling stockholders sold 600 shares of common stock, each
at the IPO price of $16.00 per share, for proceeds to the
Company, net of underwriting discounts and commissions and
offering expenses payable by the Company (Net Proceeds), of
approximately $56.5 million. Concurrently with the closing
of the IPO, all previously outstanding shares of Series A
preferred stock converted into 2,741 shares of the
Companys common stock.
|
|
2.
|
Summary
of Significant Accounting Policies
|
Basis of Presentation The accompanying
consolidated financial statements have been prepared in
accordance with accounting principles generally accepted in the
United States of America. The Company is the sole member or
shareholder of various consolidated limited liability companies
and corporations; each established to operate various acquired
skilled nursing and assisted living facilities. All intercompany
transactions and balances have been eliminated in consolidation.
Estimates and Assumptions The preparation of
consolidated financial statements in conformity with
U.S. generally accepted accounting principles (GAAP)
requires management to make estimates and assumptions that
affect the reported amounts of assets and liabilities and
disclosure of contingent assets and liabilities at the date of
the financial statements and the reported amounts of revenue and
expenses during the reporting
88
THE
ENSIGN GROUP, INC.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
periods. The most significant estimates in the Companys
consolidated financial statements relate to revenue, allowance
for doubtful accounts, intangible assets and goodwill,
impairment of long-lived assets, patient liability, general and
professional liability, workers compensation, and
healthcare claims included in accrued self-insurance
liabilities, stock-based compensation, contingent liabilities
and income taxes. Actual results could differ from those
estimates.
Business Segments The Company has a single
reportable segment long-term care services, which
includes the operation of skilled nursing and assisted living
facilities, and related ancillary services at the facilities.
The Companys single reporting segment is made up of
several individual operating segments grouped together
principally based on their geographical locations within the
United States. Based on the similar economic and other
characteristics of each of the operating segments, management
believes the Company meets the criteria for aggregating its
operations into a single reporting segment.
Comprehensive Income For the years ended
December 31, 2007, 2006 and 2005 there were no differences
between comprehensive income and net income. Therefore,
statements of comprehensive income have not been presented.
Fair Value of Financial Instruments The
Companys financial instruments consist principally of cash
and cash equivalents, accounts receivable, insurance subsidiary
deposits, accounts payable and borrowings. The Company believes
all of the financial instruments recorded values
approximate current values because of their nature and
respective durations.
Revenue Recognition The Company follows the
provisions of Staff Accounting Bulletin (SAB) No. 104,
Revenue Recognition in Financial Statements
(SAB 104), for revenue recognition. Under SAB 104,
four conditions must be met before revenue can be recognized:
(i) there is persuasive evidence that an arrangement
exists; (ii) delivery has occurred or service has been
rendered; (iii) the price is fixed or determinable; and
(iv) collection is reasonably assured.
The Companys revenue is derived primarily from providing
long-term healthcare services to residents and is recognized on
the date services are provided at amounts billable to individual
residents. For residents under reimbursement arrangements with
third-party payors, including Medicaid, Medicare and private
insurers, revenue is recorded based on contractually
agreed-upon
amounts on a per patient, daily basis.
Revenue from the Medicare and Medicaid programs accounted for
approximately 74%, 75% and 76% of the Companys revenue in
the years ended December 31, 2007, 2006 and 2005. The
Company records revenue from these governmental and managed care
programs as services are performed at their expected net
realizable amounts under these programs. The Companys
revenue from governmental and managed care programs is subject
to audit and retroactive adjustment by governmental and
third-party agencies. Consistent with healthcare industry
accounting practices, any changes to these governmental revenue
estimates are recorded in the period the change or adjustment
becomes known based on final settlements. The Company recorded
net retroactive adjustments relating to earlier periods that
increased revenue by $724, $157 and $157 for the years ended
December 31, 2007, 2006 and 2005, respectively. Also, see
Note 16 for further discussion. The Company records revenue
from private pay patients as services are performed.
Accounts Receivable Accounts receivable
consist primarily of amounts due from Medicare and Medicaid
programs, other government programs, managed care health plans
and private payor sources. Estimated provisions for doubtful
accounts are recorded to the extent it is probable that a
portion or all of a particular account will not be collected.
In evaluating the collectibility of accounts receivable, the
Company considers a number of factors, including the age of the
accounts, changes in collection patterns, the composition of
patient accounts by payor type and the status of ongoing
disputes with third-party payors. The percentages applied to the
aged receivable balances for purposes of the allowance for
doubtful accounts are based on the Companys historical
experience
89
THE
ENSIGN GROUP, INC.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
and time limits, if any, for managed care, Medicare and
Medicaid. The Company periodically refines its procedures for
estimating the allowance for doubtful accounts based on
experience with the estimation process and changes in
circumstances.
Cash and Cash Equivalents Cash and cash
equivalents consist of cash and short-term investments with
original maturities of three months or less at time of purchase
and therefore approximate fair value. The Company places its
cash and short-term investments with high credit quality
financial institutions. In addition, the Companys
insurance captive maintains cash and cash equivalents and
insurance subsidiary deposits. See discussion below.
Insurance Subsidiary Deposits In order to
reflect the nature of the Companys captive insurance
subsidiary cash and cash equivalents, insurance subsidiary cash
balances that are designated to support long-term insurance
subsidiary liabilities have been presented in a long-term
classification to reflect its purpose and the liabilities that
the cash supports. Insurance subsidiary deposits classified as
long-term were $8,810 and $8,530 as of December 31, 2007
and 2006, respectively. These deposits are currently held in a
bank account with a high credit quality financial institution.
Impairment of Long-Lived Assets The Company
reviews the carrying value of long-lived assets that are held
and used in the Companys operations for impairment
whenever events or changes in circumstances indicate that the
carrying amount of an asset may not be recoverable.
Recoverability of these assets is determined based upon expected
undiscounted future net cash flows from the operations to which
the assets relate, utilizing managements best estimate,
appropriate assumptions, and projections at the time. If the
carrying value is determined to be unrecoverable from future
operating cash flows, the asset is deemed impaired and an
impairment loss would be recognized to the extent the carrying
value exceeded the estimated fair value of the asset. The
Company estimates the fair value of assets based on the
estimated future discounted cash flows of the asset. The
Companys management has evaluated its long-lived assets
and has not identified any impairment as of December 31,
2007, 2006 and 2005.
Intangible Assets and Goodwill Intangible
assets consist primarily of deferred financing costs, lease
acquisition costs and trade names. Deferred financing costs are
amortized over the term of the related debt, ranging from seven
to 26 years. Lease acquisition costs are amortized over the
life of the lease of the facility acquired, ranging from ten to
20 years. Trade names are amortized over 30 years.
Goodwill is accounted for under Statement of Financial
Accounting Standards (SFAS) No. 141, Business
Combinations (SFAS 141) and represents the excess
of the purchase price over the fair value of identifiable net
assets acquired in business combinations. In accordance with
SFAS No. 142, Goodwill and Other Intangible Assets
(SFAS 142), goodwill is subject to annual testing for
impairment. In addition, goodwill is tested for impairment if
events occur or circumstances change that would reduce the fair
value of a reporting unit below its carrying amount. The Company
defines reporting units as the individual facilities. The
Company performs its annual test for impairment during the
fourth quarter of each year. The Company did not record any
impairment charges during the years ended December 31,
2007, 2006 or 2005.
Deferred Rent Deferred rent represents rental
expense in excess of actual rent payments and is amortized on a
straight-line basis over the life of the related lease.
Self-Insurance The Company is partially
self-insured for general and professional liability up to a base
amount per claim (the self-insured retention) with an aggregate,
one time deductible above this limit. Losses beyond these
amounts are insured through third-party policies with coverage
limits per occurrence, per location and on an aggregate basis
for the Company. For claims made in 2007, the self-insured
retention was $350 per claim with a $900 deductible. The
third-party coverage above these limits for all periods
presented was $1,000 per occurrence, $3,000 per facility with a
$6,000 blanket aggregate.
90
THE
ENSIGN GROUP, INC.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
The self-insured retention and deductible limits for general and
professional liability and workers compensation are
self-insured through a wholly-owned insurance captive (the
Captive), the related assets and liabilities of which are
included in the consolidated financial statements. The Captive
is subject to certain statutory requirements as an insurance
provider. These requirements include, but are not limited to,
maintaining statutory capital. The Companys policy is to
accrue amounts equal to the estimated costs to settle open
claims of insureds, as well as an estimate of the cost of
insured claims that have been incurred but not reported. The
Company develops information about the size of the ultimate
claims based on historical experience, current industry
information and actuarial analysis, and has evaluated the
estimates for claim loss exposure on an annual basis through
2006, and on a quarterly basis beginning with the first quarter
of 2007. Accrued general liability and professional malpractice
liabilities recorded on an undiscounted basis in the
consolidated balance sheets were $18,596 and $16,013 as of
December 31, 2007 and 2006, respectively.
The Companys operating subsidiaries are self-insured for
workers compensation liability in California. In Texas,
the operating subsidiaries have elected non-subscriber status
for workers compensation claims. The Companys
operating subsidiaries in other states have third party
guaranteed cost coverage. In California and Texas, the Company
accrues amounts equal to the estimated costs to settle open
claims, as well as an estimate of the cost of claims that have
been incurred but not reported. The Company uses actuarial
valuations to estimate the liability based on historical
experience and industry information. Accrued workers
compensation liabilities are recorded on an undiscounted basis
in the consolidated balance sheets and were $4,145 and $4,504 as
of December 31, 2007 and 2006, respectively.
During 2003 and 2004, the Companys California and Arizona
operating subsidiaries were insured for workers
compensation liability by a third-party carrier under a policy
where the retrospective premium was adjusted annually based on
incurred developed losses and allocated expenses. Based on a
comparison of the computed retrospective premium to the actual
payments funded, amounts will be due to the insurer or insured.
The funded accrual in excess of the estimated liabilities is
included in prepaid expenses and other current assets in the
consolidated balance sheets and was $431 and $930 as of
December 31, 2007 and 2006, respectively.
Effective May 1, 2006, the Company began to provide
self-insured medical (including prescription drugs) and dental
healthcare benefits to the majority of its employees. Prior to
this, the Company had multiple third-party HMO and PPO plans, of
which certain HMO plans are still active. The Company is not
aware of any run-off claim liabilities from the prior plans. The
Company is fully liable for all financial and legal aspects of
these benefit plans. To protect itself against loss exposure
with this policy, the Company has purchased individual stop-loss
insurance coverage that insures individual claims that exceed
$100 for each covered person which resets every plan year or a
maximum of $6,000 per each covered persons lifetime on the
PPO plan and unlimited on the HMO plan. The Company has also
purchased aggregate stop-loss coverage that reimburses the plan
up to $5,000 to the extent that paid claims exceed $7,225. The
aforementioned coverage only applies to claims paid during the
plan year. The Companys accrued liability under these
plans recorded on an undiscounted basis in the consolidated
balance sheets was $1,919 and $989 at December 31, 2007 and
2006, respectively.
The Company believes that adequate provision has been made in
the consolidated financial statements for liabilities that may
arise out of patient care, workers compensation,
healthcare benefits and related services provided to date. The
amount of the Companys reserves was determined based on an
estimation process that uses information obtained from both
company-specific and industry data. This estimation process
requires the Company to continuously monitor and evaluate the
life cycle of the claims. Using data obtained from this
monitoring and the Companys assumptions about emerging
trends, the Company, with the assistance of an independent
actuary, develops information about the size of ultimate claims
based on the Companys historical experience and other
available industry information. The most significant assumptions
used in the estimation process include determining the trend in
costs, the expected cost of claims incurred but not reported and
the
91
THE
ENSIGN GROUP, INC.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
expected costs to settle or pay damage awards with respect to
unpaid claims. It is possible, however, that the actual
liabilities may exceed the Companys estimate of loss.
The self-insured liabilities are based upon estimates, and while
management believes that the estimates of loss are reasonable,
the ultimate liability may be in excess of or less than the
recorded amounts. Due to the inherent volatility of actuarially
determined loss estimates, it is reasonably possible that the
Company could experience changes in estimated losses that could
be material to net income. If the Companys actual
liability exceeds its estimate of loss, its future earnings and
financial condition would be adversely affected.
Long-Term Debt The carrying value of the
Companys long-term debt is considered to approximate the
fair value of such debt for all periods presented based upon the
interest rates that the Company believes it can currently obtain
for similar debt.
Income Taxes Income taxes are accounted for
in accordance with SFAS No. 109, Accounting for
Income Taxes (SFAS 109). Under this method, deferred
tax assets and liabilities are established for temporary
differences between the financial reporting basis and the tax
basis of the Companys assets and liabilities at tax rates
expected to be in effect when such temporary differences are
expected to reverse. The temporary differences are primarily
attributable to compensation accruals, straight line rent
adjustments and reserves for doubtful accounts and insurance
liabilities. When necessary, the Company records a valuation
allowance to reduce its net deferred tax assets to the amount
that is more likely than not to be realized. In considering the
need for a valuation allowance against some portion or all of
its deferred tax assets, the Company must make certain estimates
and assumptions regarding future taxable income, the feasibility
of tax planning strategies and other factors.
Estimates and judgments regarding deferred tax assets and the
associated valuation allowance, if any, are based on, among
other things, knowledge of operations, markets, historical
trends and likely future changes and, when appropriate, the
opinions of advisors with knowledge and expertise in certain
fields. However, due to the nature of certain assets and
liabilities, there are risks and uncertainties associated with
some of the Companys estimates and judgments. Actual
results could differ from these estimates under different
assumptions or conditions. The net deferred tax assets as of
December 31, 2007 and 2006 were $11,727 and $12,558,
respectively. The Company expects to fully utilize these
deferred tax assets; however, their ultimate realization is
dependent upon the amount of future taxable income during the
periods in which the temporary differences become deductible.
As of January 1, 2007, the Company adopted Financial
Accounting Standards Board (FASB) Interpretation No. 48,
Accounting for Uncertainty in Income Taxes an
interpretation of FASB Statement No. 109 (FIN 48).
FIN 48 requires the Company to maintain a liability for
underpayment of income taxes and related interest and penalties,
if any, for uncertain income tax positions. In considering the
need for and magnitude of a liability for uncertain income tax
positions, the Company must make certain estimates and
assumptions regarding the amount of income tax benefit that will
ultimately be realized. The ultimate resolution of an uncertain
tax position may not be known for a number of years, during
which time the Company may be required to adjust these reserves,
in light of changing facts and circumstances.
The Company used an estimate of its annual income tax rate to
recognize a provision for income taxes in financial statements
for interim periods. However, changes in facts and circumstances
could result in adjustments to the Companys effective tax
rate in future quarterly or annual periods.
Stock-Based Compensation As of
January 1, 2006, the Company adopted
SFAS No. 123(R), Share-Based Payment
(SFAS 123(R)), which requires the measurement and
recognition of compensation expense for all share-based payment
awards made to employees and directors including employee stock
options based on estimated fair values, ratably over the
requisite service period of the award. Net income is reduced by
the recognition of the fair value of all stock options issued on
and subsequent to January 1, 2006, the amount of which is
contingent upon the number of future options granted and other
variables. Prior to the adoption of
92
THE
ENSIGN GROUP, INC.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
SFAS 123(R), the Company accounted for stock-based awards
to employees and directors using the intrinsic value method in
accordance with Accounting Principles Board (APB) Opinion
No. 25, Accounting for Stock Issued to Employees
(APB 25) as allowed under SFAS No. 123,
Accounting for Stock-Based Compensation (SFAS 123).
The Company adopted SFAS 123(R) using the prospective
transition method. The Companys consolidated financial
statements as of and for the periods ended December 31,
2007 and 2006 reflect the impact of SFAS 123(R). In
accordance with the prospective transition method, the
Companys consolidated financial statements for periods
prior to January 1, 2006 have not been restated to reflect,
and do not include, the impact of SFAS 123(R).
Historically, no compensation expense was recognized by the
Company in its financial statements in connection with the
awarding of stock option grants to employees provided that, as
of the grant date, all terms associated with the award were
fixed and the fair value of its stock, as of the grant date, was
equal to or less than the amount an employee must pay to acquire
the stock. The Company would have recognized compensation
expense in situations where the fair value of its common stock
on the grant date was greater than the amount an employee must
pay to acquire the stock. Stock-based compensation expense
recognized in the Companys consolidated statements of
income for the years ended December 31, 2007 and 2006 does
not include compensation expense for share-based payment awards
granted prior to, but not yet vested as of January 1, 2006,
in accordance with the pro forma provisions of SFAS 123,
but does include compensation expense for the share-based
payment awards granted subsequent to January 1, 2006 based
on the fair value on the grant date estimated in accordance with
the provisions of SFAS 123(R). Existing options at
January 1, 2006 will continue to be accounted for in
accordance with APB 25 unless such options are modified,
repurchased or canceled after the effective date.
Acquisition Policy The Company periodically
enters into agreements to acquire assets
and/or
businesses. The considerations involved in each of these
agreements may include cash, financing
and/or
long-term lease arrangements for real properties. The Company
evaluates each transaction to determine whether the acquired
interests are assets or businesses using the framework provided
by Emerging Issues Task Force (EITF) Issue
No. 98-3,
Determining Whether a Nonmonetary Transaction Involves
Receipt of Productive Assets or of a Business
(EITF 98-3).
EITF 98-3
defines a business as a self-sustaining integrated set of
activities and assets conducted and managed for the purpose of
providing a return to investors. A business consists of
(a) input, (b) processes applied to those inputs, and
(c) resulting outputs that are used to generate revenues.
In order for an acquired set of activities and assets to be a
business, it must contain all of the inputs and processes
necessary for it to continue to conduct normal operations after
the acquired entity is separated from the seller, including the
ability to sustain a revenue stream by providing its outputs to
customers. An acquired set of activities and assets fail the
definition of a business if it excludes one or more of the above
items such that it is not possible to continue normal operations
and sustain a revenue stream by providing its products
and/or
services to customers.
Operating Leases The Company accounts for
operating leases in accordance with SFAS No. 13,
Accounting for Leases, and FASB Technical
Bulletin 85-3,
Accounting for Operating Leases with Scheduled Rent
Increases. Accordingly, rent expense under operating leases
for the Companys facilities and administrative office is
recognized on a straight-line basis over the original term of
each lease, inclusive of predetermined rent escalations or
modifications.
Recent Accounting Pronouncements In December
2007, the FASB issued SFAS No. 141(R), Business
Combinations (SFAS 141(R)), which replaces
SFAS 141. The provisions of SFAS 141(R) are similar to
those of SFAS 141; however, SFAS 141(R) requires
companies to record most identifiable assets, liabilities,
noncontrolling interests, and goodwill acquired in a business
combination at full fair value. SFAS 141(R)
also requires companies to record fair value estimates of
contingent consideration and certain other potential liabilities
during the original purchase price allocation and to expense
acquisition costs as incurred. This
93
THE
ENSIGN GROUP, INC.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
statement applies to all business combinations, including
combinations by contract alone. Further, under SFAS 141(R),
all business combinations will be accounting for by applying the
acquisition method. SFAS 141(R) is effective for fiscal
years beginning on or after December 15, 2008. The Company
is currently evaluating the impact that SFAS 141(R) will
have on the consolidated financial statements.
In December 2007, the FASB issued SFAS No. 160,
Noncontrolling Interests in Consolidated Financial Statements
(SFAS 160), which will require noncontrolling interests
(previously referred to as minority interests) to be treated as
a separate component of equity, not as a liability or other item
outside of permanent equity. This Statement applies to the
accounting for noncontrolling interests and transactions with
noncontrolling interest holders in consolidated financial
statements. SFAS 160 will be applied prospectively to all
noncontrolling interests, including any that arose before the
effective date except that comparative period information must
be recast to classify noncontrolling interests in equity,
attribute net income and other comprehensive income to
noncontrolling interests, and provide other disclosures required
by Statement 160. SFAS 160 is effective for periods
beginning on or after December 15, 2008. The Company is
currently evaluating the impact that SFAS 160 will have on
its consolidated financial statements.
In September 2006, the FASB issued SFAS No. 157,
Fair Value Measurements (SFAS 157), which defines
fair value, establishes a framework for measuring fair value
under GAAP, and expands disclosures about fair value
measurements. SFAS 157 applies to other accounting
pronouncements that require or permit fair value measurements.
SFAS 157 is effective for fiscal years beginning after
November 15, 2007, and for interim periods within those
fiscal years. Subsequently, in February 2008, the FASB issued
two staff position on SFAS 157 (FSP
FAS 157-1
and 157-2)
which scopes out the lease classification measurements under
FASB Statement No. 13 from SFAS 157 and delays the
effective date on SFAS 157 for all nonrecurring fair value
measurements of nonfinancial assets and nonfinancial liabilities
until fiscal years beginning after November 15, 2008. The
Company is currently evaluating the impact, if any, that
SFAS 157 will have on the consolidated financial statements.
In February 2007, the FASB issued SFAS No. 159, The
Fair Value Option For Financial Assets and Financial
Liabilities including an amendment of FASB Statement
No. 115 (SFAS 159). SFAS 159 permits entities
to choose to measure many financial instruments and certain
other items at fair value. SFAS 159 is effective for fiscal
years beginning after November 15, 2007. The Company is
currently evaluating the impact, if any, that SFAS 159 will
have on its consolidated financial statements.
In June 2007, the FASB ratified EITF consensus
06-11,
Accounting for Income Tax Benefits of Dividends on
Share-Based Payment Awards. This EITF prescribes that the
tax benefit received on dividends associated with share-based
awards that are charged to retained earnings should be recorded
in additional paid-in capital and included in the pool of excess
tax benefits available to absorb potential future tax
deficiencies of share-based payment awards. The consensus is
effective for the tax benefits of dividends declared in fiscal
years beginning after December 15, 2007. The Company is
currently evaluating the impact that
EITF 06-11
will have on its consolidated financial statements.
Adoption of New Accounting Pronouncement In
June 2006, the FASB issued FIN 48, which clarifies the
accounting for uncertainty in income taxes recognized in
financial statements in accordance with SFAS 109 by
prescribing a recognition threshold and measurement attribute
for the financial statement recognition and measurement of a tax
position taken or expected to be taken in a tax return.
FIN 48 also provides guidance on de-recognition,
classification, interest and penalties, accounting in interim
periods, disclosures, and transition. The Company adopted
FIN 48 at the beginning of fiscal year 2007. See
Note 10 for a description of the impact of this adoption on
the Companys consolidated financial position and results
of operations.
94
THE
ENSIGN GROUP, INC.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
|
|
3.
|
Computation
of Net Income Per Common Share
|
Basic net income per share is computed by dividing net income
attributable to common shares by the weighted average number of
outstanding common shares for the period. The computation of
diluted net income per share is similar to the computation of
basic net income per share except that the denominator is
increased to include contingently returnable shares and the
number of additional common shares that would have been
outstanding if the dilutive potential common shares had been
issued. In addition, in computing the dilutive effect of
convertible securities, the numerator is adjusted to add back
(a) any convertible preferred dividends and (b) the
after-tax amount of interest, if any, recognized in the period
associated with any convertible debt.
A reconciliation of the numerator and denominator used in the
calculation of basic net income per common share follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31,
|
|
|
|
2007
|
|
|
2006
|
|
|
2005
|
|
|
Numerator:
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
$
|
20,527
|
|
|
$
|
22,549
|
|
|
$
|
18,388
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Preferred stock dividends
|
|
|
(329
|
)
|
|
|
(356
|
)
|
|
|
(247
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income available to common stockholders for basic net income
per share
|
|
$
|
20,198
|
|
|
$
|
22,193
|
|
|
$
|
18,141
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Denominator:
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average shares outstanding for basic net income per
share(1)
|
|
|
14,497
|
|
|
|
13,366
|
|
|
|
13,468
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic net income per common share
|
|
$
|
1.39
|
|
|
$
|
1.66
|
|
|
$
|
1.35
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
Basic share amounts are shown net of unvested shares subject to
the Companys repurchase right, which total 22, 302 and
432 shares at December 31, 2007, 2006 and 2005,
respectively. Upon the effectiveness of the Companys IPO,
approximately 146 unvested exercised shares, granted prior to
2006, under the 2001 Plan (defined below) immediately vested.
See notes 13 and 15 below for further discussion. |
A reconciliation of the numerator and denominator used in the
calculation of diluted net income per common share follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31,
|
|
|
|
2007
|
|
|
2006
|
|
|
2005
|
|
|
Numerator:
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
$
|
20,527
|
|
|
$
|
22,549
|
|
|
$
|
18,388
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Denominator:
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average common shares outstanding
|
|
|
14,497
|
|
|
|
13,366
|
|
|
|
13,468
|
|
Plus: incremental shares from assumed conversions(1)
|
|
|
2,973
|
|
|
|
3,457
|
|
|
|
4,037
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Adjusted weighted average common shares outstanding
|
|
|
17,470
|
|
|
|
16,823
|
|
|
|
17,505
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted net income per common share
|
|
$
|
1.17
|
|
|
$
|
1.34
|
|
|
$
|
1.05
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
Fully diluted share amounts include unvested shares subject to
the Companys repurchase right, which total 22, 302 and
432 shares at December 31, 2007, 2006 and 2005,
respectively. Upon the effectiveness of the |
95
THE
ENSIGN GROUP, INC.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
|
|
|
|
|
Companys IPO, approximately 146 unvested exercised shares,
granted prior to 2006, under the 2001 Plan (defined below)
immediately vested. See notes 13 and 15 below for further
discussion. |
|
|
4.
|
Revenue
and Accounts Receivable
|
Revenue for the years ended December 31, 2007, 2006 and
2005, respectively, is summarized in the following tables:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2007
|
|
|
2006
|
|
|
2005
|
|
|
|
|
|
|
% of
|
|
|
|
|
|
% of
|
|
|
|
|
|
% of
|
|
|
|
Revenue
|
|
|
Revenue
|
|
|
Revenue
|
|
|
Revenue
|
|
|
Revenue
|
|
|
Revenue
|
|
|
Medicaid
|
|
$
|
182,790
|
|
|
|
44.4
|
%
|
|
$
|
151,264
|
|
|
|
42.2
|
%
|
|
$
|
131,327
|
|
|
|
43.7
|
%
|
Medicare
|
|
|
123,170
|
|
|
|
30.0
|
|
|
|
117,511
|
|
|
|
32.8
|
|
|
|
96,208
|
|
|
|
32.0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Medicaid and Medicare
|
|
|
305,960
|
|
|
|
74.4
|
|
|
|
268,775
|
|
|
|
75.0
|
|
|
|
227,535
|
|
|
|
75.7
|
|
Managed care
|
|
|
52,779
|
|
|
|
12.8
|
|
|
|
44,487
|
|
|
|
12.4
|
|
|
|
33,484
|
|
|
|
11.1
|
|
Private and other payors
|
|
|
52,579
|
|
|
|
12.8
|
|
|
|
45,312
|
|
|
|
12.6
|
|
|
|
39,831
|
|
|
|
13.2
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenue
|
|
$
|
411,318
|
|
|
|
100.0
|
%
|
|
$
|
358,574
|
|
|
|
100.0
|
%
|
|
$
|
300,850
|
|
|
|
100.0
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2007
|
|
|
2006
|
|
|
Medicaid
|
|
$
|
20,842
|
|
|
$
|
22,534
|
|
Managed care
|
|
|
14,821
|
|
|
|
12,972
|
|
Medicare
|
|
|
14,521
|
|
|
|
11,974
|
|
Private and other payors
|
|
|
7,885
|
|
|
|
5,348
|
|
|
|
|
|
|
|
|
|
|
|
|
|
58,069
|
|
|
|
52,828
|
|
Less allowance for doubtful accounts
|
|
|
(7,454
|
)
|
|
|
(7,543
|
)
|
|
|
|
|
|
|
|
|
|
Accounts receivable
|
|
$
|
50,615
|
|
|
$
|
45,285
|
|
|
|
|
|
|
|
|
|
|
The Companys acquisition policy is to purchase and lease
facilities to complement the Companys existing portfolio
of long-term care facilities. The operations of all the
Companys facilities are included in the accompanying
consolidated financial statements subsequent to the date of
acquisition. Acquisitions are typically paid for in cash and are
accounted for using the purchase method of accounting in
accordance with SFAS 141. Where the Company enters into
facility operating lease agreements, the Company typically does
not pay any material amount to the prior facility operator nor
does the Company acquire any assets or assume any liabilities,
other than rights and obligations under the operating lease and
operations transfer agreement, as part of the transaction. Some
operating leases include options to purchase the facilities. As
a result, from time to time, the Company will acquire facilities
that the Company has been operating under third-party leases.
During the year ended December 31, 2007, the Company
acquired four facilities. The aggregate purchase price of three
of the four acquisitions was $9,452, which was entirely paid in
cash. The Company acquired the other facility pursuant to a
long-term operating lease arrangement between the Company and
the real property owner of the facility at prevailing fair
market lease rates. In this transaction, the Company assumed
ownership
96
THE
ENSIGN GROUP, INC.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
of the skilled nursing operating business at this facility for
no material monetary consideration. The facilities acquired
during the year ended December 31, 2007 are as follows:
|
|
|
|
|
In February 2007, the Company purchased a skilled nursing
facility in Salt Lake City, Utah, adding an additional 120
licensed beds(1);
|
|
|
|
In March 2007, the Company purchased a skilled nursing facility
in Lewisville, Texas adding an additional 120 licensed beds(1);
|
|
|
|
In March 2007, the Company purchased a skilled nursing facility
in Mesquite, Texas adding an additional 162 licensed
beds(1); and
|
|
|
|
In July 2007, the Company entered into an operating lease and
assumed the operations of a skilled nursing facility which is
also licensed for assisted living services, in Draper, Utah
adding an additional 106 beds.(1) No additional material
consideration was paid and the Company did not purchase any
assets or assume any liabilities, other than the Companys
rights and obligations under the operating lease and operations
transfer agreement, as part of this transaction. The Company
also simultaneously entered into a separate contract with the
property owner to purchase the underlying property for $3,000,
pending the property owners resolution of certain boundary
line issues with neighboring property owners. As of
December 31, 2007, these boundary line issues were not yet
resolved.
|
|
|
|
(1) |
|
All bed counts are licensed beds and may not reflect the number
of beds actually available for patient use. |
Goodwill recognized in these transactions amounted to $810,
which is expected to be fully deductible for tax purposes. The
Company recognized $33 in other intangible assets.
Additionally, during the year ended December 31, 2007, the
Company purchased the underlying assets of four facilities that
it was operating under long-term lease arrangements. The
aggregate purchase price of these facilities was $16,217, which
was entirely paid in cash. The cash outflow related to these
purchases is included in the purchase of property and equipment
under cash flows from investing activities in the consolidated
statements of cash flows.
The purchase prices in the above transactions were allocated to
real property, equipment, intangible assets and goodwill based
on the following valuation techniques:
|
|
|
|
|
The fair value of land, buildings and improvements and
equipment, furniture and fixtures (or tangible assets) was
determined utilizing a cost approach. In the cost approach, the
subject property is valued based upon the fair value of the
land, as if vacant, by comparing recent sales or asking prices
for similar land, to which the depreciated replacement cost of
the building and improvements and equipment is added. The
replacement cost of the building and improvements and equipment
is adjusted for accrued depreciation resulting from physical
deterioration, functional obsolescence and external or economic
obsolescence.
|
|
|
|
The customer base was valued under an income capitalization
approach using an excess earnings method. Excess earnings are
the earnings remaining after deducting the market rates of
return on the estimated values of contributory assets including
debt-free net working capital, tangible and intangible assets.
The excess earnings are thereby calculated and discounted to a
present value. The primary components of this method consist of
the determination of excess earnings and an appropriate rate of
return. To arrive at the excess earnings attributable to an
intangible asset, earnings after taxes derived from that asset
are projected. Thereafter, the returns on contributory debt-free
net working capital, tangible and intangible assets are deducted
from the earnings projections. After deducting returns on these
contributory assets, the remaining earnings are attributable to
the customer base. These remaining, or excess, earnings are then
discounted to a present value utilizing an appropriate discount
rate for the asset.
|
97
THE
ENSIGN GROUP, INC.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
|
|
|
|
|
Goodwill is calculated as the value that remains after
subtracting the net asset value and the value of identifiable
tangible and intangible assets and liabilities for the
respective purchase.
|
The table below presents the allocation of the purchase price
for the facilities acquired in business combinations during the
years ended December 31, 2007 and 2006:
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2007
|
|
|
2006
|
|
|
Land
|
|
$
|
2,391
|
|
|
$
|
5,782
|
|
Building and improvements
|
|
|
5,675
|
|
|
|
21,863
|
|
Equipment, furniture, and fixtures
|
|
|
543
|
|
|
|
1,168
|
|
Goodwill
|
|
|
810
|
|
|
|
2,072
|
|
Tradename and customer base intangible assets
|
|
|
33
|
|
|
|
180
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
9,452
|
|
|
$
|
31,065
|
|
|
|
|
|
|
|
|
|
|
The Companys acquisition strategy has been focused on
identifying both opportunistic and strategic acquisitions within
its target markets that offer strong opportunities for return on
invested capital. The facilities acquired by the Company are
frequently underperforming financially and can have regulatory
and clinical challenges to overcome. Financial information,
especially with underperforming facilities, is often inadequate,
inaccurate or unavailable. Consequently, the Company believes
that prior operating results are not meaningful and may be
misleading as the information is not representative of the
Companys current operating results or indicative of the
integration potential of its newly acquired facilities.
The four businesses acquired during the year ended
December 31, 2007 were not material acquisitions to the
Company, individually or in the aggregate. These acquisitions
have been included in the December 31, 2007 consolidated
balance sheet of the Company and the operating results have been
included in the consolidated statement of income of the Company
since the date the Company gained effective control. In addition
to the four businesses acquired during the year ended
December 31, 2007, four facilities that were previously
leased by the Company were purchased from the landlord and the
lease was terminated. Therefore, the assets acquired have been
included in the December 31, 2007 consolidated balance
sheet and the operating results have been included in the
consolidated statement of income since the inception of the
lease. Accordingly, pro forma financial information is not
presented for the year ended December 31, 2007.
|
|
6.
|
Property
and Equipment
|
Property and equipment are initially recorded at their original
historical cost. Repairs and maintenance are expensed as
incurred. Depreciation is computed using the straight-line
method over the estimated useful lives of the depreciable assets
(ranging from 3 to 30 years). Leasehold improvements are
amortized on a straight-line basis over the shorter of their
estimated useful lives or the remaining lease term.
98
THE
ENSIGN GROUP, INC.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
Property and equipment consists of the following:
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2007
|
|
|
2006
|
|
|
Land
|
|
$
|
26,107
|
|
|
$
|
17,265
|
|
Buildings and improvements
|
|
|
76,262
|
|
|
|
56,927
|
|
Equipment
|
|
|
17,801
|
|
|
|
11,818
|
|
Furniture and fixtures
|
|
|
6,414
|
|
|
|
3,761
|
|
Leasehold improvements
|
|
|
10,771
|
|
|
|
7,363
|
|
Construction in progress
|
|
|
4,050
|
|
|
|
135
|
|
|
|
|
|
|
|
|
|
|
|
|
|
141,405
|
|
|
|
97,269
|
|
Less accumulated depreciation
|
|
|
(16,544
|
)
|
|
|
(10,136
|
)
|
|
|
|
|
|
|
|
|
|
Property and equipment, net
|
|
$
|
124,861
|
|
|
$
|
87,133
|
|
|
|
|
|
|
|
|
|
|
|
|
7.
|
Intangible
Assets, Net
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
Weighted
|
|
|
2007
|
|
|
2006
|
|
|
|
Average
|
|
|
Gross
|
|
|
|
|
|
|
|
|
Gross
|
|
|
|
|
|
|
|
|
|
Life
|
|
|
Carrying
|
|
|
Accumulated
|
|
|
|
|
|
Carrying
|
|
|
Accumulated
|
|
|
|
|
Intangible Assets
|
|
(Years)
|
|
|
Amount
|
|
|
Amortization
|
|
|
Net
|
|
|
Amount
|
|
|
Amortization
|
|
|
Net
|
|
|
Debt issuance costs
|
|
|
9.3
|
|
|
$
|
1,808
|
|
|
$
|
(687
|
)
|
|
$
|
1,121
|
|
|
$
|
1,744
|
|
|
$
|
(504
|
)
|
|
$
|
1,240
|
|
Lease acquisition costs
|
|
|
15.5
|
|
|
|
1,071
|
|
|
|
(541
|
)
|
|
|
530
|
|
|
|
1,063
|
|
|
|
(398
|
)
|
|
|
665
|
|
Customer base
|
|
|
0.3
|
|
|
|
213
|
|
|
|
(213
|
)
|
|
|
|
|
|
|
180
|
|
|
|
(136
|
)
|
|
|
44
|
|
Tradename
|
|
|
30.0
|
|
|
|
733
|
|
|
|
(49
|
)
|
|
|
684
|
|
|
|
733
|
|
|
|
(23
|
)
|
|
|
710
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
|
|
|
$
|
3,825
|
|
|
$
|
(1,490
|
)
|
|
$
|
2,335
|
|
|
$
|
3,720
|
|
|
$
|
(1,061
|
)
|
|
$
|
2,659
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Amortization expense was $429, $470 and $359 for the years ended
December 31, 2007, 2006 and 2005, respectively. Estimated
amortization expense for each of the periods ending December 31
is as follows:
|
|
|
|
|
Year
|
|
Amount
|
|
|
2008
|
|
$
|
221
|
|
2009
|
|
|
198
|
|
2010
|
|
|
198
|
|
2011
|
|
|
197
|
|
2012
|
|
|
195
|
|
Thereafter
|
|
|
1,326
|
|
|
|
|
|
|
|
|
$
|
2,335
|
|
|
|
|
|
|
Goodwill
Pursuant to SFAS No. 142, the Company performed its
annual goodwill impairment analysis on December 31, 2007
for each reporting unit that constitutes a business for which
discrete financial information is produced and reviewed by
operating segment management and provides services that are
distinct from the other components of the operating segment. The
Company determines impairment by comparing the net assets of
each reporting unit to their respective fair values. The Company
determines the estimated fair value of each reporting unit using
a discounted cash flow analysis. In the event a units net
assets exceed its fair value, an implied fair value of goodwill
must be determined by assigning the units fair value to
each asset and liability of the unit. The excess of the fair
value of the reporting unit over the amounts assigned to its
assets and
99
THE
ENSIGN GROUP, INC.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
liabilities is the implied fair value of goodwill. An impairment
loss is measured by the difference between the goodwill carrying
value and the implied fair value. Based on the analysis
performed, the Company recorded no goodwill impairment for the
years ended December 31, 2007, 2006 or 2005.
|
|
8.
|
Restricted
and Other Assets
|
Restricted and other assets consist primarily of capital
reserves and deposits. Capital reserves are maintained as part
of the mortgage agreements of the Company and certain of its
landlords with the U.S. Department of Housing and Urban
Development. These capital reserves are restricted for capital
improvements and repairs to the related facilities.
Restricted and other assets consists of the following:
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2007
|
|
|
2006
|
|
|
Deposits with landlords
|
|
$
|
1,001
|
|
|
$
|
1,001
|
|
Capital improvement reserves with landlords and lenders
|
|
|
2,244
|
|
|
|
1,562
|
|
Other
|
|
|
28
|
|
|
|
55
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
3,273
|
|
|
$
|
2,618
|
|
|
|
|
|
|
|
|
|
|
|
|
9.
|
Other
Accrued Liabilities
|
Other accrued liabilities consists of the following:
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2007
|
|
|
2006
|
|
|
Quality assurance fee
|
|
$
|
1,853
|
|
|
$
|
1,863
|
|
Resident refunds payable
|
|
|
1,767
|
|
|
|
1,736
|
|
Deferred resident revenue
|
|
|
1,745
|
|
|
|
1,370
|
|
Cash held in trust for residents
|
|
|
1,152
|
|
|
|
1,070
|
|
Claim settlement
|
|
|
|
|
|
|
1,000
|
|
Dividends payable
|
|
|
819
|
|
|
|
657
|
|
Income taxes payable
|
|
|
|
|
|
|
1,885
|
|
Property taxes
|
|
|
838
|
|
|
|
638
|
|
Other
|
|
|
2,963
|
|
|
|
1,887
|
|
|
|
|
|
|
|
|
|
|
Other accrued liabilities
|
|
$
|
11,137
|
|
|
$
|
12,106
|
|
|
|
|
|
|
|
|
|
|
Quality assurance fee represents amounts payable to the State of
California in respect of a mandated fee based on resident days.
Resident refunds payable includes amounts due to residents for
overpayments and duplicate payments. Deferred resident revenue
occurs when the Company receives payments in advance of services
provided. Cash held in trust for residents reflects monies
received from, or on behalf of, residents. Maintaining a trust
account for residents is a regulatory requirement and, while the
trust assets offset the liability, the Company assumes a
fiduciary responsibility for these funds. The cash balance
related to this liability is included in other current assets in
the accompanying consolidated balance sheets.
100
THE
ENSIGN GROUP, INC.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
The provision for income taxes for the years ended
December 31, 2007, 2006 and 2005 is summarized as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2007
|
|
|
2006
|
|
|
2005
|
|
|
Current:
|
|
|
|
|
|
|
|
|
|
|
|
|
Federal
|
|
$
|
10,212
|
|
|
$
|
15,960
|
|
|
$
|
13,328
|
|
State
|
|
|
1,694
|
|
|
|
2,592
|
|
|
|
2,639
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
11,906
|
|
|
|
18,552
|
|
|
|
15,967
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Deferred:
|
|
|
|
|
|
|
|
|
|
|
|
|
Federal
|
|
|
840
|
|
|
|
(3,565
|
)
|
|
|
(3,395
|
)
|
State
|
|
|
159
|
|
|
|
(862
|
)
|
|
|
(518
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
999
|
|
|
|
(4,427
|
)
|
|
|
(3,913
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Benefit for FIN 48 uncertainties
|
|
|
(88
|
)
|
|
|
|
|
|
|
|
|
Interest income, gross of related tax effects
|
|
|
(123
|
)
|
|
|
|
|
|
|
|
|
Interest expense, gross of related tax effects
|
|
|
150
|
|
|
|
|
|
|
|
|
|
Tax benefits credited to paid-in capital
|
|
|
61
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
12,905
|
|
|
$
|
14,125
|
|
|
$
|
12,054
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
A reconciliation of the federal statutory rate to the effective
tax rate for the years ended December 31, 2007, 2006 and
2005, respectively, is comprised as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2007
|
|
|
2006
|
|
|
2005
|
|
|
Income tax expense at statutory rate
|
|
|
35.0
|
%
|
|
|
35.0
|
%
|
|
|
35.0
|
%
|
State income taxes net of federal benefit
|
|
|
3.6
|
|
|
|
3.1
|
|
|
|
4.5
|
|
Non-deductible expenses
|
|
|
0.4
|
|
|
|
0.1
|
|
|
|
0.1
|
|
FIN 48 uncertainties
|
|
|
(0.3
|
)
|
|
|
|
|
|
|
|
|
Net interest expense
|
|
|
0.1
|
|
|
|
|
|
|
|
|
|
Other adjustments
|
|
|
(0.2
|
)
|
|
|
0.3
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total income tax provision
|
|
|
38.6
|
%
|
|
|
38.5
|
%
|
|
|
39.6
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
101
THE
ENSIGN GROUP, INC.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
The Companys deferred tax assets and liabilities as of
December 31, 2007 and 2006 are summarized as follows:
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2007
|
|
|
2006
|
|
|
Deferred tax assets (liabilities):
|
|
|
|
|
|
|
|
|
Accrued expenses
|
|
$
|
9,243
|
|
|
$
|
9,563
|
|
Allowance for doubtful accounts
|
|
|
3,161
|
|
|
|
3,228
|
|
State taxes
|
|
|
|
|
|
|
235
|
|
Tax credits
|
|
|
1,103
|
|
|
|
622
|
|
|
|
|
|
|
|
|
|
|
Total deferred tax assets
|
|
|
13,507
|
|
|
|
13,648
|
|
State taxes
|
|
|
(199
|
)
|
|
|
|
|
Depreciation and amortization
|
|
|
(563
|
)
|
|
|
(413
|
)
|
Prepaid expenses
|
|
|
(1,018
|
)
|
|
|
(677
|
)
|
|
|
|
|
|
|
|
|
|
Total deferred tax liabilities
|
|
|
(1,780
|
)
|
|
|
(1,090
|
)
|
|
|
|
|
|
|
|
|
|
Net deferred tax assets
|
|
$
|
11,727
|
|
|
$
|
12,558
|
|
|
|
|
|
|
|
|
|
|
The Company had state credit carryforwards as of
December 31, 2007 and 2006 of $1,103 and $622,
respectively. These carryforwards primarily related to state
limitations on the application of Enterprise Zone employment
related tax credits. These Enterprise Zone credits are expected
to carryforward indefinitely and may be used to offset future
state income tax. The remainder of these carryforwards relate to
credits against the Texas margin tax and is expected to
carryforward until 2027.
The Company adopted FIN 48 effective January 1, 2007
and, as of the date of adoption, had a net amount of
unrecognized tax detriments of $36, exclusive of accrued
interest. This total consisted of $234 of unrecognized tax
benefits for permanent differences (as defined by
SFAS 109) and other items, net of $270 of unrecognized
tax detriments from temporary differences (as defined by
SFAS 109), which resulted in additional deferred tax
liability. A reconciliation of the beginning and ending amount
of unrecognized tax benefits at December 31, 2007 is as
follows:
|
|
|
|
|
Unrecognized tax detriment at January 1, 2007
|
|
$
|
(36
|
)
|
Gross increases for tax positions taken in prior years
|
|
|
137
|
|
Gross decreases for tax positions taken in prior years
|
|
|
(145
|
)
|
Gross increases for tax positions taken in the current year
|
|
|
17
|
|
Settlements with taxing authorities
|
|
|
185
|
|
Reductions due to statute lapse
|
|
|
(38
|
)
|
|
|
|
|
|
Unrecognized tax benefit at December 31, 2007
|
|
$
|
120
|
|
|
|
|
|
|
As of January 1, 2007, the Company recorded $340 as an
adjustment, net of the associated tax impact on interest
amounts, to opening retained earnings as a result of the
adoption of FIN 48. Of this total, $188 related to
unrecognized tax benefits and $152 related to accrued interest.
As of December 31, 2007, the unrecognized tax benefits, net
of their state tax benefits, that would affect the
Companys effective tax rate was $44.
The Company closed examinations by the Internal Revenue Service
(IRS) for the 2004 and 2005 income tax years and by a major
state tax jurisdiction for the 2003, 2004 and 2005 income tax
years. The Company settled with both the IRS and the major tax
jurisdiction on all outstanding requests for a net refund of
tax.
102
THE
ENSIGN GROUP, INC.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
Because the Company contemplated certain of the favorable
examination adjustments in its beginning unrecognized tax
detriment, the settlement of these items resulted in the
recognition of the tax detriments and an increase to the
Companys unrecognized tax benefits.
The Federal statute of limitations on the Companys 2003
income tax year lapsed in the third quarter of 2007, which
resulted in a reduction in unrecognized tax benefits of $38 for
uncertain tax positions. In 2008, the statute of limitations
will lapse on the Companys 2003 and 2004 income tax years
for state and Federal purposes, respectively; however, the
Company does not believe this lapse will significantly impact
unrecognized tax benefits for any uncertain tax positions. The
Company is not aware of any other event that might significantly
impact the balance of unrecognized tax benefits in the next
twelve months.
The Company has historically classified interest
and/or
penalties on income tax liabilities or refunds as additional
income tax expense or income and will continue to do so with the
adoption of FIN 48. As of the adoption date of FIN 48,
the Company recorded total accrued interest and penalties, gross
of related tax benefit, of $253. For 2007, the Company reported
$123 of interest income and $150 of interest expense, gross of
related tax benefit, in the statement of income. As of
December 31, 2007, the total amount of accrued interest and
penalties in the Companys consolidated balance sheet was
$298.
The Company leases certain facilities and its administrative
offices under non-cancelable operating leases, most of which
have initial lease terms ranging from five to 20 years. The
Company also leases certain of its equipment under
non-cancelable operating leases with initial terms ranging from
three to five years. Most of these leases contain renewal
options, certain of which involve rent increases. Total rent
expense, inclusive of straight-line rent adjustments, was
$16,972, $16,701 and $16,406 for the years ended
December 31, 2007, 2006 and 2005, respectively.
Minimum lease payments for all leases as of December 31,
2007 are as follows:
|
|
|
|
|
Year
|
|
Amount
|
|
|
2008
|
|
$
|
16,810
|
|
2009
|
|
|
16,508
|
|
2010
|
|
|
15,019
|
|
2011
|
|
|
14,793
|
|
2012
|
|
|
14,585
|
|
Thereafter
|
|
|
74,294
|
|
|
|
|
|
|
|
|
$
|
152,009
|
|
|
|
|
|
|
Six of the Companys facilities are operated under master
lease arrangements and a breach at a single facility could
subject multiple facilities covered by the same master lease to
the same default risk. Under a master lease, the Company may
lease a large number of geographically dispersed properties
through an indivisible lease. Failure to comply with Medicare or
Medicaid provider requirements is a default under several of the
Companys master lease agreements and debt financing
instruments. In addition, other potential defaults related to an
individual facility may cause a default of an entire master
lease portfolio and could trigger cross-default provisions in
the Companys outstanding debt arrangements and other
leases. With an indivisible lease, it is difficult to
restructure the composition of the portfolio or economic terms
of the lease without the consent of the landlord. In addition, a
number of the Companys individual facility leases are held
by the same or related landlords, and some of these leases
include cross-default provisions that could cause a default at
one facility to trigger a technical default with respect to
others, potentially subjecting certain leases and facilities to
the various remedies available to the landlords under separate
but cross-defaulted leases. The Company is not aware of any
defaults as of December 31, 2007.
103
THE
ENSIGN GROUP, INC.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
The Company has an Amended and Restated Loan and Security
Agreement, as amended (the Revolver) with General Electric
Capital Corporation (the Lender) under which the Company may
borrow up to the lesser of $20,000 or 85% of qualified accounts
receivable, as defined. Revolver borrowings bear interest at an
annual rate of prime plus 1%. The Revolver contains typical
representations and covenants for a loan of this type. A
violation of any of these covenants could result in a default
under the Revolver, which would result in all amounts owed by
the Company, including possibly amounts due under the Third
Amended and Restated Loan Agreement (the Term Loan) with the
Lender discussed below, to become immediately due and payable
upon receipt of notice. The Company was in compliance with all
covenants as of December 31, 2007. At December 31,
2007 and 2006, there were no outstanding borrowings under the
Revolver and $8,449 of borrowing capacity was pledged to secure
outstanding letters of credit in the same periods. The Revolver
was set to mature in March 2007 but was extended until
February 22, 2008.
On February 21, 2008, the Company amended the Revolver by
extending the term to 2012, increasing the available credit
thereunder up to the lesser of $50,000 or 85% of the eligible
accounts receivable, and changing the interest rate for all or
any portion of the outstanding indebtedness thereunder to any of
three options, as the Company may elect from time to time,
(i) the one, two, three or six month LIBOR (at the
Companys option) plus 2.5%, or (ii) the greater of
(a) prime plus 1.0% or (b) the federal funds rate plus
1.5% or (iii) a floating LIBOR rate. The signed agreement
is contingent on final execution and delivery of appropriate
amendatory documentation. The Revolver contains typical
representations and financial and non-financial covenants for a
loan of this type, a violation of which could result in a
default under the Revolver and could possibly cause the entire
amount outstanding, under the Revolver and all amounts owed by
the Company, including amounts due under the Term Loan, to be
declared immediately due and payable.
Long-term debt consists of the following:
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2007
|
|
|
2006
|
|
|
Term Loan with the Lender, multiple-advance term loan, principal
and interest payable monthly; interest is fixed at time of draw
at 10-year
treasury note rate plus 2.25% (rates in effect at
December 31, 2007 range from 6.95% to 7.50%), balance due
June 2016, collateralized by deeds of trust on real property,
assignments of rents, security agreements and fixture financing
statements
|
|
$
|
54,929
|
|
|
$
|
55,653
|
|
Mortgage note, principal, and interest of $54 payable monthly
and continuing through February 2027, interest at fixed rate of
7.5%, collateralized by deed of trust on real property,
assignment of rents and security agreement
|
|
|
6,612
|
|
|
|
6,774
|
|
Mortgage note, principal, and interest of $18 payable monthly
and continuing through September 2008, interest at fixed rate of
7.49%, collateralized by a deed of trust and security agreement
and an assignment of rents
|
|
|
2,029
|
|
|
|
2,094
|
|
Notes payable, principal and interest payable monthly at fixed
rate of 6.9%, balance due November 2008, collateralized by
equipment
|
|
|
|
|
|
|
7
|
|
|
|
|
|
|
|
|
|
|
|
|
|
63,570
|
|
|
|
64,528
|
|
Less current maturities
|
|
|
(2,993
|
)
|
|
|
(941
|
)
|
|
|
|
|
|
|
|
|
|
|
|
$
|
60,577
|
|
|
$
|
63,587
|
|
|
|
|
|
|
|
|
|
|
Under the Term Loan, the Company is subject to standard
reporting requirements and other typical covenants for a loan of
this type. Effective October 1, 2006 and continuing each
calendar quarter thereafter, the Company is subject to
restrictive financial covenants, including occupancy,
restrictions on capital expenditures, Fixed Charge Coverage (as
defined in the agreement) and Net Worth (as defined in the
agreement). Under the Revolver the Company is subject to typical
representations and financial and non-
104
THE
ENSIGN GROUP, INC.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
financial covenants for a loan of this type, a violation of
which could result in a default under the Revolver and could
possibly cause all amounts owed by the Company, including
amounts due under the Term Loan, to be declared immediately due
and payable. As of December 31, 2007 and 2006, the Company
was in compliance with such loan covenants.
Long-term debt matures in fiscal years ending after
December 31, 2007 as follows:
|
|
|
|
|
Years Ending December 31,
|
|
Amount
|
|
|
2008
|
|
$
|
2,993
|
|
2009
|
|
|
1,075
|
|
2010
|
|
|
1,158
|
|
2011
|
|
|
1,246
|
|
2012
|
|
|
1,330
|
|
Thereafter
|
|
|
55,768
|
|
|
|
|
|
|
|
|
$
|
63,570
|
|
|
|
|
|
|
Series A Preferred Stock The Company
issued shares of Series A preferred stock in 2000 in
conjunction with the cancellation of $2,330 of debt at a
purchase price of $3.40 per share. These shares were convertible
on a four-to-one basis, at the holders option into shares
of common stock with the conversion rate determined by dividing
$3.40 by the then current Series A conversion price ($0.85
per share as of December 31, 2006 and November 8,
2007). The conversion was automatic in certain circumstances,
including a public offering of the Companys common stock.
On November 8, 2007, in connection with the closing of the
Companys IPO, all previously outstanding shares of
Series A preferred stock converted into 2,741 shares
of the Companys common stock.
Redemption Rights The holder of the
Series A preferred stock did not exercise its redemption
option, which expired 90 days after the Company delivered
its audited financial statements for fiscal 2003. The redemption
option required the Company to redeem all (but not less than
all) of such holders Series A preferred stock for the
conversion price then in effect of the redeeming holders
shares of Series A preferred stock, plus accumulated but
unpaid declared dividends, plus any premium due thereon, if
exercised. Additionally, if, by December 31, 2010, the
Company had not completed a public offering, as defined, the
holder of Series A preferred stock shall have the option,
for a 90-day
period (beginning on the date that the Company delivers its
audited financial statements for fiscal 2010), to require the
Company to redeem all (but not less than all) of such
holders Series A preferred stock for the conversion
price then in effect of the redeeming holders shares of
Series A preferred stock, plus (i) accumulated but
unpaid declared dividends, plus (ii) an amount equal to the
greater of (a) cash in the amount of $1.43 per share for
each of such redeeming holders shares of Series A
preferred stock (adjusted to reflect stock dividends, stock
splits, recapitalizations, or similar transactions affecting the
outstanding Series A preferred stock) or (b) a
per-share amount for each of such redeeming holders shares
of Series A preferred stock (on an as-if-converted basis)
equal to the aggregate amount of cash dividends declared for
each share of common stock into which each share of
Series A preferred stock being redeemed could then be
converted, less (iii) the actual amount of any dividends
paid prior to the redemption.
The Companys policy is to pay declared dividends in the
month following the month of declaration. The Company does not
have a formal policy with respect to if or when to declare
dividends or the amounts of dividends, but it currently intends
to continue to pay regular quarterly dividends to the holders of
its common
105
THE
ENSIGN GROUP, INC.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
stock. The payment of dividends is subject to the discretion of
the board of directors and will depend on many factors,
including results of operations, financial condition and capital
requirements, earnings, general business conditions, legal
restrictions on the payment of dividends and other factors the
board of directors deems relevant. The Revolver restricts the
Companys ability to pay dividends to shareholders if it
receives notice that it is in default under this agreement. At
December 31, 2007, 2006 and 2005, declared but unpaid
preferred and common stock dividends totaled approximately $819,
$657 and $500, respectively, which were included in other
accrued liabilities.
Dividends declared for the years ended December 31, 2007,
2006 and 2005, respectively, were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31,
|
|
|
|
2007
|
|
|
2006
|
|
|
2005
|
|
|
Preferred stock
|
|
$
|
329
|
|
|
$
|
356
|
|
|
$
|
247
|
|
Common stock
|
|
|
2,463
|
|
|
|
1,776
|
|
|
|
1,255
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
2,792
|
|
|
$
|
2,132
|
|
|
$
|
1,502
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock-based compensation expense recognized under
SFAS 123(R) consists of share-based payment awards made to
employees and directors including employee stock options based
on estimated fair values. Stock-based compensation expense
recognized in the Companys consolidated statements of
income for the years ended December 31, 2007 and 2006 does
not include compensation expense for share- based payment awards
granted prior to, but not yet vested as of January 1, 2006,
in accordance with the provisions of SFAS 123 but does
include compensation expense for the share-based payment awards
granted on or subsequent to January 1, 2006 based on the
grant date fair value estimated in accordance with the adoption
provisions of SFAS 123(R). As stock-based compensation
expense recognized in the Companys consolidated statements
of income for the years ended December 31, 2007 and 2006
was based on awards ultimately expected to vest, it has been
reduced for estimated forfeitures. SFAS 123(R) requires
forfeitures to be estimated at the time of grant and revised, if
necessary, in subsequent periods if actual forfeitures differ
from those estimates.
The Company has three option plans, all of which have been
approved by the stockholders. In the 2001 Plan and 2005 Plan
(defined below), options may be exercised for unvested shares of
common stock, which have full stockholder rights including
voting, dividend and liquidation rights. The Company retains the
right to repurchase any or all unvested shares at the exercise
price paid per share of any or all unvested shares should the
optionee cease to remain in service while holding such unvested
shares.
2001 Stock Option, Deferred Stock and Restricted Stock
Plan The 2001 Stock Option, Deferred Stock and
Restricted Stock Plan (2001 Plan) authorizes the sale of up to
1,980 shares of common stock to officers, employees,
directors, and consultants of the Company. Granted non-employee
director options vest and become exercisable immediately.
Generally, all other granted options and restricted stock vest
over five years at 20% per year on the anniversary of the grant
date. Options expire ten years from the date of grant. The
exercise price of the stock is determined by the board of
directors, but shall not be less than 100% of the fair value on
the date of grant. Shares issued upon early exercise of options
granted prior to 2006 vested in full upon the consummation of
the Companys IPO, such shares will vest in full upon
exercise. At December 31, 2007 and 2006, there were 247 and
257, respectively, unissued shares of common stock available for
issuance under this plan, including shares that have been
forfeited and are available for reissue.
2005 Stock Incentive Plan The 2005 Stock
Incentive Plan (2005 Plan) authorizes the sale of up to
1,000 shares of treasury stock of which only
800 shares were repurchased and therefore eligible for
reissuance as of December 31, 2007 and 2006, to officers,
employees, directors and consultants of the Company. Options
106
THE
ENSIGN GROUP, INC.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
granted to non-employee directors vest and become exercisable
immediately. All other granted options vest over five years at
20% per year on the anniversary of the grant date. Options
expire ten years from the date of grant. At December 31,
2007 and 2006, there were 112 and 6, respectively, unissued
shares of common stock available for issuance under this plan,
including shares that have been forfeited and are available for
reissue.
2007 Omnibus Incentive Plan The 2007 Omnibus
Incentive Plan (2007 Plan) authorizes the sale of up to
1,000 shares of common stock to officers, employees,
directors and consultants of the Company. In addition, the
number of shares of common stock reserved under the 2007 Plan
will automatically increase on the first day of each fiscal
year, beginning on January 1, 2008, in an amount equal to
the lesser of (i) 1,000 shares of common stock, or
(ii) 2% of the number of shares outstanding as of the last
day of the immediately preceding fiscal year, or (iii) such
lesser number as determined by the Companys board of
directors. Granted non-employee director options vest and become
exercisable in three equal annual installments, or the length of
the term if less than three years, on the completion of each
year of service measured from the grant date. All other granted
options vest over five years at 20% per year on the anniversary
of the grant date. Options expire ten years from the date of
grant. At December 31, 2007, there were 1,000 unissued
shares of common stock available for issuance under this plan.
The Company uses the Black-Scholes option-pricing model to
recognize the value of stock-based compensation expense for all
share-based payment awards. Determining the appropriate
fair-value model and calculating the fair value of stock-based
awards at the grant date requires considerable judgment,
including estimating stock price volatility, expected option
life and forfeiture rates. The Company develops estimates based
on historical data and market information, which can change
significantly over time. The Black-Scholes model required the
Company to make several key judgments including:
|
|
|
|
|
The expected option term reflects the application of the
simplified method set out in
SAB No. 107 Share-Based Payment (SAB 107),
which was issued in March 2005. In December 2007, the SEC
released Staff Accounting Bulletin No. 110
(SAB 110), which extends the use of the
simplified method, under certain circumstances, in
developing an estimate of expected term of plain
vanilla share options. Accordingly, the Company has
utilized the average of the contractual term of the options and
the weighted average vesting period for all options to calculate
the expected option term.
|
|
|
|
Estimated volatility also reflects the application of
SAB 107 interpretive guidance and, accordingly,
incorporates historical volatility of similar public entities
until sufficient information regarding the volatility of the
Companys share price becomes available.
|
|
|
|
The dividend yield is based on the Companys historical
pattern of dividends as well as expected dividend patterns.
|
|
|
|
The risk-free rate is based on the implied yield of
U.S. Treasury notes as of the grant date with a remaining
term approximately equal to the expected term.
|
|
|
|
Estimated forfeiture rate of approximately 8% per year is based
on the Companys historical forfeiture activity of unvested
stock options.
|
No options were granted during the year ended December 31,
2007.
107
THE
ENSIGN GROUP, INC.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
The Company used the following assumptions for stock options
granted during the year ended December 31, 2006:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted
|
|
|
|
|
|
|
|
|
Weighted
|
|
|
|
|
|
|
Average
|
|
|
|
|
|
Weighted
|
|
|
Average
|
|
|
|
Options
|
|
|
Risk-Free
|
|
|
Expected
|
|
|
Average
|
|
|
Dividend
|
|
Plan
|
|
Granted
|
|
|
Rate
|
|
|
Life
|
|
|
Volatility
|
|
|
Yield
|
|
|
2001
|
|
|
286
|
|
|
|
4.9
|
%
|
|
|
6.5 years
|
|
|
|
46
|
%
|
|
|
1.19
|
%
|
2005
|
|
|
400
|
|
|
|
5.0
|
%
|
|
|
6.5 years
|
|
|
|
45
|
%
|
|
|
1.06
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
686
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the year ended December 31, 2006, the following
represent the Companys weighted average exercise price,
grant date intrinsic value and fair value displayed by grant
date:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted
|
|
|
Weighted
|
|
|
Weighted
|
|
|
Weighted
|
|
|
|
|
|
|
|
|
|
Average
|
|
|
Average
|
|
|
Average
|
|
|
Average
|
|
|
|
|
|
|
Options
|
|
|
Exercise
|
|
|
Grant Date
|
|
|
Fair Value
|
|
|
Fair Value of
|
|
Plan
|
|
Grant Date
|
|
|
Granted
|
|
|
Price
|
|
|
Intrinsic Value
|
|
|
of Options
|
|
|
Common Stock
|
|
|
2001
|
|
|
1/17/2006
|
|
|
|
22
|
|
|
$
|
7.05
|
|
|
$
|
0.00
|
|
|
$
|
2.51
|
|
|
$
|
5.96
|
|
|
|
|
7/26/2006
|
|
|
|
264
|
|
|
$
|
7.50
|
|
|
$
|
7.59
|
|
|
$
|
9.69
|
|
|
$
|
15.09
|
|
2005
|
|
|
7/26/2006
|
|
|
|
400
|
|
|
$
|
7.50
|
|
|
$
|
7.59
|
|
|
$
|
9.69
|
|
|
$
|
15.09
|
|
As of December 31, 2006 and 2005, the Company valued its
common stock using a combination of weighted income and market
valuation approaches. The income approach was based on
discounted cash flows. The market approach employed both a
guideline company method and merger and acquisition method.
On July 26, 2006, in a manner generally consistent with
historical valuation and grant practices, the Company granted
options to purchase approximately 664 shares of common
stock to employees. The exercise price was based on a
contemporaneous fair value calculation. Subsequently, a weighted
valuation was performed, which produced a fair value less than
the exercise price. Then, in March 2007, an additional
retrospective weighted valuation was performed. This weighted
valuation took into consideration the possibility of the Company
entering the public marketplace in 2007. This re-measurement
resulted in the adjusted fair value exceeding the exercise
price. As a result of the finalized valuations and the adoption
of SFAS 123(R), the Company recorded aggregate compensation
expense of approximately $1,468 and $443 during the years ended
December 31, 2007 and 2006, respectively.
108
THE
ENSIGN GROUP, INC.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
The following table represents the employee stock option
activity during the year ended December 31, 2007:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted
|
|
|
Number of
|
|
|
Weighted
|
|
|
|
Number of
|
|
|
Average
|
|
|
Shares
|
|
|
Average
|
|
|
|
Shares
|
|
|
Exercise
|
|
|
Vested and
|
|
|
Exercise
|
|
|
|
Outstanding
|
|
|
Price
|
|
|
Exercisable
|
|
|
Price
|
|
|
December 31, 2004
|
|
|
648
|
|
|
$
|
1.19
|
|
|
|
98
|
|
|
$
|
0.47
|
|
Granted
|
|
|
465
|
|
|
$
|
5.67
|
|
|
|
|
|
|
|
|
|
Forfeitures
|
|
|
(71
|
)
|
|
$
|
1.20
|
|
|
|
|
|
|
|
|
|
Exercised
|
|
|
(254
|
)
|
|
$
|
0.87
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2005
|
|
|
788
|
|
|
$
|
3.94
|
|
|
|
132
|
|
|
$
|
2.21
|
|
Granted
|
|
|
686
|
|
|
$
|
7.48
|
|
|
|
|
|
|
|
|
|
Forfeitures
|
|
|
(46
|
)
|
|
$
|
2.41
|
|
|
|
|
|
|
|
|
|
Exercised
|
|
|
(184
|
)
|
|
$
|
2.48
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2006
|
|
|
1,244
|
|
|
$
|
6.17
|
|
|
|
148
|
|
|
$
|
3.82
|
|
Granted
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Forfeitures
|
|
|
(173
|
)
|
|
$
|
6.03
|
|
|
|
|
|
|
|
|
|
Exercised
|
|
|
(48
|
)
|
|
$
|
6.04
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2007
|
|
|
1,023
|
|
|
$
|
6.19
|
|
|
|
316
|
|
|
$
|
5.25
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The following summary information reflects stock options
outstanding, vesting and related details as of December 31,
2007:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock Options Outstanding
|
|
|
Stock Options Vested
|
|
|
|
|
|
|
|
|
|
Black-
|
|
|
Remaining
|
|
|
Number
|
|
|
|
|
Year of
|
|
Number
|
|
|
Exercise
|
|
|
Scholes Fair
|
|
|
Contractual
|
|
|
Vested and
|
|
|
Exercise
|
|
Grant
|
|
Outstanding
|
|
|
Price
|
|
|
Value
|
|
|
Life (Years)
|
|
|
Exercisable
|
|
|
Price
|
|
|
2003
|
|
|
50
|
|
|
$
|
0.67-0.81
|
|
|
$
|
38
|
|
|
|
6
|
|
|
|
37
|
|
|
$
|
0.67-0.81
|
|
2004
|
|
|
83
|
|
|
$
|
1.95-2.46
|
|
|
|
191
|
|
|
|
7
|
|
|
|
48
|
|
|
$
|
1.95-2.46
|
|
2005
|
|
|
310
|
|
|
$
|
4.99-5.75
|
|
|
|
1,762
|
|
|
|
8
|
|
|
|
115
|
|
|
$
|
4.99-5.75
|
|
2006
|
|
|
580
|
|
|
$
|
7.05-7.50
|
|
|
|
5,516
|
|
|
|
9
|
|
|
|
116
|
|
|
$
|
7.05-7.50
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
1,023
|
|
|
|
|
|
|
$
|
7,507
|
|
|
|
|
|
|
|
316
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The Company recognized $1,468 and $443, respectively, in
compensation expense during the years ended December 31,
2007 and 2006. The Company expects to recognize $567 and $169,
respectively, in tax benefits when the options vest and are
exercised. As of December 31, 2007 and 2006, the total fair
value of shares vested was approximately $1,892 and $567,
respectively.
In future periods, the Company expects to recognize
approximately $3,698 in stock-based compensation expense over
the next 3.2 weighted average years for unvested options that
were outstanding as of December 31, 2007.
There were 707 unvested and outstanding options at
December 31, 2007, of which 576 are expected to vest. The
weighted average contractual life for options vested at
December 31, 2007 was 7.5 years. The weighted average
contractual life for options outstanding at December 31,
2007 was 8 years. In addition, the Company has 22 unvested
exercised shares with a weighted average contractual life of
9 years.
The aggregate intrinsic value of options outstanding, expected
to vest, vested and exercised as of December 31, 2007 was
approximately $8,392, $4,509, $2,890 and $404, respectively. The
aggregate intrinsic
109
THE
ENSIGN GROUP, INC.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
value of options outstanding, expected to vest, vested and
exercised as of December 31, 2006 was approximately
$13,659, $9,107, $1,978, and $2,691, respectively. The intrinsic
value is calculated as the difference between the market value
and the exercise price of the options.
|
|
16.
|
Commitments
and Contingencies
|
Regulatory Matters Laws and regulations
governing Medicare and Medicaid programs are complex and subject
to interpretation. Compliance with such laws and regulations can
be subject to future governmental review and interpretation, as
well as significant regulatory action including fines,
penalties, and exclusion from certain governmental programs. The
Company believes that it is in compliance with all applicable
laws and regulations.
A significant portion of the Companys revenue is derived
from Medicaid and Medicare, for which reimbursement rates are
subject to regulatory changes and government funding
restrictions. Although the Company is not aware of any
significant future rate changes, significant changes to the
reimbursement rates could have a material effect on the
Companys operations.
Cost-Containment Measures Both government and
private pay sources have instituted cost-containment measures
designed to limit payments made to providers of healthcare
services, and there can be no assurance that future measures
designed to limit payments made to providers will not adversely
affect the Company.
Indemnities From time to time, the Company
enters into certain types of contracts that contingently require
the Company to indemnify parties against third-party claims.
These contracts primarily include (i) certain real estate
leases, under which the Company may be required to indemnify
property owners or prior facility operators for post-transfer
environmental or other liabilities and other claims arising from
the Companys use of the applicable premises,
(ii) operations transfer agreements, in which the Company
agrees to indemnify past operators of facilities the Company
acquires against certain liabilities arising from the transfer
of the operation
and/or the
operation thereof after the transfer, (iii) certain lending
agreements, under which the Company may be required to indemnify
the lender against various claims and liabilities,
(iv) agreements with certain lenders under which the
Company may be required to indemnify such lenders against
various claims and liabilities, and (v) certain agreements
with the Companys officers, directors and employees, under
which the Company may be required to indemnify such persons for
liabilities arising out of their employment relationships. The
terms of such obligations vary by contract and, in most
instances, a specific or maximum dollar amount is not explicitly
stated therein. Generally, amounts under these contracts cannot
be reasonably estimated until a specific claim is asserted.
Consequently, because no claims have been asserted, no
liabilities have been recorded for these obligations on the
Companys balance sheets for any of the periods presented.
Litigation The skilled nursing business
involves a significant risk of liability given the age and
health of the Companys patients and residents and the
services the Company provides. The Company and others in the
industry are subject to an increasing number of claims and
lawsuits, including professional liability claims, alleging that
services have resulted in personal injury, elder abuse, wrongful
death or other related claims. The defense of these lawsuits may
result in significant legal costs, regardless of the outcome,
and can result in large settlement amounts or damage awards.
A class action suit was previously filed against the Company
alleging, among other things, violations of applicable
California Health and Safety Code provisions and a violation of
the California Consumer Legal Remedies Act at certain of the
Companys facilities. The Company has received court
approval for its settlement and the obligation to pay has been
capped, not to exceed $3,000. As of December 31, 2006, the
Companys best estimate of the ultimate liability it
believed it would likely be subject to after all payments to
class claimants and related estimated legal expenses was
approximately $1,000. This amount was recorded in accrued other
liabilities in the accompanying condensed consolidated financial
statements as of December 31,
110
THE
ENSIGN GROUP, INC.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
2006. The Company settled this class action suit and the
settlement was approved by the affected class and the court in
April 2007. The ultimate amount of legal expenses and claims was
approximately $1,100, which was paid as of June 30, 2007.
In addition to the class action, professional liability and
other types of lawsuits and claims described above, the Company
is also subject to potential lawsuits under the Federal False
Claims Act and comparable state laws alleging submission of
fraudulent claims for services to any healthcare program (such
as Medicare) or payor. A violation may provide the basis for
exclusion from federally-funded healthcare programs. Such
exclusions could have a correlative negative impact on the
Companys financial performance. Some states, including
California, Arizona and Texas, have enacted similar
whistleblower and false claims laws and regulations. In
addition, the Deficit Reduction Act of 2005 created incentives
for states to enact anti-fraud legislation modeled on the
Federal False Claims Act. As such, the Company could face
increased scrutiny, potential liability and legal expenses and
costs based on claims under state false claims acts in markets
in which it does business.
On June 5, 2006, a complaint was filed against the Company
in the Superior Court of the State of California for the County
of Los Angeles, purportedly on behalf of the United States,
claiming that the Company violated the Medicare Secondary Payer
Act. In the complaint, the plaintiff alleged that the Company
has inappropriately received and retained reimbursement from
Medicare for treatment given to certain unidentified patients
and residents of its facilities whose injuries were caused by
the Company as a result of unidentified and unadjudicated
incidents of medical malpractice. The plaintiff in this action
is seeking damages of twice the amount that the Company was
allegedly obligated to pay or reimburse to Medicare in
connection with the treatment in question under the Medicare
Secondary Payer Act, plus interest, together with
plaintiffs costs and fees, including attorneys fees.
The plaintiffs case was dismissed in the Companys
favor by the trial court, and the dismissal is currently on
appeal. At this time the loss or possible range of loss is not
estimable or probable; accordingly, the Company has not recorded
an accrual for this matter.
The Company has been, and continues to be, subject to claims and
legal actions that arise in the ordinary course of business
including potential claims related to care and treatment
provided at its facilities, as well as employment related
claims. The Company does not believe that the ultimate
resolution of these actions will have a material adverse effect
on the Companys financial business, financial condition
or, results of operations. A significant increase in the number
of these claims or an increase in amounts owing under successful
claims could materially adversely affect the Companys
business, financial condition, results of operations and cash
flows.
Medicare Revenue Recoupments The Company is
subject to reviews relating to Medicare services, billings and
potential overpayments. Recent probe reviews resulted in
Medicare revenue recoupment, net of appeal recoveries, to the
federal government and related resident copayments of
approximately $35 during the year ended December 31, 2007.
The Company anticipates that these probe reviews will increase
in frequency in the future. In addition, two of the
Companys facilities are currently on prepayment review,
and others may be placed on prepayment review in the future. If
a facility fails prepayment review, the facility could then be
subject to undergo targeted review, which is a review that
targets perceived claims deficiencies. The Company has no
facilities that are currently undergoing targeted reviews.
Other Matters In March 2007, the Company and
certain of its officers received a series of notices from the
Companys bank indicating that the United States Attorney
(U.S. Attorney) for the Central District of California had
issued an authorized investigative demand, a request for records
similar to a subpoena, to the Companys bank and then
rescinded that demand. This rescinded demand originally
requested documents from the Companys bank related to
financial transactions involving the Company, ten of its
operating subsidiaries, an outside investor group, and certain
of its current and former officers. Subsequently, in June 2007,
the U.S. Attorney sent a letter to one of the
Companys current employees requesting a meeting. The
letter indicated that the U.S. Attorney and the
U.S. Department of Health and Human Services Office of
Inspector
111
THE
ENSIGN GROUP, INC.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
General were conducting an investigation of claims submitted to
the Medicare program for rehabilitation services provided at the
Companys facilities. Although both the Company and the
employee offered to cooperate, the U.S. Attorney later
withdrew its meeting request. From these contacts, the Company
believed that an investigation was underway, but to date the
Company has been unable to determine the exact cause or nature
of the U.S. Attorneys interest in the Company or its
subsidiaries, and until recently the Company has been unable to
even verify whether the investigation was continuing.
On December 17, 2007, the Company was informed by
Deloitte & Touche LLP, the Companys independent
registered public accounting firm that the U.S. Attorney
served a grand jury subpoena on Deloitte & Touche LLP,
relating to the Company and several of its operating
subsidiaries. The subpoena confirmed the Companys
previously reported belief that the U.S. Attorney is
conducting an investigation involving certain of the
Companys operating subsidiaries. Based on these most
recent events, the Company believes that the United States
Government may be conducting parallel criminal, civil and
administrative investigations involving The Ensign Group and one
or more of its skilled nursing facilities. To the Companys
knowledge, however, neither The Ensign Group, Inc. nor any of
its operating subsidiaries or employees has been formally
charged with any wrongdoing, served with any related subpoenas
or requests, or been directly notified of any concerns or
related investigations by the U.S. Attorney or any
government agency. Subsequently, in February 2008, the
U.S. Attorney contacted two additional current employees.
Both the Company and all three of the employees contacted have
offered to cooperate and meet with the U.S. Attorney. While
the Company has no reason to believe that the assertion of
criminal charges, civil claims, administrative sanctions or
whistleblower actions would be warranted, to date the
U.S. Attorneys office has declined to provide the
Company with any specific information with respect to this
matter, other than to confirm that an investigation is ongoing.
The Company continued to request a meeting with the
U.S. Attorney to discuss the grand jury subpoena, the
Companys internal investigation described below, and any
specific allegations or concerns they may have. The Company
cannot predict or provide any assurance as to the possible
outcome of the investigation or any possible related
proceedings, or as to the possible outcome of any qui tam
litigation that may follow, nor can the Company estimate the
possible loss or range of loss that may result from any such
proceedings and, therefore, the Company has not recorded any
related accruals. To the extent the U.S. Attorneys
office elects to pursue this matter, or if the investigation has
been instigated by a qui tam relator who elects to pursue
the matter, the Companys business, financial condition and
results of operations could be materially and adversely affected.
In November 2006, the Company became aware of an allegation of
possible reimbursement irregularities at one or more of its
facilities. That same month, the Company retained outside
counsel and initiated an internal investigation into these
matters. The Company and its outside counsel concluded this
investigation without identifying any systemic patterns or
practices of fraudulent or intentional misconduct. The Company
made observations at certain facilities regarding areas of
potential improvement in some of its recordkeeping and billing
practices and has implemented measures, some of which were
already underway before the investigation began, that it
believes will strengthen recordkeeping and billing processes.
None of these additional findings or observations appears to be
rooted in fraudulent or intentional misconduct. The Company
continues to evaluate the measures implemented for
effectiveness, and is continuing to seek ways to improve these
processes.
As a byproduct of its investigation, the Company identified a
limited number of selected Medicare claims for which adequate
backup documentation could not be located or for which other
billing deficiencies exist. The Company, with the assistance of
independent consultants experienced in Medicare billing,
completed a billing review on these claims. To the extent
missing documentation was not located, the Company treated these
claims as overpayments. Consistent with healthcare industry
accounting practices, the Company records any charge for
refunded payments against revenue in the period in which the
claim adjustment becomes known. During the year ended
December 31, 2007, the Company accrued a liability of
approximately $224, plus interest, for selected Medicare claims
for which documentation had not been located or for other
billing
112
THE
ENSIGN GROUP, INC.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
deficiencies identified to date. The remittance of these claims
started with the Companys filing of its Quarterly Credit
Balance Reports, which were submitted to the Medicare Fiscal
Intermediary on or before January 31, 2008, and will be
completed with the next Quarterly Credit Balance Report which
will be submitted on or before April 30, 2008. If
additional reviews result in identification and quantification
of additional amounts to be refunded, the Company would accrue
additional liabilities for claim costs and interest and repay
any amounts due in normal course. If future investigations
ultimately result in findings of significant billing and
reimbursement noncompliance which could require the Company to
record significant additional provisions or remit payments, the
Companys business, financial condition and results of
operations could be materially and adversely affected.
Concentrations
Credit Risk The Company has significant
accounts receivable balances, the collectibility of which is
dependent on the availability of funds from certain governmental
programs, primarily Medicare and Medicaid. These receivables
represent the only significant concentration of credit risk for
the Company. The Company does not believe there is significant
credit risks associated with these governmental programs. The
Company believes that an adequate allowance has been recorded
for the possibility of these receivables proving uncollectible,
and continually monitors and adjusts these allowances as
necessary. The Companys receivables from Medicare and
Medicaid payor programs accounted for approximately 61% and 65%
of its total accounts receivable as of December 31, 2007
and 2006, respectively. Revenue from reimbursements under the
Medicare and Medicaid programs accounted for approximately 74%,
75% and 76% of the Companys revenue for the years ended
December 31, 2007, 2006 and 2005, respectively.
Cash in Excess of FDIC Limits The Company
currently has bank deposits with a financial institution that
exceed FDIC insurance limits. FDIC insurance provides protection
for bank deposits up to $100.
|
|
17.
|
Defined
Contribution Plan
|
The Company has a 401(k) defined contribution plan (the 401(k)
Plan), whereby eligible employees may contribute up to 15% of
their annual basic earnings. Additionally, the 401(k) Plan
provides for discretionary matching contributions (as defined)
by the Company. The Company contributed, $270, $231 and $196 to
the 401(k) Plan during the years ended December 31, 2007,
2006 and 2005, respectively. Beginning in 2007, the
Companys plan allowed eligible employees to contribute up
to 90% of their eligible compensation, subject to applicable
annual Internal Revenue Code limits.
113
(b) Financial Statement Schedules
THE
ENSIGN GROUP, INC. and SUBSIDIARIES
Schedule II
Valuation
and Qualifying Accounts
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Additions
|
|
|
|
|
|
|
|
|
|
Balance at
|
|
|
Charged
|
|
|
|
|
|
|
|
|
|
Beginning of
|
|
|
to Costs and
|
|
|
|
|
|
Balance at
|
|
|
|
Year
|
|
|
Expenses
|
|
|
Deductions
|
|
|
End of Year
|
|
|
|
(In thousands)
|
|
|
Year Ended December 31, 2005
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Allowance for doubtful accounts
|
|
$
|
(4,213
|
)
|
|
$
|
(3,092
|
)
|
|
$
|
2,346
|
|
|
$
|
(4,959
|
)
|
Year Ended December 31, 2006
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Allowance for doubtful accounts
|
|
$
|
(4,959
|
)
|
|
$
|
(4,191
|
)
|
|
$
|
1,607
|
|
|
$
|
(7,543
|
)
|
Year Ended December 31, 2007
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Allowance for doubtful accounts
|
|
$
|
(7,543
|
)
|
|
$
|
(3,135
|
)
|
|
$
|
3,224
|
|
|
$
|
(7,454
|
)
|
All other schedules have been omitted because the information
required to be set forth therein is not applicable or is shown
in the consolidated financial statements or notes thereto.
114
(c) Exhibit Index
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exhibit
|
|
Filing
|
|
Filed
|
Exhibit No.
|
|
Exhibit Description
|
|
Form
|
|
File No.
|
|
No.
|
|
Date
|
|
Herewith
|
|
|
3
|
.1
|
|
Fifth Amended and Restated Certificate of Incorporation of The
Ensign Group, Inc., filed with the Delaware Secretary of State
on November 15, 2007
|
|
10-Q
|
|
001-33757
|
|
|
3
|
.1
|
|
12/21/07
|
|
|
|
3
|
.3
|
|
Amended and Restated Bylaws of The Ensign Group, Inc.
|
|
10-Q
|
|
001-33757
|
|
|
3
|
.2
|
|
12/21/07
|
|
|
|
4
|
.1
|
|
Specimen common stock certificate
|
|
S-1
|
|
333-142897
|
|
|
4
|
.1
|
|
10/05/07
|
|
|
|
10
|
.1+
|
|
The Ensign Group, Inc. 2001 Stock Option, Deferred Stock and
Restricted Stock Plan, form of Stock Option Grant Notice for
Executive Officers and Directors, stock option agreement and
form of restricted stock agreement for Executive Officers and
Directors
|
|
S-1
|
|
333-142897
|
|
|
10
|
.1
|
|
07/26/07
|
|
|
|
10
|
.2+
|
|
The Ensign Group, Inc. 2005 Stock Incentive Plan, form of
Nonqualified Stock Option Award for Executive Officers and
Directors, and form of restricted stock agreement for Executive
Officers and Directors
|
|
S-1
|
|
333-142897
|
|
|
10
|
.2
|
|
07/26/07
|
|
|
|
10
|
.3+
|
|
The Ensign Group, Inc. 2007 Omnibus Incentive Plan
|
|
S-1
|
|
333-142897
|
|
|
10
|
.3
|
|
10/05/07
|
|
|
|
10
|
.4+
|
|
Form of 2007 Omnibus Incentive Plan Notice of Grant of Stock
Options; and form of Non-Incentive Stock Option Award Terms and
Conditions
|
|
|
|
|
|
|
|
|
|
|
|
X
|
|
10
|
.5+
|
|
Form of 2007 Omnibus Incentive Plan Restricted Stock Agreement
|
|
S-1
|
|
333-142897
|
|
|
10
|
.5
|
|
10/05/07
|
|
|
|
10
|
.6+
|
|
Form of Indemnification Agreement entered into between The
Ensign Group, Inc. and its directors, officers and certain key
employees
|
|
S-1
|
|
333-142897
|
|
|
10
|
.6
|
|
10/05/07
|
|
|
|
10
|
.7
|
|
Third Amended and Restated Loan Agreement, dated as of
December 29, 2006, by and among certain subsidiaries of The
Ensign Group, Inc. as Borrowers, and General Electric Capital
Corporation as Agent and Lender
|
|
S-1
|
|
333-142897
|
|
|
10
|
.7
|
|
05/14/07
|
|
|
|
10
|
.8
|
|
Consolidated, Amended and Restated Promissory Note, dated as of
December 29, 2006, in the original principal amount of
$64,692,111.67, by certain subsidiaries of The Ensign Group,
Inc. in favor of General Electric Capital Corporation
|
|
S-1
|
|
333-142897
|
|
|
10
|
.8
|
|
07/26/07
|
|
|
|
10
|
.9
|
|
Third Amended and Restated Guaranty of Payment and Performance,
dated as of December 29, 2006, by The Ensign Group, Inc. as
Guarantor and General Electric Capital Corporation as Agent and
Lender, under which Guarantor guarantees the payment and
performance of the obligations of certain of Guarantors
subsidiaries under the Third Amended and Restated Loan Agreement
|
|
S-1
|
|
333-142897
|
|
|
10
|
.9
|
|
07/26/07
|
|
|
115
(c) Exhibit
Index
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exhibit
|
|
Filing
|
|
Filed
|
Exhibit No.
|
|
Exhibit Description
|
|
Form
|
|
File No.
|
|
No.
|
|
Date
|
|
Herewith
|
|
|
10
|
.10
|
|
Form of Amended and Restated Deed of Trust, Assignment of Rents,
Security Agreement and Fixture Financing Statement, dated as of
June 30, 2006 (filed against Desert Terrace Nursing Center,
Desert Sky Nursing Home, Highland Manor Health and
Rehabilitation Center and North Mountain Medical and
Rehabilitation Center), by and among Terrace Holdings AZ LLC,
Sky Holdings AZ LLC, Ensign Highland LLC and Valley Health
Holdings LLC as Grantors, Chicago Title Insurance Company
as Trustee, and General Electric Capital Corporation as
Beneficiary and Schedule of Material Differences therein
|
|
S-1
|
|
333-142897
|
|
|
10
|
.10
|
|
07/26/07
|
|
|
|
10
|
.11
|
|
Deed of Trust, Assignment of Rents, Security Agreement and
Fixture Financing Statement, dated as of June 30, 2006
(filed against Park Manor), by and among Plaza Health Holdings
LLC as Grantor, Chicago Title Insurance Company as Trustee,
and General Electric Capital Corporation as Beneficiary
|
|
S-1
|
|
333-142897
|
|
|
10
|
.11
|
|
07/26/07
|
|
|
|
10
|
.12
|
|
Deed of Trust, Assignment of Rents, Security Agreement and
Fixture Financing Statement, dated as of June 30, 2006
(filed against Catalina Care and Rehabilitation Center), by and
among Rillito Holdings LLC as Grantor, Chicago
Title Insurance Company as Trustee, and General Electric
Capital Corporation as Beneficiary
|
|
S-1
|
|
333-142897
|
|
|
10
|
.12
|
|
07/26/07
|
|
|
|
10
|
.13
|
|
Deed of Trust, Assignment of Rents, Security Agreement and
Fixture Financing Statement, dated as of October 16, 2006
(filed against Park View Gardens at Montgomery), by and among
Mountainview Communitycare LLC as Grantor, Chicago
Title Insurance Company as Trustee, and General Electric
Capital Corporation as Beneficiary
|
|
S-1
|
|
333-142897
|
|
|
10
|
.13
|
|
07/26/07
|
|
|
|
10
|
.14
|
|
Deed of Trust, Assignment of Rents, Security Agreement and
Fixture Financing Statement, dated as of October 16, 2006
(filed against Sabino Canyon Rehabilitation and Care Center), by
and among Meadowbrook Health Associates LLC as Grantor, Chicago
Title Insurance Company as Trustee and General Electric
Capital Corporation as Beneficiary
|
|
S-1
|
|
333-142897
|
|
|
10
|
.14
|
|
07/26/07
|
|
|
116
(c) Exhibit
Index
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exhibit
|
|
Filing
|
|
Filed
|
Exhibit No.
|
|
Exhibit Description
|
|
Form
|
|
File No.
|
|
No.
|
|
Date
|
|
Herewith
|
|
|
10
|
.15
|
|
Form of Deed of Trust, Assignment of Rents, Security Agreement
and Fixture Financing Statement, dated as of December 29,
2006 (filed against Upland Care and Rehabilitation Center and
Camarillo Care Center), by and among Cedar Avenue Holdings LLC
and Granada Investments LLC as Grantors, Chicago
Title Insurance Company as Trustee and General Electric
Capital Corporation as Beneficiary and Schedule of Material
Differences therein
|
|
S-1
|
|
333-142897
|
|
|
10
|
.15
|
|
07/26/07
|
|
|
|
10
|
.16
|
|
Form of First Amendment to (Amended and Restated) Deed of Trust,
Assignment of Rents, Security Agreement and Fixture Financing
Statement, dated as of December 29, 2006 (filed against
Desert Terrace Nursing Center, Desert Sky Nursing Home, Highland
Manor Health and Rehabilitation Center, North Mountain Medical
and Rehabilitation Center, Catalina Care and Rehabilitation
Center, Park Manor, Park View Gardens at Montgomery, Sabino
Canyon Rehabilitation and Care Center), by and among Terrace
Holdings AZ LLC, Sky Holdings AZ LLC, Ensign Highland LLC,
Valley Health Holdings LLC, Rillito Holdings LLC, Plaza Health
Holdings LLC, Mountainview Communitycare LLC and Meadowbrook
Health Associates LLC as Grantors, Chicago Title Insurance
Company as Trustee, and General Electric Capital Corporation as
Beneficiary and Schedule of Material Differences therein
|
|
S-1
|
|
333-142897
|
|
|
10
|
.16
|
|
07/26/07
|
|
|
|
10
|
.17
|
|
Amended and Restated Loan and Security Agreement, dated as of
March 25, 2004, by and among The Ensign Group, Inc. and
certain of its subsidiaries as Borrower, and General Electric
Capital Corporation as Agent and Lender
|
|
S-1
|
|
333-142897
|
|
|
10
|
.19
|
|
05/14/07
|
|
|
|
10
|
.18
|
|
Amendment No. 1, dated as of December 3, 2004, to the
Amended and Restated Loan and Security Agreement, by and among
The Ensign Group, Inc. and certain of its subsidiaries as
Borrower, and General Electric Capital Corporation as Lender
|
|
S-1
|
|
333-142897
|
|
|
10
|
.20
|
|
05/14/07
|
|
|
|
10
|
.19
|
|
Second Amended and Restated Revolving Credit Note, dated as of
December 3, 2004, in the original principal amount of
$20,000,000, by The Ensign Group, Inc. and certain of its
subsidiaries in favor of General Electric Capital Corporation
|
|
S-1
|
|
333-142897
|
|
|
10
|
.19
|
|
07/26/07
|
|
|
117
(c) Exhibit
Index
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exhibit
|
|
Filing
|
|
Filed
|
Exhibit No.
|
|
Exhibit Description
|
|
Form
|
|
File No.
|
|
No.
|
|
Date
|
|
Herewith
|
|
|
10
|
.20
|
|
Amendment No. 2, dated as of March 25, 2007, to the
Amended and Restated Loan and Security Agreement, by and among
The Ensign Group, Inc. and certain of its subsidiaries as
Borrower, and General Electric Capital Corporation as Lender
|
|
S-1
|
|
333-142897
|
|
|
10
|
.22
|
|
05/14/07
|
|
|
|
10
|
.21
|
|
Amendment No. 3, dated as of June 22, 2007, to the
Amended and Restated Loan and Security Agreement, by and among
The Ensign Group, Inc. and certain of its subsidiaries as
Borrower and General Electric Capital Corporation as Lender
|
|
S-1
|
|
333-142897
|
|
|
10
|
.21
|
|
07/26/07
|
|
|
|
10
|
.22
|
|
Amendment No. 4, dated as of August 1, 2007, to the
Amended and Restated Loan and Security Agreement, by and among
The Ensign Group, Inc. and certain of its subsidiaries as
Borrowers and General Electric Capital Corporation as Lender
|
|
S-1
|
|
333-142897
|
|
|
10
|
.42
|
|
08/17/07
|
|
|
|
10
|
.23
|
|
Amendment No. 5, dated September 13, 2007, to the
Amended and Restated Loan and Security Agreement, by and among
The Ensign Group, Inc. and certain of its subsidiaries as
Borrowers and General Electric Capital Corporation as Lender
|
|
S-1
|
|
333-142897
|
|
|
10
|
.43
|
|
10/05/07
|
|
|
|
10
|
.24
|
|
Revolving Credit Note, dated as of September 13, 2007, in
the original principal amount of $5,000,000 by The Ensign Group,
Inc. and certain of its subsidiaries in favor of General
Electric Capital Corporation
|
|
S-1
|
|
333-142897
|
|
|
10
|
.44
|
|
10/05/07
|
|
|
|
10
|
.25
|
|
Commitment Letter, dated October 3, 2007, from General
Electric Capital Corporation to The Ensign Group, Inc., setting
forth the general terms and conditions of the proposed amendment
to the revolving credit facility, which will increase the
available credit thereunder to $50.0 million
|
|
S-1
|
|
333-142897
|
|
|
10
|
.46
|
|
10/05/07
|
|
|
|
10
|
.26
|
|
Amendment No. 6, dated November 19, 2007, to the
Amended and Restated Loan and Security Agreement, by and among
The Ensign Group, Inc. and certain of its subsidiaries as
Borrowers and General Electric Capital Corporation as Lender
|
|
8-K
|
|
001-33757
|
|
|
10
|
.1
|
|
11/21/07
|
|
|
|
10
|
.27
|
|
Amendment No. 7, dated December 21, 2007, to the
Amended and Restated Loan and Security Agreement, by and among
The Ensign Group, Inc. and certain of its subsidiaries as
Borrowers and General Electric Capital Corporation as Lender
|
|
8-K
|
|
001-33757
|
|
|
10
|
.1
|
|
12/27/07
|
|
|
118
(c) Exhibit
Index
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exhibit
|
|
Filing
|
|
Filed
|
Exhibit No.
|
|
Exhibit Description
|
|
Form
|
|
File No.
|
|
No.
|
|
Date
|
|
Herewith
|
|
|
10
|
.28
|
|
Second Amended and Restated Loan and Security Agreement, dated
February 21, 2008, by and among The Ensign Group, Inc.,
certain of its subsidiaries as either Borrowers or Guarantors
and General Electric Capital Corporation as Lender
|
|
8-K
|
|
001-33757
|
|
|
10
|
.1
|
|
02/27/08
|
|
|
|
10
|
.29
|
|
Amended and Restated Revolving Credit Note, dated
February 21, 2008, by certain subsidiaries of The Ensign
Group, Inc. as Borrowers for the benefit of General Electric
Capital Corporation as Lender
|
|
8-K
|
|
001-33757
|
|
|
10
|
.2
|
|
02/27/08
|
|
|
|
10
|
.30
|
|
Ensign Guaranty, dated February 21, 2008, between The
Ensign Group, Inc. as Guarantor and General Electric Capital
Corporation as Lender
|
|
8-K
|
|
001-33757
|
|
|
10
|
.3
|
|
02/27/08
|
|
|
|
10
|
.31
|
|
Holding Company Guaranty, dated February 21, 2008, by and
among The Ensign Group, Inc. and certain of its subsidiaries as
Guarantors and General Electric Capital Corporation as Lender
|
|
8-K
|
|
001-33757
|
|
|
10
|
.4
|
|
02/27/08
|
|
|
|
10
|
.32
|
|
Pacific Care Center Loan Agreement, dated as of August 6,
1998, by and between G&L Hoquiam, LLC as Borrower and GMAC
Commercial Mortgage Corporation as Lender (later assumed by
Cherry Health Holdings, Inc. as Borrower and Wells Fargo Bank,
N.A. as Lender)
|
|
S-1
|
|
333-142897
|
|
|
10
|
.23
|
|
05/14/07
|
|
|
|
10
|
.33
|
|
Deed of Trust and Security Agreement, dated as of August 6,
1998, by and among G&L Hoquiam, LLC as Grantor, Ticor
Title Insurance Company as Trustee and GMAC Commercial
Mortgage Corporation as Beneficiary
|
|
S-1
|
|
333-142897
|
|
|
10
|
.24
|
|
07/26/07
|
|
|
|
10
|
.34
|
|
Promissory Note, dated as of August 6, 1998, in the
original principal amount of $2,475,000, by G&L Hoquiam,
LLC in favor of GMAC Commercial Mortgage Corporation
|
|
S-1
|
|
333-142897
|
|
|
10
|
.25
|
|
07/26/07
|
|
|
|
10
|
.35
|
|
Loan Assumption Agreement, by and among G&L Hoquiam, LLC as
Prior Owner; G&L Realty Partnership, L.P. as Prior
Guarantor; Cherry Health Holdings, Inc. as Borrower; and Wells
Fargo Bank, N.A., the Trustee for GMAC Commercial Mortgage
Securities, Inc., as Lender
|
|
S-1
|
|
333-142897
|
|
|
10
|
.26
|
|
05/14/07
|
|
|
|
10
|
.36
|
|
Exceptions to Nonrecourse Guaranty, dated as of October 2006, by
The Ensign Group, Inc. as Guarantor and Wells Fargo Bank, N.A.
as Trustee for GMAC Commercial Mortgage Securities, Inc., under
which Guarantor guarantees full and prompt payment of all
amounts due and owing by Cherry Health Holdings, Inc. under the
Promissory Note
|
|
S-1
|
|
333-142897
|
|
|
10
|
.22
|
|
07/26/07
|
|
|
119
(c) Exhibit
Index
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exhibit
|
|
Filing
|
|
Filed
|
Exhibit No.
|
|
Exhibit Description
|
|
Form
|
|
File No.
|
|
No.
|
|
Date
|
|
Herewith
|
|
|
10
|
.37
|
|
Deed of Trust with Assignment of Rents, dated as of
January 30, 2001, by and among Ensign Southland LLC as
Trustor, Brian E. Callahan as Trustee and Continental Wingate
Associates, Inc. as Beneficiary
|
|
S-1
|
|
333-142897
|
|
|
10
|
.27
|
|
07/26/07
|
|
|
|
10
|
.38
|
|
Deed of Trust Note, dated as of January 30, 2001, in
the original principal amount of $7,455,100, by Ensign
Southland, LLC in favor of Continental Wingate Associates,
Inc.
|
|
S-1
|
|
333-142897
|
|
|
10
|
.28
|
|
05/14/07
|
|
|
|
10
|
.39
|
|
Security Agreement, dated as of January 30, 2001, by and
between Ensign Southland, LLC and Continental Wingate
Associates, Inc.
|
|
S-1
|
|
333-142897
|
|
|
10
|
.29
|
|
05/14/07
|
|
|
|
10
|
.40
|
|
Master Lease Agreement, dated July 3, 2003, between
Adipiscor LLC as Lessee and LTC Partners VI, L.P., Coronado
Corporation and Park Villa Corporation collectively as Lessor
|
|
S-1
|
|
333-142897
|
|
|
10
|
.30
|
|
05/14/07
|
|
|
|
10
|
.41
|
|
Lease Guaranty, dated July 3, 2003, between The Ensign
Group, Inc. as Guarantor and LTC Partners VI, L.P., Coronado
Corporation and Park Villa Corporation collectively as Lessor,
under which Guarantor guarantees the payment and performance of
Adipiscor LLCs obligations under the Master Lease Agreement
|
|
S-1
|
|
333-142897
|
|
|
10
|
.31
|
|
05/14/07
|
|
|
|
10
|
.42
|
|
Master Lease Agreement, dated September 30, 2003, between
Permunitum LLC as Lessee, Vista Woods Health Associates LLC,
City Heights Health Associates LLC, and Claremont Foothills
Health Associates LLC as Sublessees, and OHI Asset (CA), LLC as
Lessor
|
|
S-1
|
|
333-142897
|
|
|
10
|
.32
|
|
05/14/07
|
|
|
|
10
|
.43
|
|
Lease Guaranty, dated September 30, 2003, between The
Ensign Group, Inc. as Guarantor and OHI Asset (CA), LLC as
Lessor, under which Guarantor guarantees the payment and
performance of Permunitum LLCs obligations under the
Master Lease Agreement
|
|
S-1
|
|
333-142897
|
|
|
10
|
.33
|
|
05/14/07
|
|
|
|
10
|
.44
|
|
Lease Guaranty, dated September 30, 2003, between Vista
Woods Health Associates LLC, City Heights Health Associates LLC
and Claremont Foothills Health Associates LLC as Guarantors and
OHI Asset (CA), LLC as Lessor, under which Guarantors guarantee
the payment and performance of Permunitum LLCs obligations
under the Master Lease Agreement
|
|
S-1
|
|
333-142897
|
|
|
10
|
.34
|
|
05/14/07
|
|
|
|
10
|
.46
|
|
Master Lease Agreement, dated January 31, 2003, between
Moenium Holdings LLC as Lessee and Healthcare Property
Investors, Inc., d/b/a in the State of Arizona as HC Properties,
Inc., and Healthcare Investors III collectively as Lessor
|
|
S-1
|
|
333-142897
|
|
|
10
|
.35
|
|
05/14/07
|
|
|
120
(c) Exhibit
Index
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exhibit
|
|
Filing
|
|
Filed
|
Exhibit No.
|
|
Exhibit Description
|
|
Form
|
|
File No.
|
|
No.
|
|
Date
|
|
Herewith
|
|
|
10
|
.47
|
|
Lease Guaranty, between The Ensign Group, Inc. as Guarantor and
Healthcare Property Investors, Inc. as Owner, under which
Guarantor guarantees the payment and performance of Moenium
Holdings LLCs obligations under the Master Lease Agreement
|
|
S-1
|
|
333-142897
|
|
|
10
|
.36
|
|
05/14/07
|
|
|
|
10
|
.48
|
|
First Amendment to Master Lease Agreement, dated May 27,
2003, between Moenium Holdings LLC as Lessee and Healthcare
Property Investors, Inc., d/b/a in the State of Arizona as HC
Properties, Inc., and Healthcare Investors III collectively
as Lessor
|
|
S-1
|
|
333-142897
|
|
|
10
|
.37
|
|
05/14/07
|
|
|
|
10
|
.49
|
|
Second Amendment to Master Lease Agreement, dated
October 31. 2004, between Moenium Holdings LLC as Lessee
and Healthcare Property Investors, Inc., d/b/a in the State of
Arizona as HC Properties, Inc., and Healthcare
Investors III collectively as Lessor
|
|
S-1
|
|
333-142897
|
|
|
10
|
.38
|
|
05/14/07
|
|
|
|
10
|
.50
|
|
Lease Agreement, by and between Mission Ridge Associates LLC as
Landlord and Ensign Facility Services, Inc. as Tenant; and
Guaranty of Lease, dated August 2, 2003, by The Ensign
Group, Inc. as Guarantor in favor of Landlord, under which
Guarantor guarantees Tenants obligations under the Lease
Agreement
|
|
S-1
|
|
333-142897
|
|
|
10
|
.39
|
|
05/14/07
|
|
|
|
10
|
.51
|
|
First Amendment to Lease Agreement dated January 15, 2004,
by and between Mission Ridge Associates LLC as Landlord and
Ensign Facility Services, Inc. as Tenant
|
|
S-1
|
|
333-142897
|
|
|
10
|
.40
|
|
05/14/07
|
|
|
|
10
|
.52
|
|
Second Amendment to Lease Agreement dated December 13,
2007, by and between Mission Ridge Associates LLC as Landlord
and Ensign Facility Services, Inc. as Tenant; and Reaffirmation
of Guaranty of Lease, dated December 13, 2007, by The
Ensign Group, Inc. as Guarantor in favor of Landlord, under
which Guarantor reaffirms its guaranty of Tenants obligations
under the Lease Agreement
|
|
|
|
|
|
|
|
|
|
|
|
X
|
|
10
|
.53
|
|
Form of Independent Consulting and Centralized Services
Agreement between Ensign Facility Services, Inc. and certain of
its subsidiaries
|
|
S-1
|
|
333-142897
|
|
|
10
|
.41
|
|
05/14/07
|
|
|
|
10
|
.54
|
|
Agreement of Purchase and Sale and Joint Escrow Instructions,
dated August 31, 2007, as amended on September 6, 2007
|
|
S-1
|
|
333-142897
|
|
|
10
|
.45
|
|
10/05/07
|
|
|
|
10
|
.55
|
|
Form of Health Insurance Benefit Agreement pursuant to which
certain subsidiaries of The Ensign Group, Inc. participate in
the Medicare program
|
|
S-1
|
|
333-142897
|
|
|
10
|
.48
|
|
10/19/07
|
|
|
|
10
|
.56
|
|
Form of Medi-Cal Provider Agreement pursuant to which certain
subsidiaries of The Ensign Group, Inc. participate in the
California Medicaid program
|
|
S-1
|
|
333-142897
|
|
|
10
|
.49
|
|
10/19/07
|
|
|
121
(c) Exhibit
Index
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exhibit
|
|
Filing
|
|
Filed
|
Exhibit No.
|
|
Exhibit Description
|
|
Form
|
|
File No.
|
|
No.
|
|
Date
|
|
Herewith
|
|
|
10
|
.57
|
|
Form of Provider Participation Agreement pursuant to which
certain subsidiaries of The Ensign Group, Inc. participate in
the Arizona Medicaid program
|
|
S-1
|
|
333-142897
|
|
|
10
|
.50
|
|
10/19/07
|
|
|
|
10
|
.58
|
|
Form of Contract to Provide Nursing Facility Services under the
Texas Medical Assistance Program pursuant to which certain
subsidiaries of The Ensign Group, Inc. participate in the Texas
Medicaid program
|
|
S-1
|
|
333-142897
|
|
|
10
|
.51
|
|
10/19/07
|
|
|
|
10
|
.59
|
|
Form of Client Service Contract pursuant to which certain
subsidiaries of The Ensign Group, Inc. participate in the
Washington Medicaid program
|
|
S-1
|
|
333-142897
|
|
|
10
|
.52
|
|
10/19/07
|
|
|
|
10
|
.60
|
|
Form of Provider Agreement for Medicaid and UMAP pursuant to
which certain subsidiaries of The Ensign Group, Inc. participate
in the Utah Medicaid program
|
|
S-1
|
|
333-142897
|
|
|
10
|
.53
|
|
10/19/07
|
|
|
|
10
|
.61
|
|
Form of Medicaid Provider Agreement pursuant to which a
subsidiary of The Ensign Group, Inc. participates in the Idaho
Medicaid program
|
|
S-1
|
|
333-142897
|
|
|
10
|
.54
|
|
10/19/07
|
|
|
|
21
|
.1
|
|
Subsidiaries of The Ensign Group, Inc., as amended
|
|
S-1
|
|
333-142897
|
|
|
21
|
.1
|
|
10/05/07
|
|
|
|
23
|
.1
|
|
Consent of Deloitte & Touche LLP
|
|
|
|
|
|
|
|
|
|
|
|
X
|
|
31
|
.1
|
|
Certification of Chief Executive Officer pursuant to
Section 302 of the Sarbanes-Oxley Act of 2002
|
|
|
|
|
|
|
|
|
|
|
|
X
|
|
31
|
.2
|
|
Certification of Chief Financial Officer pursuant to
Section 302 of the Sarbanes-Oxley Act of 2002
|
|
|
|
|
|
|
|
|
|
|
|
X
|
|
32
|
.1
|
|
Certification of Chief Executive Officer pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002
|
|
|
|
|
|
|
|
|
|
|
|
X
|
|
32
|
.2
|
|
Certification of Chief Financial Officer pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002
|
|
|
|
|
|
|
|
|
|
|
|
X
|
|
|
|
+ |
|
Indicates management contract or compensatory plan. |
122